JA

Profile

Research

Social

Other

Kaneda Yasufumi

金田　安史

Osaka University, Executive Vice President

keyword Human Genetics，Molecular Biology

Education

  • 1980/04 - 1984/03, Osaka University, Graduate School, Division of Medicine
  • - 1984, Osaka University
  • 1974/04 - 1980/03, Osaka University, Faculty of Medicine
  • - 1980, Osaka University, Faculty of Medicine

Research History

  • 2019/04 - Present, Osaka University, Vice President
  • 2019/04 - Present, Osaka University
  • 2019/02 - Present, 大阪大学 共創機構副機構長、産学共創本部長
  • 1999/04 - Present, Osaka University, Graduate School of Medicine, Full Professor
  • 2017/04 - 2019/03, Osaka University, Graduate School of Medicine, Dean
  • 2013/04 - 2015/03, Osaka University, Graduate School of Medicine, Dean
  • 1998/07 - 1999/03, Osaka University, Faculty of Medicine, Full Professor
  • 1992 - 1998, : : Associate Professor,Inst. for Mol. Cell.
  • 1984 - 1992, : : Assistant Professor, Inst. for Mol. Cell.
  • - , medicine, Osaka Univ.
  • - , Medicine.
  • - , Biol., Osaka Univ.

Research Areas

  • Life sciences, Tumor diagnostics and therapeutics
  • Life sciences, Genomics
  • Life sciences, Pathobiochemistry

Professional Memberships

  • 日本遺伝子診療学会
  • 日本遺伝子治療学会
  • アメリカ遺伝子治療学会
  • 生化学会
  • 分子生物学会
  • 癌学会

Papers

  • Gene-Modified Blister Fluid-Derived Mesenchymal Stromal Cells for Treating Recessive Dystrophic Epidermolysis Bullosa., Yasushi Kikuchi,Tomoki Tamakoshi,Ryuichi Ishida,Ryosuke Kobayashi,Shiho Mori,Akemi Ishida-Yamamoto,Manabu Fujimoto,Yasufumi Kaneda,Katsuto Tamai, The Journal of investigative dermatology, 2023/06/10
  • Add-On Effect of Hemagglutinating Virus of Japan Envelope Combined with Chemotherapy or Immune Checkpoint Inhibitor against Malignant Pleural Mesothelioma: An In Vivo Study., Kazuma Sakura,Masao Sasai,Soichiro Funaki,Yasushi Shintani,Meinoshin Okumura,Yasufumi Kaneda, Cancers, Vol. 15, No. 3, 2023/02/01
  • DNA barcoding and gene expression recording reveal the presence of cancer cells with unique properties during tumor progression., Yuka Umeki,Noriaki Ogawa,Yuko Uegaki,Kotaro Saga,Yasufumi Kaneda,Keisuke Nimura, Cellular and molecular life sciences : CMLS, Vol. 80, No. 1, p. 17-17, 2022/12/23
  • Novel pathophysiological roles of α‐synuclein in age‐related vascular endothelial dysfunction, Yoichi Takami,Cheng Wang,Hironori Nakagami,Koichi Yamamoto,Yoichi Nozato,Yuki Imaizumi,Motonori Nagasawa,Hikari Takeshita,Tsuneo Nakajima,Shuko Takeda,Yasushi Takeya,Yasufumi Kaneda,Hiromi Rakugi, The FASEB Journal, Wiley, Vol. 36, No. 10, 2022/10
  • 前立腺癌におけるアンドロゲン受容体研究の最前線 前立腺癌におけるAndrogen receptor splicing variant 7(AR-V7)の発現機構の解明 新たな治療方法を目指して, 川村 憲彦,二村 圭祐,石井 信,吉村 明洋,山本 致之,永原 啓,中井 康友,中山 雅志,金田 安史,野々村 祝夫,西村 和郎, 泌尿器外科, 医学図書出版(株), Vol. 35, No. 8, p. 885-887, 2022/08
  • A phase I dose-escalation, safety/tolerability, and preliminary efficacy study of the intratumoral administration of GEN0101 in patients with advanced melanoma, Eiji Kiyohara,Atsushi Tanemura,Kazuma Sakura,Toshihiro Nakajima,Akira Myoui,Naoya Yamazaki,Yoshio Kiyohara,Ichiro Katayama,Manabu Fujimoto,Yasufumi Kaneda, Cancer Immunology, Immunotherapy, Springer Science and Business Media LLC, Vol. 71, No. 8, p. 2041-2049, 2022/08
  • Identification of Malignant Cell Populations Associated with Poor Prognosis in High-Grade Serous Ovarian Cancer Using Single-Cell RNA Sequencing., Naoki Sumitani,Kyoso Ishida,Kenjiro Sawada,Tadashi Kimura,Yasufumi Kaneda,Keisuke Nimura, Cancers, Vol. 14, No. 15, 2022/07/22
  • Dual function of SF3B2 on chromatin and RNA to regulate transcription in head and neck squamous cell carcinoma., Koji Kitamura,Hidefumi Suzuki,Ryota Abe,Hidenori Inohara,Yasufumi Kaneda,Hidehisa Takahashi,Keisuke Nimura, Cell & bioscience, Vol. 12, No. 1, p. 92-92, 2022/06/17
  • Longitudinal Single-Cell Transcriptomics Reveals a Role for Serpina3n-Mediated Resolution of Inflammation in a Mouse Colitis Model., Yen-Ting Ho,Takashi Shimbo,Edward Wijaya,Tomomi Kitayama,Satoshi Takaki,Kentaro Ikegami,Kazuya Miyashita,Yuya Ouchi,Eiichi Takaki,Ryoma Yamamoto,Yasufumi Kaneda,Katsuto Tamai, Cellular and molecular gastroenterology and hepatology, Vol. 12, No. 2, p. 547-566, 2021/04/13
  • CXCL2 combined with HVJ-E suppresses tumor growth and lung metastasis in breast cancer and enhances anti-PD-1 antibody therapy, Yi Chun Pan,Tomoyuki Nishikawa,Chin Yang Chang,Jiayu A. Tai,Yasufumi Kaneda, Molecular Therapy - Oncolytics, Elsevier BV, Vol. 20, p. 175-186, 2021/03
  • Hemagglutinating virus of Japan‐envelope containing programmed cell death‐ligand 1 siRNA inhibits immunosuppressive activities and elicits antitumor immune responses in glioma, Narushi Sugii,Masahide Matsuda,Genki Okumura,Akira Shibuya,Eiichi Ishikawa,Yasufumi Kaneda,Akira Matsumura, Cancer Science, Wiley, Vol. 112, No. 1, p. 81-90, 2021/01
  • CRISPRスクリーニングによる前立腺癌におけるPARPの合成致死遺伝子の網羅的探索, 石津谷 祐,植村 元秀,松下 慎,中野 剛佑,林 裕次郎,加藤 大悟,波多野 浩士,河嶋 厚成,氏家 剛,藤田 和利,二村 圭佑,金田 安史,野々村 祝夫, 日本泌尿器科学会総会, (一社)日本泌尿器科学会総会事務局, Vol. 108回, p. 861-861, 2020/12
  • CRISPRスクリーニングによる前立腺癌におけるPARPの合成致死遺伝子の網羅的探索, 石津谷 祐,植村 元秀,松下 慎,中野 剛佑,林 裕次郎,加藤 大悟,波多野 浩士,河嶋 厚成,氏家 剛,藤田 和利,二村 圭佑,金田 安史,野々村 祝夫, 日本泌尿器科学会総会, (一社)日本泌尿器科学会総会事務局, Vol. 108回, p. 861-861, 2020/12
  • Evaluation of HPV16 E7 expression in head and neck carcinoma cell lines and clinical specimens, Koji Kitamura,Keisuke Nimura,Rie Ito,Kotaro Saga,Hidenori Inohara,Yasufumi Kaneda, Scientific Reports, Springer Science and Business Media LLC, Vol. 10, No. 1, 2020/12
  • A simple method using CRISPR-Cas9 to knock-out genes in murine cancerous cell lines, Airi Ishibashi,Kotaro Saga,Yuuta Hisatomi,Yue Li,Yasufumi Kaneda,Keisuke Nimura, Scientific Reports, Springer Science and Business Media LLC, Vol. 10, No. 1, 2020/12
  • Correction to: Efficient photodynamic therapy against drug-resistant prostate cancer using replication-deficient virus particles and talaporfin sodium., Sharmin Akter,Sachiko Saito,Mizuho Inai,Norihiro Honda,Hisanao Hazama,Tomoyuki Nishikawa,Yasufumi Kaneda,Kunio Awazu, Lasers in medical science, 2020/07/13
  • Efficient photodynamic therapy against drug-resistant prostate cancer using replication-deficient virus particles and talaporfin sodium., Sharmin Akter,Sachiko Saito,Mizuho Inai,Norihiro Honda,Hisanao Hazama,Tomoyuki Nishikawa,Yasufumi Kaneda,Kunio Awazu, Lasers in medical science, 2020/06/27
  • Cancer immunotherapy using the Fusion gene of Sendai virus., Jiayu A Tai,Chin Yang Chang,Tomoyuki Nishikawa,Yasufumi Kaneda, Cancer gene therapy, Vol. 27, No. 6, p. 498-508, 2020/06
  • Design and Synthesis of 1,2-Deoxy-pyranose Derivatives of Spliceostatin A toward Prostate Cancer Treatment, Yusuke Yoshikawa,Airi Ishibashi,Tsunayoshi Takehara,Takeyuki Suzuki,Kenichi Murai,Yasufumi Kaneda,Keisuke Nimura,Mitsuhiro Arisawa, ACS MEDICINAL CHEMISTRY LETTERS, AMER CHEMICAL SOC, Vol. 11, No. 6, p. 1310-1315, 2020/06
  • Intratumoral injection of hemagglutinating virus of Japan-envelope vector yielded an antitumor effect for advanced melanoma: a phase I/IIa clinical study, Eiji Kiyohara,Atsushi Tanemura,Megumi Nishioka,Mizuho Yamada,Aya Tanaka,Akinori Yokomi,Atsuhiro Saito,Kazuma Sakura,Toshihiro Nakajima,Akira Myoui,Toshiharu Sakurai,Yutaka Kawakami,Yasufumi Kaneda,Ichiro Katayama, Cancer Immunology, Immunotherapy, Springer Science and Business Media LLC, Vol. 69, No. 6, p. 1131-1140, 2020/06
  • Intratumoral and subcutaneous injection of HVJ-E (GEN0101) in metastatic castration-resistant prostate cancer., Kazutoshi Fujita,Taigo Kato,Koji Hatano,Atsunari Kawashima,Takeshi Ujike,Motohide Uemura,Ryoichi Imamura,Koji Okihara,Osamu Ukimura,Tsuneharu Miki,Toshihiro Nakajima,Yasufumi Kaneda,Norio Nonomura, Cancer science, Vol. 111, No. 5, p. 1692-1698, 2020/02/29
  • Enhancement of ionization efficiency using zeolite in matrix-assisted laser desorption/ionization mass spectrometry of multiple drugs in cancer cells (Mass spectrometry of multiple drugs in cells using zeolite), Hiroki Kannen,Shusei Nomura,Hisanao Hazama,Yasufumi Kaneda,Tatsuya Fujino,Kunio Awazu, Mass Spectrometry, Vol. 9, No. 1, p. 1-6, 2020
  • Photodynamic therapy by lysosomal-targeted drug delivery using talaporfin sodium incorporated into inactivated virus particles., Sharmin Akter,Mizuho Inai,Sachiko Saito,Norihiro Honda,Hisanao Hazama,Tomoyuki Nishikawa,Yasufumi Kaneda,Kunio Awazu, Laser therapy, Vol. 28, No. 4, p. 245-256, 2019/12/31
  • Design and synthesis of a phenyl C-glycoside derivative of Spliceostatin A and its biological evaluation toward prostate cancer treatment, Yusuke Yoshikawa,Airi Ishibashi,Kenichi Murai,Yasufumi Kaneda,Keisuke Nimura,Mitsuhiro Arisawa, Tetrahedron Letters, Vol. 60, No. 51, 2019/12/19
  • Stable Immune Response Induced by Intradermal DNA Vaccination by a Novel Needleless Pyro-Drive Jet Injector., Chinyang Chang,Jiao Sun,Hiroki Hayashi,Ayano Suzuki,Yuko Sakaguchi,Hiroshi Miyazaki,Tomoyuki Nishikawa,Hironori Nakagami,Kunihiko Yamashita,Yasufumi Kaneda, AAPS PharmSciTech, Vol. 21, No. 1, p. 19-19, 2019/12/09
  • SF3B2-mediated RNA splicing drives human prostate cancer progression, Norihiko Kawamura,Keisuke Nimura,Kotaro Saga,Airi Ishibashi,Koji Kitamura,Hiromichi Nagano,Yusuke Yoshikawa,Kyoso Ishida,Norio Nonomura,Mitsuhiro Arisawa,Jun Luo,Yasufumi Kaneda, Cancer Research, Vol. 79, No. 20, p. 5204-5217, 2019/10/15
  • 去勢抵抗性前立腺癌に対するGEN0101の安全性及び抗腫瘍効果 第I相医師主導臨床試験, 藤田 和利,波多野 浩士,加藤 大悟,河嶋 厚成,氏家 剛,植村 元秀,沖原 宏治,浮村 理,三木 恒治,金田 安史,野々村 祝夫, 日本癌治療学会学術集会抄録集, (一社)日本癌治療学会, Vol. 57回, p. O33-2, 2019/10
  • NANOG helps cancer cells escape NK cell attack by downregulating ICAM1 during tumorigenesis., Saga K,Park J,Nimura K,Kawamura N,Ishibashi A,Nonomura N,Kaneda Y, Journal of experimental & clinical cancer research : CR, Vol. 38, No. 1, 2019/10
  • 卵巣癌患者を対象とした患者由来不活化卵巣癌細胞と樹状細胞の融合細胞を用いたがんワクチン療法オープンラベル試験(An open-label trial of cancer vaccination by fusion cells from patient-derived ovarian cancer cells and dendritic cells), 石田 享相,西川 智之,清水 亜麻,澤田 健二郎,木村 正,金田 安史, 日本癌学会総会記事, 日本癌学会, Vol. 78回, p. P-1299, 2019/09
  • Cut-C: cleavage under tethered nuclease for conformational capture., Takashi Shimbo,Machika Kawamura,Edward Wijaya,Eiichi Takaki,Yasufumi Kaneda,Katsuto Tamai, BMC genomics, Vol. 20, No. 1, p. 614-614, 2019/07/29
  • Transcriptionally distinct mesenchymal stem/stromal cells circulate in fetus., Aiko Okada,Takashi Shimbo,Masayuki Endo,Sayuri Iwai,Tomomi Kitayama,Yuya Ouchi,Ryoma Yamamoto,Eiichi Takaki,Sho Yamazaki,Mami Nishida,Xin Wang,Yasushi Kikuchi,Takuji Tomimatsu,Yasufumi Kaneda,Tadashi Kimura,Katsuto Tamai, Biochemical and biophysical research communications, Vol. 512, No. 2, p. 326-330, 2019/04/30
  • Transcriptionally distinct mesenchymal stem/stromal cells circulate in fetus., Aiko Okada,Takashi Shimbo,Masayuki Endo,Sayuri Iwai,Tomomi Kitayama,Yuya Ouchi,Ryoma Yamamoto,Eiichi Takaki,Sho Yamazaki,Mami Nishida,Xin Wang,Yasushi Kikuchi,Takuji Tomimatsu,Yasufumi Kaneda,Tadashi Kimura,Katsuto Tamai, Biochemical and biophysical research communications, Vol. 512, No. 2, p. 326-330, 2019/04/30
  • Chromatin accessibility identifies diversity in mesenchymal stem cells from different tissue origins., Ho YT,Shimbo T,Wijaya E,Ouchi Y,Takaki E,Yamamoto R,Kikuchi Y,Kaneda Y,Tamai K, 2018/12
  • RUNX1 positively regulates the ErbB2/HER2 signaling pathway through modulating SOS1 expression in gastric cancer cells, Yoshihide Mitsuda,Ken Morita,Gengo Kashiwazaki,Junichi Taniguchi,Toshikazu Bando,Moeka Obara,Masahiro Hirata,Tatsuki R. Kataoka,Manabu Muto,Yasufumi Kaneda,Tatsutoshi Nakahata,Pu Paul Liu,Souichi Adachi,Hiroshi Sugiyama,Yasuhiko Kamikubo, Scientific Reports, Nature Publishing Group, Vol. 8, No. 1, 2018/12/01
  • Highly Selective Photodynamic Therapy with a Short Drug-Light Interval Using a Cytotoxic Photosensitizer Porphyrus Envelope for Drug-Resistant Prostate Cancer Cells, Youngsoon Hong,Mizuho Inai,Norihiro Honda,Hisanao Hazama,Manjusha A. Joshi,Hiroyuki Nakamura,Tomoyuki Nishikawa,Yasufumi Kaneda,Kunio Awazu, International Journal of Clinical Medicine, 2018/01
  • A New Approach to Castration-Resistant Prostate Cancer Using Inactivated Virus, Kazutoshi Fujita,Yasufumi Kaneda,Norio Nonomura, Hormone Therapy and Castration Resistance of Prostate Cancer, Springer Singapore, 2018
  • Inactivated Sendai virus particle upregulates cancer cell expression of intercellular adhesion molecule-1 and enhances natural killer cell sensitivity on cancer cells, Simin Li,Tomoyuki Nishikawa,Yasufumi Kaneda, CANCER SCIENCE, WILEY, Vol. 108, No. 12, p. 2333-2341, 2017/12
  • Inactivated Sendai virus particle upregulates cancer cell expression of intercellular adhesion molecule-1 and enhances natural killer cell sensitivity on cancer cells, Simin Li,Tomoyuki Nishikawa,Yasufumi Kaneda, Cancer Science, Blackwell Publishing Ltd, Vol. 108, No. 12, p. 2333-2341, 2017/12/01
  • Photodynamic therapy using a cytotoxic photosensitizer porphyrus envelope that targets the cell membrane, Mizuho Inai,Norihiro Honda,Hisanao Hazama,Sharmin Akter,Shinichiro Fuse,Hiroyuki Nakamura,Tomoyuki Nishikawa,Yasufumi Kaneda,Kunio Awazu, PHOTODIAGNOSIS AND PHOTODYNAMIC THERAPY, ELSEVIER SCIENCE BV, Vol. 20, p. 238-245, 2017/12
  • Physician-initiated first-in-human clinical study using a novel angiogenic peptide, AG30/5C, for patients with severe limb ulcers, Hironori Nakagami,Toshifumi Yamaoka,Misa Hayashi,Atsushi Tanemura,Yasushi Takeya,Hitomi Kurinami,Ken Sugimoto,Ayumi Nakamura,Kazunori Tomono,Katsuto Tamai,Ichiro Katayama,Hiromi Rakugi,Yasufumi Kaneda, GERIATRICS & GERONTOLOGY INTERNATIONAL, WILEY, Vol. 17, No. 11, p. 2150-2156, 2017/11
  • Evaluation of therapeutic efficacy induced by a novel photosensitizer: talaporfin sodium-incorporated viral particle, Sharmin Akter,Sachiko Saito,Mizuho Inai,Norihiro Honda,Hisanao Hazama,Yoshiharu Okamoto,Yasufumi Kaneda,Kunio Awazu, 2017/08
  • Phase I/II clinical trial to assess safety and efficacy of intratumoral and subcutaneous injection of HVJ-E in castration-resistant prostate cancer patients, K. Fujita,Y. Nakai,A. Kawashima,T. Ujike,A. Nagahara,T. Nakajima,T. Inoue,C. M. Lee,M. Uemura,Y. Miyagawa,Y. Kaneda,N. Nonomura, Cancer Gene Therapy, Nature Publishing Group, Vol. 24, No. 7, p. 277-281, 2017/07/01
  • タラポルフィンナトリウム封入不活性化センダイウイルスを用いたPDTのin vivo坑腫瘍効果, 稲井瑞穂,斎藤祥子,本多典広,大崎 智弘,間久直,岡本芳晴,金田安史,粟津邦男, 2017/07
  • 複製能欠損ウイルス粒子とプロトポルフィリンIX脂質を用いたPDTにおける腫瘍選択性向上のための治療条件の検討, 洪 暎淳,稲井 瑞穂,本多 典広,間 久直,布施 新一郎,中村 浩之,金田 安史,粟津 邦男, 2017/07
  • Genetic regulation of the RUNX transcription factor family has antitumor effects, Ken Morita,Kensho Suzuki,Shintaro Maeda,Akihiko Matsuo,Yoshihide Mitsuda,Chieko Tokushige,Gengo Kashiwazaki,Junichi Taniguchi,Rina Maeda,Mina Noura,Masahiro Hirata,Tatsuki Kataoka,Ayaka Yano,Yoshimi Yamada,Hiroki Kiyose,Mayu Tokumasu,Hidemasa Matsuo,Sunao Tanaka,Yasushi Okuno,Manabu Muto,Kazuhito Naka,Kosei Ito,Toshio Kitamura,Yasufumi Kaneda,Paul P. Liu,Toshikazu Bando,Souichi Adachi,Hiroshi Sugiyama,Yasuhiko Kamikubo, JOURNAL OF CLINICAL INVESTIGATION, AMER SOC CLINICAL INVESTIGATION INC, Vol. 127, No. 7, p. 2815-2828, 2017/06
  • Wolf-Hirschhorn Syndrome Candidate 1 Is Necessary for Correct Hematopoietic and B Cell Development, Elena Campos-Sanchez,Nerea Deleyto-Seldas,Veronica Dominguez,Enrique Carrillo-de-Santa-Pau,Kiyoe Ura,Pedro P. Rocha,JungHyun Kim,Arafat Aljoufi,Anna Esteve-Codina,Marc Dabad,Marta Gut,Holger Heyn,Yasufumi Kaneda,Keisuke Nimura,Jane A. Skok,Maria Luisa Martinez-Frias,Cesar Cobaleda, CELL REPORTS, CELL PRESS, Vol. 19, No. 8, p. 1586-1601, 2017/05
  • Phase I/II clinical trial to assess safety and efficacy of intratumoral and subcutaneous injection of HVJ-E to castration resistant prostate cancer patients., Fujita, K,Nakai, Y,Kawashima, A,Ujike, T,Nagahara, A,Uemura, M,Miyagawa Y,Lee, C-M,Inoue, T,Kaneda, Y,Nonomura, I, Cancer Gene Ther., 2017/05
  • Physician-initiated First-in-human Clinical Study using a Novel Angiogenic Peptide, AG30/5C, for Patients with Severe Limb Ulcers., Nakagami, H,Yamaoka, T,Hayashi, M,Tanemura, A,Takeya Y,Kurinami, H,Sugimoto, K,Nakamura, A,Tomono, K,Tamai, K,Katayama, I,Rakugi, H,Kaneda, Y, Geriatrics & Gerontology International, 2017/05
  • Salmonella mediated the hemagglutinating virus of Japan-envelope transfer suppresses tumor growth, Che-Hsin Lee,Tomoyuki Nishikawa,Yasufumi Kaneda, ONCOTARGET, IMPACT JOURNALS LLC, Vol. 8, No. 21, p. 35048-35060, 2017/05
  • Wolf-Hirschhorn Syndrome Candidate 1 Is Necessary for Correct Hematopoietic and B Cell Development, Elena Campos-Sanchez,Nerea Deleyto-Seldas,Veronica Dominguez,Enrique Carrillo-de-Santa-Pau,Kiyoe Ura,Pedro P. Rocha,JungHyun Kim,Arafat Aljoufi,Anna Esteve-Codina,Marc Dabad,Marta Gut,Holger Heyn,Yasufumi Kaneda,Keisuke Nimura,Jane A. Skok,Maria Luisa Martinez-Frias,Cesar Cobaleda, CELL REPORTS, CELL PRESS, Vol. 19, No. 8, p. 1586-1601, 2017/05
  • Glypican-1 targeted antibody-based therapy induces preclinical antitumor activity against esophageal squamous cell carcinoma, Emi Harada,Satoshi Serada,Minoru Fujimoto,Yusuke Takahashi,Tsuyoshi Takahashi,Hisashi Hara,Rie Nakatsuka,Takahito Sugase,Takahiko Nishigaki,Yurina Saito,Kosuke Hiramatsu,Satoshi Nojima,Risa Mitsuo,Tomoharu Ohkawara,Eiichi Morii,Masaki Mori,Yuichiro Doki,Yasufumi Kaneda,Tetsuji Naka, ONCOTARGET, IMPACT JOURNALS LLC, Vol. 8, No. 15, p. 24741-24752, 2017/04
  • Glypican-1 targeted antibody-based therapy induces preclinical antitumor activity against esophageal squamous cell carcinoma, Emi Harada,Satoshi Serada,Minoru Fujimoto,Yusuke Takahashi,Tsuyoshi Takahashi,Hisashi Hara,Rie Nakatsuka,Takahito Sugase,Takahiko Nishigaki,Yurina Saito,Kosuke Hiramatsu,Satoshi Nojima,Risa Mitsuo,Tomoharu Ohkawara,Eiichi Morii,Masaki Mori,Yuichiro Doki,Yasufumi Kaneda,Tetsuji Naka, ONCOTARGET, IMPACT JOURNALS LLC, Vol. 8, No. 15, p. 24741-24752, 2017/04
  • Development of a photosensitizing drug using replication-deficient virus particles and talaporfin sodium for photodynamic therapy of prostate cancer, Sachiko Saito,Mizuho Inai,Norihiro Honda,Hisanao Hazama,Yasufumi Kaneda,Kunio Awazu, 2017/03
  • Development and application of DDS to activate anti-tumor immunity, Yasufumi Kaneda, Drug Delivery System, Japan Society of Drug Delivery System, Vol. 32, No. 3, p. 208-217, 2017
  • 複製能欠損ウイルス粒子をキャリアとした新規光感受性物質による光線力学治療の作用機序の検討, 古山祐,稲井瑞穂,本多典広,間久直,布施新一郎,中村浩之,金田安史,粟津邦男, 2017/01
  • ホルモン拮抗ヒト前立腺癌細胞株PC-3における新規光感受性物質porphyrus envelope細胞内局在の検討, 稲井瑞穂,本多典広,間久直,中村浩之,保田英洋,西川智之,金田安史,粟津邦男, 日本レーザー医学会誌, 2017/01
  • Salmonella mediated the hemagglutinating virus of Japan-envelope transfer suppresses tumor growth, Che-Hsin Lee,Tomoyuki Nishikawa,Yasufumi Kaneda, Oncotarget, Impact Journals LLC, Vol. 8, No. 21, p. 35048-35060, 2017
  • Receptor for Advanced Glycation End Products-Mediated Signaling Impairs the Maintenance of Bone Marrow Mesenchymal Stromal Cells in Diabetic Model Mice, Eriko Aikawa,Ryo Fujita,Maiko Asai,Yasufumi Kaneda,Katsuto Tamai, STEM CELLS AND DEVELOPMENT, MARY ANN LIEBERT, INC, Vol. 25, No. 22, p. 1721-1732, 2016/11
  • USAGE OF REPRICATION-DEFICIENT VIRAL PARTICLE FOR PHOTODYNAMIC THERAPY AGAINST PROSTATE CANCER ALLOWS HIGH CYTOTOXICITY THROUGH DIFFERENT PATHWAYS, Norihiro Honda,Mizuho Inai,Tasuku Furuyama,Young Soon Hong,Hisanao Hazama,Hiroyuki Nakamura,Hidehiro Yasuda,Tomoyuki Nishikawa,Yasufumi Kaneda,Kunio Awazu, 2016/10
  • Induction of photosensitizer into replication-defective viral vector for fast drug delivery to anticancer drug resistant prostate cancer cells, Youngsoon Hong,Mizuho Ina,Tasuku Furuyama,Norihiro Honda,Hisanao Hazama,Shinichiro Fuse,Hiroyuki Nakamura,Yasufumi Kaneda,Kunio Awazu, 2016/09
  • Virus-stimulated neutrophils in the tumor microenvironment enhance T cell-mediated anti-tumor immunity, Chin Yang Chang,Jiayu A. Tai,Sumin Li,Tomoyuki Nishikawa,Yasufumi Kaneda, ONCOTARGET, IMPACT JOURNALS LLC, Vol. 7, No. 27, p. 42195-42207, 2016/07
  • Regulation of alternative polyadenylation by Nkx2-5 and Xrn2 during mouse heart development., Keisuke Nimura,Masamichi Yamamoto,Makiko Takeichi,Kotaro Saga,Katsuyoshi Takaoka,Norihiko Kawamura,Hirohisa Nitta,Hiromichi Nagano,Saki Ishino,Tatsuya Tanaka,Robert J Schwartz,Hiroyuki Aburatani,Yasufumi Kaneda, eLife, Vol. 5, 2016/06/22
  • 迅速な薬剤輸送に向けた複製能欠損センダイウイルス粒子への光感受性物質の封入条件の検討, 洪 暎淳,稲井 瑞穂,本多 典広,間 久直,布施 新一郎,中村 浩之,金田 安史,粟津 邦男, 2016/06
  • タラポルフィンナトリウムを封入した複製能欠損ウイルスを用いた効果的なPDTの検討, 斎藤 祥子,稲井 瑞穂,本多 典広,間 久直,金田 安史,粟津 邦男, 2016/06
  • 複製能欠損ウイルス粒子とプロトポルフィリンIX脂質を利用したPDT過程のタイムラプス撮影による作用機序の検討, 古山 祐,稲井 瑞穂,本多 典広,間 久直,布施 新一郎,中村 浩之,金田 安史,粟津 邦男, 2016/06
  • Cytoplasmic calcium increase via fusion with inactivated Sendai virus induces apoptosis in human multiple myeloma cells by downregulation of c-Myc oncogene, Yingzhe Jiang,Kotaro Saga,Yasuhide Miyamoto,Yasufumi Kaneda, ONCOTARGET, IMPACT JOURNALS LLC, Vol. 7, No. 24, p. 36034-36048, 2016/06
  • [Development of virosome-mediated cancer therapy]., Kaneda Y, Nihon yakurigaku zasshi. Folia pharmacologica Japonica, Vol. 147, No. 6, p. 330-333, 2016/06
  • Platelet-cytokine Complex Suppresses Tumour Growth by Exploiting Intratumoural Thrombin-dependent Platelet Aggregation, Yu-Tung Li,Tomoyuki Nishikawa,Yasufumi Kaneda, SCIENTIFIC REPORTS, NATURE PUBLISHING GROUP, Vol. 6, 2016/04
  • Effective photodynamic therapy in drug-resistant prostate cancer cells utilizing a non-viral antitumor vector (a secondary publication), Masaya Yamauchi,Norihiro Honda,Hisanao Hazama,Shoji Tachikawa,Hiroyuki Nakamura,Yasufumi Kaneda,Kunio Awazu, Laser Therapy, Japan Medical Laser Laboratory, Vol. 25, No. 1, p. 55-62, 2016/03/31
  • Elucidating the mechanisms of transcription regulation during heart development by next-generation sequencing, Keisuke Nimura,Yasufumi Kaneda, JOURNAL OF HUMAN GENETICS, NATURE PUBLISHING GROUP, Vol. 61, No. 1, p. 5-12, 2016/01
  • An RNA Molecule Derived From Sendai Virus DI Particles Induces Antitumor Immunity and Cancer Cell-selective Apoptosis, Li-Wen Liu,Tomoyuki Nishikawa,Yasufumi Kaneda, MOLECULAR THERAPY, NATURE PUBLISHING GROUP, Vol. 24, No. 1, p. 135-145, 2016/01
  • Localization-dependent cell-killing effects of protoporphyrin (PPIX)-lipid micelles and liposomes in photodynamic therapy, Shoji Tachikawa,Shinichi Sato,Hisanao Hazama,Yasufumi Kaneda,Kunio Awazu,Hiroyuki Nakamura, BIOORGANIC & MEDICINAL CHEMISTRY, PERGAMON-ELSEVIER SCIENCE LTD, Vol. 23, No. 24, p. 7578-7584, 2015/12
  • Cinnamtannin B-1 Promotes Migration of Mesenchymal Stem Cells and Accelerates Wound Healing in Mice, Kosuke Fujita,Katsunori Kuge,Noriyasu Ozawa,Shunya Sahara,Kaori Zaiki,Koichi Nakaoji,Kazuhiko Hamada,Yukiko Takenaka,Takao Tanahashi,Katsuto Tamai,Yasufumi Kaneda,Akito Maeda, PLOS ONE, PUBLIC LIBRARY SCIENCE, Vol. 10, No. 12, 2015/12
  • CRISPR/Cas9-mediated gene knockout of NANOG and NANOGP8 decreases the malignant potential of prostate cancer cells, Norihiko Kawamura,Keisuke Nimura,Hiromichi Nagano,Sohei Yamaguchi,Norio Nonomura,Yasufumi Kaneda, ONCOTARGET, IMPACT JOURNALS LLC, Vol. 6, No. 26, p. 22361-22374, 2015/09
  • ASGCT and JSGT Joint Position Statement on Human Genomic Editing, Theodore Friedmann,Erica C. Jonlin,Nancy M. P. King,Bruce E. Torbett,Nelson A. Wivel,Yasufumi Kaneda,Michel Sadelain, MOLECULAR THERAPY, NATURE PUBLISHING GROUP, Vol. 23, No. 8, p. 1282-1284, 2015/08
  • Elucidating the mechanisms of transcription regulation during heart development by next-generation sequencing., Nimura K,Kaneda Y, J. Human Genetics, 2015/07
  • Low alpha-synuclein levels in the blood are associated with insulin resistance, Gerardo Rodriguez-Araujo,Hironori Nakagami,Yoichi Takami,Tomohiro Katsuya,Hiroshi Akasaka,Shigeyuki Saitoh,Kazuaki Shimamoto,Ryuichi Morishita,Hiromi Rakugi,Yasufumi Kaneda, SCIENTIFIC REPORTS, NATURE PUBLISHING GROUP, Vol. 5, 2015/07
  • Low alpha-synuclein levels in the blood are associated with insulin resistance, Gerardo Rodriguez-Araujo,Hironori Nakagami,Yoichi Takami,Tomohiro Katsuya,Hiroshi Akasaka,Shigeyuki Saitoh,Kazuaki Shimamoto,Ryuichi Morishita,Hiromi Rakugi,Yasufumi Kaneda, SCIENTIFIC REPORTS, NATURE PUBLISHING GROUP, Vol. 5, 2015/07
  • CRISPR/Cas9-mediated gene knockout of NANOG1 and NANOGP8 leads to low malignant potential in prostate cancer., Kawamura, N,Nimura, K,Nagano, H,Yamaguchi, S,Nonomura, N,Kaneda. Y, Oncotarget, 2015/06
  • Systemic high-mobility group box 1 administration suppresses skin inflammation by inducing an accumulation of PDGFR alpha(+) mesenchymal cells from bone marrow, Eriko Aikawa,Ryo Fujita,Yasushi Kikuchi,Yasufumi Kaneda,Katsuto Tamai, SCIENTIFIC REPORTS, NATURE PUBLISHING GROUP, Vol. 5, 2015/06
  • Systemic high-mobility group box 1 administration suppresses skin inflammation by inducing an accumulation of PDGFR alpha(+) mesenchymal cells from bone marrow, Eriko Aikawa,Ryo Fujita,Yasushi Kikuchi,Yasufumi Kaneda,Katsuto Tamai, SCIENTIFIC REPORTS, NATURE PUBLISHING GROUP, Vol. 5, 2015/06
  • Effective Photodynamic Therapy to Drug-Resistant Prostate Cancer Cells Utilizing Non-Viral Antitumor Vector, Masaya Yamauchi,Norihiro Honda,Hisanao Hazama,Shoji Tachikawa,Hiroyuki Nakamura,Yasufumi Kaneda,Kunio Awazu, The Journal of Japan Society for Laser Surgery and Medicine, Vol. 36, No. 1, p. 18-24, 2015/04
  • Endogenous Mesenchymal Stromal Cells in Bone Marrow Are Required to Preserve Muscle Function in mdx Mice, Ryo Fujita,Katsuto Tamai,Eriko Aikawa,Keisuke Nimura,Saki Ishino,Yasushi Kikuchi,Yasufumi Kaneda, STEM CELLS, WILEY-BLACKWELL, Vol. 33, No. 3, p. 962-975, 2015/03
  • Endogenous Mesenchymal Stromal Cells in Bone Marrow Are Required to Preserve Muscle Function in mdx Mice, Ryo Fujita,Katsuto Tamai,Eriko Aikawa,Keisuke Nimura,Saki Ishino,Yasushi Kikuchi,Yasufumi Kaneda, STEM CELLS, WILEY-BLACKWELL, Vol. 33, No. 3, p. 962-975, 2015/03
  • Transplanted Bone Marrow-Derived Circulating PDGFR alpha(+) Cells Restore Type VII Collagen in Recessive Dystrophic Epidermolysis Bullosa Mouse Skin Graft, Shin Iinuma,Eriko Aikawa,Katsuto Tamai,Ryo Fujita,Yasushi Kikuchi,Takenao Chino,Junichi Kikuta,John A. McGrath,Jouni Uitto,Masaru Ishii,Hajime Iizuka,Yasufumi Kaneda, JOURNAL OF IMMUNOLOGY, AMER ASSOC IMMUNOLOGISTS, Vol. 194, No. 4, p. 1996-2003, 2015/02
  • Transplanted Bone Marrow-Derived Circulating PDGFR alpha(+) Cells Restore Type VII Collagen in Recessive Dystrophic Epidermolysis Bullosa Mouse Skin Graft, Shin Iinuma,Eriko Aikawa,Katsuto Tamai,Ryo Fujita,Yasushi Kikuchi,Takenao Chino,Junichi Kikuta,John A. McGrath,Jouni Uitto,Masaru Ishii,Hajime Iizuka,Yasufumi Kaneda, JOURNAL OF IMMUNOLOGY, AMER ASSOC IMMUNOLOGISTS, Vol. 194, No. 4, p. 1996-2003, 2015/02
  • Photodynamic therapy using hemagglutinating virus of Japan envelope (HVJ-E): a novel therapeutic approach for the treatment of hormone antagonistic prostate cancer, Mizuho Inai,Masaya Yamauchi,Norihiro Honda,Hisanao Hazama,Shoji Tachikawa,Hiroyuki Nakamura,Tomoki Nishida,Hidehiro Yasuda,Yasufumi Kaneda,Kunio Awazu, OPTICAL METHODS FOR TUMOR TREATMENT AND DETECTION: MECHANISMS AND TECHNIQUES IN PHOTODYNAMIC THERAPY XXIV, SPIE-INT SOC OPTICAL ENGINEERING, Vol. 9308, 2015
  • Oncolytic Sendai virus-based virotherapy for cancer: recent advances., Saga K,Kaneda Y, Oncolytic virotherapy, Vol. 4, p. 141-147, 2015
  • 筋ジストロフィーにおける内在性骨髄間葉系細胞の生理的意義, 藤田 諒,相川 恵梨子,玉井 克人,金田 安史, 体力科学, (一社)日本体力医学会, Vol. 63, No. 6, p. 555-555, 2014/12
  • Systemic Administration of Platelets Incorporating Inactivated Sendai Virus Eradicates Melanoma in Mice, Tomoyuki Nishikawa,Li Yu Tung,Yasufumi Kaneda, MOLECULAR THERAPY, CELL PRESS, Vol. 22, No. 12, p. 2046-2055, 2014/12
  • Systemic Administration of Platelets Incorporating Inactivated Sendai Virus Eradicates Melanoma in Mice, Tomoyuki Nishikawa,Li Yu Tung,Yasufumi Kaneda, MOLECULAR THERAPY, CELL PRESS, Vol. 22, No. 12, p. 2046-2055, 2014/12
  • Histone H3 Lysine 36 Methyltransferase Whsc1 Promotes the Association of Runx2 and p300 in the Activation of Bone-Related Genes, Yu Fei Lee,Keisuke Nimura,Wan Ning Lo,Kotaro Saga,Yasufumi Kaneda, PLOS ONE, PUBLIC LIBRARY SCIENCE, Vol. 9, No. 9, 2014/09
  • Development of Laser Ionization Techniques for Evaluation of the Effect of Cancer Drugs Using Imaging Mass Spectrometry, Hiroki Kannen,Hisanao Hazama,Yasufumi Kaneda,Tatsuya Fujino,Kunio Awazu, INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, MDPI AG, Vol. 15, No. 7, p. 11234-11244, 2014/07
  • 不活性センダイウイルス粒子HVJ-Eはcaspase-8欠損神経芽腫に対してnecroptosisを誘導する, 野村 元成,福澤 正洋,金田 安史, 日本小児外科学会雑誌, (一社)日本小児外科学会, Vol. 50, No. 3, p. 483-483, 2014/04
  • 神経芽腫におけるCaM kinase II活性化を介した新たな細胞死誘導機構の解明, 野村 元成,福澤 正洋,金田 安史, 日本外科学会雑誌, (一社)日本外科学会, Vol. 115, No. 臨増2, p. 776-776, 2014/03
  • A novel photodynamic therapy for drug-resistant prostate cancer cells using porphyrus envelope as a novel photosensitizer, Masaya Yamauchi,Norihiro Honda,Hisanao Hazama,Shoji Tachikawa,Hiroyuki Nakamura,Yasufumi Kaneda,Kunio Awazu, PHOTODIAGNOSIS AND PHOTODYNAMIC THERAPY, ELSEVIER SCIENCE BV, Vol. 11, No. 1, p. 48-54, 2014/03
  • Novel Anti-Microbial Peptide SR-0379 Accelerates Wound Healing via the PI3 Kinase/Akt/mTOR Pathway, Hideki Tomioka,Hironori Nakagami,Akiko Tenma,Yoshimi Saito,Toshihiro Kaga,Toshihide Kanamori,Nao Tamura,Kazunori Tomono,Yasufumi Kaneda,Ryuichi Morishita, PLOS ONE, PUBLIC LIBRARY SCIENCE, Vol. 9, No. 3, 2014/03
  • Mallotus philippinensis bark extracts promote preferential migration of mesenchymal stem cells and improve wound healing in mice, Tadashi Furumoto,Noriyasu Ozawa,Yuta Inami,Misaki Toyoshima,Kosuke Fujita,Kaori Zaiki,Shunya Sahara,Mariko Akita,Keiko Kitamura,Koichi Nakaoji,Kazuhiko Hamada,Katsuto Tamai,Yasufumi Kaneda,Akito Maeda, PHYTOMEDICINE, ELSEVIER GMBH, URBAN & FISCHER VERLAG, Vol. 21, No. 3, p. 247-253, 2014/02
  • Accumulation of Cytosolic Calcium Induces Necroptotic Cell Death in Human Neuroblastoma, Motonari Nomura,Ayumi Ueno,Kotaro Saga,Masahiro Fukuzawa,Yasufumi Kaneda, CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, Vol. 74, No. 4, p. 1056-1066, 2014/02
  • Development of LC-MS/MS quantification of the novel antimicrobial peptide, SR-0379, and its pharmacokinetics in rats, Hideki Tomioka,Hironori Nakagami,Tomokazu Sano,Kazuaki Takafuji,Seiji Takashima,Yasufumi Kaneda,Ryuichi Morishita, Immunology, Endocrine and Metabolic Agents in Medicinal Chemistry, Bentham Science Publishers B.V., Vol. 14, No. 1, p. 26-31, 2014
  • Virosome presents multimodel cancer therapy without viral replication., Saga K,Kaneda Y, Biomedical Research Int., 2013/12
  • トランスレーショナル研究と新規治療 皮膚と骨髄のクロストーク 間葉系幹細胞の体内移動メカニズム解明と治療への応用, 玉井 克人,菊池 康,相川 恵梨子,金田 安史,片山 一郎, 神経免疫学, 日本神経免疫学会, Vol. 18, No. 1, p. 56-56, 2013/11
  • 神経芽腫におけるCa2+/カルモデュリン依存性プロテインキナーゼII活性化を介した新たな細胞死誘導機構, 野村 元成,福澤 正洋,金田 安史, 日本小児血液・がん学会学術集会・日本小児がん看護学会・公益財団法人がんの子どもを守る会公開シンポジウムプログラム総会号, (NPO)日本小児血液・がん学会・(NPO)日本小児がん看護学会・(公財)がんの子供を守る会, Vol. 55回・11回・18回, p. 229-229, 2013/11
  • トランスレーショナル研究と新規治療 皮膚と骨髄のクロストーク 間葉系幹細胞の体内移動メカニズム解明と治療への応用, 玉井 克人,菊池 康,相川 恵梨子,金田 安史,片山 一郎, 日本臨床免疫学会会誌, 日本臨床免疫学会, Vol. 36, No. 5, p. 299-299, 2013/10
  • Anti-tumor effects of inactivated Sendai virus particles with an IL-2 gene on angiosarcoma, Yuki Takehara,Takahiro Satoh,Aya Nishizawa,Kazumi Saeki,Masataka Nakamura,Mikio Masuzawa,Yasufumi Kaneda,Ichiro Katayama,Hiroo Yokozeki, CLINICAL IMMUNOLOGY, ACADEMIC PRESS INC ELSEVIER SCIENCE, Vol. 149, No. 1, p. 1-10, 2013/10
  • Residual Prostate Cancer Cells after Docetaxel Therapy Increase the Tumorigenic Potential via Constitutive Signaling of CXCR4, ERK1/2 and c-Myc, Koji Hatano,Souhei Yamaguchi,Keisuke Nimura,Kouki Murakami,Akira Nagahara,Kazutoshi Fujita,Motohide Uemura,Yasutomo Nakai,Mutsumi Tsuchiya,Masashi Nakayama,Norio Nonomura,Yasufumi Kaneda, MOLECULAR CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, Vol. 11, No. 9, p. 1088-1100, 2013/09
  • 再生医療と新規材料 骨髄間葉系幹細胞の動員による組織再生の分子機構, 金田 安史,玉井 克人, 日本DDS学会学術集会プログラム予稿集, 日本DDS学会, Vol. 29回, p. 75-75, 2013/06
  • Occurrence of free deaminoneuraminic acid (KDN)-containing complex-type N-glycans in human prostate cancers, Masahiko Yabu,Hiroaki Korekane,Koji Hatano,Yasufumi Kaneda,Norio Nonomura,Chihiro Sato,Ken Kitajima,Yasuhide Miyamoto, GLYCOBIOLOGY, OXFORD UNIV PRESS INC, Vol. 23, No. 6, p. 634-642, 2013/06
  • 不活化センダイウイルス粒子HVJ-Eによる新たな神経芽腫細胞死誘導機構の解明, 野村 元成,金田 安史, 日本小児外科学会雑誌, (一社)日本小児外科学会, Vol. 49, No. 3, p. 689-689, 2013/05
  • The RIG-I/MAVS signaling pathway in cancer cell-selective apoptosis, Yasufumi Kaneda, OncoImmunology, Vol. 2, No. 4, 2013/04
  • 【臓器円環による生体恒常性のダイナミクス 神経・免疫・循環・内分泌系の連関による維持、ライフステージに応じた変容と破綻】(第1章)組織幹細胞における恒常性維持・変容・破綻 骨髄由来幹細胞による組織修復機構, 金田 安史,玉井 克人, 実験医学, (株)羊土社, Vol. 31, No. 5, p. 655-661, 2013/03
  • Future directions for gene therapy, Yasufumi Kaneda, Gene Therapy: Technologies and Applications, Future Medicine Ltd., 2013/03/01
  • Alpha-synuclein elicits glucose uptake and utilization in adipocytes through the Gab1/PI3K/Akt transduction pathway, Gerardo Rodriguez-Araujo,Hironori Nakagami,Hiroki Hayashi,Masaki Mori,Tetsuya Shiuchi,Yasuhiko Minokoshi,Yoshikazu Nakaoka,Yoichi Takami,Issei Komuro,Ryuichi Morishita,Yasufumi Kaneda, Cellular and Molecular Life Sciences, Vol. 70, No. 6, p. 1123-1133, 2013/03
  • 13-Cis retinoic acid can enhance the antitumor activity of non-replicating Sendai virus particle against neuroblastoma, Motonari Nomura,Takashi Shimbo,Yasuhide Miyamoto,Masahiro Fukuzawa,Yasufumi Kaneda, CANCER SCIENCE, WILEY-BLACKWELL, Vol. 104, No. 2, p. 238-244, 2013/02
  • Systemic Administration of a Novel Immune-Stimulatory Pseudovirion Suppresses Lung Metastatic Melanoma by Regionally Enhancing IFN-gamma Production, Kotaro Saga,Katsuto Tamai,Takehiko Yamazaki,Yasufumi Kaneda, CLINICAL CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, Vol. 19, No. 3, p. 668-679, 2013/02
  • The Transcription Factors Tbx18 and Wt1 Control the Epicardial Epithelial-Mesenchymal Transition through Bi-Directional Regulation of Slug in Murine Primary Epicardial Cells, Makiko Takeichi,Keisuke Nimura,Masaki Mori,Hironori Nakagami,Yasufumi Kaneda, PLOS ONE, PUBLIC LIBRARY SCIENCE, Vol. 8, No. 2, 2013/02
  • Lymphedema and Therapeutic Lymphangiogenesis, Yukihiro Saito,Hironori Nakagami,Yasufumi Kaneda,Ryuichi Morishita, BIOMED RESEARCH INTERNATIONAL, HINDAWI PUBLISHING CORPORATION, Vol. 2013, 2013
  • Virosome Presents Multimodel Cancer Therapy without Viral Replication, Kotaro Saga,Yasufumi Kaneda, BIOMED RESEARCH INTERNATIONAL, HINDAWI PUBLISHING CORPORATION, Vol. 2013, 2013
  • The study of novel DNA vaccines against tuberculosis: Induction of pathogen-specific CTL in the mouse and monkey models of tuberculosis., Okada M,Kita Y,Nakajima T,Hashimoto S,Nakatani H,Nishimatsu S,Nishida Y,Kanamaru N,Kaneda Y,Takamori Y,McMurray D,Tan EV,Cang ML,Saunderson P,Dela Cruz EC, Human vaccines & immunotherapeutics, 3, Vol. 9, 2012/12
  • 不活化センダイウイルス粒子HVJ-Eの神経芽腫に対する抗腫瘍効果は13cisレチノイン酸により増強される, 野村 元成,新保 敬史,宮本 泰豪,金田 安史,福澤 正洋, 日本小児血液・がん学会学術集会・日本小児がん看護学会・公益財団法人がんの子どもを守る会公開シンポジウムプログラム総会号, (NPO)日本小児血液・がん学会・(NPO)日本小児がん看護学会・(公財)がんの子供を守る会, Vol. 54回・10回・17回, p. 292-292, 2012/11
  • TRAIL and Noxa Are Selectively Upregulated in Prostate Cancer Cells Downstream of the RIG-I/MAVS Signaling Pathway by Nonreplicating Sendai Virus Particles, Taeko Matsushima-Miyagi,Koji Hatano,Motonari Nomura,Liu Li-Wen,Tomoyuki Nishikawa,Kotaro Saga,Takashi Shimbo,Yasufumi Kaneda, CLINICAL CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, Vol. 18, No. 22, p. 6271-6283, 2012/11
  • Long-Term Follow-Up Evaluation of Results From Clinical Trial Using Hepatocyte Growth Factor Gene to Treat Severe Peripheral Arterial Disease, Hirofumi Makino,Motokuni Aoki,Naotaka Hashiya,Keita Yamasaki,Junya Azuma,Yoshiki Sawa,Yasufumi Kaneda,Toshio Ogihara,Ryuichi Morishita, ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, LIPPINCOTT WILLIAMS & WILKINS, Vol. 32, No. 10, p. 2503-+, 2012/10
  • 損傷組織の放出するHMGB1は骨髄間葉系幹細胞を動員して損傷組織の再生を誘導する(Injured tissues release HMGB1 to recruit bone marrow mesenchymal stem cells for inducing regeneration of the injury), 玉井 克人,菊池 康,飯沼 晋,金田 安史, 日本癌学会総会記事, 日本癌学会, Vol. 71回, p. 292-292, 2012/08
  • 不活化センダイウイルス粒子(HVJ-E)は神経芽腫細胞株SK-N-SHに対してRIP1を介したネクロプトーシスを誘導する(Inactivated Sendai virus particle (HVJ-E) causes RIP1-mediated necroptosis in neuroblastoma cell line SK-N-SH), 野村 元成,新保 敬史,宮本 泰豪,福澤 正洋,金田 安史, 日本癌学会総会記事, 日本癌学会, Vol. 71回, p. 526-526, 2012/08
  • 【最新疾患モデルと病態解明、創薬応用研究、細胞医薬創製研究の最前線 最新疾患モデル動物、ヒト化マウス、モデル細胞、ES・iPS細胞を利用した病態解明から創薬まで】(第2章)各種病態モデルと創薬研究 皮膚・炎症性疾患 生体内骨髄間葉系幹/前駆細胞動員因子を利用した体内再生誘導医薬開発の展望, 玉井 克人,金田 安史, 遺伝子医学MOOK, (株)メディカルドゥ, No. 22, p. 207-212, 2012/07
  • The combination of chemotherapy with HVJ-E containing Rad51 siRNA elicited diverse anti-tumor effects and synergistically suppressed melanoma, E. Kiyohara,K. Tamai,I. Katayama,Y. Kaneda, GENE THERAPY, NATURE PUBLISHING GROUP, Vol. 19, No. 7, p. 734-741, 2012/07
  • Modification of a novel angiogenic peptide, AG30, for the development of novel therapeutic agents, Hironori Nakagami,Tomoyuki Nishikawa,Nao Tamura,Akito Maeda,Hajime Hibino,Masayoshi Mochizuki,Takashi Shimosato,Toshinori Moriya,Ryuichi Morishita,Katsuto Tamai,Kazunori Tomono,Yasufumi Kaneda, JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, WILEY-BLACKWELL, Vol. 16, No. 7, p. 1629-1639, 2012/07
  • In vitro investigation of efficient photodynamic therapy using a nonviral vector; hemagglutinating virus of Japan envelope, Makoto Sakai,Naohiro Fujimoto,Katsunori Ishii,Hiroyuki Nakamura,Yasufumi Kaneda,Kunio Awazu, JOURNAL OF BIOMEDICAL OPTICS, SPIE-SOC PHOTO-OPTICAL INSTRUMENTATION ENGINEERS, Vol. 17, No. 7, 2012/07
  • In vitro investigation of efficient photodynamic therapy using a nonviral vector; hemagglutinating virus of Japan envelope, Makoto Sakai,Naohiro Fujimoto,Katsunori Ishii,Hiroyuki Nakamura,Yasufumi Kaneda,Kunio Awazu, JOURNAL OF BIOMEDICAL OPTICS, SPIE-SOC PHOTO-OPTICAL INSTRUMENTATION ENGINEERS, Vol. 17, No. 7, 2012/07
  • In vitro investigation of efficient photodynamic therapy using a nonviral vector; hemagglutinating virus of Japan envelope, Makoto Sakai,Naohiro Fujimoto,Katsunori Ishii,Hiroyuki Nakamura,Yasufumi Kaneda,Kunio Awazu, JOURNAL OF BIOMEDICAL OPTICS, SPIE-SOC PHOTO-OPTICAL INSTRUMENTATION ENGINEERS, Vol. 17, No. 7, 2012/07
  • Virosome: A novel vector to enable multi-modal strategies for cancer therapy, Yasufumi Kaneda, ADVANCED DRUG DELIVERY REVIEWS, ELSEVIER SCIENCE BV, Vol. 64, No. 8, p. 730-738, 2012/06
  • HIG1, a novel regulator of mitochondrial gamma-secretase, maintains normal mitochondrial function, Hiroki Hayashi,Hironori Nakagami,Makiko Takeichi,Munehisa Shimamura,Nobutaka Koibuchi,Eiji Oiki,Naoyuki Sato,Hiroshi Koriyama,Masaki Mori,Rodriguez Gerardo Araujo,Akito Maeda,Ryuichi Morishita,Katsuto Tamai,Yasufumi Kaneda, FASEB JOURNAL, FEDERATION AMER SOC EXP BIOL, Vol. 26, No. 6, p. 2306-2317, 2012/06
  • Therapeutic strategies for controlling the metastasis and recurrence of cancers: contribution of drug delivery technologies Preface, Yasufumi Kaneda, ADVANCED DRUG DELIVERY REVIEWS, ELSEVIER SCIENCE BV, Vol. 64, No. 8, p. 707-709, 2012/06
  • 神経芽腫に対する不活化ウイルス粒子HVJ-Eの抗腫瘍効果の検討, 野村 元成,新保 敬史,宮本 泰豪,金田 安史,福澤 正洋, 日本小児外科学会雑誌, (一社)日本小児外科学会, Vol. 48, No. 3, p. 469-469, 2012/05
  • パーキンソン病関連分子αシヌクレインの老化関連疾患における新規機能 メタボリック症候群及び血管内皮機能への関与, 鷹見 洋一,大石 充,中神 啓徳,神出 計,山本 浩一,金田 安史,楽木 宏実, 日本高血圧学会臨床高血圧フォーラムプログラム・抄録集, (NPO)日本高血圧学会, Vol. 1回, p. 139-139, 2012/04
  • 表皮水疱症に対する骨髄間葉系幹細胞移植治療の可能性, 玉井 克人,知野 剛直,飯沼 晋,梅垣 知子,金田 安史,片山 一朗,中野 創,澤村 大輔,橋本 功,北島 康雄,飯塚 一,白方 祐司,橋本 公二, 西日本皮膚科, 日本皮膚科学会-西部支部, Vol. 74, No. 2, p. 206-206, 2012/04
  • Essential Role for miR-196a in Brown Adipogenesis of White Fat Progenitor Cells, Masaki Mori,Hironori Nakagami,Gerardo Rodriguez-Araujo,Keisuke Nimura,Yasufumi Kaneda, PLOS BIOLOGY, PUBLIC LIBRARY SCIENCE, Vol. 10, No. 4, 2012/04
  • Essential role for miR-196a in brown adipogenesis of white fat progenitor cells, Masaki Mori,Hironori Nakagami,Gerardo Rodriguez-Araujo,Keisuke Nimura,Yasufumi Kaneda, PLoS Biology, Vol. 10, No. 4, 2012/04
  • Androgen-Regulated Transcriptional Control of Sialyltransferases in Prostate Cancer Cells, Koji Hatano,Yasuhide Miyamoto,Masaki Mori,Keisuke Nimura,Yasutomo Nakai,Norio Nonomura,Yasufumi Kaneda, PLOS ONE, PUBLIC LIBRARY SCIENCE, Vol. 7, No. 2, 2012/02
  • Tissue regeneration by recruitment of stem cells to injured tissues, Yasufumi Kaneda, Drug Delivery System, Vol. 27, No. 4, p. 246-256, 2012
  • 【組織・臓器を修復するStem Cell】骨髄間葉系幹細胞に備わる組織損傷シグナルへの応答機構, 玉井 克人,金田 安史, 実験医学, (株)羊土社, Vol. 29, No. 19, p. 3085-3090, 2011/12
  • Development of Liposomes and Pseudovirions with Fusion Activity for Efficient Gene Delivery, Yasufumi Kaneda, CURRENT GENE THERAPY, BENTHAM SCIENCE PUBL LTD, Vol. 11, No. 6, p. 434-441, 2011/12
  • Expression of gangliosides, GD1a, and sialyl paragloboside is regulated by NF-kappa B-dependent transcriptional control of alpha 2,3-sialyltransferase I, II, and VI in human castration-resistant prostate cancer cells, Koji Hatano,Yasuhide Miyamoto,Norio Nonomura,Yasufumi Kaneda, INTERNATIONAL JOURNAL OF CANCER, WILEY-BLACKWELL, Vol. 129, No. 8, p. 1838-1847, 2011/10
  • Critical Roles of Cold Shock Domain Protein A as an Endogenous Angiogenesis Inhibitor in Skeletal Muscle, Yukihiro Saito,Hironori Nakagami,Nobuyoshi Azuma,Satoshi Hirata,Fumihiro Sanada,Yoshiaki Taniyama,Ryuichi Morishita,Yasufumi Kaneda,Tadahiro Sasajima, ANTIOXIDANTS & REDOX SIGNALING, MARY ANN LIEBERT INC, Vol. 15, No. 8, p. 2109-2120, 2011/10
  • HVJ liposomes and HVJ envelope vectors., Kaneda Y, Cold Spring Harbor protocols, Vol. 2011, No. 10, p. 1281-1289, 2011/10
  • 非ウイルスベクターHVJ-Eを用いた高効率光線力学療法の開発, 藤本尚弘,酒井真理,石井克典,M.E. El-Zaria,H.S. Ban,中村浩之,金田安史,粟津邦男, 2011/07
  • Methyl-beta cyclodextrin alters the production and infectivity of Sendai virus, Hiroshi Fujita,Katsuto Tamai,Masako Kawachi,Kotaro Saga,Takashi Shimbo,Takehiko Yamazaki,Yasufumi Kaneda, ARCHIVES OF VIROLOGY, SPRINGER WIEN, Vol. 156, No. 6, p. 995-1005, 2011/06
  • In vitro investigation for high efficiency PPIX-PDT with nonviral vector; HVJ-E, K. Awazu,N. Fujimoto,M. Sakai,K. Ishii,M.E. El-Zaria,H.S. Ban,H. Nakamura,Y. Kaneda, 2011/05
  • Immunogene therapy using immunomodulating HVJ-E vector augments anti-tumor effects in murine malignant glioma, Masahide Matsuda,Keisuke Nimura,Takashi Shimbo,Toshimitsu Hamasaki,Tetsuya Yamamoto,Akira Matsumura,Yasufumi Kaneda, JOURNAL OF NEURO-ONCOLOGY, SPRINGER, Vol. 103, No. 1, p. 19-31, 2011/05
  • Photodynamic therapywith high PPIX uptake using a nonviral vector DDS, K. Awazu,K. Ishii,N. Fujimoto,M. Sakai,M.E. El-Zaria,H.S. Ban,H. Nakamura,Y. Kaneda, 2011/04
  • PDGFR alpha-positive cells in bone marrow are mobilized by high mobility group box 1 (HMGB1) to regenerate injured epithelia, Katsuto Tamai,Takehiko Yamazaki,Takenao Chino,Masaru Ishii,Satoru Otsuru,Yasushi Kikuchi,Shin Iinuma,Kotaro Saga,Keisuke Nimura,Takashi Shimbo,Noriko Umegaki,Ichiro Katayama,Jun-ichi Miyazaki,Junji Takeda,John A. McGrath,Jouni Uitto,Yasufumi Kaneda, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, NATL ACAD SCIENCES, Vol. 108, No. 16, p. 6609-6614, 2011/04
  • 骨髄細胞による表皮恒常性維持機構, 玉井 克人,知野 剛直,飯沼 晋,金田 安史,梅垣 知子,片山 一朗, 角化症研究会記録集, 角化症研究会事務局, Vol. 25, p. 38-40, 2011/03
  • Phase I/IIa Clinical Trial of Therapeutic Angiogenesis Using Hepatocyte Growth Factor Gene Transfer to Treat Critical Limb Ischemia, Ryuichi Morishita,Hirofumi Makino,Motokuni Aoki,Naotaka Hashiya,Keita Yamasaki,Junya Azuma,Yoshiaki Taniyama,Yoshiki Sawa,Yasufumi Kaneda,Toshio Ogihara, ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, LIPPINCOTT WILLIAMS & WILKINS, Vol. 31, No. 3, p. 713-720, 2011/03
  • DNA methyltransferase 3b preferentially associates with condensed chromatin, Katsunobu Kashiwagi,Keisuke Nimura,Kiyoe Ura,Yasufumi Kaneda, NUCLEIC ACIDS RESEARCH, OXFORD UNIV PRESS, Vol. 39, No. 3, p. 874-888, 2011/02
  • A Novel Therapeutic and Prophylactic Vaccine against Tuberculosis Using the Cynomolgus Monkey Model and Mouse Model, M. Okada,Y. Kita,T. Nakajima,N. Kanamaru,Y. Kaneda,P. Saunderson,E. Tan,N. McMurray D, 4TH VACCINE AND ISV ANNUAL GLOBAL CONGRESS, ELSEVIER SCIENCE BV, Vol. 4, 2011
  • Cationized gelatin-HVJ envelope with sodium borocaptate improved the BNCT efficacy for liver tumors in vivo, Hitoshi Fujii,Akifumi Matsuyama,Hiroshi Komoda,Masao Sasai,Minoru Suzuki,Tomoyuki Asano,Yuichiro Doki,Mitsunori Kirihata,Koji Ono,Yasuhiko Tabata,Yasufumi Kaneda,Yoshiki Sawa,Chun Man Lee, RADIATION ONCOLOGY, BIOMED CENTRAL LTD, Vol. 6, 2011/01
  • Development of therapeutic and prophylactic vaccine against tuberculosis using monkey and transgenic mice models, Yoko Kita,Masaji Okada,Toshihiro Nakajima,Noriko Kanamaru,Satomi Hashimoto,Tetsuji Nagasawa,Yasufumi Kaneda,Shigeto Yoshida,Yasuko Nishida,Hitoshi Nakatani,Kyoko Takao,Chie Kishigami,Shiho Nishimatsu,Yuki Sekine,Yasushi Takamori,David N. McMurray,E. C. De la Cruz,E. V. Tan,R. M. Abalos,J. A. Burgos,Paul Saunderson,Mitsunori Sakatani, HUMAN VACCINES, LANDES BIOSCIENCE, Vol. 7, p. 108-114, 2011/01
  • Novel Prophylactic Vaccine Using a Prime-Boost Method and Hemagglutinating Virus of Japan-Envelope against Tuberculosis, Masaji Okada,Yoko Kita,Toshihiro Nakajima,Noriko Kanamaru,Satomi Hashimoto,Tetsuji Nagasawa,Yasufumi Kaneda,Shigeto Yoshida,Yasuko Nishida,Hitoshi Nakatani,Kyoko Takao,Chie Kishigami,Shiho Nishimatsu,Yuki Sekine,Yoshikazu Inoue,David N. McMurray,Andmitsunori Sakatani, CLINICAL & DEVELOPMENTAL IMMUNOLOGY, HINDAWI PUBLISHING CORPORATION, Vol. 2011, 2011
  • Novel therapeutic vaccine Granulysin and new DNA vaccine against tuberculosis, Masaji Okada,Yoko Kita,Toshihiro Nakajima,Noriko Kanamaru,Satomi Hashimoto,Tetsuji Nagasawa,Yasufumi Kaneda,Shigeto Yoshida,Yasuko Nishida,Hitoshi Nakatani,Kyoko Takao,Chie Kishigami,Shiho Nishimatsu,Yuki Sekine,Yoshikazu Inoue,Makoto Matsumoto,David N. McMurray,E. C. Dela Cruz,E. V. Tan,R. M. Abalos,J. A. Burgos,Paul Saunderson,Mitsunori Sakatani, HUMAN VACCINES, LANDES BIOSCIENCE, Vol. 7, p. 60-67, 2011/01
  • EG5 siRNA COMBINED WITH HVJ ENVELOPE SYNERGISTICALLY INDUCED CELL DEATH IN GLIOBLASTOMA, Matsuda, Masahide,Yamamoto, Tetsuya,Matsumura, Akira,Kaneda, Yasufumi, JOURNAL OF GENE MEDICINE, JOHN WILEY & SONS LTD, Vol. 12, No. 12, p. 1043-1043, 2010/12
  • Histone methyltransferases: regulation of transcription and contribution to human disease, Keisuke Nimura,Kiyoe Ura,Yasufumi Kaneda, JOURNAL OF MOLECULAR MEDICINE-JMM, SPRINGER, Vol. 88, No. 12, p. 1213-1220, 2010/12
  • A non-replicating oncolytic vector as a novel therapeutic tool against cancer, Yasufumi Kaneda, BMB REPORTS, KOREAN SOCIETY BIOCHEMISTRY & MOLECULAR BIOLOGY, Vol. 43, No. 12, p. 773-780, 2010/12
  • 非ウイルスベクターHVJ-Eを用いた高効率PPIX-PDTの培養がん細胞での検討, 藤本尚弘,酒井真理,石井克典,E. El-Zaria Mohamed,潘鉉承,中村浩之,金田安史,粟津邦男, 2010/11
  • Cold shock domain protein A (CSDA) overexpression inhibits tumor growth and lymph node metastasis in a mouse model of squamous cell carcinoma, Goichi Matsumoto,Nobuyuki Yajima,Hiroyuki Saito,Hironori Nakagami,Yasushi Omi,Ushaku Lee,Yasufumi Kaneda, CLINICAL & EXPERIMENTAL METASTASIS, SPRINGER, Vol. 27, No. 7, p. 539-547, 2010/10
  • Update on non-viral delivery methods for cancer therapy: possibilities of a drug delivery system with anticancer activities beyond delivery as a new therapeutic tool, Yasufumi Kaneda, EXPERT OPINION ON DRUG DELIVERY, INFORMA HEALTHCARE, Vol. 7, No. 9, p. 1079-1093, 2010/09
  • 悪性黒色腫の新規血清腫瘍マーカーとしての抗BPAG1抗体(Serum anti-BPAG1 auto-antibody is a novel marker for human melanoma), 新保 敬史,種村 篤,玉井 克人,片山 一郎,金田 安史, 日本癌学会総会記事, (一社)日本癌学会, Vol. 69回, p. 76-77, 2010/08
  • 癌治療を目指した高性能HVJ-Eの全身投与による癌治療(Systemic injection of high performance HVJ-E for cancer therapy), 佐賀 公太郎,玉井 克人,金田 安史, 日本癌学会総会記事, (一社)日本癌学会, Vol. 69回, p. 101-101, 2010/08
  • HVJ-Eを利用した悪性黒色腫への新規免疫療法(A novel immunotherapy with HVJ envelope to malignant melanoma), 清原 英司,種村 篤,西岡 めぐみ,山中 隆嗣,谷 守,李 千萬,玉井 克人,片山 一朗,金田 安史,河上 裕, 日本癌学会総会記事, 日本癌学会, Vol. 69回, p. 101-101, 2010/08
  • [Current status of gene therapy in Japan and other countries]., Kaneda Y, Nihon rinsho. Japanese journal of clinical medicine, Vol. 68 Suppl 8, p. 577-583, 2010/08
  • Basic investigation of boron neutron capture therapy (BNCT) using HVJ-E and accelerator-based neutron source, M. Sakai,N. Fujimoto,K. Ishii,I. Murata,Y. Kaneda,K. Awazu, 2010/06
  • Variation in OSBPL10 is associated with dyslipidemia, Hiroshi Koriyama,Hironori Nakagami,Tomohiro Katsuya,Hiroshi Akasaka,Shigeyuki Saitoh,Kazuaki Shimamoto,Toshio Ogihara,Yasufumi Kaneda,Ryuichi Morishita,Hiromi Rakugi, HYPERTENSION RESEARCH, NATURE PUBLISHING GROUP, Vol. 33, No. 5, p. 511-514, 2010/05
  • Dodecaborate lipid liposomes as new vehicles for boron delivery system of neutron capture therapy, Manabu Ueno,Hyun Seung Ban,Kei Nakai,Ryu Inomata,Yasufumi Kaneda,Akira Matsumura,Hiroyuki Nakamura, BIOORGANIC & MEDICINAL CHEMISTRY, PERGAMON-ELSEVIER SCIENCE LTD, Vol. 18, No. 9, p. 3059-3065, 2010/05
  • Serum Anti-BPAG1 Auto-Antibody Is a Novel Marker for Human Melanoma, Takashi Shimbo,Atsushi Tanemura,Takehiko Yamazaki,Katsuto Tamai,Ichiro Katayama,Yasufumi Kaneda, PLOS ONE, PUBLIC LIBRARY SCIENCE, Vol. 5, No. 5, 2010/05
  • Sterile alpha motif containing domain 9 is involved in death signaling of malignant glioma treated with inactivated Sendai virus particle (HVJ-E) or type I interferon, Masahiko Tanaka,Takashi Shimbo,Yasushi Kikuchi,Masahide Matsuda,Yasufumi Kaneda, INTERNATIONAL JOURNAL OF CANCER, JOHN WILEY & SONS INC, Vol. 126, No. 8, p. 1982-1991, 2010/04
  • Controlled Release of Bone Morphogenetic Protein-2 Enhances Recruitment of Osteogenic Progenitor Cells for De Novo Generation of Bone Tissue, Yu Kimura,Nobuhiko Miyazaki,Naoki Hayashi,Satoru Otsuru,Katsuto Tamai,Yasufumi Kaneda,Yasuhiko Tabata, TISSUE ENGINEERING PART A, MARY ANN LIEBERT, INC, Vol. 16, No. 4, p. 1263-1270, 2010/04
  • メラノーマのすべて メラノーマ治療の展望, 種村 篤,清原 英司,片山 一朗,金田 安史,河上 裕, 日本皮膚科学会雑誌, (公社)日本皮膚科学会, Vol. 120, No. 3, p. 515-515, 2010/03
  • 非ウイルスベクターHVJ-Eを用いた光線力学療法の基礎検討, 藤本 尚弘,酒井 真理,石井 克典,金田 安史,M.E. El-Zaria,H.S. Ban,中村 浩之,粟津 邦男, 2010/02
  • Therapeutic strategies for controlling metastasis and recurrence of cancers, Yasufumi Kaneda, Drug Delivery System, Vol. 25, No. 2, p. 94-102, 2010
  • 非ウイルスベクターを用いたがんに対する光線力学療法, 藤本尚弘,酒井真理,石井克典,M.E. El-Zaria,潘鉉承,中村浩之,金田安史,粟津邦男, 2010
  • Identification of Evidence Suggestive of an Association with Peripheral Arterial Disease at the OSBPL10 Locus by Genome-Wide Investigation in the Japanese Population, Hiroshi Koriyama,Hironori Nakagami,Tomohiro Katsuya,Ken Sugimoto,Hidetoshi Yamashita,Yoichi Takami,Shiro Maeda,Michiaki Kubo,Atsushi Takahashi,Yusuke Nakamura,Toshio Ogihara,Hiromi Rakugi,Yasufumi Kaneda,Ryuichi Morishita, JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, JAPAN ATHEROSCLEROSIS SOC, Vol. 17, No. 10, p. 1054-1062, 2010
  • Highly efficient eradication of intracranial glioblastoma using Eg5 siRNA combined with HVJ envelope, Matsuda, M,Yamamoto, T,Matsumura, A,Kaneda, Y, GENE THERAPY, NATURE PUBLISHING GROUP, Vol. 16, No. 12, p. 1465-1476, 2009/12
  • メラノーマ免疫療法 現況と展望 悪性黒色腫におけるHVJ-E腫瘍内投与による抗腫瘍効果の検討について, 種村 篤,清原 英司,片山 一朗,金田 安史,河上 裕, Skin Cancer, (一社)日本皮膚悪性腫瘍学会, Vol. 24, No. 2, p. 181-191, 2009/10
  • 加速器及びHVJ-E を用いたホウ素中性子捕捉療法の基礎的検討, 藤本 尚弘,酒井 真理,石井 克典,村田 勲,粟津 邦男,李 千萬,金田 安史,浅野 智之,中村 浩之, 2009/09
  • 癌治療を目指した高性能免疫賦活化ビロソームの開発(Development of high-performance immunovirosome for cancer therapy), 佐賀 公太郎,玉井 克人,金田 安史, 日本癌学会総会記事, (一社)日本癌学会, Vol. 68回, p. 241-241, 2009/08
  • 化学療法とRad51 siRNAを封入したHVJ-E併用の相乗効果によるメラノーマの抑制(The combination of chemotherapy with immune-competent HVJ-E containing Rad51 siRNA synergistically suppressed melanoma), 清原 英司,玉井 克人,片山 一朗,金田 安史, 日本癌学会総会記事, 日本癌学会, Vol. 68回, p. 88-88, 2009/08
  • Development of boron nanocapsules for neutron capture therapy, H. Nakamura,M. Ueno,H. S. Ban,K. Nakai,K. Tsuruta,Y. Kaneda,A. Matsumura, Applied Radiation and Isotopes, Vol. 67, No. 7-8, p. S84-S87, 2009/07
  • 大学院生を対象としたESPアプローチの医学英語論文講座の試みについて, 馬場 幸子,野口 ジュディー,和佐 勝史,渡部 健二,倉智 嘉久,金田 安史, 医学教育, (一社)日本医学教育学会, Vol. 40, No. Suppl., p. 57-57, 2009/07
  • Zyxin Mediates Actin Fiber Reorganization in Epithelial-Mesenchymal Transition and Contributes to Endocardial Morphogenesis, Masaki Mori,Hironori Nakagami,Nobutaka Koibuchi,Koichi Miura,Yoichi Takami,Hiroshi Koriyama,Hiroki Hayashi,Hisataka Sabe,Naoki Mochizuki,Ryuichi Morishita,Yasufumi Kaneda, MOLECULAR BIOLOGY OF THE CELL, AMER SOC CELL BIOLOGY, Vol. 20, No. 13, p. 3115-3124, 2009/07
  • A histone H3 lysine 36 trimethyltransferase links Nkx2-5 to Wolf-Hirschhorn syndrome, Keisuke Nimura,Kiyoe Ura,Hidetaka Shiratori,Masato Ikawa,Masaru Okabe,Robert J. Schwartz,Yasufumi Kaneda, NATURE, NATURE PUBLISHING GROUP, Vol. 460, No. 7252, p. 287-U157, 2009/07
  • Molecular therapies for heritable blistering diseases, Katsuto Tamai,Yasufumi Kaneda,Jouni Uitto, TRENDS IN MOLECULAR MEDICINE, ELSEVIER SCI LTD, Vol. 15, No. 7, p. 285-292, 2009/07
  • Ex Vivo Transfer of Nuclear Factor-kappa B Decoy Ameliorates Hepatic Cold Ischemia/Reperfusion Injury, T. Yoshizumi,Y. Ikeda,Y. Kaneda,K. Sueishi, TRANSPLANTATION PROCEEDINGS, ELSEVIER SCIENCE INC, Vol. 41, No. 5, p. 1504-1507, 2009/06
  • FHL-2 Suppresses VEGF-Induced Phosphatidylinositol 3-Kinase/Akt Activation via Interaction With Sphingosine Kinase-1, Hiroki Hayashi,Hironori Nakagami,Yoichi Takami,Hiroshi Koriyama,Masaki Mori,Katsuto Tamai,Jianxin Sun,Kaori Nagao,Ryuichi Morishita,Yasufumi Kaneda, ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, LIPPINCOTT WILLIAMS & WILKINS, Vol. 29, No. 6, p. 909-U331, 2009/06
  • [Progress of human gene therapy]., Kaneda Y, Nihon rinsho. Japanese journal of clinical medicine, Vol. 67, No. 6, p. 1180-1184, 2009/06
  • Eg5 siRNA Combined with HVJ Envelope Synergistically Induced Cell Death in Glioblastoma, Matsuda, Masahide,Yamamoto, Tetsuya,Matsumura, Akira,Kaneda, Yasufumi, MOLECULAR THERAPY, NATURE PUBLISHING GROUP, Vol. 17, No. Suppl. 1, p. 0-0, 2009/05
  • Zyxin Mediates Actin Fiber Reorganization in Epithelial-Mesenchymal Transition and Contributes to Endocardial Morphogenesis, Mori Masaki,Nakagami Hironori,Koibuchi Nobutaka,Miura Koichi,Sabe Hisataka,Mochizuki Naoki,Kaneda Yasufumi, MOLECULAR THERAPY, Vol. 17, 2009/05
  • Efficient eradication of hormone-resistant human prostate cancers by inactivated Sendai virus particle, Yoshifumi Kawaguchi,Yasuhide Miyamoto,Takehiro Inoue,Yasufumi Kaneda, INTERNATIONAL JOURNAL OF CANCER, WILEY-LISS, Vol. 124, No. 10, p. 2478-2487, 2009/05
  • Novel prophylactic and therapeutic vaccine against tuberculosis, Masaji Okada,Yoko Kita,Toshihiro Nakajima,Noriko Kanamaru,Satomi Hashimoto,Tetsuji Nagasawa,Yasufumi Kaneda,Shigeto Yoshida,Yasuko Nishida,Hitoshi Nakatani,Kyoko Takao,Chie Kishigami,Yoshikazu Inoue,Makoto Matsumoto,David N. McMurray,E. C. dela Cruz,E. V. Tan,R. M. Abalos,J. A. Burgos,Paul Saunderson,Mitsunori Sakatani, VACCINE, ELSEVIER SCI LTD, Vol. 27, No. 25-26, p. 3267-3270, 2009/05
  • 遺伝性皮膚疾患の根治的治療法開発, 玉井 克人,山崎 尊彦,知野 剛直,金田 安史,片山 一朗, 角化症研究会記録集, 角化症研究会事務局, Vol. 23, p. 142-147, 2009/03
  • Development of a novel antimicrobial peptide, AG-30, with angiogenic properties, Tomoyuki Nishikawa,Hironori Nakagami,Akito Maeda,Ryuichi Morishita,Nobuhiko Miyazaki,Toshihiro Ogawa,Yasuhiko Tabata,Yasushi Kikuchi,Hiroki Hayashi,Yoshiro Tatsu,Noboru Yumoto,Katsuto Tamai,Kazunori Tomono,Yasufumi Kaneda, JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, WILEY-BLACKWELL PUBLISHING, INC, Vol. 13, No. 3, p. 535-546, 2009/03
  • Injection of HGF plasmid cDNA to prevent manifestation of Parkinson disease: a preclinical study using a primate model., Koike H,Ishida A,Hayashi T,Shimamura M,Mizuno S,Nakamura T,Iida H,Ogihara T,Kaneda Y,Morishita R, Open Gene Therapy Journal, Vol. 2, p. 38-44, 2009
  • Nonviral Retrograde Gene Transfer of Human Hepatocyte Growth Factor Improves Neuropathic Pain-related Phenomena in Rats, Toyokazu Tsuchihara,Sho Ogata,Koichi Nemoto,Takatoshi Okabayashi,Kuniaki Nakanishi,Naoki Kato,Ryuichi Morishita,Yasufumi Kaneda,Maki Uenoyama,Shinya Suzuki,Masatoshi Amako,Toshiaki Kawai,Hiroshi Arino, MOLECULAR THERAPY, NATURE PUBLISHING GROUP, Vol. 17, No. 1, p. 42-50, 2009/01
  • ゲノムワイド関連解析による閉塞性動脈硬化症感受性遺伝子座の同定, 郡山 弘,中神 啓徳,勝谷 友宏,杉本 研,山下 英俊,鷹見 洋一,赤坂 憲,斎藤 重幸,前田 士朗,中村 裕輔,金田 安史,樂木 宏実,森下 竜一,島本 和明,荻原 俊男, 日本高血圧学会総会プログラム・抄録集, (NPO)日本高血圧学会, Vol. 31回, p. 170-170, 2008/10
  • 子宮局所における一過性遺伝子導入方法を用いた着床不全マウスモデルの作製, 香山 晋輔,中村 仁美,谷口 武,荻田 和秀,熊澤 恵一,張 慶,筒井 建紀,金田 安史,木村 正, 日本生殖医学会雑誌, (一社)日本生殖医学会, Vol. 53, No. 4, p. 284-284, 2008/10
  • Cold shock domain protein A, novel endogenous regulator of angiogenesis in heart, Yukihiro Saito,Hironori Nakagami,Nobuyoshi Azuma,Ryuichi Morishita,Yasufumi Kaneda,Tadahiro Sasajima, Journal of Molecular and Cellular Cardiology, Elsevier {BV}, Vol. 45, No. 4, 2008/10
  • 着床期子宮局所におけるSTAT-3活性の役割, 中村 仁美,香山 晋輔,谷口 武,荻田 和秀,熊澤 恵一,張 慶,筒井 建紀,古山 将康,杉野 法広,田村 博史,金田 安史,木村 正, 日本内分泌学会雑誌, (一社)日本内分泌学会, Vol. 84, No. 2, p. 629-630, 2008/09
  • 損傷組織による骨髄由来間葉系前駆細胞動員機構(Recruiting mechanism of bone marrow mesenchymal progenitor cells by tissue injury), 玉井 克人,金田 安史, 日本癌学会総会記事, (一社)日本癌学会, Vol. 67回, p. 300-300, 2008/09
  • Bone marrow cell transfer into fetal circulation can ameliorate genetic skin diseases by providing fibroblasts to the skin and inducing immune tolerance, Takenao Chino,Katsuto Tamai,Takehiko Yamazaki,Satoru Otsuru,Yasushi Kikuchi,Keisuke Nimura,Masayuki Endo,Miki Nagai,Jouni Uitto,Yasuo Kitajima,Yasufumi Kaneda, AMERICAN JOURNAL OF PATHOLOGY, AMER SOC INVESTIGATIVE PATHOLOGY, INC, Vol. 173, No. 3, p. 803-814, 2008/09
  • Atrial natriuretic peptide gene transfection with a novel envelope vector system ameliorates pulmonary hypertension in rats, Yoshihide Mitani,Junko Maruyama,Bao Hua Jiang,Hirofumi Sawada,Hideto Shimpo,Kyoko Imanaka-Yoshida,Yasufumi Kaneda,Yoshihiro Komada,Kazuo Maruyama, JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, MOSBY-ELSEVIER, Vol. 136, No. 1, p. 142-149, 2008/07
  • 子宮局所における一過性遺伝子導入方法を用いたヒト不妊症のマウスモデルの作製, 中村 仁美,香山 晋輔,荻田 和秀,谷口 武,筒井 建紀,金田 安史,木村 正, Drug Delivery System, 日本DDS学会, Vol. 23, No. 3, p. 417-417, 2008/05
  • New potential therapy for orthotopic bladder carcinoma by combining HVJ envelope with doxorubicin, Hirokazu Kawano,Shintaro Komaba,Tsugiko Yamasaki,Mitsuyo Maeda,Yoshimitsu Kimura,Akito Maeda,Yasufumi Kaneda, CANCER CHEMOTHERAPY AND PHARMACOLOGY, SPRINGER, Vol. 61, No. 6, p. 973-978, 2008/05
  • Cutaneous gene delivery, Yasushi Kikuchi,Katsuto Tamai,Yasufumi Kaneda, JOURNAL OF DERMATOLOGICAL SCIENCE, ELSEVIER IRELAND LTD, Vol. 50, No. 2, p. 87-98, 2008/05
  • Identification of angiogenic and antimicrobial factor, AG-30, and analysis of its De Novo engineered variants, Tomoyuki Nishikawa,Hironori Nakagami,Akito Maeda,Nobuhiko Miyazaki,Yasuhiko Tabata,Ryuichi Morishita,Katsuto Tamai,Yasufumi Kaneda, JOURNAL OF GENE MEDICINE, JOHN WILEY & SONS LTD, Vol. 10, No. 4, p. 473-473, 2008/04
  • Sendai virus F glycoprotein induces IL-6 production in dendritic cells in a fusion-independent manner, Hayato Suzuki,Masayuki Kurooka,Yoko Hiroaki,Yoshinori Fujiyoshi,Yasufumi Kaneda, FEBS LETTERS, ELSEVIER SCIENCE BV, Vol. 582, No. 9, p. 1325-1329, 2008/04
  • 創傷治療のニューウェーブ, 玉井 克人,金田 安史,片山 一朗, 日本皮膚科学会雑誌, (公社)日本皮膚科学会, Vol. 118, No. 4, p. 645-645, 2008/03
  • Cold shock domain protein A represses angiogenesis and lymphangiogenesis via inhibition of serum response element., Saito Y,Nakagami H,Kurooka M,Takami Y,Kikuchi Y,Hayashi H,Nishikawa T,Tamai K,Morishita R,Azuma N,Sasajima T,Kaneda Y,Oncogene, Oncogene, Vol. 27, No. 13, p. 1821-1833, 2008/03
  • Potential role of CYLD (cylindromatosis) as a deubiquitinating enzyme in vascular cells, Yoichi Takami,Hironori Nakagami,Ryuichi Morishita,Tomohiro Katsuya,Hiroki Hayashi,Masaki Mori,Hiroshi Koriyama,Yoshichika Baba,Osamu Yasuda,Hiromi Rakugi,Toshio Ogihara,Yasufumi Kaneda, AMERICAN JOURNAL OF PATHOLOGY, AMER SOC INVESTIGATIVE PATHOLOGY, INC, Vol. 172, No. 3, p. 818-829, 2008/03
  • Current status of gene therapy in Asia, Sunyoung Kim,Zhaohui Peng,Yasufumi Kaneda, MOLECULAR THERAPY, NATURE PUBLISHING GROUP, Vol. 16, No. 2, p. 237-243, 2008/02
  • Functional modification of Sendai virus by siRNA, Kotaro Saga,Katsuto Tamai,Masako Kawachi,Takashi Shimbo,Hiroshi Fujita,Takehiko Yamazaki,Yasufumi Kaneda, JOURNAL OF BIOTECHNOLOGY, ELSEVIER SCIENCE BV, Vol. 133, No. 3, p. 386-394, 2008/02
  • Applications of Hemagglutinating Virus of Japan in therapeutic delivery systems, Yasufumi Kaneda, EXPERT OPINION ON DRUG DELIVERY, INFORMA HEALTHCARE, Vol. 5, No. 2, p. 221-233, 2008/02
  • OP-375 マウスRenca腎癌に対するSendai virus partide(HVJ-E)の抗腫瘍効果の検討(腎腫瘍/基礎,一般演題口演,第96回日本泌尿器科学会総会), 藤原 敦子,三木 恒治,金田 安史, 日本泌尿器科学会雑誌, 一般社団法人 日本泌尿器科学会, Vol. 99, No. 2, p. 365-365, 2008
  • Polymorphism of myospryn is associated with left ventricular diastolic dysfunction, Kikuchi Yasushi,Nakagami Hironori,Katsuya Tomohiro,Morishita Ryuichi,Horio Takeshi,Kamide Kei,Miyata Toshiyuki,Kawano Yuhei,Takami Yoichi,Rakugi Hiromi,Kaneda Yasufumi,Ogihara Toshio, Anti-Aging Med, Japanese Society of Anti-Aging Medicine, Vol. 5, No. 4, p. 49-52, 2008
  • Intratumoral injection of inactivated Sendai virus particles elicits strong antitumor activity by enhancing local CXCL10 expression and systemic NK cell activation, Atsuko Fujihara,Masayuki Kurooka,Tsuneharu Miki,Yasufumi Kaneda, CANCER IMMUNOLOGY IMMUNOTHERAPY, SPRINGER, Vol. 57, No. 1, p. 73-84, 2008/01
  • Circulating bone marrow-derived osteoblast progenitor cells are recruited to the bone-forming site by the CXCR4/stromal cell-derived factor-1 pathway, Satoru Otsuru,Katsuto Tamai,Takehiko Yamazaki,Hideki Yoshikawa,Yasufumi Kaneda, STEM CELLS, ALPHAMED PRESS, Vol. 26, No. 1, p. 223-234, 2008
  • Development of a transferrin receptor-targeting HVXE vector, Takashi Shimbo,Masako Kawachi,Kotaro Saga,Hiroshi Fujita,Takehiko Yamazaki,Katsuto Tanial,Yasufunii Kaneda, BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, ACADEMIC PRESS INC ELSEVIER SCIENCE, Vol. 364, No. 3, p. 423-428, 2007/12
  • Gene polymorphism of myospryn (cardiomyopathy-associated 5) is associated with left ventricular wall thickness in patients with hypertension, Hironori Nakagami,Yasushi Kikuchi,Tomohiro Katsuya,Ryuichi Morishita,Hiroshi Akasaka,Shigeyuki Saitoh,Hiromi Rakugi,Yasufumi Kaneda,Kazuaki Shimamoto,Toshio Ogihara, HYPERTENSION RESEARCH, JAPANESE SOC HYPERTENSION CENT ACADEMIC SOC, PUBL OFFICE, Vol. 30, No. 12, p. 1239-1246, 2007/12
  • Regression of abdominal aortic aneurysms by simultaneous inhibition of nuclear factor kappa B and ets in a rabbit model, Takashi Miyake,Motokuni Aoki,Hisao Masaki,Tomio Kawasaki,Masako Oishi,Kazusaburo Kataoka,Toshio Ogihara,Yasufumi Kaneda,Ryuichi Morishita, CIRCULATION RESEARCH, LIPPINCOTT WILLIAMS & WILKINS, Vol. 101, No. 11, p. 1175-1184, 2007/11
  • Involvement of gamma-secretase in postnatal angiogenesis, Hiroki Hayashi,Hironori Nakagami,Yoichi Takami,Naoyuki Sato,Yukihiro Saito,Tomoyuki Nishikawa,Masaki Mori,Hiroshi Koriyama,Katsuto Tamai,Ryuichi Morishita,Yasufumi Kaneda, BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, ACADEMIC PRESS INC ELSEVIER SCIENCE, Vol. 363, No. 3, p. 584-590, 2007/11
  • 脱ユビキチン化酵素CYLD(cylindromatosis)の血管における機能, 鷹見 洋一,中神 啓徳,森下 竜一,勝谷 友宏,楽木 宏実,金田 安史,荻原 俊男, 日本高血圧学会総会プログラム・抄録集, (NPO)日本高血圧学会, Vol. 30回, p. 160-160, 2007/10
  • Ubiquitin carboxyl-terminal hydrolase L1, a novel deubiquitinating enzyme in the vasculature, attenuates NF-kappa B activation, Yoichi Takami,Hironori Nakagami,Ryuichi Morishita,Tomohiro Katsuya,Tai-Xing Cui,Tomonaga Ichikawa,Yukihiro Saito,Hiroki Hayashi,Yasushi Kikuchi,Tomoyuki Nishikawa,Yoshichika Baba,Osamu Yasuda,Hiromi Rakugi,Toshio Ogihara,Yasufumi Kaneda, ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, LIPPINCOTT WILLIAMS & WILKINS, Vol. 27, No. 10, p. 2184-2190, 2007/10
  • Development of tissue-targeting hemagglutinating virus of Japan envelope vector for successful delivery of therapeutic gene to mouse skin, Masako Kawachi,Katsuto Tamai',Kotaro Saga,Takehiko Yamazaki,Hiroshi Fujita,Takashi Shimbo,Yasushi Kikuchi,Keisuke Nimura,Koji Nishifuji,Masayuki Amagai,Jouni Uitto,Yasufumi Kaneda, HUMAN GENE THERAPY, MARY ANN LIEBERT INC, Vol. 18, No. 10, p. 881-894, 2007/10
  • Selective inactivation of NF-kappa B in the liver using NF-kappa B decoy suppresses CCl4-induced liver injury and fibrosis, Gakuhei Son,Yuji Iimuro,Ekihiro Seki,Tadamichi Hirano,Yasufumi Kaneda,Jiro Fujimoto, AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, AMER PHYSIOLOGICAL SOC, Vol. 293, No. 3, p. G631-G639, 2007/09
  • A new therapy for highly effective tumor eradication using HVJ-E combined with chemotherapy, Hirokazu Kawano,Shintarou Komaba,Toshihide Kanamori,Yasufumi Kaneda, BMC MEDICINE, BIOMED CENTRAL LTD, Vol. 5, 2007/09
  • 運動器の再生 骨折治癒 生体内骨形成プロセスにおける骨髄由来骨前駆細胞関与のメカニズム, 大鶴 聰,玉井 克人,山崎 尊彦,吉川 秀樹,金田 安史, 日本整形外科学会雑誌, (公社)日本整形外科学会, Vol. 81, No. 8, p. S890-S890, 2007/08
  • Effect on vein graft intimal hyperplasia of nuclear factor-kappa B decoy transfection using the second generation of HVJ vector, N. Shimizu,N. Azuma,T. Nishikawa,S. Hirata,R. Morishita,Y. Kaneda,T. Sasajima, JOURNAL OF CARDIOVASCULAR SURGERY, EDIZIONI MINERVA MEDICA, Vol. 48, No. 4, p. 463-470, 2007/08
  • Epstein-Barr virus-based vector improves the tumor cell killing effect of pituitary tumor in HVJ-liposome-mediated transcriptional targeting suicide gene therapy, Tsuyoshi Izumo,Akira Ohtsuru,Yoshiharu Tokunaga,Hiroyuki Namba,Yasufumi Kaneda,Izumi Nagata,Shunichi Yamashita, INTERNATIONAL JOURNAL OF ONCOLOGY, SPANDIDOS PUBL LTD, Vol. 31, No. 2, p. 379-387, 2007/08
  • [Development of viral envelope-based drug delivery vectors]., Kaneda Y, Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme, Vol. 52, No. 10 Suppl, p. 1268-1273, 2007/08
  • Differential regulation of karyopherin alpha 2 expression by TGF-beta(1), and IFN-gamma in normal human epidermal keratinocytes: Evident contribution of KPNA2 for nuclear translocation of IRF-1, Noriko Umegaki,Katsuto Tamai,Hajime Nakano,Ryuta Moritsugu,Takehiko Yamazaki,Katsumi Hanada,Ichiro Katayama,Yasufumi Kaneda, JOURNAL OF INVESTIGATIVE DERMATOLOGY, NATURE PUBLISHING GROUP, Vol. 127, No. 6, p. 1456-1464, 2007/06
  • [Anticancer immunotherapy using inactivated Sendai virus particles]., Kurooka M,Kaneda Y, Uirusu, The Japanese Society for Virology, Vol. 57, No. 1, p. 19-27, 2007/06
  • Evaluation of a novel vaccine (HVJ-liposome/HSP65 DNA+IL-12 DNA) against tuberculosis using the cynomolgus monkey model of TB, Masaji Okada,Yoko Kita,Toshihiro Nakajima,Noriko Kanamaru,Satomi Hashimoto,Tetsuji Nagasawa,Yasufumi Kaneda,Shigeto Yoshida,Yasuko Nishida,Reiko Fukamizu,Yoshie Tsunai,Ruriko Inoue,Hitoshi Nakatani,Yumi Namie,Junko Yamada,Kyoko Takao,Ritsuko Asai,Ryoko Asaki,Makoto Matsumoto,David N. McMurray,E. C. Dela Cruz,E. V. Tan,R. M. Abalos,J. A. Burgos,Robert Gelber,Mitsunori Sakatani, VACCINE, ELSEVIER SCI LTD, Vol. 25, No. 16, p. 2990-2993, 2007/04
  • Comparative roles of Twist-1 and Id1 in transcriptional regulation by BMP signaling, Masanori Hayashi,Keisuke Nimura,Katsunobu Kashiwagi,Taku Harada,Kunio Takaoka,Hiroyuki Kato,Katsuto Tamai,Yasufumi Kaneda, JOURNAL OF CELL SCIENCE, COMPANY OF BIOLOGISTS LTD, Vol. 120, No. 8, p. 1350-1357, 2007/04
  • 骨髄細胞による表皮形成, 玉井 克人,山崎 尊彦,菊池 康,知野 剛直,金田 安史, 角化症研究会記録集, 角化症研究会事務局, Vol. 21, p. 34-37, 2007/03
  • Needleless intranasal administration of HVJ-E containing allergen attenuates experimental allergic rhinitis, Eri Yasuoka,Kazuo Oshima,Katsuto Tamai,Takeshi Kubo,Yasufumi Kaneda, JOURNAL OF MOLECULAR MEDICINE-JMM, SPRINGER, Vol. 85, No. 3, p. 279-288, 2007/03
  • Bone marrow-derived osteoblast progenitor cells in circulating blood contribute to ectopic bone formation in mice, Satoru Otsuru,Katsuto Tamai,Takehiko Yamazaki,Hideki Yoshikawa,Yasufumi Kaneda, BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, ACADEMIC PRESS INC ELSEVIER SCIENCE, Vol. 354, No. 2, p. 453-458, 2007/03
  • APP-007 不活化 Sendai virus particle (HVJ-E) によるマウス腎癌細胞に対する抗腫瘍効果の機序の検討(第95回日本泌尿器科学会総会), 藤原 敦子,三木 恒治,金田 安史, 日本泌尿器科学会雑誌, 一般社団法人 日本泌尿器科学会, Vol. 98, No. 2, p. 244-244, 2007
  • Novel vaccination (HVJ-liposome/HSP65 DNA+ IL-12 DNA) against tuberculosis using cynomolgus monkey, M. Okada,Y. Kita,T. Nakajima,N. Kanamaru,S. Hashimoto,T. Nagasawa,Y. Kaneda,Y. Nishida,H. Nakatani,K. Takao,R. Asai,R. Suhara,E. C. Dela Cruz,E. V. Tan,R. M. Abajos,R. Gelber,P. Sanderson,S. Yoshida,M. Matsumoto,D. McMurray,M. Sakatani, 13TH INTERNATIONAL CONGRESS OF IMMUNOLOGY, MEDIMOND S R L, p. 119-+, 2007
  • Immunity against breast cancer by TERT DNA vaccine primed with chemokine CCL21, Yamano, T.,Kaneda, Y.,Hiramatsu, S.H.,Huang, S.,Tran, A.N.,Giuliano, A.E.,Hoon, D.S.B., Cancer Gene Therapy, Vol. 14, No. 5, p. 451-459, 2007
  • Rapid transport of plasmid DNA into the nucleolus via actin depolymerization using the HVJ envelope vector, Saroj Suvanasuthi,Katsuto Tamai,Yasufumi Kaneda, JOURNAL OF GENE MEDICINE, JOHN WILEY & SONS LTD, Vol. 9, No. 1, p. 55-62, 2007/01
  • Inactivated Sendai virus particles eradicate tumors by inducing immune responses through blocking regulatory T cells, Masayuki Kurooka,Yasufumi Kaneda, CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, Vol. 67, No. 1, p. 227-236, 2007/01
  • Delivery of viral vectors to hepatic stellate cells in fibrotic livers using HVJ envelopes fused with targeted liposomes, Joanna E. Adrian,Jan A. A. M. Kamps,Klaas Poelstra,Gerrit L. Scherphof,Dirk K. F. Meijer,Yasufumi Kaneda, JOURNAL OF DRUG TARGETING, TAYLOR & FRANCIS LTD, Vol. 15, No. 1, p. 75-82, 2007
  • Transient local overexpression of human vascular endothelial growth factor (VEGF) in mouse feto-maternal interface during mid-term pregnancy lowers systemic maternal blood pressure., Koyama S,Kimura T,Ogita K,Nakamura H,Khan MA,Yoshida S,Watanabe M,Shimoya K,Kaneda Y,Murata Y, Horm Metab Res., Vol. 38, No. 10, p. 619-624, 2006/10
  • Hypertension accelerated experimental abdominal aortic aneurysm through upregulation of nuclear factor kappa B and ets, Suguru Shiraya,Ken Miwa,Motokuni Aoki,Takashi Miyake,Masako Oishi,Kazusaburo Kataoka,Shigetsup Ohgi,Toshio Ogihara,Yasufutni Kaneda,Ryuichi Morishita, HYPERTENSION, LIPPINCOTT WILLIAMS & WILKINS, Vol. 48, No. 4, p. 628-636, 2006/10
  • Dnmt3a2 targets endogenous Dnmt3L to ES cell chromatin and induces regional DNA methylation, Keisuke Nimura,Chisaki Ishida,Hiroshi Koriyama,Kenichiro Hata,Shinya Yamanaka,En Li,Kiyoe Ura,Yasufumi Kaneda, GENES TO CELLS, WILEY, Vol. 11, No. 10, p. 1225-1237, 2006/10
  • NFκBデコイDNA軟膏によるアトピー性皮膚炎治療, 玉井 克人,金田 安史,森下 竜一,片山 一朗, 感染・炎症・免疫, 鳥居薬品(株), Vol. 36, No. 3, p. 238-240, 2006/09
  • Inhibitory effects of NF kappa B decoy oligodeoxynucleotides on neointimal hyperplasia in a rabbit vein graft model, Takashi Miyake,Motokuni Aoki,Suguru Shiraya,Kazuo Tanemoto,Toshio Ogihara,Yasufumi Kaneda,Ryuichi Morishita, JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD, Vol. 41, No. 3, p. 431-440, 2006/09
  • Transfection of human hepatocyte growth factor gene ameliorates secondary lymphedema via promotion of lymphangiogenesis, Yukihiro Saito,Hironori Nakagami,Ryuichi Morishita,Yoichi Takami,Yasushi Kikuchi,Hiroki Hayashi,Tomoyuki Nishikawa,Katsuto Tamai,Nobuyoshi Azuma,Tadahiro Sasajima,Yasufumi Kaneda, CIRCULATION, LIPPINCOTT WILLIAMS & WILKINS, Vol. 114, No. 11, p. 1177-1184, 2006/09
  • Novel drug delivery system by surface modified magnetic nanoparticles, Shin-ichi Takeda,Bungo Terazono,Fumihito Mishima,Hironori Nakagami,Shigehiro Nishijima,Yasufumi Kaneda, JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY, AMER SCIENTIFIC PUBLISHERS, Vol. 6, No. 9-10, p. 3269-3276, 2006/09
  • E2F decoy oligodeoxynucleotide ameliorates cartilage invasion by infiltrating synovium derived from rheumatoid arthritis, Tetsuya Tomita,Yasuo Kunugiza,Naruya Tomita,Hiroshi Takano,Ryuichi Morishita,Yasufumi Kaneda,Hideki Yoshikawa, INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, PROFESSOR D A SPANDIDOS, Vol. 18, No. 2, p. 257-265, 2006/08
  • NFkappaB decoy oligodeoxynucleotides ameliorates osteoporosis through inhibition of activation and differentiation of osteoclasts., Shimizu H,Nakagami H,Tsukamoto I,Morita S,Kunugiza Y,Tomita T,Yoshikawa H,Kaneda Y,Ogihara T,Morishita R,Gene therapy, Vol. 13, No. 12, p. 933-941, 2006/06
  • Simple and highly efficient method for transient in vivo gene transfer to mid-late pregnant mouse uterus, S Koyama,T Kimura,K Ogita,H Nakamura,C Tabata,KMAHN Ali,K Temma-Asano,K Shimoya,T Tsutsui,M Koyama,Y Kaneda,Y Murata, JOURNAL OF REPRODUCTIVE IMMUNOLOGY, ELSEVIER IRELAND LTD, Vol. 70, No. 1-2, p. 59-69, 2006/06
  • Total vascular exclusion safely facilitates liver specific gene transfer by the HVJ (sendai virus)-liposome method in rats, Y Kawashita,H Fujioka,A Ohtsuru,H Kuroda,S Eguchi,Y Kaneda,S Yamashita,T Kanematsu, JOURNAL OF SURGICAL RESEARCH, ACADEMIC PRESS INC ELSEVIER SCIENCE, Vol. 132, No. 1, p. 136-141, 2006/05
  • Tumor necrosis factor-alpha antisense transfer remarkably improves hepatic graft viability, T Yoshizumi,Y Yonemitsu,Y Ikeda,Y Kaneda,K Yanaga,K Sugimachi,K Sueishi, LIVER INTERNATIONAL, BLACKWELL PUBLISHING, Vol. 26, No. 4, p. 451-456, 2006/05
  • Non-viral vectors for cancer therapy, Y Kaneda,Y Tabata, CANCER SCIENCE, BLACKWELL PUBLISHING, Vol. 97, No. 5, p. 348-354, 2006/05
  • The effect of VEGF on blood vessels and blood cells during Xenopus development, N Koibuchi,Y Taniyama,K Nagao,T Ogihara,Y Kaneda,R Morishita, BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, ACADEMIC PRESS INC ELSEVIER SCIENCE, Vol. 344, No. 1, p. 339-345, 2006/05
  • Mouse model of human infertility: Transient and local inhibition of endometrial STAT-3 activation results in implantation failure, H Nakamura,T Kimura,S Koyama,K Ogita,T Tsutsui,K Shimoya,T Taniguchi,M Koyama,Y Kaneda,Y Murata, FEBS LETTERS, ELSEVIER SCIENCE BV, Vol. 580, No. 11, p. 2717-2722, 2006/05
  • Interferon-gamma down-regulates expression of the 230-kDa bullous pemphigoid antigen gene (BPAG1) in epidermal keratinocytes via novel chimeric sequences of ISRE and GAS., Kaneko T,Tamai K,Matsuzaki Y,Yamazaki T,Nakano H,Kon A,Hashimoto I,Hanada K,Kaneda Y,Uitto J, Experimental dermatology, Vol. 15, No. 4, p. 308-314, 2006/04
  • Gene transfer of hepatocyte growth factor gene improves learning and memory in the chronic stage of cerebral infarction, M Shimamura,N Sato,S Waguri,Y Uchiyama,T Hayashi,H Iida,T Nakamura,T Ogihara,Y Kaneda,R Morishita, HYPERTENSION, LIPPINCOTT WILLIAMS & WILKINS, Vol. 47, No. 4, p. 742-751, 2006/04
  • Development of high-throughput functional screening of therapeutic genes, using a hemagglutinating virus of Japan envelope vector, T Nishikawa,H Nakagami,A Matsuki,A Maeda,CY Yo,T Harada,R Morishita,K Tamai,Y Kaneda, HUMAN GENE THERAPY, MARY ANN LIEBERT INC, Vol. 17, No. 4, p. 470-475, 2006/04
  • Construction of a novel DNA decoy that inhibits the oncogenic beta-catenin/T-cell factor pathway, Y Seki,H Yamamoto,CY Ngan,M Yasui,N Tomita,K Kitani,Takemasa, I,M Ikeda,M Sekimoto,N Matsuura,C Albanese,Y Kaneda,RG Pestell,M Monden, MOLECULAR CANCER THERAPEUTICS, AMER ASSOC CANCER RESEARCH, Vol. 5, No. 4, p. 985-994, 2006/04
  • Targeted chemotherapy against intraperitoneally disseminated colon carcinoma using a cationized gelatin-conjugated HVJ envelope vector, H Mima,S Yamamoto,M Ito,R Tomoshige,Y Tabata,K Tamai,Y Kaneda, MOLECULAR CANCER THERAPEUTICS, AMER ASSOC CANCER RESEARCH, Vol. 5, No. 4, p. 1021-1028, 2006/04
  • Anti-oxidant gene therapy by NF kappa B decoy oligodeoxynucleotide, Hironori Nakagami,Naruya Tomita,Yasufumi Kaneda,Toshio Ogihara,Ryuichi Morishita, CURRENT PHARMACEUTICAL BIOTECHNOLOGY, BENTHAM SCIENCE PUBL LTD, Vol. 7, No. 2, p. 95-100, 2006/04
  • Adipose tissue-derived stromal cells as a novel option for regenerative cell therapy, H Nakagami,R Morishita,K Maeda,Y Kikuchi,T Ogihara,Y Kaneda, JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, JAPAN ATHEROSCLEROSIS SOC, Vol. 13, No. 2, p. 77-81, 2006/04
  • Heat-directed suicide gene therapy mediated by heat shock protein promoter for gastric cancer, H Isomoto,A Ohtsuru,Braiden, V,M Iwamatsu,F Miki,Y Kawashita,Y Mizuta,Y Kaneda,S Kohno,S Yamashita, ONCOLOGY REPORTS, PROFESSOR D A SPANDIDOS, Vol. 15, No. 3, p. 629-635, 2006/03
  • Liver-directed gene therapy of diabetic rats using an HVJ-E vector containing EBV plasmids expressing insulin and GLUT 2 transporter, YD Kim,KG Park,R Morishita,Y Kaneda,SY Kim,DK Song,HS Kim,CW Nam,HC Lee,KU Lee,JY Park,BW Kim,JG Kim,IK Lee, GENE THERAPY, NATURE PUBLISHING GROUP, Vol. 13, No. 3, p. 216-224, 2006/02
  • DNA vaccine using hemagglutinating virus of Japan-liposome encapsulating combination encoding mycobacterial heat shock protein 65 and interleukin-12 confers protection against Mycobacterium tuberculosis by T cell activation, S Yoshida,T Tanaka,Y Kita,S Kuwayama,N Kanamaru,Y Muraki,S Hashimoto,Y Inoue,M Sakatani,E Kobayashi,Y Kaneda,M Okada, VACCINE, ELSEVIER SCI LTD, Vol. 24, No. 8, p. 1191-1204, 2006/02
  • Prevention of onset of Parkinson's disease by in vivo gene transfer of human hepatocyte growth factor in rodent model: a model of gene therapy for Parkinson's disease., Koike H,Ishida A,Shimamura M,Mizuno S,Nakamura T,Ogihara T,Kaneda Y,Morishita R, Gene Therapy, Vol. 13, p. 1639-1644, 2006
  • Enhancement of immunity by a DNA melanoma vaccine against TRP2 with CCL21 as an adjuvant, T Yamano,Y Kaneda,S Huang,SH Hiramatsu,DSB Hoon, MOLECULAR THERAPY, ACADEMIC PRESS INC ELSEVIER SCIENCE, Vol. 13, No. 1, p. 194-202, 2006/01
  • HVJ-based non-viral gene transfer method: successful gene therapy using HGF and VEGF genes in experimental ischemia, M Shimamura,N Sato,S Yoshimura,Y Kaneda,R Morishita, FRONTIERS IN BIOSCIENCE, FRONTIERS IN BIOSCIENCE INC, Vol. 11, p. 753-759, 2006/01
  • Novel autologous cell therapy in ischemic limb disease through growth factor secretion by cultured adipose tissue-derived stromal cells, H Nakagami,K Maeda,R Morishita,S Iguchi,T Nishikawa,Y Takami,Y Kikuchi,Y Saito,K Tamai,T Ogihara,Y Kaneda, ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, LIPPINCOTT WILLIAMS & WILKINS, Vol. 25, No. 12, p. 2542-2547, 2005/12
  • Assembly of additional heterochromatin distinct from centromere-kinetochore chromatin is required for de novo formation of human artificial chromosome, H Nakashima,M Nakano,R Ohnishi,Y Hiraoka,Y Kaneda,A Sugino,H Masumoto, JOURNAL OF CELL SCIENCE, COMPANY OF BIOLOGISTS LTD, Vol. 118, No. 24, p. 5885-5898, 2005/12
  • The efficacy and safety of gene transfer into the porcine liver in vivo by HVJ (Sendai virus) liposome, Y Kawashita,H Fujioka,A Ohtsuru,Y Kaneda,Y Kamohara,Y Kawazoe,S Yamashita,T Kanematsu, TRANSPLANTATION, LIPPINCOTT WILLIAMS & WILKINS, Vol. 80, No. 11, p. 1623-1629, 2005/12
  • [Current status and future prospective of gene therapy]., Kaneda Y, Nihon rinsho. Japanese journal of clinical medicine, Vol. 63 Suppl 12, p. 469-474, 2005/12
  • [Strategies for gene therapy]., Kaneda Y, Nihon rinsho. Japanese journal of clinical medicine, Vol. 63 Suppl 12, p. 486-490, 2005/12
  • [Future view of gene therapy in cardiovascular field]., Nkagami H,Kaneda Y,Morishita R, Nihon rinsho. Japanese journal of clinical medicine, Vol. 63 Suppl 12, p. 577-581, 2005/12
  • NFkappaB decoy DNA for treatment of atopic dermatitis, Katsuto Tamai,Yasufumi Kaneda,Hiroshige Nakamura,Motohiro Aoki,Ryuichi Morishita,Koji Hashimoto,Akimichi Morita,Ichiro Katayama,Katsumi Hanada, Nippon rinsho. Japanese journal of clinical medicine, Vol. 63 Suppl 12, p. 659-663, 2005/12
  • Gene transfer into adult rat spinal cord using naked plasmid DNA and ultrasound microbubbles, M Shimamura,N Sato,Y Taniyama,H Kurinami,H Tanaka,T Takami,T Ogihara,M Tohyama,Y Kaneda,R Morishita, JOURNAL OF GENE MEDICINE, JOHN WILEY & SONS LTD, Vol. 7, No. 11, p. 1468-1474, 2005/11
  • Microbubble-enhanced ultrasound for gene transfer into living skin equivalents, LJ Yang,Y Shirakata,K Tamai,XJ Dai,Y Hanakawa,S Tokumaru,Y Yahata,M Tohyama,K Shiraishi,H Nagai,XL Wang,S Murakami,K Sayama,Y Kaneda,K Hashimoto, JOURNAL OF DERMATOLOGICAL SCIENCE, ELSEVIER IRELAND LTD, Vol. 40, No. 2, p. 105-114, 2005/11
  • Gene transfer of prostaglandin synthase maintains patency of the newborn lamb arterial duct, T Humpl,SHE Zaidi,JY Coe,J Russell,Y Kaneda,H Massaeli,LN Benson,M Rabinovitch, PEDIATRIC RESEARCH, INT PEDIATRIC RESEARCH FOUNDATION, INC, Vol. 58, No. 5, p. 976-980, 2005/11
  • In vivo gene transfer into the mouse uterus: A powerful tool for investigating implantation physiology, T Kimura,H Nakamura,S Koyama,K Ogita,C Tabata,T Tsutsui,K Shimoya,M Koyama,Y Kaneda,Y Murata, JOURNAL OF REPRODUCTIVE IMMUNOLOGY, ELSEVIER IRELAND LTD, Vol. 67, No. 1-2, p. 13-20, 2005/10
  • HVJ-Eベクターを用いたHigh Throughput Screeningによる新規遺伝子機能スクリーニング 血管リモデリング抑制遺伝子の検索, 鷹見 洋一,中神 啓徳,勝谷 友宏,楽木 宏実,森下 竜一,金田 安史,荻原 俊男, 日本高血圧学会総会プログラム・抄録集, (NPO)日本高血圧学会, Vol. 28回, p. 84-84, 2005/09
  • Hepatocyte growth factor(HGF)によるリンパ管新生作用, 斉藤 幸裕,中神 啓徳,鷹見 洋一,森下 竜一,金田 安史,東 信良,笹嶋 唯博, 日本高血圧学会総会プログラム・抄録集, (NPO)日本高血圧学会, Vol. 28回, p. 87-87, 2005/09
  • Development of novel method of non-viral efficient gene transfer into neonatal cardiac myocytes, H Tashiro,M Aoki,M Isobe,N Hashiya,H Makino,Y Kaneda,T Ogihara,R Morishita, JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD, Vol. 39, No. 3, p. 503-509, 2005/09
  • Magnetic nanoparticles with surface modification enhanced gene delivery of HVJ-E vector, N Morishita,H Nakagami,R Morishita,S Takeda,F Mishima,B Terazono,S Nishijima,Y Kaneda,N Tanaka, BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, ACADEMIC PRESS INC ELSEVIER SCIENCE, Vol. 334, No. 4, p. 1121-1126, 2005/09
  • Gene transfection with human hepatocyte growth factor complementary DNA plasmids attenuates cardiac remodeling after acute myocardial infarction in goat hearts implanted with ventricular assist devices, Y Shirakawa,Y Sawa,Y Takewa,E Tatsumi,Y Kaneda,Y Taenaka,H Matsuda, JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, MOSBY, INC, Vol. 130, No. 3, p. 624-632, 2005/09
  • Rad51 siRNA delivered by HVJ envelope vector enhances the anti-cancer effect of cisplatin, M Ito,S Yamamoto,K Nimura,K Hiraoka,K Tamai,Y Kaneda, JOURNAL OF GENE MEDICINE, JOHN WILEY & SONS LTD, Vol. 7, No. 8, p. 1044-1052, 2005/08
  • Nonviral HVJ (hemagglutinating virus of Japan) liposome-mediated retrograde gene transfer of human hepatocyte growth factor into rat nervous system promotes functional and histological recovery of the crushed nerve, N Kato,K Nemoto,K Nakanishi,R Morishita,Y Kaneda,M Uenoyama,T Ikeda,K Fujikawa, NEUROSCIENCE RESEARCH, ELSEVIER IRELAND LTD, Vol. 52, No. 4, p. 299-310, 2005/08
  • Inhibition of ets, an essential transcription factor for angiogenesis, to prevent the development of abdominal aortic aneurysm in a rat model., Miwa K,Nakashima H,Aoki M,Miyake T,Kawasaki T,Iwai M,Oishi M,Kataoka,K,Ohgi S,Ogihara T,Kaneda Y,Morishita R, Gene Therapy, 2005/07
  • Biocompatible polymer enhances the in vitro and in vivo transfection efficiency of HVJ envelope vector, H Mima,R Tomoshige,T Kanamori,Y Tabata,S Yamamoto,S Ito,K Tamai,Y Kaneda, JOURNAL OF GENE MEDICINE, JOHN WILEY & SONS LTD, Vol. 7, No. 7, p. 888-897, 2005/07
  • Induction of compensatory lung growth in pulmonary emphysema improves surgical outcomes in rats, N Shigemura,Y Sawa,S Mizuno,M Ono,M Minami,M Okumura,T Nakamura,Y Kaneda,H Matsuda, AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, AMER THORACIC SOC, Vol. 171, No. 11, p. 1237-1245, 2005/06
  • Hepatocyte growth factor gene therapy reduces ventricular arrhythmia in animal models of myocardial ischemia, A Yumoto,KF Kusano,K Nakamura,K Hashimoto,M Aoki,R Morishita,Y Kaneda,T Ohe, ACTA MEDICA OKAYAMA, OKAYAMA UNIV MED SCHOOL, Vol. 59, No. 3, p. 73-78, 2005/06
  • Hepatocyte growth factor as potential cardiovascular therapy, Hironori Nakagami,Yasufumi Kaneda,Toshio Ogihara,Ryuichi Morishita, Expert Review of Cardiovascular Therapy, Vol. 3, No. 3, p. 513-519, 2005/05
  • Hemagglutinating virus of Japan-artificial viral envelope liposome-mediated cotransfer of bag-1 and bcl-2 genes protects hepatic cells against ischemic injury through BAG-1-Assisted preferential enhancement of Bcl-2 protein expression, S Yanada,M Sasaki,S Takayama,Y Kaneda,N Miwa, HUMAN GENE THERAPY, MARY ANN LIEBERT INC, Vol. 16, No. 5, p. 627-633, 2005/05
  • 超音波とマイクロバブルを用いた三次元皮膚への遺伝子導入, 楊 旅軍,白方 裕司,花川 靖,玉井 克人,金田 安史,橋本 公二, 日本研究皮膚科学会年次学術大会・総会プログラム, (一社)日本研究皮膚科学会, Vol. 30回, p. 92-92, 2005/04
  • Ameliorating effect of hepatocyte growth factor on inflammatory bowel disease in a murine model, K Oh,Y Iimuro,M Takeuchi,Y Kaneda,T Iwasaki,N Terada,T Matsumoto,K Nakanishi,J Fujimoto, AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, AMER PHYSIOLOGICAL SOC, Vol. 288, No. 4, p. G729-G735, 2005/04
  • Linker histone variants control chromatin dynamics during early embryogenesis, H Saeki,K Ohsumi,H Aihara,T Ito,S Hirose,K Ura,Y Kaneda, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, NATL ACAD SCIENCES, Vol. 102, No. 16, p. 5697-5702, 2005/04
  • The effect of gene transfer with hepatocyte growth factor for pulmonary vascular hypoplasia in neonatal porcine model, M Ono,Y Sawa,Y Miyamoto,N Fukushima,H Ichikawa,T Ishizaka,Y Kaneda,H Matsuda, JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, MOSBY, INC, Vol. 129, No. 4, p. 740-745, 2005/04
  • 遺伝性皮膚疾患の遺伝子治療法開発, 玉井 克人,山崎 尊彦,大鶴 聡,知野 剛直,菊池 康,金田 安史,片山 一朗, 角化症研究会記録集, 角化症研究会事務局, Vol. 19, p. 52-55, 2005/03
  • Nonviral gene transfer of human hepatocyte growth factor improves streptozotocin-induced diabetic neuropathy in rats, N Kato,K Nemoto,K Nakanishi,R Morishita,Y Kaneda,M Uenoyama,T Ikeda,K Fujikawa, DIABETES, AMER DIABETES ASSOC, Vol. 54, No. 3, p. 846-854, 2005/03
  • Novel recombinant BCG and DNA-vaccination against tuberculosis in a cynomolgus monkey, Y Kita,T Tanaka,S Yoshida,N Ohara,Y Kaneda,S Kuwayama,Y Muraki,N Kanamaru,S Hashimoto,H Takai,C Okada,Y Fukunaga,Y Sakaguchi,IN Furukawa,K Yamada,Y Inoue,Y Takemoto,M Naito,T Yamada,M Matsumoto,DN McMurray,EC Dela Cruz,EV Tan,RM Abalos,JA Burgos,R Gelber,Y Skeiky,S Reed,M Sakatani,M Okada, VACCINE, ELSEVIER SCI LTD, Vol. 23, No. 17-18, p. 2132-2135, 2005/03
  • Amelioration of pulmonary emphysema by in vivo gene transfection with hepatocyte growth factor in rats, N Shigemura,Y Sawa,S Mizuno,M Ono,M Ohta,T Nakamura,Y Kaneda,H Matsuda, CIRCULATION, LIPPINCOTT WILLIAMS & WILKINS, Vol. 111, No. 11, p. 1407-1414, 2005/03
  • 妊娠中期後期の妊娠関連事象研究のための一過性遺伝子導入系の開発, 香山 晋輔,木村 正,中村 仁美,荻田 和秀,田畑 知沙,古山 将康,村田 雄二,金田 安史, 日本産科婦人科学会雑誌, (公社)日本産科婦人科学会, Vol. 57, No. 2, p. 546-546, 2005/02
  • Endothelial dysfunction in hyperglycemia as a trigger of atherosclerosis., Nakagami H,Kaneda Y,Ogihara T,Morishita R, Current diabetes reviews, Vol. 1, No. 1, p. 59-63, 2005/02
  • Endothelial Dysfunction in Hyperglycemia as a Trigger of Atherosclerosis., Nakagami H,Kaneda Y,Ogihara T,Morishita R, Current Diabetes Reviews, 2005/01
  • Endothelial dysfunction in hyperglycemia as a trigger of atherosclerosis., Nakagami H,Kaneda Y,Ogihara T,Morishita R, Current Diabetes Reviews, 2005/01
  • Development of HVJ Envelope Vector and Its Application to Gene Therapy, Yasufumi Kaneda,Seiji Yamamoto,Toshihiro Nakajima, NON-VIRAL VECTORS FOR GENE THERAPY, 2ND EDITION: PART 1, ELSEVIER ACADEMIC PRESS INC, Vol. 53, p. 307-332, 2005
  • Development of HVJ Envelope Vector and Its Application to Gene Therapy, Yasufumi Kaneda,Seiji Yamamoto,Toshihiro Nakajima, NON-VIRAL VECTORS FOR GENE THERAPY, 2ND EDITION: PART 1, ELSEVIER ACADEMIC PRESS INC, Vol. 53, p. 307-332, 2005
  • In vivo transfection of a cis element 'decoy' against signal transducers and activators of transcription 6 (STAT6)-binding site ameliorates IgE-mediated late-phase reaction in an atopic dermatitis mouse model, H. Yokozeki,M. H. Wu,K. Sumi,K. Awad,T. Satoh,I. Katayama,K. Takeda,S. Akira,Y. Kaneda,K. Nishioka, Gene Therapy, Vol. 11, No. 24, p. 1753-1762, 2004/12
  • In vivo transfection of a cis element 'decoy' against signal transducers and activators of the transcription 6 (STAT6) binding site ameliorates the response of contact hypersensitivity, K. Sumi,H. Yokozeki,M. H. Wu,T. Satoh,Y. Kaneda,K. Takeda,S. Akira,K. Nishioka, Gene Therapy, Vol. 11, No. 24, p. 1763-1771, 2004/12
  • Cytoprotection by bcl-2 gene transfer against ischemic liver injuries together with repressed lipid peroxidation and increased ascorbic acid in livers and serum, S Yanada,Y Saitoh,Y Kaneda,N Miwa, JOURNAL OF CELLULAR BIOCHEMISTRY, WILEY-BLACKWELL, Vol. 93, No. 5, p. 857-870, 2004/11
  • Somatic gene targeting with RNA/DNA chimeric oligonucleotides: an analysis with a sensitive reporter mouse system, A Ino,S Yamamoto,Y Kaneda,Kobayashi, I, JOURNAL OF GENE MEDICINE, JOHN WILEY & SONS LTD, Vol. 6, No. 11, p. 1272-1280, 2004/11
  • Application of decoy oligodeoxynucleotides-based approach to renal diseases, N Tomita,H Azuma,Y Kaneda,T Ogihara,R Morishita, CURRENT DRUG TARGETS, BENTHAM SCIENCE PUBL LTD, Vol. 5, No. 8, p. 717-733, 2004/11
  • Subcellular trafficking of exogenously expressed interferon-beta in Madin-Darby canine kidney cells, M Maruyama,T Nishio,T Kato,T Yoshida,C Ishida,Y Watanabe,M Nishikawa,Y Kaneda,Y Takakura, JOURNAL OF CELLULAR PHYSIOLOGY, WILEY-LISS, Vol. 201, No. 1, p. 117-125, 2004/10
  • Enhanced tumor-specific long-term immunity of hemaggluttinating virus of Japan-mediated dendritic cell-tumor fused cell vaccination-by coadministration with CpG oligodeoxynucleotides, K Hiraoka,S Yamamoto,S Otsuru,S Nakai,K Tamai,R Morishita,T Ogihara,Y Kaneda, JOURNAL OF IMMUNOLOGY, AMER ASSOC IMMUNOLOGISTS, Vol. 173, No. 7, p. 4297-4307, 2004/10
  • Safety evaluation of clinical gene therapy using hepatocyte growth factor to treat peripheral arterial disease., Morishita Ryuichi, Hypertension, 2004/09
  • Alteration of the timing of implantation by in vivo gene transfer: delay of implantation by suppression of nuclear factor kappa B activity and partial rescue by leukemia inhibitory factor, H Nakamura,T Kimura,K Ogita,S Koyama,T Tsujie,T Tsutsui,K Shimoya,M Koyama,Y Kaneda,Y Murata, BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, ACADEMIC PRESS INC ELSEVIER SCIENCE, Vol. 321, No. 4, p. 886-892, 2004/09
  • Periostin as a novel factor responsible for ventricular dilation, N Katsuragi,R Morishita,N Nakamura,T Ochiai,Y Taniyama,Y Hasegawa,K Kawashima,Y Kaneda,T Ogihara,K Sugimura, CIRCULATION, LIPPINCOTT WILLIAMS & WILKINS, Vol. 110, No. 13, p. 1806-1813, 2004/09
  • Effective accumulation of poly(vinylpyrrolidone-co-vinyl laurate) into the spleen, Y Yoshioka,Y Tsutsumi,Y Mukai,H Shibata,T Okamoto,Y Kaneda,S Tsunoda,H Kamada,K Koizumi,Y Yamamoto,Y Mu,H Kodaira,K Sato-Kamada,S Nakagawa,T Mayumi, JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A, WILEY-LISS, Vol. 70A, No. 2, p. 219-223, 2004/08
  • Safety evaluation of clinical gene therapy using hepatocyte growth factor to treat peripheral arterial disease., Morishita R,Aoki M,Hashiya N,Makino H,Yamasaki K,Azuma J,Sawa Y,Matsuda H,Kaneda Y,Ogihara T, Hypertension, 2004/08
  • Safety evaluation of clinical gene therapy using hepatocyte growth factor to treat peripheral arterial disease, R Morishita,M Aoki,N Hashiya,H Makino,K Yamasaki,J Azuma,Y Sawa,H Matsuda,Y Kaneda,T Ogihara, HYPERTENSION, LIPPINCOTT WILLIAMS & WILKINS, Vol. 44, No. 2, p. 203-209, 2004/08
  • Hemagglutinating virus of Japan protein is efficient for induction of CD4(+) T-cell response by a hepatitis B core particle-based HIV vaccine, S Takeda,K Shiosaki,Y Kaneda,T Nakasatomi,H Yoshizaki,K Someya,Y Konno,Y Eda,Y Kino,N Yamamoto,M Honda, CLINICAL IMMUNOLOGY, ACADEMIC PRESS INC ELSEVIER SCIENCE, Vol. 112, No. 1, p. 92-105, 2004/07
  • Transcription factor decoy for AP-1 reduces mesangial cell proliferation and extracellular matrix production in vitro and in vivo, JD Ahn,R Morishita,Y Kaneda,HJ Kim,YD Kim,HJ Lee,KU Lee,JY Park,YH Kim,KK Park,YC Chang,KH Yoon,HS Kwon,KG Park,IK Lee, GENE THERAPY, NATURE PUBLISHING GROUP, Vol. 11, No. 11, p. 916-923, 2004/06
  • Inhibition of experimental abdominal aortic aneurysm in the rat by use of decoy oligodeoxynucleotides suppressing activity of nuclear factor kappaB and ets transcription factors., Nakashima H, Circulation, 2004/06
  • In vivo evidence of angiogenesis induced by transcription factor ets-1 - Ets-1 is located upstream of angiogenesis cascade, N Hashiya,N Jo,M Aoki,K Matsumoto,T Nakamura,Y Sato,N Ogata,T Ogihara,Y Kaneda,R Morishita, CIRCULATION, LIPPINCOTT WILLIAMS & WILKINS, Vol. 109, No. 24, p. 3035-3041, 2004/06
  • Enhanced therapeutic angiogenesis by cotransfection of prostacyclin synthase gene or optimization of intramusclular injection of naked plasmid DNA, Hiraoka, K,Koike, H,Yamamoto, S,Tomita, N,Yokoyama, C,Tanabe, T,Aikou, T,Ogihara, T,Kaneda, Y,Morishita, R, Circulation, 2004/06
  • Essential role of HGF (hepatocyte growth factor) in blood formation in Xenopus., Koibuchi, N,Kaneda, Y,Taniyama, Y,Matsumoto, K,Nakamura, T,Ogihara, T,Morishita, R, Blood, 2004/06
  • In vivo evidence of angiogenesis induced by transcription factor ets-1 - Ets-1 is located upstream of angiogenesis cascade, N Hashiya,N Jo,M Aoki,K Matsumoto,T Nakamura,Y Sato,N Ogata,T Ogihara,Y Kaneda,R Morishita, CIRCULATION, LIPPINCOTT WILLIAMS & WILKINS, Vol. 109, No. 24, p. 3035-3041, 2004/06
  • The HVJ-envelope as an innovative vector system for cardiovascular disease, H Kotani,T Nakajima,SP Lai,R Morishita,Y Kaneda, CURRENT GENE THERAPY, BENTHAM SCIENCE PUBL LTD, Vol. 4, No. 2, p. 183-194, 2004/06
  • Lack of association between the hepatocyte growth factor receptor, c-met, and the anti-apoptotic action of bag-1 in endothelial cells, H Nakagami,R Morishita,T Nishikawa,H Shimizu,S Iguchi,K Matsumoto,T Nakamura,Y Kaneda,T Ogihara, HYPERTENSION RESEARCH, JAPANESE SOC HYPERTENSION CENT ACADEMIC SOC, PUBL OFFICE, Vol. 27, No. 5, p. 359-365, 2004/05
  • Gene therapy with an E2F transcription factor decoy inhibits cell cycle progression in rat anti-Thy 1 glomerulonephritis, N Tomita,JYS Kim,GH Gibbons,LN Zhang,Y Kaneda,RAK Stahl,M Ogborn,B Venderville,R Morishita,D Baran,VJ Dzau, INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, PROFESSOR D A SPANDIDOS, Vol. 13, No. 5, p. 629-636, 2004/05
  • Transposon-independent increase of transcription by the Sleeping Beauty transposase, K Masuda,S Yamamoto,M Endoh,Y Kaneda, BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, ACADEMIC PRESS INC ELSEVIER SCIENCE, Vol. 317, No. 3, p. 796-800, 2004/05
  • Lack of association between the hepatocyte growth factor receptor, c-met, and the anti-apoptotic action of bag-1 in endothelial cells, H Nakagami,R Morishita,T Nishikawa,H Shimizu,S Iguchi,K Matsumoto,T Nakamura,Y Kaneda,T Ogihara, HYPERTENSION RESEARCH, JAPANESE SOC HYPERTENSION CENT ACADEMIC SOC, PUBL OFFICE, Vol. 27, No. 5, p. 359-365, 2004/05
  • 【皮膚科医のための臨床トピックス】遺伝子治療の現状 おとり型核酸医薬など, 玉井 克人,金田 安史,中邨 弘重,森下 竜一,中野 創,花田 勝美,板見 智,片山 一郎, 臨床皮膚科, (株)医学書院, Vol. 58, No. 5, p. 171-174, 2004/04
  • Molecular therapy to inhibit NF kappa B activation by transcription factor decoy oligonucleotides, R Morishita,N Tomita,Y Kaneda,T Ogihara, CURRENT OPINION IN PHARMACOLOGY, ELSEVIER SCI LTD, Vol. 4, No. 2, p. 139-146, 2004/04
  • Local delivery of E2F decoy oligodeoxynucleotides using ultrasound with microbubble agent (Optison) inhibits intimal hyperplasia after balloon injury in rat carotid artery model, N Hashiya,M Aoki,K Tachibana,Y Taniyama,K Yamasaki,K Hiraoka,H Makino,K Yasufumi,T Ogihara,R Morishita, BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, ACADEMIC PRESS INC ELSEVIER SCIENCE, Vol. 317, No. 2, p. 508-514, 2004/04
  • 医学研究者,医療者における様々な遺伝子診断に対する意識調査, 駒沢 伸泰,村岡 潔,玉井 克人,金田 安史,森本 兼嚢, 日本遺伝カウンセリング学会誌, (一社)日本遺伝カウンセリング学会, Vol. 25, No. 1, p. 41-41, 2004/03
  • Lamr1 functional retroposon causes right ventricular dysplasia in mice, Y Asano,S Takashima,M Asakura,Y Shintani,YL Liao,T Minamino,H Asanuma,S Sanada,J Kim,A Ogai,T Fukushima,Y Oikawa,Y Okazaki,Y Kaneda,M Sato,J Miyazaki,S Kitamura,H Tomoike,M Kitakaze,M Hori, NATURE GENETICS, NATURE PUBLISHING GROUP, Vol. 36, No. 2, p. 123-130, 2004/02
  • No influence of tumor growth by intramuscular injection of hepatocyte growth factor plasmid DNA: safety evaluation of therapeutic angiogenesis gene therapy in mice, A Matsuki,S Yamamoto,H Nakagami,M Aoki,K Tamai,K Matsumoto,T Nakamura,T Ogihara,Y Kaneda,R Morishita, BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, ACADEMIC PRESS INC ELSEVIER SCIENCE, Vol. 315, No. 1, p. 59-65, 2004/02
  • Delivery of siRNA using HVJ envelope vector, Yasufumi Kaneda, Drug Delivery System, Vol. 19, No. 4, p. 379-384, 2004
  • Hepatocyte growth factor both prevents and ameliorates the symptoms of dermal sclerosis in a mouse model of scleroderma, M. H. Wu,H. Yokozeki,S. Takagawa,T. Yamamoto,T. Satoh,Y. Kaneda,I. Katayama,K. Nishioka, Gene Therapy, Vol. 11, No. 2, p. 170-180, 2004/01
  • Novel (recombinant BCG- and DNA-) vaccination against tuberculosis using cynomolgus monkey, Kita, I,T Tanaka,S Yoshida,N Ohara,Y Kaneda,Kuwayama, I,Muraki, I,Kanamaru, I,S Hashimoto,H Takai,C Okada,Y Fukunaga,Y Sakaguchi,Furukawa, I,K Yamada,Inoue, I,Takemoto, I,M Naito,T Yamada,M Matsumoto,EC Cruz,EV Tan,RM Abalos,LJ Young,JA Burgos,R Gelber,Y Skeiky,S Reed,M Sakatani,M Okada, IMMUNOLOGY 2004: IMMUNODEFICIENCY, INFECTIOUS DISEASES, IMMUNOMODULATION, AND VACCINES, MEDIMOND PUBLISHING CO, p. 403-406, 2004
  • Inhibition of neointimal hyperplasia after balloon injury by cis-element 'decoy' of early growth response gene-1 in hypercholesterolemic rabbits, K Ohtani,K Egashira,M Usui,M Ishibashi,KI Hiasa,Q Zhao,M Aoki,Y Kaneda,R Morishita,A Takeshita, GENE THERAPY, NATURE PUBLISHING GROUP, Vol. 11, No. 2, p. 126-132, 2004/01
  • Intrathecal injection of HVJ-E containing HGF gene to cerebrospinal fluid can prevent and ameliorate hearing impairment in rats, K Oshima,M Shimamura,S Mizuno,K Tamai,K Doi,R Morishita,T Nakamura,T Kubo,Y Kaneda, FASEB JOURNAL, FEDERATION AMER SOC EXP BIOL, Vol. 18, No. 1, p. 212-214, 2004/01
  • Inhibition of experimental abdominal aortic aneurysm in the rat by use of decoy oligodeoxynucleotides suppressing activity of nuclear factor kappa B and ets transcription factors, H Nakashima,M Aoki,T Miyake,T Kawasaki,M Iwai,N Jo,M Oishi,K Kataoka,S Ohgi,T Ogihara,Y Kaneda,R Morishita, CIRCULATION, LIPPINCOTT WILLIAMS & WILKINS, Vol. 109, No. 1, p. 132-138, 2004/01
  • Novel therapeutic strategy to treat brain ischemia - Overexpression of hepatocyte growth factor gene reduced ischemic injury without cerebral edema in rat model, M Shimamura,N Sato,K Oshima,M Aoki,H Kurinami,S Waguri,Y Uchiyama,T Ogihara,Y Kaneda,R Morishita, CIRCULATION, LIPPINCOTT WILLIAMS & WILKINS, Vol. 109, No. 3, p. 424-431, 2004/01
  • Intramuscular gene transfer of interleukin-10 cDNA reduces atherosclerosis in apolipoprotein E-knockout mice, M Namiki,S Kawashima,T Yamashita,M Ozaki,T Sakoda,N Inoue,KI Hirata,R Morishita,Y Kaneda,M Yokoama, ATHEROSCLEROSIS, ELSEVIER SCI IRELAND LTD, Vol. 172, No. 1, p. 21-29, 2004/01
  • [Gene transfer with ultrasound and microbubbles (optison) as a potential treatment for cardiovascular diseases]., Taniyama Y,Tomita N,Endoh S,Kaneda Y,Ogihara T,Morishita R, Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics, The Japan Geriatrics Society, Vol. 41, No. 1, p. 51-54, 2004/01
  • Egr-1 in vascular smooth muscle cell proliferation in response to allo-antigen, Y Wada,M Fujimori,J Suzuki,K Tsukioka,K Ito,Y Sawa,R Morishita,Y Kaneda,M Isobe,J Amano, JOURNAL OF SURGICAL RESEARCH, ACADEMIC PRESS INC ELSEVIER SCIENCE, Vol. 115, No. 2, p. 294-302, 2003/12
  • Enhanced therapeutic angiogenesis by cotransfection of prostacyclin synthase gene or optimization of intramuscular injection of naked plasmid DNA, K Hiraoka,H Koike,S Yamamoto,N Tomita,C Yokoyama,T Tanabe,T Aikou,T Ogihara,Y Kaneda,R Morishita, CIRCULATION, LIPPINCOTT WILLIAMS & WILKINS, Vol. 108, No. 21, p. 2689-2696, 2003/11
  • Angiogenesis induced by endothelial nitric oxide synthase gene through vascular endothelial growth factor expression in a rat hindlimb ischemia model, T Namba,H Koike,K Murakami,M Aoki,H Makino,N Hashiya,T Ogihara,Y Kaneda,M Kohno,R Morishita, CIRCULATION, LIPPINCOTT WILLIAMS & WILKINS, Vol. 108, No. 18, p. 2250-2257, 2003/11
  • New vector innovation for drug delivery: Development of fusigenic non-viral particles, Y Kaneda, CURRENT DRUG TARGETS, BENTHAM SCIENCE PUBL LTD, Vol. 4, No. 8, p. 599-602, 2003/11
  • Mice with defects in HB-EGF ectodomain shedding show severe developmental abnormalities, S Yamazaki,R Iwamoto,K Saeki,M Asakura,S Takashima,A Yamazaki,R Kimura,H Mizushima,H Moribe,S Higashiyama,M Endoh,Y Kaneda,S Takagi,S Itami,N Takeda,G Yamada,E Mekada, JOURNAL OF CELL BIOLOGY, ROCKEFELLER UNIV PRESS, Vol. 163, No. 3, p. 469-475, 2003/11
  • Ribosomal proteins S0 and S21 are involved in the stability of 18S rRNA in fission yeast, Schizosaccharomyces pombe, M Sato,CJ Kong,H Yoshida,T Nakamura,A Wada,C Shimoda,Y Kaneda, BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, ACADEMIC PRESS INC ELSEVIER SCIENCE, Vol. 311, No. 4, p. 942-947, 2003/11
  • Highly efficient and minimally invasive in-vivo gene transfer to the mouse uterus using haemagglutinating virus of Japan (HVJ) envelope vector, H Nakamura,T Kimura,H Ikegami,K Ogita,S Koyama,K Shimoya,T Tsujie,M Koyama,Y Kaneda,Y Murata, MOLECULAR HUMAN REPRODUCTION, OXFORD UNIV PRESS, Vol. 9, No. 10, p. 603-609, 2003/10
  • Inhibition of inducible NF-kappa B activity reduces chemoresistance to 5-fluorouracil in human stomach cancer cell line, H Uetsuka,M Haisa,M Kimura,M Gunduz,Y Kaneda,T Ohkawa,M Takaoka,T Murata,T Nobuhisa,T Yamatsuji,J Matsuoka,N Tanaka,Y Naomoto, EXPERIMENTAL CELL RESEARCH, ACADEMIC PRESS INC ELSEVIER SCIENCE, Vol. 289, No. 1, p. 27-35, 2003/09
  • [Gene therapy for colorectal cancer in clinical trials]., Hiraoka K,Kaneda Y, Nihon rinsho. Japanese journal of clinical medicine, Vol. 61 Suppl 7, p. 522-525, 2003/09
  • Nuclear factor kappa B decoy oligodeoxynucleotides prevent endotoxin-induced fatal liver failure in a murine model, Ogushi, I,Y Iimuro,E Seki,G Son,T Hirano,T Hada,H Tsutsui,K Nakanishi,R Morishita,Y Kaneda,J Fujimoto, HEPATOLOGY, WILEY-BLACKWELL, Vol. 38, No. 2, p. 335-344, 2003/08
  • Development of Cationic Liposomes Conjugated with HVJ and Immunoliposomes with anti-Thy-1 Antibody, TOMITA Naruya,MORISHITA Ryuichi,KANEDA Yasufumi, Ensho, The Japanese Society of Inflammation and Regeneration, Vol. 23, No. 3, p. 170-174, 2003/05/10
  • Efficient gene transfer from innervated muscle into rat peripheral and central nervous systems using a non-viral haemagglutinating virus of Japan (HVJ)-liposome method, N Kato,K Nakanishi,K Nemoto,R Morishita,Y Kaneda,M Uenoyama,T Ikeda,K Fujikawa, JOURNAL OF NEUROCHEMISTRY, BLACKWELL PUBLISHING LTD, Vol. 85, No. 3, p. 810-815, 2003/05
  • Gene therapy with transcription factor decoy oligonucleotides as a potential treatment for cardiovascular diseases, N Tomita,H Azuma,Y Kaneda,T Ogihara,R Morishita, CURRENT DRUG TARGETS, BENTHAM SCIENCE PUBL LTD, Vol. 4, No. 4, p. 339-346, 2003/05
  • Genomic organization and promoter analysis of the Dnmt3b gene, C Ishida,K Ura,A Hirao,H Sasaki,A Toyoda,Y Sakaki,H Niwa,E Li,Y Kaneda, GENE, ELSEVIER SCIENCE BV, Vol. 310, p. 151-159, 2003/05
  • Suppression of oxidative stress-induced hepatocyte injury by calpain antisense, K Taniguchi,K Umeshita,M Sakon,H Miyoshi,M Tokunaga,H Ariyoshi,T Yamano,Y Kaneda,M Monden, JOURNAL OF SURGICAL RESEARCH, ACADEMIC PRESS INC ELSEVIER SCIENCE, Vol. 111, No. 1, p. 23-27, 2003/05
  • 先天性表皮水疱症 遺伝子治療法の開発, 玉井 克人,菊池 康,花田 勝美,小川 秀興,金田 安史, 日本皮膚科学会雑誌, (公社)日本皮膚科学会, Vol. 113, No. 4, p. 462-462, 2003/04
  • Current status and future prospects of gene therapy technologies toward the treatment of intractable skin diseases, Yasufumi Kaneda,Katsuto Tamai, Archives of Dermatological Research, Supplement, Vol. 295, No. 1, p. S63-S66, 2003/04
  • Current status and future prospects of gene therapy technologies toward the treatment of intractable skin diseases, Y Kaneda,K Tamai, ARCHIVES OF DERMATOLOGICAL RESEARCH, SPRINGER-VERLAG, Vol. 295, p. S63-S66, 2003/04
  • 【アトピー性皮膚炎・蕁麻疹の治療ガイド】新規アトピー性皮膚炎治療薬の開発 転写因子NFκBを標的としたODNの臨床応用, 玉井 克人,森下 竜一,中邨 弘重,千葉 容子,金田 安史,花田 勝美, アレルギーの臨床, (株)北隆館, Vol. 23, No. 3, p. 196-201, 2003/03
  • Antisense in vivo knockdown of synaptotagmin I and synapsin I by HVJ-liposome mediated gene transfer modulates ischemic injury of hippocampus in opposing ways, M Iwakuma,T Anzai,S Kobayashi,M Ogata,Y Kaneda,K Ohno,M Saji, NEUROSCIENCE RESEARCH, ELSEVIER SCI IRELAND LTD, Vol. 45, No. 3, p. 285-296, 2003/03
  • A novel combination of suicide gene therapy and histone deacetylase inhibitor for treatment of malignant melanoma, S Yamamoto,T Yamano,M Tanaka,DSB Hoon,S Takao,R Morishita,T Aikou,Y Kaneda, CANCER GENE THERAPY, NATURE PUBLISHING GROUP, Vol. 10, No. 3, p. 179-186, 2003/03
  • Angiogenic property of hepatocyte growth factor is dependent on Upregulation of essential transcription factor for angiogenesis, ets-1, N Tomita,R Morishita,Y Taniyama,H Koike,M Aoki,H Shimizu,K Matsumoto,T Nakamura,Y Kaneda,T Ogihara, CIRCULATION, LIPPINCOTT WILLIAMS & WILKINS, Vol. 107, No. 10, p. 1411-1417, 2003/03
  • 【アレルギー性疾患の特殊な治療の現状と展望】アトピー性皮膚炎に対する核酸医薬導入による新しい治療法, 玉井 克人,森下 竜一,中邨 広重,金田 安史,花田 勝美, アレルギー・免疫, (株)医薬ジャーナル社, Vol. 10, No. 3, p. 349-356, 2003/02
  • Gene therapy for ischemic brain diseases., Saitoh Y,Kato A,Hagihara Y,Kaneda Y,Yoshimine T, Current gene therapy, Vol. 3, No. 1, p. 49-58, 2003/02
  • Enhanced angiogenesis and improvement of neuropathy by cotransfection of human hepatocyte growth factor and prostacyclin synthase gene, H Koike,R Morishita,S Iguchi,M Aoki,K Matsumoto,T Nakamura,C Yokoyama,T Tanabe,T Ogihara,Y Kaneda, FASEB JOURNAL, FEDERATION AMER SOC EXP BIOL, Vol. 17, No. 2, p. 779-+, 2003/02
  • HGF/NK4 inhibited VEGF-induced angiogenesis in in vitro cultured endothelial cells and in vivo rabbit model., Nakabayashi M,Morishita R,Nakagami H,Kuba K,Matsumoto K,Nakamura T,Tano Y,Kaneda Y,Diabetologia, v, Vol. 46, No. 1, p. 115-123, 2003/01
  • HVJ-envelope vector for gene transfer into central nervous system, M Shimamura,R Morishita,M Endoh,K Oshima,M Aoki,S Waguri,Y Uchiyama,Y Kaneda, BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, ACADEMIC PRESS INC ELSEVIER SCIENCE, Vol. 300, No. 2, p. 464-471, 2003/01
  • Genetic modification of cold-preserved renal grafts using HSP70 or bcl-2 HVJ-liposome method, J Kita,E Kobayashi,A Hishinuma,Y Kaneda, TRANSPLANT IMMUNOLOGY, ELSEVIER SCIENCE BV, Vol. 11, No. 1, p. 7-14, 2003/01
  • Therapeutic potential of oligonucleotide-based therapy in cardiovascular disease, R Morishita,Y Kaneda,T Ogihara, BIODRUGS, ADIS INTERNATIONAL LTD, Vol. 17, No. 6, p. 383-389, 2003
  • The Hemagglutinating Virus of Japan-Liposome Method for Gene Delivery, Yasufumi Kaneda,Seiji Yamamoto,Kazuya Hiraoka, LIPOSOMES, PT C, ELSEVIER ACADEMIC PRESS INC, Vol. 373, p. 482-493, 2003
  • Novel E2F decoy oligodeoxynucleotides inhibit in vitro vascular smooth muscle cell proliferation and in vivo neointimal hyperplasia, JD Ahn,R Morishita,Y Kaneda,HS Kim,YC Chang,KU Lee,JY Park,HW Lee,YH Kim,IK Lee, GENE THERAPY, NATURE PUBLISHING GROUP, Vol. 9, No. 24, p. 1682-1692, 2002/12
  • Synaptotagmin I hypothalamic knockdown prevents amygdaloid seizure-induced damage of hippocampal neurons but not of entorhinal neurons, S Kobayashi,K Ohno,M Iwakuma,Y Kaneda,M Saji, NEUROSCIENCE RESEARCH, ELSEVIER SCI IRELAND LTD, Vol. 44, No. 4, p. 455-465, 2002/12
  • Tissue factor pathway inhibitor gene delivery using HVJ-AVE liposomes markedly reduces restenosis in atherosclerotic arteries, XH Yin,C Yutani,Y Ikeda,K Enjyoji,H Ishibashi-Ueda,S Yasuda,Y Tsukamoto,H Nonogi,Y Kaneda,H Kato, CARDIOVASCULAR RESEARCH, ELSEVIER SCIENCE BV, Vol. 56, No. 3, p. 454-463, 2002/12
  • Expression of matrix metalloproteinases in cardiac allograft vasculopathy and its attenuation by anti MMP-2 ribozyme gene transfection, K Tsukioka,J Suzuki,M Fujimori,Y Wada,K Yamaura,K Ito,R Morishita,Y Kaneda,M Isobe,J Amano, CARDIOVASCULAR RESEARCH, ELSEVIER SCIENCE BV, Vol. 56, No. 3, p. 472-478, 2002/12
  • Gene transfer of human hepatocyte growth factor into rat skin wounds mediated by liposomes coated with the Sendai virus (hemagglutinating virus of Japan), K Nakanishi,M Uenoyama,N Tomita,R Morishita,Y Kaneda,T Ogihara,K Matsumoto,T Nakamura,K Maruta,S Matsuyama,T Kawai,T Aurues,T Hayashi,T Ikeda, AMERICAN JOURNAL OF PATHOLOGY, AMER SOC INVESTIGATIVE PATHOLOGY, INC, Vol. 161, No. 5, p. 1761-1772, 2002/11
  • Targeted gene therapy for rat glomerulonephritis using HVJ-immunoliposomes, N Tomita,R Morishita,K Yamamoto,J Higaki,VJ Dzau,T Ogihara,Y Kaneda, JOURNAL OF GENE MEDICINE, JOHN WILEY & SONS LTD, Vol. 4, No. 5, p. 527-535, 2002/09
  • Human cytomegalovirus immediate-early protein IE2-86, but not IE1-72, causes graft coronary arteriopathy in the transplanted rat heart, K Suzuki,B Murtuza,N Suzuki,M Khan,Y Kaneda,MH Yacoub, CIRCULATION, LIPPINCOTT WILLIAMS & WILKINS, Vol. 106, No. 13, p. I158-I162, 2002/09
  • In vivo gene transfection with hepatocyte growth factor via the pulmonary artery induces angiogenesis in the rat lung, M Ono,Y Sawa,K Matsumoto,T Nakamura,Y Kaneda,H Matsuda, CIRCULATION, LIPPINCOTT WILLIAMS & WILKINS, Vol. 106, No. 13, p. I264-I269, 2002/09
  • Heat shock protein 72 enhances manganese superoxide dismutase activity during myocardial ischemia-reperfusion injury, associated with myocardial protection and apoptosis reduction, K Suzuki,B Murtuza,IA Sammut,N Latif,J Jayakumar,RT Smolenski,Y Kaneda,Y Sawa,H Matsuda,MH Yacoub, CIRCULATION, LIPPINCOTT WILLIAMS & WILKINS, Vol. 106, No. 13, p. I270-I276, 2002/09
  • 転写因子NFkBを標的としたdecoy oligo deoxynucleotides(ODN)による新規アトピー性皮膚炎治療薬の開発と臨床応用, 玉井 克人,森下 竜一,千葉 容子,中邨 弘重,金子 高英,水木 大介,原田 研,中野 創,金田 安史,花田 勝美, 日本研究皮膚科学会年次学術大会・総会プログラム, (一社)日本研究皮膚科学会, Vol. 27回, p. 104-104, 2002/08
  • クロマチン 生命情報発現の拠点 発生分化に伴うクロマチン構造変換とDNAのメチル化, 浦 聖恵,佐伯 英昭,石田 智咲,柏木 克信,森田 奈亜子,金田 安史, 生化学, (公社)日本生化学会, Vol. 74, No. 8, p. 651-651, 2002/08
  • Therapeutic approach to familial hypercholesterolemia by HVJ-liposomes in LDL receptor knockout mouse, N Tomita,R Morishita,H Koike,M Hashizume,M Notake,B Fujitani,Y Kaneda,M Horiuchi,T Ogihara, INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, PROFESSOR D A SPANDIDOS, Vol. 10, No. 2, p. 137-143, 2002/08
  • Hepatocyte growth factor prevents endothelial cell death through inhibition of bax translocation from cytosol to mitochondrial membrane, H Nakagami,R Morishita,K Yamamoto,Y Taniyama,M Aoki,K Yamasaki,K Matsumoto,T Nakamura,Y Kaneda,T Ogihara, DIABETES, AMER DIABETES ASSOC, Vol. 51, No. 8, p. 2604-2611, 2002/08
  • Hemagglutinating virus of Japan (HVJ) envelope vector as a versatile gene delivery system, Y Kaneda,T Nakajima,T Nishikawa,S Yamamoto,H Ikegami,N Suzuki,H Nakamura,R Morishita,H Kotani, MOLECULAR THERAPY, ACADEMIC PRESS INC ELSEVIER SCIENCE, Vol. 6, No. 2, p. 219-226, 2002/08
  • Angiogenesis and antifibrotic action by hepatocyte growth factor in cardiomyopathy, Y Taniyama,R Morishita,M Aoki,K Hiraoka,K Yamasaki,N Hashiya,K Matsumoto,T Nakamura,Y Kaneda,T Ogihara, HYPERTENSION, LIPPINCOTT WILLIAMS & WILKINS, Vol. 40, No. 1, p. 47-53, 2002/07
  • Inhibitory effects of novel AP-1 decoy oligodeoxynucleotides on vascular smooth muscle cell proliferation in vitro and neointimal formation in vivo, JD Ahn,R Morishita,Y Kaneda,SJ Lee,KY Kwon,SY Choi,KU Lee,JY Park,IJ Moon,JG Park,M Yoshizumi,Y Ouchi,IK Lee, CIRCULATION RESEARCH, LIPPINCOTT WILLIAMS & WILKINS, Vol. 90, No. 12, p. 1325-1332, 2002/06
  • Transluminal gene transfer into brain capillary endothelial cells in vivo with HVJ-liposomes, C Jiang,H Matsuo,N Koyabu,H Ohtani,H Fujimoto,Y Yonemitsu,Y Kaneda,M Naito,T Tsuruo,Y Sawada, JOURNAL OF DRUG TARGETING, TAYLOR & FRANCIS LTD, Vol. 10, No. 4, p. 345-352, 2002/06
  • Effective transfection of a cis element "decoy" of the nuclear factor-kappa B binding site into the experimental choroidal neovascularization, N Jo,N Ogata,M Aoki,T Otsuji,R Morishita,Y Kaneda,M Matsumura, CURRENT EYE RESEARCH, SWETS ZEITLINGER PUBLISHERS, Vol. 24, No. 6, p. 465-473, 2002/06
  • 高齢者閉塞性動脈硬化症に対するHGF遺伝子プラスミドを用いた血管新生療法の検討, 若山 幸示,森下 竜一,青木 元邦,山崎 慶太,牧野 寛史,橋弥 尚孝,東 純哉,村上 和司,金田 安史,荻原 俊男, 日本老年医学会雑誌, (一社)日本老年医学会, Vol. 39, No. Suppl., p. 89-89, 2002/05
  • Fetal gene transfer by intrauterine injection with microbubble-enhanced ultrasound, M Endoh,N Koibuchi,M Sato,R Morishita,T Kanzaki,Y Murata,Y Kaneda, MOLECULAR THERAPY, ACADEMIC PRESS INC ELSEVIER SCIENCE, Vol. 5, No. 5, p. 501-508, 2002/05
  • Gene transfer of hepatocyte growth factor to subarachnoid space in cerebral hypoperfusion model, S Yoshimura,R Morishita,K Hayashi,J Kokuzawa,M Aoki,K Matsumoto,T Nakamura,T Ogihara,N Sakai,Y Kaneda, HYPERTENSION, LIPPINCOTT WILLIAMS & WILKINS, Vol. 39, No. 5, p. 1028-1034, 2002/05
  • Molecular strategy using cis-element 'decay' of E2F binding site inhibits neointimal formation in porcine balloon-injured coronary artery model, T Nakamura,R Morishita,T Asai,N Tsuboniwa,M Aoki,H Sakonjo,K Yamasaki,N Hashiya,Y Kaneda,T Ogihara, GENE THERAPY, NATURE PUBLISHING GROUP, Vol. 9, No. 8, p. 488-494, 2002/04
  • N141I mutant Presenilin-2 gene enhances neuronal cell death and decreases bcl-2 expression, M Mori,H Nakagami,R Morishita,N Mitsuda,K Yamamoto,S Yoshimura,N Ohkubo,N Sato,T Ogihara,Y Kaneda, LIFE SCIENCES, PERGAMON-ELSEVIER SCIENCE LTD, Vol. 70, No. 21, p. 2567-2580, 2002/04
  • Induction of a systemic immune response by a polyvalent melanoma-associated antigen DNA vaccine for prevention and treatment of malignant melanoma, M Tanaka,Y Kaneda,S Fujii,T Yamano,K Hashimoto,SKS Huang,DSB Hoon, MOLECULAR THERAPY, ACADEMIC PRESS INC ELSEVIER SCIENCE, Vol. 5, No. 3, p. 291-299, 2002/03
  • Local delivery of plasmid DNA into rat carotid artery using ultrasound, Y Taniyama,K Tachibana,K Hiraoka,T Namba,K Yamasaki,N Hashiya,M Aoki,T Ogihara,K Yasufumi,R Morishita, CIRCULATION, LIPPINCOTT WILLIAMS & WILKINS, Vol. 105, No. 10, p. 1233-1239, 2002/03
  • Impairment of collateral formation in lipoprotein(a) transgenic mice - Therapeutic angiogenesis induced by human hepatocyte growth factor gene, R Morishita,M Sakaki,K Yamamoto,S Iguchi,M Aoki,K Yamasaki,K Matsumoto,T Nakamura,R Lawn,T Ogihara,Y Kaneda, CIRCULATION, LIPPINCOTT WILLIAMS & WILKINS, Vol. 105, No. 12, p. 1491-1496, 2002/03
  • Gene Therapy, KANEDA Yasufumi, Skin research, Meeting of Osaka Dermatological Association/Meeting of Keiji Dermatological Association, Vol. 1, No. 1, p. 7-14, 2002
  • Local overexpression of monocyte chemoattractant protein-1 at vessel wall induces infiltration of macrophages and formation of atherosclerotic lesion - Synergism with hypercholesterolemia, M Namiki,S Kawashima,T Yamashita,M Ozaki,T Hirase,T Ishida,N Inoue,K Hirata,A Matsukawa,R Morishita,Y Kaneda,M Yokoyama, ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, LIPPINCOTT WILLIAMS & WILKINS, Vol. 22, No. 1, p. 115-120, 2002/01
  • HVJ (hemagglutinating virus of Japan; Sendai virus) - Liposome method, R Morishita,Y Kaneda, GENE THERAPY METHODS, ACADEMIC PRESS INC, Vol. 346, p. 619-627, 2002
  • Molecular therapy via transcriptional regulation with double-stranded oligodeoxynucleotides as decoys, H Nakamura,R Morishita,Y Kaneda, IN VIVO, INT INST ANTICANCER RESEARCH, Vol. 16, No. 1, p. 45-48, 2002/01
  • Viral liposomes. Preparation and use., Kaneda Y, Methods in molecular medicine, Vol. 69, p. 63-72, 2002
  • cis element decoy against nuclear factor-kappa B attenuates development of experimental autoimmune myocarditis in rats, O Yokoseki,J Suzuki,H Kitabayashi,N Watanabe,Y Wada,M Aoki,R Morishita,Y Kaneda,T Ogihara,H Futamatsu,Y Kobayashi,M Isobe, CIRCULATION RESEARCH, LIPPINCOTT WILLIAMS & WILKINS, Vol. 89, No. 10, p. 899-906, 2001/11
  • Novel immunotherapy for peritoneal dissemination of murine colon cancer with macrophage inflammatory protein-1 beta mediated by a tumor-specific vector, HVJ cationic liposomes, T Miyata,S Yamamoto,K Sakamoto,R Morishita,Y Kaneda, CANCER GENE THERAPY, NATURE PUBLISHING GROUP, Vol. 8, No. 11, p. 852-860, 2001/11
  • Therapeutic angiogenesis induced by human hepatocyte growth factor gene in rat diabetic hind limb ischemia model: molecular mechanisms of delayed angiogenesis in diabetes., Taniyama Y,Morishita R,Hiraoka K,Aoki M,Nakagami H,Yamasaki K,Matsumoto K,Nakamura T,Kaneda Y,Ogihara T,Circulation, Circulation, Vol. 104, No. 19, p. 2344-2350, 2001/11
  • Inhibition of intimal hyperplasia after balloon injury in rat carotid artery model using cis-element 'decoy' of nuclear factor-kappaB binding site as a novel molecular strategy., Yoshimura S,Morishita R,Hayashi K,Yamamoto K,Nakagami H,Kaneda Y,Sakai N,Ogihara T,Gene therapy, Gene Ther, Vol. 8, No. 21, p. 1635-1642, 2001/11
  • 転写因子NFκBをターゲットにしたアトピー治療 NFκBデコイ含有軟膏による皮膚症状の改善, 中邨 弘重,森下 竜一,青木 元邦,大石 雅子,玉井 克人,金田 安史, 日本小児アレルギー学会誌, (一社)日本小児アレルギー学会, Vol. 15, No. 4, p. 490-490, 2001/09
  • Mouse macrophage metalloelastase gene delivery by HVJ-cationic liposomes in experimental antiangiogenic gene therapy for murine CT-26 colon cancer, Manuel J. Gorrin-Rivas,Shigeki Arii,Akira Mori,Yasufumi Kaneda,Masayuki Imamura, International Journal of Cancer, Vol. 93, No. 5, p. 731-735, 2001/09/01
  • Effects of gene transfection of human bcl-2 on concordant cardiac xenografts in hamster to rat model., Kobayashi Y,Fukushima N,Sawa Y,Ohtake S,Matsumiya G,Horiguchi K,Kawaguchi N,Matsuura N,Kaneda Y,Matsuda H, The Japanese journal of thoracic and cardiovascular surgery : official publication of the Japanese Association for Thoracic Surgery = Nihon Kyobu Geka Gakkai zasshi, Vol. 49, No. 9, p. 570-575, 2001/09
  • Inhibition of neointimal formation after balloon injury by cilostazol, accompanied by improvement of endothelial dysfunction and induction of hepatocyte growth factor in rat diabetes model, M Aoki,R Morishita,S Hayashi,N Jo,K Matsumoto,T Nakamura,Y Kaneda,T Ogihara, DIABETOLOGIA, SPRINGER-VERLAG, Vol. 44, No. 8, p. 1034-1042, 2001/08
  • Gene therapy for preventing neuronal death using hepatocyte growth factor: in vivo gene transfer of HGF to subarachnoid space prevents delayed neuronal death in gerbil hippocampal CA1 neurons., Hayashi K,Morishita R,Nakagami H,Yoshimura S,Hara A,Matsumoto K,Nakamura T,Ogihara T,Kaneda Y,Sakai N,Gene therapy, Gene Ther, Vol. 8, No. 15, p. 1167-1173, 2001/08
  • Leptin Induces Mitochondrial Superoxide Production and Monocyte Chemoattractant Protein-1 Expression in Aortic Endothelial Cells by Increasing Fatty Acid Oxidation via Protein Kinase A, Sho-Ichi Yamagishi,Diane Edelstein,Xue-Liang Du,Yasufumi Kaneda,Manuel Guzmán,Michael Brownlee, Journal of Biological Chemistry, Vol. 276, No. 27, p. 25096-25100, 2001/07/06
  • Endothelial apoptosis induced by oxidative stress through activation of NF-kappaB: antiapoptotic effect of antioxidant agents on endothelial cells., Aoki M,Nata T,Morishita R,Matsushita H,Nakagami H,Yamamoto K,Yamazaki K,Nakabayashi M,Ogihara T,Kaneda Y,Hypertension,Dallas, Te, Hypertension, Vol. 38, No. 1, p. 48-55, 2001/07
  • EBV replicon vector system enhances transgene expression in vivo: applications to cancer gene therapy., Otomo T,Yamamoto S,Morishita R,Kaneda Y, The journal of gene medicine, Vol. 3, No. 4, p. 345-352, 2001/07
  • Transcription factor decoy for activator protein-1 (AP-1) inhibits high glucose- and angiotensin II-induced type 1 plasminogen activator inhibitor (PAI-1) gene expression in cultured human vascular smooth muscle cells, JD Ahn,R Morishita,Y Kaneda,KU Lee,JY Park,YJ Jeon,HS Song,IK Lee, DIABETOLOGIA, SPRINGER-VERLAG, Vol. 44, No. 6, p. 713-720, 2001/06
  • Intravenous injection of oligodeoxynucleotides to the NF-kappaB binding site inhibits hepatic metastasis of M5076 reticulosarcoma in mice, Kawamura, I,R Morishita,S Tsujimoto,T Manda,M Tomoi,N Tomita,T Goto,T Ogihara,Y Kaneda, GENE THERAPY, NATURE PUBLISHING GROUP, Vol. 8, No. 12, p. 905-912, 2001/06
  • Hepatocyte growth factor ameliorates acute graft-versus-host disease and promotes hematopoietic function, T Kuroiwa,E Kakishita,T Hamano,Y Kataoka,Y Seto,N Iwata,Y Kaneda,K Matsumoto,T Nakamura,T Ueki,J Fujimoto,T Iwasaki, JOURNAL OF CLINICAL INVESTIGATION, AMER SOC CLINICAL INVESTIGATION INC, Vol. 107, No. 11, p. 1365-1373, 2001/06
  • Phosphorylation of p38 mitogen-activated protein kinase downstream of bax-caspase-3 pathway leads to cell death induced by high D-glucose in human endothelial cells., Nakagami H,Morishita R,Yamamoto K,Yoshimura SI,Taniyama Y,Aoki M,Matsubara H,Kim S,Kaneda Y,Ogihara T,Diabetes, Diabetes, Vol. 50, No. 6, p. 1472-1481, 2001/06
  • Contribution of Bcl-2, but not Bcl-xL and Bax, to antiapoptotic actions of hepatocyte growth factor in hypoxia-conditioned human endothelial cells., Yamamoto K,Morishita R,Hayashi S,Matsushita H,Nakagami H,Moriguchi A,Matsumoto K,Nakamura T,Kaneda Y,Ogihara T,Hypertension,Dallas, Te, Hypertension (Dallas, Tex. : 1979), Vol. 37, No. 5, p. 1341-1348, 2001/05
  • Prolonged transgene expression in glomeruli using an EBV replicon vector system combined with HVJ liposomes, M Tsujie,Y Isaka,H Nakamura,Y Kaneda,E Imai,M Hori, KIDNEY INTERNATIONAL, BLACKWELL SCIENCE INC, Vol. 59, No. 4, p. 1390-1396, 2001/04
  • ATP-dependent chromatin remodeling facilitates nucleotide excision repair of UV-induced DNA lesions in synthetic dinucleosomes, Kiyoe Ura,Marito Araki,Hideaki Saeki,Chikahide Masutani,Takashi Ito,Shigenori Iwai,Toshimi Mizukoshi,Yasufumi Kaneda,Fumio Hanaoka, EMBO Journal, Vol. 20, 2001/04
  • Safety evaluation of hemagglutinating virus of Japan-artificial viral envelope liposomes in nonhuman primates, N Tsuboniwa,R Morishita,T Hirano,J Fujimoto,S Furukawa,M Kikumori,A Okuyama,Y Kaneda, HUMAN GENE THERAPY, MARY ANN LIEBERT INC PUBL, Vol. 12, No. 5, p. 469-487, 2001/03
  • Downregulation of nuclear factor kappa B expression in primate cardiac allograft arteries after E2F decoy transfection, M Kawauchi,J Suzuki,Y Wada,R Morishita,Y Kaneda,M Isobe,J Amano,S Takamoto, TRANSPLANTATION PROCEEDINGS, ELSEVIER SCIENCE INC, Vol. 33, No. 1-2, p. 451-451, 2001/02
  • Therapeutic angiogenesis induced by human hepatocyte growth factor gene in rat and rabbit hindlimb ischemia models: preclinical study for treatment of peripheral arterial disease., Taniyama Y,Morishita R,Aoki M,Nakagami H,Yamamoto K,Yamazaki K,Matsumoto K,Nakamura T,Kaneda Y,Ogihara T,Gene therapy, Gene Ther., Vol. 8, No. 3, p. 181-189, 2001/02
  • Mitogenic and antiapoptotic actions of hepatocyte growth factor through ERK, STAT3, and AKT in endothelial cells., Nakagami H,Morishita R,Yamamoto K,Taniyama Y,Aoki M,Matsumoto K,Nakamura T,Kaneda Y,Horiuchi M,Ogihara T,Hypertension,Dallas, Te, Vol. 37, No. 2 Pt 2, p. 581-586, 2001/02
  • A novel strategy of decoy transfection against nuclear factor-kappaB in myocardial preservation., Sakaguchi T,Sawa Y,Fukushima N,Nishimura M,Ichikawa H,Kaneda Y,Matsuda H, The Annals of thoracic surgery, Vol. 71, No. 2, p. 624-9; discussion 629, 2001/02
  • Dominant negative c-Jun gene transfer inhibits vascular smooth muscle cell proliferation and neointimal hyperplasia in rats, H. Yasumoto,S. Kim,Y. Zhan,H. Miyazaki,M. Hoshiga,Y. Kaneda,R. Morishita,H. Iwao, Gene Therapy, Vol. 8, No. 22, p. 1682-1689, 2001
  • Gene Therapy: A Battle Against Biological Barriers, Yasufumi Kaneda, Current Molecular Medicine, Bentham Science Publishers B.V., Vol. 1, No. 4, p. 493-499, 2001
  • Improvements in gene therapy technologies, Y. Kaneda, Molecular Urology, Mary Ann Liebert Inc., Vol. 5, No. 2, p. 85-89, 2001
  • Preclinical and therapeutic utility of HVJ liposomes as a gene transfer vector for hepatocellular carcinoma using herpes simplex virus thymidine kinase, Hirofumi Hasegawa,Mitsuo Shimada,Yoshikazu Yonemitsu,Tohru Utsunomiya,Tomonobu Gion,Yasufumi Kaneda,Keizo Sugimachi, Cancer Gene Therapy, Vol. 8, No. 4, p. 252-258, 2001
  • Efficient transfer of intact oligonucleotides into the nucleus of ligament scar fibroblasts by HVJ-cationic liposomes is correlated with effective antisense gene inhibition, Norimasa Nakamura,David A. Hart,Cyril B. Frank,Linda L. Marchuk,Nigel G. Shrive,Naruhisa Ota,Kazunari Taira,Hideki Yoshikawa,Yasufumi Kaneda, Journal of Biochemistry, Vol. 129, No. 5, p. 755-759, 2001
  • An essential role of the antioxidant gene bcl-2 in myocardial adaptation to ischemia: An insight with antisense bcl-2 therapy, R. Hattori,T. Estrada Hernandez,L. Zhu,N. Maulik,H. Otani,Y. Kaneda,D. K. Das, Antioxidants and Redox Signaling, Mary Ann Liebert Inc., Vol. 3, No. 3, p. 403-413, 2001
  • Gene therapy of ischemic-damaged kidney in the rat using hepatocyte growth factor gene, M. Kitamura,N. Tsuboniwa,H. Azuma,J. D. Wang,K. Matsumiya,K. Matsumoto,Y. Kaneda,S. Takahara,A. Okuyama, Transplantation Proceedings, Vol. 33, No. 5, p. 2865-2867, 2001
  • Cells derived from tuberous sclerosis show a prolonged S phase of the cell cycle and increased apoptosis, M. Wataya-Kaneda,Yasufumi Kaneda,Okio Hino,Hiroyuki Adachi,Youko Hirayama,Kuniaki Seyama,Teruhiko Satou,Kunihiko Yoshikawa, Archives of Dermatological Research, Vol. 293, No. 9, p. 460-469, 2001
  • HVJ-liposome-mediated transfection of HSVtk gene driven by AFP promoter inhibits hepatic tumor growth of hepatocellular carcinoma in SCID mice, T Hirano,S Kaneko,Y Kaneda,Saito, I,T Tamaoki,J Furuyama,T Tamaoki,K Kobayashi,T Ueki,J Fujimoto, GENE THERAPY, NATURE PUBLISHING GROUP, Vol. 8, No. 1, p. 80-83, 2001/01
  • Decoy oligodeoxynucleotides as novel cardiovascular drugs for cardiovascular disease, R Morishita,M Aoki,Y Kaneda, ATHEROSCLEROSIS VI, NEW YORK ACAD SCIENCES, Vol. 947, p. 294-302, 2001
  • Inhibition of TNF-a, induced cytokine and adhesion molecule, N Tomita,R Morishita,S Tomita,Y Kaneda,J Higaki,T Ogihara,M Horiuchi, EXPERIMENTAL NEPHROLOGY, KARGER, Vol. 9, No. 3, p. 181-190, 2001
  • Gene transfer of dominant-negative mutants of extracellular signal-regulated kinase and c-Jun NH2-terminal kinase prevents neointimal formation in balloon-injured rat artery., Izumi Y,Kim S,Namba M,Yasumoto H,Miyazaki H,Hoshiga M,Kaneda Y,Morishita R,Zhan Y,Iwao H, Circ Res, Vol. 88, p. 1120-1126, 2001
  • Gene therapy for attenuating cardiac allograft arteriopathy using ex vivo E2F decoy transfection by HVJ-AVE-liposome method in mice and nonhuman primates, M Kawauchi,J Suzuki,R Morishita,Y Wada,A Izawa,N Tomita,J Amano,Y Kaneda,T Ogihara,S Takamoto,M Isobe, CIRCULATION RESEARCH, LIPPINCOTT WILLIAMS & WILKINS, Vol. 87, No. 11, p. 1063-1068, 2000/11
  • Decoy against nuclear factor-kappa B attenuates myocardial cell infiltration and arterial neointimal formation in murine cardiac allografts, J Suzuki,R Morishita,J Amano,Y Kaneda,M Isobe, GENE THERAPY, NATURE PUBLISHING GROUP, Vol. 7, No. 21, p. 1847-1852, 2000/11
  • Gene transfer of the serine elastase inhibitor elafin protects against vein graft degeneration, SB O'Blenes,SHE Zaidi,AYL Cheah,B McIntyre,Y Kaneda,M Rabinovitch, CIRCULATION, LIPPINCOTT WILLIAMS & WILKINS, Vol. 102, No. 19, p. 289-295, 2000/11
  • Sp1 decoy transfected to carcinoma cells suppresses the expression of vascular endothelial growth factor, transforming growth factor beta(1), and tissue factor and also cell growth and invasion activities, H Ishibashi,K Nakagawa,M Onimaru,EJ Castellanous,Y Kaneda,Y Nakashima,K Shirasuna,K Sueishi, CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, Vol. 60, No. 22, p. 6531-6536, 2000/11
  • Anti-monocyte chemoattractant protein-1 gene therapy inhibits vascular remodeling in rats: blockade of MCP-1 activity after intramuscular transfer of a mutant gene inhibits vascular remodeling induced by chronic blockade of NO synthesis, K Egashira,M Koyanagi,S Kitamoto,WH Ni,C Kataoka,R Morishita,Y Kaneda,C Akiyama,KI Nishida,K Sueishi,A Takeshita, FASEB JOURNAL, FEDERATION AMER SOC EXP BIOL, Vol. 14, No. 13, p. 1974-1978, 2000/10
  • In vivo transfer of human hepatocyte growth factor gene accelerates re-endothelialization and inhibits neointimal formation after balloon injury in rat model, K Hayashi,S Nakamura,R Morishita,A Moriguchi,M Aoki,K Matsumoto,T Nakamura,Y Kaneda,N Sakai,T Ogihara, GENE THERAPY, NATURE PUBLISHING GROUP, Vol. 7, No. 19, p. 1664-1671, 2000/10
  • Gene transfer of human prostacyclin synthase ameliorates monocrotaline-induced pulmonary hypertension in rats, N Nagaya,C Yokoyama,S Kyotani,M Shimonishi,R Morishita,M Uematsu,T Nishikimi,N Nakanishi,T Ogihara,M Yamagishi,K Miyatake,Y Kaneda,T Tanabe, CIRCULATION, LIPPINCOTT WILLIAMS & WILKINS, Vol. 102, No. 16, p. 2005-2010, 2000/10
  • Complexity of determining cause and effect in vivo after antisense gene therapy, DA Hart,N Nakamura,L Marchuk,H Hiraoka,R Boorman,Y Kaneda,NG Shrive,CB Frank, CLINICAL ORTHOPAEDICS AND RELATED RESEARCH, LIPPINCOTT WILLIAMS & WILKINS, No. 379, p. S242-S251, 2000/10
  • Gene therapy : its present status and future direction, TOYO-OKA Teruhiko,KANEDA Y.,AOKI M.,KAWADA T.,MONAHAN John,FUJIWARA T.,SAKIYAMA Y., Folia Pharmacologica Japonica, The Japanese Pharmacological Society, Vol. 116, No. 3, p. 158-162, 2000/09/01
  • HVJ-リポソームを用いた脳毛細血管内皮細胞における遺伝子の導入及び発現, 蒋 晨,松尾 浩民,小薮 紀子,大谷 壽一,藤本 英典,米満 吉和,居石 克夫,金田 安史,内藤 幹彦,鶴尾 隆, 薬物動態, (一社)日本薬物動態学会, Vol. 15, No. Suppl., p. S286-S286, 2000/09
  • Catheter-delivered in vivo gene transfer into rat myocardium using the fusigenic liposomal mediated method, K Shinmura,R Morishita,M Aoki,J Higaki,T Ogihara,Y Kaneda,M Tani, JAPANESE HEART JOURNAL, JAPAN HEART JOURNAL, SECOND DEPT OF INTERNAL MED, Vol. 41, No. 5, p. 633-647, 2000/09
  • Ribozyme oligonucleotides against transforming growth factor-beta inhibited neointimal formation after vascular injury in rat model - Potential application of ribozyme strategy to treat cardiovascular disease, K Yamamoto,R Morishita,N Tomita,T Shimozato,H Nakagami,A Kikuchi,M Aoki,J Higaki,Y Kaneda,T Ogihara, CIRCULATION, LIPPINCOTT WILLIAMS & WILKINS, Vol. 102, No. 11, p. 1308-1314, 2000/09
  • Increased activity of nuclear factor-kappa B participates in cardiovascular remodeling induced by chronic inhibition of nitric oxide synthesis in rats, S Kitamoto,K Egashira,C Kataoka,M Koyanagi,M Katoh,H Shimokawa,R Morishita,Y Kaneda,K Sueishi,A Takeshita, CIRCULATION, LIPPINCOTT WILLIAMS & WILKINS, Vol. 102, No. 7, p. 806-812, 2000/08
  • Ecto-5 '-nucleotidase plays a role in the cardioprotective effects of heat shock protein 72 in ischemia-reperfusion injury in rat hearts, T Sakaguchi,Y Sawa,M Kitakaze,K Suzuki,M Nishimura,Y Kaneda,H Matsuda, CARDIOVASCULAR RESEARCH, ELSEVIER SCIENCE BV, Vol. 47, No. 1, p. 74-80, 2000/07
  • Systemic administration of HVJ viral coat-liposome complex containing human insulin vector decreases glucose level in diabetic mouse: A model of gene therapy, R Morishita,GH Gibbons,Y Kaneda,T Ogihara,VJ Dzau, BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, ACADEMIC PRESS INC, Vol. 273, No. 2, p. 666-674, 2000/07
  • Transcription factor decoy for NF kappa B inhibits cytokine and adhesion molecule expressions in synovial cells derived from rheumatoid arthritis, T Tomita,H Takano,H Tomita,R Morishita,M Kaneko,K Shi,K Takahi,T Nakase,Y Kaneda,H Yoshikawa,T Ochi, RHEUMATOLOGY, OXFORD UNIV PRESS, Vol. 39, No. 7, p. 749-757, 2000/07
  • Introduction of the interleukin-10 gene into mice inhibited bleomycin- induced lung injury in vivo, Toru Arai,Kin'ya Abe,Hiroto Matsuoka,Mitsuhiro Yoshida,Masahide Mori,Sho Goya,Hiroshi Kida,Kazumi Nishino,Tadashi Osaki,Isao Tachibana,Yasufumi Kaneda,Seiji Hayashi, American Journal of Physiology - Lung Cellular and Molecular Physiology, Vol. 278, No. 5, p. L914-L922, 2000/05
  • Gene therapy as a potential treatment for restenosis and myocardial infarction, N Tomita,R Morishita,Y Kaneda,J Higaki,T Ogihara, DRUG NEWS & PERSPECTIVES, PROUS SCIENCE, SA, Vol. 13, No. 4, p. 206-212, 2000/05
  • Hypoxia-induced endothelial apoptosis through nuclear factor-kappa B (NF-kappa B)-mediated bcl-2 suppression - In vivo evidence of the importance of NF-kappa B in endothelial cell regulation, H Matsushita,R Morishita,T Nata,M Aoki,H Nakagami,Y Taniyama,K Yamamoto,J Higaki,K Yasufumi,T Ogihara, CIRCULATION RESEARCH, LIPPINCOTT WILLIAMS & WILKINS, Vol. 86, No. 9, p. 974-981, 2000/05
  • Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage, Takeshi Nishikawa,Diane Edelstein,Xue Liang Du,Sho-Ichi Yamagishi,Takeshi Matsumura,Yasufumi Kaneda,Mark A. Yorek,David Beebe,Peter J. Oates,Hans-Peter Hammes,Ida Glardino,Michael Brownlee, Nature, Vol. 404, No. 6779, p. 787-790, 2000/04/13
  • Antisense oligodeoxynucleotide inhibition of vascular angiotensin-converting enzyme expression attenuates neointimal formation - Evidence for tissue angiotensin-converting enzyme function, R Morishita,GH Gibbons,N Tomita,LN Zhang,Y Kaneda,T Ogihara,VJ Dzau, ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, LIPPINCOTT WILLIAMS & WILKINS, Vol. 20, No. 4, p. 915-922, 2000/04
  • Transfection of antisense p53 tumor suppressor gene oligodeoxynucleotides into rat carotid artery results in abnormal growth of vascular smooth muscle cells, H Matsushita,R Morishita,M Aoki,N Tomita,Y Taniyama,H Nakagami,T Shimozato,J Higaki,Y Kaneda,T Ogihara, CIRCULATION, LIPPINCOTT WILLIAMS & WILKINS, Vol. 101, No. 12, p. 1447-1452, 2000/03
  • Antisense Bcl-x oligonucleotide induces apoptosis and prevents arterial neointimal formation in murine cardiac allografts, J Suzuki,M Isobe,R Morishita,T Niskikawa,J Amano,Y Kaneda, CARDIOVASCULAR RESEARCH, ELSEVIER SCIENCE BV, Vol. 45, No. 3, p. 783-787, 2000/02
  • Enhancement of transgene expression by cotransfection of oriP plasmid with EBNA-1 expression vector, Y Kaneda,Y Saeki,M Nakabayashi,WZ Zhou,MW Kaneda,R Morishita, HUMAN GENE THERAPY, MARY ANN LIEBERT INC PUBL, Vol. 11, No. 3, p. 471-479, 2000/02
  • Efficacy of hepatocyte-based bioartificial liver on hepatic failure in pigs and several attempts towards clinical application, H Fujioka,Y Kamohara,Y Kawashita,S Eguchi,Y Kawazoe,N Sugiyama,A Tamura,H Moriuchi,J Furui,A Ohtsuru,S Yamashita,Y Kaneda,T Kanematsu, TISSUE ENGINEERING FOR THERAPEUTIC USE 4, ELSEVIER SCIENCE BV, Vol. 1198, p. 167-176, 2000
  • Phorbol ester-potentiated liposomal transfection to monocytic PLB-985 cells, Li Jun Hao,Dan Yang,Yoshito Fujii,Akira Yamauchi,Norio Suzuki,Hiroshi Kikuchi,Yasufumi Kaneda,Michio Nakamura, Journal of Biochemistry, Vol. 128, No. 6, p. 989-998, 2000
  • Inhibition of experimental choroidal neovascularization by overexpression of tissue inhibitor of metalloproteinases-3 in retinal pigment epithelium cells, Tadashi Takahashi,Takao Nakamura,Atsushi Hayashi,Motohiro Kamei,Mari Nakabayashi,Annabelle A. Okada,Naruya Tomita,Yasufumi Kaneda,Yasuo Tano, American Journal of Ophthalmology, Vol. 130, No. 6, p. 774-781, 2000
  • Inhibition of growth of melanoma cells by CD95 (Fas/APO-1) gene transfer in vivo, Yoshinori Aragane,Akira Maeda,Chang-Yi Cui,Tadashi Tezuka,Yasufumi Kaneda,Thomas Schwarz, Journal of Investigative Dermatology, Blackwell Publishing Inc., Vol. 115, No. 6, p. 1008-1014, 2000
  • Decorin antisense gene therapy improves functional healing of early rabbit ligament scar with enhanced collagen fibrillogenesis in vivo, Norimasa Nakamura,David A. Hart,Richard S. Boorman,Yasufumi Kaneda,Nigel G. Shrive,Linda L. Marchuk,Konsei Shino,Takahiro Ochi,Cyril B. Frank, Journal of Orthopaedic Research, J Bone Jt Surgery Inc., Vol. 18, No. 4, p. 517-523, 2000
  • Oligonucleotide-based Gene Therapy for Cardiovascular Disease: Are Oligonucleotide Therapeutics Novel Cardiovascular Drugs ?, Ryuichi Morishita,Motokuni Aoki,Yasufumi Kaneda, Current Drug Targets, Bentham Science Publishers B.V., Vol. 1, No. 1, p. 15-23, 2000
  • Suppression of copulatory behavior by intracerebroventricular infusion of antisense oligodeoxynucleotide of granulin in neonatal male rats, Masatoshi Suzuki,Makoto Bannai,Mie Matsumuro,Yasufumi Furuhata,Ryota Ikemura,Erina Kuranaga,Yasufumi Kaneda,Masugi Nishihara,Michio Takahashi, Physiology and Behavior, Elsevier Inc., Vol. 68, No. 5, p. 707-713, 2000
  • In vivo gene transfer into choroidal neovascularization by the HVJ liposome method, Tsuyoshi Otsuji,Nahoko Ogata,Kanji Takahashi,Masashi Matsushima,Masanobu Uyama,Yasufumi Kaneda, Graefe's Archive for Clinical and Experimental Ophthalmology, Springer Verlag, Vol. 238, No. 2, p. 191-199, 2000
  • Gene transfer targeting interstitial fibroblasts by the artificial viral envelope-type hemagglutinating virus of Japan liposome method, Michiko Tsujie,Yoshitaka Isaka,Yutaka Ando,Yoshitaka Akagi,Yasufumi Kaneda,Naohiko Ueda,Enyu Imai,Masatsugu Hori, Kidney International, Blackwell Publishing Inc., Vol. 57, No. 5, p. 1973-1980, 2000
  • Changes in pulmonary histology and exfoliated bronchoalveolar cells induced by in vivo introduction of the tumor necrosis factor-α gene, Junko Sakuma-Mochizuki,Mitsuhiro Yoshida,Kin'Ya Abe,Toru Arai,Masahide Mori,Yasufumi Kaneda,Seiji Hayashi, Inflammation, Vol. 24, No. 1, p. 11-19, 2000
  • Introduction of plasmid DNA and oligonucleotides into lung epithelial cells by the hemagglutinating virus of Japan (HVJ)-liposome method, Mitsuhiro Yoshida,Seiji Hayashi,Junko Sakuma-Mochizuki,Kin'nya Abe,Toru Arai,Masahide Mori,Sho Goya,Hiroto Matsuoka,Yasufumi Kaneda,Tadamitsu Kishimoto, Somatic Cell and Molecular Genetics, Vol. 25, No. 1, p. 49-57, 2000
  • Reduction in myocardial apoptosis associated with overexpression of heat shock protein 70, Ken Suzuki,Yoshiki Sawa,Koji Kagisaki,Satoshi Taketani,Hajime Ichikawa,Yasufumi Kaneda,Hikaru Matsuda, Basic Research in Cardiology, Vol. 95, No. 5, p. 397-403, 2000
  • Transforming growth factor-β1 antisense oligodeoxynucleotides block interstitial fibrosis in unilateral ureteral obstruction, Y. Isaka,M. Tsujie,Y. Ando,H. Nakamura,Y. Kaneda,E. Imai,M. Hori, Kidney International, Blackwell Publishing Inc., Vol. 58, No. 5, p. 1885-1892, 2000
  • Gene therapy for heart transplantation-associated coronary arteriosclerosis, M Isobe,JI Suzuki,R Morishita,Y Kaneda,J Amano, ATHEROSCLEROSIS V: THE FIFTH SARATOGA CONFERENCE, NEW YORK ACAD SCIENCES, Vol. 902, p. 77-83, 2000
  • Gene therapy for myocardial infarction: A real medicine in the next millenium?, R Morishita,M Aoki,H Nakagami,Y Taniyama,K Yamamoto,H Matsushita,K Matsumoto,J Higaki,Y Kaneda,T Ogihara, HEART FAILURE, SPRINGER-VERLAG TOKYO, p. 219-226, 2000
  • Efficient introduction of macromolecules and oligonucleotides into brain capillary endothelial cells using HVJ-liposomes, H Matsuo,T Okamura,J Chen,H Takanaga,Y Kaneda,M Naito,T Tsuruo,Y Sawada, JOURNAL OF DRUG TARGETING, HARWOOD ACAD PUBL GMBH, Vol. 8, No. 4, p. 207-+, 2000
  • Gene therapy for cardiovascular disease using hepatocyte growth factor, R Morishita,M Aoki,S Nakamura,J Higaki,Y Kaneda,T Ogihara, ATHEROSCLEROSIS V: THE FIFTH SARATOGA CONFERENCE, NEW YORK ACAD SCIENCES, Vol. 902, p. 369-376, 2000
  • Eradication of breast cancer xenografts by hyperthermic suicide gene therapy under the control of the heat shock protein promoter., Braiden V,Ohtsuru A,Kawashita Y,Miki F,Sawada T,Ito M,Cao Y,Kaneda Y,Koji T,Yamashita S, Hum Gene Ther, Vol. 11, No. 18, p. 2453-2463, 2000
  • Amplification of transgene expression in vitro and in vivo using a novel inhibitor of histone deacetylase, Yamano, T.,Ura, K.,Morishita, R.,Nakajima, H.,Monden, M.,Kaneda, Y., Molecular Therapy, Vol. 1, No. 6, p. 574-580, 2000
  • Suppressed severity of collagen-induced arthritis by in vivo transfection of nuclear factor kappa B decoy oligodeoxynucleotides as a gene therapy, T Tomita,E Takeuchi,N Tomita,R Morishita,M Kaneko,K Yamamoto,T Nakase,H Seki,K Kato,Y Kaneda,T Ochi, ARTHRITIS AND RHEUMATISM, LIPPINCOTT WILLIAMS & WILKINS, Vol. 42, No. 12, p. 2532-2542, 1999/12
  • Transfection of rat kidney with human 15-lipoxygenase suppresses inflammation and preserves function in experimental glomerulonephritis, Karen A. Munger,Angel Montero,Megumu Fukunaga,Susumu Uda,Takafumi Yura,Enyu Imai,Yasufumi Kaneda,José M. Valdivielso,Kamal F. Badr, Proceedings of the National Academy of Sciences of the United States of America, Vol. 96, No. 23, p. 13375-13380, 1999/11/09
  • Allogeneic class I major histocompatibility complex gene transfer in murine neuroblastoma in vivo, Hiroyuki Ishida,Yasufumi Kaneda,Shuich Yamane,Tadashi Sawada,Gregory E. Plautz,Takafumi Matsumura, Anticancer Research, Vol. 19, No. 6 B, p. 5367-5373, 1999/11
  • In vivo gene transfer of an extracellular domain of platelet-derived growth factor beta receptor by the HVJ-liposome method ameliorates bleomycin-induced pulmonary fibrosis, M Yoshida,J Sakuma-Mochizuki,K Abe,T Arai,M Mori,S Goya,H Matsuoka,S Hayashi,Y Kaneda,T Kishimoto, BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, ACADEMIC PRESS INC, Vol. 265, No. 2, p. 503-508, 1999/11
  • Myocardial protection with endogenous overexpression of manganese superoxide dismutase, Ken Suzuki,Yoshiki Sawa,Hajime Ichikawa,Yasufumi Kaneda,Hikaru Matsuda, Annals of Thoracic Surgery, Vol. 68, No. 4, p. 1266-1271, 1999/10
  • Protective immunization against melanoma by gp100 DNA-HVJ-liposome vaccine, WZ Zhou,Y Kaneda,SKS Huang,R Morishita,DSB Hoon, GENE THERAPY, STOCKTON PRESS, Vol. 6, No. 10, p. 1768-1773, 1999/10
  • Gene transfection of beta 2-adrenergic receptor into the normal rat heart enhances cardiac response to beta-adrenergic agonist, Y Kawahira,Y Sawa,M Nishimura,S Sakakida,H Ueda,Y Kaneda,H Matsuda, JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, MOSBY-YEAR BOOK INC, Vol. 118, No. 3, p. 446-451, 1999/09
  • E2F decoy suppresses E-selectin expression in murine cardiac allograft arteriopathy, J Suzuki,M Isobe,R Morishita,A Izawa,S Yamazaki,Y Okubo,Y Kaneda,M Sekiguchi, TRANSPLANTATION PROCEEDINGS, ELSEVIER SCIENCE INC, Vol. 31, No. 5, p. 2018-2019, 1999/08
  • Activation of the brain angiotensin system by in vivo human angiotensin-converting enzyme gene transfer in rats, S Nakamura,A Moriguchi,R Morishita,K Yamada,T Nishii,N Tomita,M Ohishi,Y Kaneda,J Higaki,T Ogihara, HYPERTENSION, LIPPINCOTT WILLIAMS & WILKINS, Vol. 34, No. 2, p. 302-308, 1999/08
  • Inhibition of the p53 tumor suppressor gene results in growth of human aortic vascular smooth muscle cells. Potential role of p53 in regulation of vascular smooth muscle cell growth., Aoki M,Morishita R,Matsushita H,Hayashi S,Nakagami H,Yamamoto K,Moriguchi A,Kaneda Y,Higaki J,Ogihara T,Hypertension,Dallas, Te, Hypertension (Dallas, Tex. : 1979), Vol. 34, No. 2, p. 192-200, 1999/08
  • Gene transfection of hepatocyte growth factor attenuates reperfusion injury in the heart, H Ueda,Y Sawa,K Matsumoto,S Kitagawa-Sakakida,Y Kawahira,T Nakamura,Y Kaneda,H Matsuda, ANNALS OF THORACIC SURGERY, ELSEVIER SCIENCE INC, Vol. 67, No. 6, p. 1726-1731, 1999/06
  • Transcription factor decoy to study the molecular mechanism of negative regulation of renin gene expression in the liver in vivo, S Tomita,N Tomita,T Yamada,LN Zhang,Y Kaneda,R Morishita,T Ogihara,VJ Dzau,M Horiuchi, CIRCULATION RESEARCH, LIPPINCOTT WILLIAMS & WILKINS, Vol. 84, No. 9, p. 1059-1066, 1999/05
  • 【イオンチャネルと疾患】イオンチャネル病の遺伝子治療 嚢胞性線維症遺伝子治療臨床試験の現状と展望, 米満 吉和,金田 安史,Alton Eric WFW, 現代医療, (株)現代医療社, Vol. 31, No. 4, p. 1044-1050, 1999/04
  • Phosphorothioate oligonucleotides induction into experimental choroidal neovascularization by HVJ-liposome system, N Ogata,T Otsuji,M Matsushima,T Kimoto,R Yamanaka,K Takahashi,M Wada,M Uyama,Y Kaneda, CURRENT EYE RESEARCH, SWETS ZEITLINGER PUBLISHERS, Vol. 18, No. 4, p. 261-269, 1999/04
  • Ribosome-associated protein LBP/p40 binds to S21 protein of 40S ribosome: Analysis using a yeast two-hybrid system, Manabu Sato,Yoshinaga Saeki,Kiyoji Tanaka,Yasufumi Kaneda, Biochemical and Biophysical Research Communications, Academic Press Inc., Vol. 256, No. 2, p. 385-390, 1999/03/16
  • Prevention of cardiac allograft arteriopathy by antisense cdc2 kinase oligonucleotide, J Suzuki,A Izawa,R Morishita,Y Kaneda,Y Sawa,Y Okubo,T Ogihara,M Sekiguchi,M Isobe, TRANSPLANTATION PROCEEDINGS, ELSEVIER SCIENCE INC, Vol. 31, No. 1-2, p. 867-868, 1999/02
  • Antisense Cdc2 kinase oligonucleotide inhibits adhesion molecule expression in cardiac allograft arteriopathy, J Suzuki,A Izawa,R Morishita,Y Kaneda,Y Sawa,Y Okubo,T Ogihara,M Sekiguchi,M Isobe, TRANSPLANTATION PROCEEDINGS, ELSEVIER SCIENCE INC, Vol. 31, No. 1-2, p. 955-956, 1999/02
  • Gene transfer in utero biologically engineers a patent ductus arteriosus in lambs by arresting fibronectin-dependent neointimal formation, CAE Mason,JL Bigras,SB O'Blenes,B Zhou,B McIntyre,N Nakamura,Y Kaneda,M Rabinovitch, NATURE MEDICINE, NATURE AMERICA INC, Vol. 5, No. 2, p. 176-182, 1999/02
  • Optimization of the biology of soft tissue repair., Frank C,Shrive, N,Hiraoka, H,Nakamura, N,Kaneda, Y,Hart, D, J. Sci. Med. Sport, Vol. 2, p. 190-210, 1999
  • Gene Therapy for Attenuating Chronic Rejection of Cardiac Allografts, Jun-ichi Suzuki,Mitsuaki Isobe,Ryuichi Morishita,Yasufumi Kaneda,Motohiro Kawauchi,Jun Amano, Japanese Journal of Clinical Immunology, Vol. 22, No. 6, p. 418-421, 1999
  • Gene transfer to the rat biliary tract with the HVJ-cationic liposome method, Tetsuya Uehara,Kazuo Honda,Etsuro Hatano,Ryuta Terao,Yuji Iimuro,Naritaka Yamamoto,Masayuki Yamamoto,Yasufumi Kaneda,Yoshio Yamaoka, Journal of Hepatology, Blackwell Munksgaard, Vol. 30, No. 5, p. 836-842, 1999
  • Direct in vivo gene transfer to healing rat patellar ligament by intra-arterial delivery of haemagglutinating virus of Japan liposomes, I. Özkan,K. Shino,N. Nakamura,T. Natsu-ume,N. Matsumoto,S. Horibe,T. Tomita,Y. Kaneda,T. Ochi, European Journal of Clinical Investigation, Vol. 29, No. 1, p. 63-67, 1999
  • Gene therapy by transforming growth factor-β receptor-IgG Fc chimera suppressed extracellular matrix accumulation in experimental glomerulonephritis, Yoshitaka Isaka,Yoshitaka Akagi,Yutaka Ando,Michiko Tsujie,Tetsuo Sudo,Noriko Ohno,Wayne A. Border,Nancy A. Noble,Yasufumi Kaneda,Masatsugu Hori,Enyu Imai, Kidney International, Blackwell Publishing Inc., Vol. 55, No. 2, p. 465-475, 1999
  • Development of a novel fusogenic viral liposome system (HVJ-liposomes) and its applications to the treatment of acquired diseases, Yasufumi Kaneda, Molecular Membrane Biology, Taylor and Francis Ltd, Vol. 16, No. 1, p. 119-122, 1999
  • Gene transfer of human prostacyclin synthase prevents neointimal formation after carotid balloon injury in rats, T. Todaka,T. Todaka,C. Yokoyama,Hiroji Yanamoto,Hiroji Yanamoto,Hiroji Yanamoto,N. Hashimoto,I. Nagata,T. Tsukahara,S. Hara,T. Hatae,R. Morishita,M. Aoki,T. Ogihara,Y. Kaneda,T. Tanabe,T. Tanabe, Stroke, Vol. 30, p. 419-426, 1999/01/01
  • LBP-p40 binds DNA tightly through associations with histones H2A, H2B, and H4, Katsunari Kinoshita,Yoshinao Kaneda,Manabu Sato,Yoshinaga Saeki,Mari Wataya-Kaneda,Alexander Hoffmann,Yasufumi Kaneda, Biochemical and Biophysical Research Communications, Academic Press Inc., Vol. 253, No. 2, p. 277-282, 1998/12/18
  • Prolonged survival of rat liver allografts transfected with Fas ligand- expressing plasmid, Xiao-Kang Li,Torayuki Okuyama,Akihiko Tamura,Shin Enosawa,Yasufumi Kaneda,Shiro Takahara,Naoko Funashima,Masao Yamada,Hiroshi Amemiya,Seiichi Suzuki, Transplantation, Vol. 66, No. 11, p. 1416-1423, 1998/12/15
  • Efficient transfer of oligonucleotides and plasmid DNA into the whole heart through the coronary artery, Y Sawa,Y Kaneda,HZ Bai,K Suzuki,J Fujimoto,R Morishita,H Matsuda, GENE THERAPY, STOCKTON PRESS, Vol. 5, No. 11, p. 1472-1480, 1998/11
  • In vivo transfer of a beta(2)-adrenergic receptor gene into the pressure-overloaded rat heart enhances cardiac response to beta-adrenergic agonist, Y Kawahira,Y Sawa,M Nishimura,S Sakakida,H Ueda,Y Kaneda,H Matsuda, CIRCULATION, LIPPINCOTT WILLIAMS & WILKINS, Vol. 98, No. 19, p. II262-II267, 1998/11
  • Novel therapeutic strategy for atherosclerosis - Ribozyme oligonucleotides against apolipoprotein(a) selectively inhibit apolipoprotein(a) but not plasminogen gene expression, R Morishita,S Yamada,K Yamamoto,N Tomita,Kida, I,Sakurabayashi, I,A Kikuchi,Y Kaneda,R Lawn,J Higaki,T Ogihara, CIRCULATION, LIPPINCOTT WILLIAMS & WILKINS, Vol. 98, No. 18, p. 1898-1904, 1998/11
  • Gene transfer to vein graft wall by HVJ-liposome method: Time course and localization of gene expression, HZ Bai,Y Sawa,WD Zhang,T Yamakawa,R Morishita,Y Kaneda,H Matsuda, ANNALS OF THORACIC SURGERY, ELSEVIER SCIENCE INC, Vol. 66, No. 3, p. 814-819, 1998/09
  • Stimulatory effect of lipoprotein (a) on proliferation of human mesangial cells: Role of lipoprotein (a) in renal disease, R Morishita,K Yamamoto,S Yamada,H Matsushita,N Tomita,Sakurabayashi, I,Y Kaneda,A Moriguchi,J Higaki,T Ogihara, BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, ACADEMIC PRESS INC, Vol. 249, No. 2, p. 313-320, 1998/08
  • Conditioned medium from HepG2 cells transfected with human apolipoprotein(a) gene stimulates growth of human vascular smooth muscle cells - Effects of overexpression of human apolipoprotein(a) gene, R Morishita,S Yamada,J Higaki,N Tomita,Kida, I,M Aoki,A Moriguchi,S Hayashi,Sakurabayashi, I,Y Kaneda,T Ogihara, HYPERTENSION, LIPPINCOTT WILLIAMS & WILKINS, Vol. 32, No. 2, p. 215-222, 1998/08
  • Functional analysis of cis-element and binding protein as regulators of angiotensinogen generation in SHR., T Nishii,A Moriguchi,R Morishita,N Tomita,S Nakamura,Y Kaneda,J Higaki,T Ogihara, JAPANESE HEART JOURNAL, JAPAN HEART JOURNAL, SECOND DEPT OF INTERNAL MED, Vol. 39, No. 4, p. 554-554, 1998/07
  • Gene Transfer by HVJ-liposome, KANEDA Yasufumi, KAGAKU TO SEIBUTSU, Japan Society for Bioscience, Biotechnology, and Agrochemistry, Vol. 36, No. 6, p. 376-384, 1998/06/25
  • Overexpressed heat shock protein 70 attenuates hypoxic injury in coronary endothelial cells, K Suzuki,Y Sawa,Y Kaneda,H Ichikawa,R Shirakura,H Matsuda, JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD, Vol. 30, No. 6, p. 1129-1136, 1998/06
  • HVJ (Sendai virus) liposome-mediated gene transfer: current status and future perspectives (Review), Y Yonemitsu,EWFW Alton,K Komori,T Yoshizumi,K Sugimachi,Y Kaneda, INTERNATIONAL JOURNAL OF ONCOLOGY, PROFESSOR D A SPANDIDOS, Vol. 12, No. 6, p. 1277-1285, 1998/06
  • Downregulation of endothelin expression in allograft coronary arteries after gene therapy targeting Cdk2 kinase, M Isobe,J Suzuki,R Morishita,Y Kaneda,Y Sawa,H Matsuda,T Ogihara,S Horie,Y Okubo,J Amano, TRANSPLANTATION PROCEEDINGS, ELSEVIER SCIENCE INC, Vol. 30, No. 4, p. 1007-1008, 1998/06
  • Heterogeneous induction of apoptosis in colon cancer cells by wild-type p53 gene transfection, M Namoto,Y Yonemitsu,K Nakagawa,S Hashimoto,Y Kaneda,H Nawata,K Sueishi, INTERNATIONAL JOURNAL OF ONCOLOGY, PROFESSOR D A SPANDIDOS, Vol. 12, No. 4, p. 777-784, 1998/04
  • Persistent gene expression in rat liver in vivo by repetitive transfections using HVJ-liposome, T Hirano,J Fujimoto,T Ueki,H Yamamoto,T Iwasaki,R Morisita,Y Sawa,Y Kaneda,H Takahashi,E Okamoto, GENE THERAPY, STOCKTON PRESS, Vol. 5, No. 4, p. 459-464, 1998/04
  • Introduction of DNA into the rat and primate trabecular meshwork by fusogenic liposomes, Masanori Hangai,Hidenobu Tanihara,Yoshihito Honda,Yasufumi Kaneda, Investigative Ophthalmology and Visual Science, Vol. 39, No. 3, p. 509-516, 1998/03
  • Transfer of wild-type p53 gene effectively inhibits vascular smooth muscle cell proliferation in vitro and in vivo, Y Yonemitsu,Y Kaneda,S Tanaka,Y Nakashima,K Komori,K Sugimachi,K Sueishi, CIRCULATION RESEARCH, LIPPINCOTT WILLIAMS & WILKINS, Vol. 82, No. 2, p. 147-156, 1998/02
  • Role of AP-1 complex in angiotensin II-mediated transforming growth factor-beta expression and growth of smooth muscle cells: Using decoy approach against AP-1 binding site, R Morishita,GH Gibbons,M Horiuchi,Y Kaneda,T Ogihara,VJ Dzau, BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, ACADEMIC PRESS INC, Vol. 243, No. 2, p. 361-367, 1998/02
  • Antisense Cdk2 kinase oligodeoxynucleotide inhibits ICAM-1 expression in murine cardiac allograft arteriopathy, J Suzuki,M Isobe,R Morishita,M Aoki,S Yamazaki,Y Kaneda,Y Sawa,H Matsuda,T Ogihara,S Horie,Y Okubo,M Sekiguchi, TRANSPLANTATION PROCEEDINGS, ELSEVIER SCIENCE INC, Vol. 30, No. 1, p. 89-90, 1998/02
  • Prolonged survival of recipient rats with Fas-ligand-transfected liver allografts by using HVJ-liposome, X. K. Li,T. Okuyama,A. Tamura,M. Fujino,N. Funeshima,Y. Kaneda,Y. Kita,S. Enosawa,H. Amemiya,S. Suzuki, Transplantation Proceedings, Vol. 30, No. 4, 1998
  • Growth inhibition of cultured human Tenon's fibroblastic cells by targeting the E2F transcription factor, Masayuki Akimoto,Masanori Hangai,Kazushiro Okazaki,Junichi Kogishi,Yoshihito Honda,Yasufumi Kaneda, Experimental Eye Research, Academic Press, Vol. 67, No. 4, p. 395-401, 1998
  • The HVJ liposome method, Yoshitaka Isaka,Yoshitaka Akagi,Yasufumi Kaneda,Enyu Imai, Experimental Nephrology, Vol. 6, No. 2, p. 144-147, 1998
  • The induction of apoptosis in HeLa cells by the loss of LBP-p40, Yasufumi Kaneda,Yoshinao Kaneda,Katsunari Kinoshita,Manabu Sato,Yoshinaga Saeki,Ryo Yamada,Mari Wataya-Kaneda,Kiyoji Tanaka, Cell Death and Differentiation, Nature Publishing Group, Vol. 5, No. 1, p. 20-28, 1998
  • A comparison of in vivo gene delivery methods for antisense therapy in ligament healing, N. Nakamura,S. A. Timmermann,D. A. Hart,Y. Kaneda,N. G. Shrive,K. Shino,T. Ochi,C. B. Frank, Gene Therapy, Nature Publishing Group, Vol. 5, No. 11, p. 1455-1461, 1998
  • Sustained transgene expression in vitro and in vivo using an epstein-barr virus replicon vector system combined with HVJ liposomes, Y. Saeki,M. Wataya-Kaneda,K. Tanaka,Y. Kaneda, Gene Therapy, Nature Publishing Group, Vol. 5, No. 8, p. 1031-1037, 1998
  • Early biological effect of in vivo gene transfer of platelet-derived growth factor (PDGF)-B into healing patellar ligament, N. Nakamura,K. Shino,T. Natsuume,S. Horibe,N. Matsumoto,Y. Kaneda,T. Ochi, Gene Therapy, Nature Publishing Group, Vol. 5, No. 9, p. 1165-1170, 1998
  • Antitumor activity of tumor necrosis factor alpha conjugated with divinyl ether and maleic anhydride copolymer on solid tumors in mice, Y Kaneda,Y Yamamoto,H Kamada,S Tsunoda,Y Tsutsumi,T Hirano,T Mayumi, CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, Vol. 58, No. 2, p. 290-295, 1998/01
  • Inhibition of growth of human vascular smooth muscle cells by overexpression of p21 gene through induction of apoptosis, H Matsushita,R Morishita,Kida, I,M Aoki,S Hayashi,N Tomita,K Yamamoto,A Moriguchi,A Noda,Y Kaneda,J Higaki,T Ogihara, HYPERTENSION, LIPPINCOTT WILLIAMS & WILKINS, Vol. 31, No. 1, p. 493-498, 1998/01
  • Hemagglutinating virus of Japan-liposome-mediated gene transfer of endothelial cell nitric oxide synthase inhibits intimal hyperplasia of canine vein grafts under conditions of poor runoff, T Matsumoto,K Komori,Y Yonemitsu,R Morishita,K Sueishi,Y Kaneda,K Sugimachi, JOURNAL OF VASCULAR SURGERY, MOSBY-YEAR BOOK INC, Vol. 27, No. 1, p. 135-144, 1998/01
  • Ribozyme-based gene cleavage approach to chronic arthritis associated with human T cell leukemia virus type I, Isao Kitajima,Naohiro Hanyu,Koichi Kawahara,Yasuko Soejima,Toshikazu Kubo,Ryo Yamada,Yasufumi Kaneda,Ikuro Maruyama, Arthritis and Rheumatism, Vol. 40, No. 12, p. 2118-2127, 1997/12
  • Development and characterization of cationic liposomes conjugated with HVJ (Sendai virus): Reciprocal effect of cationic lipid for in vitro and in vivo gene transfer, Yoshinaga Saeki,Norinao Matsumoto,Yoshiro Nakano,Masato Mori,Koji Awai,Yasufumi Kaneda, Human Gene Therapy, Mary Ann Liebert Inc., Vol. 8, No. 17, p. 2133-2141, 1997/11/20
  • A novel strategy for myocardial protection using in vivo transfection of cis element 'decoy' against NFkB binding site - Evidence for a role of NFkB in ischemia-reperfusion injury, Y Sawa,R Morishita,K Suzuki,K Kagisaki,Y Kaneda,R Maeda,K Kadoba,H Matsuda, CIRCULATION, AMER HEART ASSOC, Vol. 96, No. 9, p. 280-284, 1997/11
  • 【遺伝子診断】染色体構造蛋白の免疫染色法, 金田 眞理,金田 安史, 臨床検査, (株)医学書院, Vol. 41, No. 10, p. 1173-1178, 1997/10
  • HVJ (Sendai virus)-cationic liposomes: A novel and potentially effective liposome-mediated technique for gene transfer to the airway epithelium, Y Yonemitsu,Y Kaneda,A Muraishi,T Yoshizumi,K Sugimachi,K Sueishi, GENE THERAPY, STOCKTON PRESS, Vol. 4, No. 7, p. 631-638, 1997/07
  • In vivo direct gene transfer into articular cartilage by intraarticular injection mediated by HVJ (Sendai virus) and liposomes, T Tomita,H Hashimoto,N Tomita,R Morishita,SB Lee,K Hayashida,N Nakamura,K Yonenobu,Y Kaneda,T Ochi, ARTHRITIS AND RHEUMATISM, LIPPINCOTT-RAVEN PUBL, Vol. 40, No. 5, p. 901-906, 1997/05
  • In vivo gene transfection with heat shock protein 70 enhances myocardial tolerance to ischemia-reperfusion injury in rat, K Suzuki,Y Sawa,Y Kaneda,H Ichikawa,R Shirakura,H Matsuda, JOURNAL OF CLINICAL INVESTIGATION, ROCKEFELLER UNIV PRESS, Vol. 99, No. 7, p. 1645-1650, 1997/04
  • Efficient in vivo gene transfer into the heart in the rat myocardial infarction model using the HVJ (hemagglutinating virus of Japan) - Liposome method, M Aoki,R Morishita,A Muraishi,A Moriguchi,T Sugimoto,K Maeda,VJ Dzau,Y Kaneda,J Higaki,T Ogihara, JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD, Vol. 29, No. 3, p. 949-959, 1997/03
  • In vivo transfer efficiency of antisense oligonucleotides into the myocardium using HVJ-liposome method, M Aoki,R Morishita,J Higaki,A Moriguchi,Kida, I,S Hayashi,H Matsushita,Y Kaneda,T Ogihara, BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, ACADEMIC PRESS INC JNL-COMP SUBSCRIPTIONS, Vol. 231, No. 3, p. 540-545, 1997/02
  • The immediate early gene of human cytomegalovirus stimulates vascular smooth muscle cell proliferation in vitro and in vivo, Y Yonemitsu,Y Kaneda,K Komori,K Hirai,K Sugimachi,K Sueishi, BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, ACADEMIC PRESS INC JNL-COMP SUBSCRIPTIONS, Vol. 231, No. 2, p. 447-451, 1997/02
  • Survival of grafts of genetically modified cardiac myocytes transfected with FITC-labeled oligodeoxynucleotides and the beta-galactosidase gene in the noninfarcted area, but not the myocardial infarcted area, M Aoki,R Morishita,J Higaki,A Moriguchi,S Hayashi,H Matsushita,Kida, I,N Tomita,Y Sawa,Y Kaneda,T Ogihara, GENE THERAPY, STOCKTON PRESS, Vol. 4, No. 2, p. 120-127, 1997/02
  • In vivo gene transfection of human endothelial cell nitric oxide synthase in cardiomyocytes causes apoptosis-like cell death: Identification using Sendai virus-coated liposomes, Hiroyuki Kawaguchi,Wee Soo Shin,Yuepeng Wang,Masao Inukai,Masayoshi Kato,Yoko Matsuo-Okai,Aiji Sakamoto,Yoshio Uehara,Yasufumi Kaneda,Teruhiko Toyo-oka, Circulation, Lippincott Williams and Wilkins, Vol. 95, No. 10, p. 2441-2447, 1997
  • Efficient gene transfer method into the whole heart through the coronary artery with hemagglutinating virus of Japan liposome, A. S. Weebster,Y. Sawa,K. Kadoba,K. Suzuki,H. Z. Bai,Y. Kaneda,R. Shirakura,H. Matsuda,E. D. Verrier,J. K. Kirklin,F. W. Sellke, Journal of Thoracic and Cardiovascular Surgery, Vol. 113, No. 3, p. 510-519, 1997
  • Experimental bronchiolitis obliterans induced by in vivo HVJ-liposome- mediated endothelin-1 gene transfer, Shin-Ichi Takeda,Yoshiki Sawa,Masato Minami,Yasufumi Kaneda,Yoshitaka Fujii,Ryota Shirakura,Masashi Yanagisawa,Hikaru Matsuda, Annals of Thoracic Surgery, Elsevier USA, Vol. 63, No. 6, p. 1562-1567, 1997
  • Wild-type p53 gene transfer: A novel therapeutic strategy for neointimal hyperplasia after arterial injury, Yoshikazu Yonemitsu,Yasufumi Kaneda,Yasuaki Hata,Yutaka Nakashima,Katsuo Sueishi, Annals of the New York Academy of Sciences, Blackwell Publishing Inc., Vol. 811, p. 395-400, 1997
  • Its pathophysiological significance in humans as well as in an animal model induced by the gene transfer of vascular endothelial growth factor, K Sueishi,Y Yonemitsu,K Nakagawa,Y Kaneda,M Kumamoto,Y Nakashima, ATHEROSCLEROSIS IV: RECENT ADVANCES IN ATHEROSCLEROSIS RESEARCH, NEW YORK ACAD SCIENCES, Vol. 811, p. 311-324, 1997
  • Prevention of restenosis by gene therapy, Y Kaneda,R Morishita,VJ Dzau, ATHEROSCLEROSIS IV: RECENT ADVANCES IN ATHEROSCLEROSIS RESEARCH, NEW YORK ACAD SCIENCES, Vol. 811, p. 299-310, 1997
  • Analysis of nuclear localization of laminin binding protein precursor p40 (LBP/p40), Manabu Sato,Katsunari Kinoshita,Yoshinao Kaneda,Yoshinaga Saeki,Akihiro Iwamatsu,Kiyoji Tanaka,Yasufumi Kaneda, Biochemical and Biophysical Research Communications, Academic Press Inc., Vol. 229, No. 3, p. 896-901, 1996/12/24
  • In vivo gene transfer into the retina mediated by a novel liposome system, Masanori Hangai,Yasufumi Kaneda,Hidenobu Tanihara,Yoshihito Honda, Investigative Ophthalmology and Visual Science, Vol. 37, No. 13, p. 2678-2685, 1996/12
  • Efficient oligonucleotide delivery using the HVJ-liposome method in the central nervous system, Kazuo Yamada,Atsushi Moriguchi,Ryuichi Morishita,Motokuni Aoki,Yoshio Nakamura,Hiroshi Mikami,Takeo Oshima,Mitsuyoshi Ninomiya,Yasufumi Kaneda,Jitsuo Higaki,Toshio Ogihara, American Journal of Physiology - Regulatory Integrative and Comparative Physiology, Vol. 271, No. 5, p. R1212-R1220, 1996/11
  • Fusigenic viral liposome for gene therapy in cardiovascular diseases, VJ Dzau,MJ Mann,R Morishita,Y Kaneda, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, NATL ACAD SCIENCES, Vol. 93, No. 21, p. 11421-11425, 1996/10
  • In vivo transfer of gene and oligodeoxynucleotides into skin of fetal rats by incubation in amniotic fluid, SI Hayashi,R Morishita,M Aoki,A Moriguchi,Kida, I,M Nakajima,Y Kaneda,J Higaki,T Ogihara, GENE THERAPY, STOCKTON PRESS, Vol. 3, No. 10, p. 878-885, 1996/10
  • Characterization of in vivo gene transfer into the arterial wall mediated by the sendai virus (Hemagglutinating virus of Japan) liposomes: An effective tool for the in vivo study of arterial diseases, Y Yonemitsu,Y Kaneda,R Morishita,K Nakagawa,Y Nakashima,K Sueishi, LABORATORY INVESTIGATION, WILLIAMS & WILKINS, Vol. 75, No. 3, p. 313-323, 1996/09
  • Fusigenic liposome-mediated DNA transfer into cardiac myocytes, KE Ellison,NH Bishopric,KA Webster,R Morishita,GH Gibbons,Y Kaneda,B Sato,VJ Dzau, JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD, Vol. 28, No. 7, p. 1385-1399, 1996/07
  • Sustained transgene expression by transfection of renin gene into liver of neonates, N Tomita,R Morishita,J Higaki,S Tomita,M Aoki,Y Kaneda,T Ogihara, BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, ACADEMIC PRESS INC JNL-COMP SUBSCRIPTIONS, Vol. 224, No. 1, p. 43-49, 1996/07
  • Expression of full-length human dystrophin cDNA in mdx mouse muscle by HVJ-liposome injection, I. Yanagihara,K. Inui,G. Dickson,G. Turner,T. Piper,Y. Kaneda,S. Okada, Gene Therapy, Vol. 3, No. 6, p. 549-553, 1996/06
  • Autocrine paracrine effects of overexpression of hepatocyte growth factor gene on growth of endothelial cells, S Hayashi,R Morishita,J Higaki,M Aoki,A Moriguchi,Kida, I,S Yoshiki,K Matsumoto,T Nakamura,Y Kaneda,T Ogihara, BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, ACADEMIC PRESS INC JNL-COMP SUBSCRIPTIONS, Vol. 220, No. 3, p. 539-545, 1996/03
  • Preparation of laminin-related peptide analogs and their inhibitory effect on experimental metastasis in mice, Y Izuno,M Kakiuchi,M Maeda,K Kawasaki,Y Kaneda,Y Tsutsumi,S Nakagawa,T Mayumi, PEPTIDE CHEMISTRY 1995, PROTEIN RESEARCH FOUNDATION, p. 401-404, 1996
  • Inhibition of TGF-β1 expression by antisense oligonucleotides suppressed extracellular matrix accumulation in experimental glomerulonephritis, Yoshitaka Akagi,Yoshitaka Isaka,Makoto Arai,Tetsuya Kaneko,Masaru Takenaka,Toshiki Moriyama,Yasufumi Kaneda,Akio Ando,Yoshimasa Orita,Takenobu Kamada,Naohiko Ueda,Enyu Imai, Kidney International, Nature Publishing Group, Vol. 50, No. 1, p. 148-155, 1996
  • Gene therapy by skeletal muscle expression of decorin prevents fibrotic disease in rat kidney, Yoshitaka Isaka,Douglas K. Brees,Kazuko Ikegaya,Yasufumi Kaneda,Enyu Imai,Nancy A. Noble,Wayne A. Border, Nature Medicine, Vol. 2, No. 4, p. 418-423, 1996
  • Novel strategy of gene therapy in cardiovascular disease with HVJ-liposome method, R Morishita,J Higaki,M Aoki,S Hayashi,Kida, I,Y Kaneda,T Ogihara, PROGRESSION OF CHRONIC RENAL DISEASES, KARGER, Vol. 118, p. 254-264, 1996
  • Transient introduction of a foreign gene into healing rat patellar ligament, N Nakamura,S Horibe,N Matsumoto,T Tomita,T Natsuume,Y Kaneda,K Shino,T Ochi, JOURNAL OF CLINICAL INVESTIGATION, ROCKEFELLER UNIV PRESS, Vol. 97, No. 1, p. 226-231, 1996/01
  • Role of transcriptional cis-elements, angiotensinogen gene-activating elements, of angiotensinogen gene in blood pressure regulation., Morishita R,Higaki J,Tomita N,Aoki M,Moriguchi A,Tamura K,Murakami K,Kaneda Y,Ogihara T, Hypertension, Vol. 27, p. 502-507, 1996
  • Effect of angiotensinogen on blood pressure regulation in normotensive rats: Application of a loss of function approach, N Tomita,R Morishita,J Higaki,S Tomita,M Aoki,Y Kaneda,T Ogihara, JOURNAL OF HYPERTENSION, RAPID SCIENCE PUBLISHERS, Vol. 13, No. 12, p. 1767-1774, 1995/12
  • The loss of 40-kDa chromosomal protein in tuberous sclerosis lesions, M WatayaKaneda,K Hashimoto,K Yoshikawa,Y Kaneda, BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, ACADEMIC PRESS INC ELSEVIER SCIENCE, Vol. 217, No. 2, p. 599-607, 1995/12
  • EFFICIENCY OF IN-VIVO GENE TRANSFECTION INTO TRANSPLANTED RAT-HEART BY CORONARY INFUSION OF HVJ LIPOSOME, Y SAWA,K SUZUKI,HZ BAI,R SHIRAKURA,R MORISHITA,Y KANEDA,H MATSUDA, CIRCULATION, AMER HEART ASSOC, Vol. 92, No. 9, p. 479-482, 1995/11
  • Overexpression of Prostacyclin Synthase Inhibits Growth of Vascular Smooth Muscle Cells, Shuntaro Hara,Ryuichi Morishita,Yoshinori Tone,Chieko Yokoyama,Hiroyasu Inoue,Yasufumi Kaneda,Toshio Ogihara,Tadashi Tanabe, Biochemical and Biophysical Research Communications, Vol. 216, p. 862-867, 1995/01/01
  • EVIDENCE FOR DIRECT LOCAL EFFECT OF ANGIOTENSIN IN VASCULAR HYPERTROPHY - IN-VIVO GENE-TRANSFER OF ANGIOTENSIN-CONVERTING ENZYME, R MORISHITA,GH GIBBONS,KE ELLISON,W LEE,LN ZHANG,H YU,Y KANEDA,T OGIHARA,VJ DZAU, JOURNAL OF CLINICAL INVESTIGATION, ROCKEFELLER UNIV PRESS, Vol. 94, No. 3, p. 978-984, 1994/09
  • AUTOCRINE AND PARACRINE EFFECTS OF ATRIAL-NATRIURETIC-PEPTIDE GENE-TRANSFER ON VASCULAR SMOOTH-MUSCLE AND ENDOTHELIAL CELLULAR GROWTH, R MORISHITA,GH GIBBONS,RE PRATT,N TOMITA,Y KANEDA,T OGIHARA,VJ DZAU, JOURNAL OF CLINICAL INVESTIGATION, ROCKEFELLER UNIV PRESS, Vol. 94, No. 2, p. 824-829, 1994/08
  • Introduction and expression of human CD59 gene in the canine kidney, T. Akami,K. Arakawa,M. Okamoto,K. Akioka,I. Fujiwara,I. Nakai,M. Mitsuo,N. Tomita,Y. Kaneda,K. Tanaka,T. Oka, Transplantation Proceedings, Vol. 26, No. 3, p. 1315-1317, 1994
  • A novel gene-transfer technique mediated by HVJ (Sendai Virus), nuclear protein, and liposomes., Tomita, N,Higaki, J,Ogihara, T,Kondo,T,Kaneda, Y, Can. Det. and Prev., Vol. 18, No. 6, p. 485-491, 1994
  • Construction of radiation-reduced hybrids and their use in mapping of microclones from chromosome 10p11.2-q11.2, Shoichi Fujita,Eisei Shin,Tsutomu Nakamura,Hiroki Kurahashi,Yasufumi Kaneda,Kiyoji Tanaka,Takesada Mori,Shin-ichiro Takai,Isamu Nishisho, The Japanese Journal of Human Genetics, Springer-Verlag, Vol. 38, No. 4, p. 361-370, 1993/12
  • HYPERTENSIVE RATS PRODUCED BY IN-VIVO INTRODUCTION OF THE HUMAN RENIN GENE, N TOMITA,J HIGAKI,Y KANEDA,H YU,R MORISHITA,H MIKAMI,T OGIHARA, CIRCULATION RESEARCH, AMER HEART ASSOC, Vol. 73, No. 5, p. 898-905, 1993/11
  • SINGLE INTRALUMINAL DELIVERY OF ANTISENSE CDC2 KINASE AND PROLIFERATING-CELL NUCLEAR ANTIGEN OLIGONUCLEOTIDES RESULTS IN CHRONIC INHIBITION OF NEOINTIMAL HYPERPLASIA, R MORISHITA,GH GIBBONS,KE ELLISON,M NAKAJIMA,L ZHANG,Y KANEDA,T OGIHARA,VJ DZAU, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, NATL ACAD SCIENCES, Vol. 90, No. 18, p. 8474-8478, 1993/09
  • NOVEL AND EFFECTIVE GENE-TRANSFER TECHNIQUE FOR STUDY OF VASCULAR RENIN-ANGIOTENSIN SYSTEM, R MORISHITA,GH GIBBONS,Y KANEDA,T OGIHARA,VJ DZAU, JOURNAL OF CLINICAL INVESTIGATION, ROCKEFELLER UNIV PRESS, Vol. 91, No. 6, p. 2580-2585, 1993/06
  • NOVEL INVITRO GENE-TRANSFER METHOD FOR STUDY OF LOCAL MODULATORS IN VASCULAR SMOOTH-MUSCLE CELLS, R MORISHITA,GH GIBBONS,Y KANEDA,T OGIHARA,VJ DZAU, HYPERTENSION, AMER HEART ASSOC, Vol. 21, No. 6, p. 894-899, 1993/06
  • Transfection of Interleukin 2 Gene into Human Melanoma Cells Augments Cellular Immune Response, Akihiko Uchiyama,Dave S. B. Hoon,Takashi Morisaki,Yasufumi Kaneda,Dale H. Yuzuki,Donald L. Morton, Cancer Research, Vol. 53, No. 5, p. 949-952, 1993/03/01
  • IMPLEMENTATION OF A PARALLEL-PROCESSING SYSTEM FOR INFERENCE OF PHYLOGENETIC TREES, H MATSUDA,GJ OLSEN,R HAGSTROM,R OVERBEEK,Y KANEDA, IEEE PACIFIC RIM CONFERENCE ON COMMUNICATIONS, COMPUTERS AND SIGNAL PROCESSING : PROCEEDINGS, VOLS 1 AND 2, I E E E, p. 280-283, 1993
  • Glomerulosclerosis induced by in vivo transfection of transforming growth factor-β or platelet-derived growth factor gene into the rat kidney, Yoshitaka Isaka,Yoshihiro Fujiwara,Naohiko Ueda,Yasufumi Kaneda,Takenobu Kamada,Enyu Imai, Journal of Clinical Investigation, The American Society for Clinical Investigation, Vol. 92, No. 6, p. 2597-2601, 1993
  • ANTISENSE OLIGONUCLEOTIDES DIRECTED AT CELL-CYCLE REGULATORY GENES AS STRATEGY FOR RESTENOSIS THERAPY, R MORISHITA,GH GIBBONS,KE ELLISON,M NAKAJIMA,H VONDERLEYEN,LN ZHANG,Y KANEDA,T OGIHARA,VJ DZAU, TRANSACTIONS OF THE ASSOCIATION OF AMERICAN PHYSICIANS, VOL 106, ASSOC AMER PHYSICIANS, Vol. 106, p. 54-61, 1993
  • DIRECT INVIVO GENE INTRODUCTION INTO RAT-KIDNEY, N TOMITA,J HIGAKI,R MORISHITA,K KATO,H MIKAMI,Y KANEDA,T OGIHARA, BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, ACADEMIC PRESS INC JNL-COMP SUBSCRIPTIONS, Vol. 186, No. 1, p. 129-134, 1992/07
  • Monoclonal antibodies specific for human chromosome 5 obtained with a monochromosomal hybrid can be used to sort out cells containing the chromosome with a FACS, Akihiro Yoneda,Yoshihiro Yoneda,Yasufumi Kaneda,Helene Hayes,Tsuyoshi Uchida,Yoshio Okada, Chromosoma, Springer-Verlag, Vol. 100, No. 3, p. 187-192, 1991/03
  • A case of Fabry's disease in a patient with no α-galactosidase A activity caused by a single amino acid substitution of Pro-40 by Ser, Tsuyoshi Koide,Masahiro Ishiura,Kunimitu Iwai,Michitoshi Inoue,Yasufumi Kaneda,Yoshio Okada,Tsuyoshi Uchida, FEBS Letters, Vol. 259, No. 2, p. 353-356, 1990/01/01
  • INTRODUCTION OF DOSIM PREDICATE TO PROLOG, Y KANEDA,H MATSUDA, NEW GENERATION COMPUTING, SPRINGER VERLAG, Vol. 8, No. 2, p. 163-181, 1990
  • Secretion of mr 46,000 protein from human hepatoma cells treated with tumor promotors is regulated by c-myc gene expression, Hiroshi Miwatani,Yoshihiro Yoneda,Yasufumi Kaneda,Tsuyoshi Uchida,Hideo Maki,Tsuyoshi Uchida, Cell Structure and Function, Vol. 14, No. 2, p. 183-192, 1989
  • Regional assignment of the gene for diphtheria toxin sensitivity using subchromosomal fragments in microcell hybrids, Hélène Hayes,Yasufumi Kaneda,Tsuyoshi Uchida,Yoshio Okada, Chromosoma, Springer-Verlag, Vol. 96, No. 1, p. 26-32, 1987/12
  • Immunofluorescence analysis of cultured mammalian cell nucleus using four monoclonal antibodies against the nucleus, Mari Wataya-Kaneda,Kiyoshi Nishioka,Yasufumi Kaneda,Tsuyoshi Uchida, Journal of Dermatology, Blackwell Publishing Ltd, Vol. 14, No. 4, p. 316-321, 1987/08/01
  • A monoclonal antibody against the nucleus reveals the presence of a common protein in the nuclear envelope, the perichromosomal region, and cytoplasmic vesicles, M. Wataya-Kaneda,Y. Kaneda,T. Sakurai,H. Sugawa,T. Uchida, Journal of Cell Biology, Vol. 104, No. 1, p. 1-7, 1987
  • PARALLEL PROLOG MACHINE PARK - ITS HARDWARE STRUCTURE AND PROLOG SYSTEM, H MATSUDA,M KOHATA,T MASUO,Y KANEDA,S MAEKAWA, LECTURE NOTES IN COMPUTER SCIENCE, SPRINGER VERLAG, Vol. 221, p. 35-43, 1986

Misc.

  • NOVEL PATHOPHYSIOLOGICAL ROLES OF ALPHA-SYNUCLEIN (SNCA) IN AGE-RELATED VASCULAR ENDOTHELIAL DYSFUNCTION, Yoichi Takami,Hironori Nakagami,Koichi Yamamoto,Yasushi Takeya,Ryuichi Morishita,Shuko Takeda,Yasufumi Kaneda,Hiromi Rakugi, JOURNAL OF HYPERTENSION, LIPPINCOTT WILLIAMS & WILKINS, Vol. 39, p. E179-E179, 2021/04
  • 加齢性血管内皮障害におけるαシヌクレイン(SNCA)の病態生理機能, 鷹見洋一,王誠,中神啓徳,山本浩一,武田朱公,竹屋泰,金田安史,樂木宏実, 日本動脈硬化学会総会・学術集会プログラム・抄録集(Web), Vol. 53rd, 2021
  • Further Development and Intra-Laboratory Validation of a Novel Pyro-Drive Jet Injector (PJI), Kunihiko Yamashita,Chinyang Chang,Jiayu A. Tai,Jiao Sun,Hiroki Hayashi,Hiroshi Miyazaki,Hironori Nakagami,Yasufumi Kaneda, MOLECULAR THERAPY, CELL PRESS, Vol. 28, No. 4, p. 294-294, 2020/04
  • Histological Changes of Feline Mammary Carcinoma Treated by NPe6 HVJ-E PDT, 山下真路,大崎智弘,寸田祐嗣,斎藤祥子,稲井瑞穂,本多典広,本多典広,西村隆宏,間久直,粟津邦男,粟津邦男,粟津邦男,金田安史,岡本芳晴, 日本レーザー医学会誌, Vol. 40, No. 4, 2020
  • 去勢抵抗性再燃前立腺癌患者を対象としたGEN0101前立腺腫瘍内投与、皮下投与による安全性/忍容性及び予備的な有効性検討のためのオープンラベル用量漸増試験(第1相), 藤田 和利,中井 康友,加藤 大悟,河嶋 厚成,氏家 剛,永原 啓,植村 元秀,今村 亮一,沖原 宏治,浮村 理,三木 恒治,金田 安史,野々村 祝夫, 日本泌尿器科学会総会, (一社)日本泌尿器科学会総会事務局, Vol. 107回, p. AOP-132, 2019/04
  • Altered RNA splicing by SFX promotes malignancy in prostate cancer, Norihiko Kawamura,Keisuke Nimura,Kotaro Saga,Yohei Okuda,Takuya Ito,Kentaro Takezawa,Koichi Tsutahara,Go Tanigawa,Tetsuya Takao,Yasufumi Kaneda,Norio Nonomura,Seiji Yamaguchi, INTERNATIONAL JOURNAL OF UROLOGY, WILEY, Vol. 25, p. 186-186, 2018/10
  • RNA splicing altered by SFX promotes malignancy in prostate cancer, Norihiko Kawamura,Keisuke Nimura,Kotaro Saga,Youhei Okuda,Takuya Ito,Kentaro Takezawa,Koichi Tsutahara,Go Tanigawa,Tetsuya Takao,Yasufumi Kaneda,Norio Nonomura,Seiji Yamaguchi, INTERNATIONAL JOURNAL OF UROLOGY, WILEY, Vol. 25, p. 349-349, 2018/10
  • 表皮水疱症に対する治療法開発, 玉井 克人,小紫 雄貴,外村 香子,林 美沙,奥田 英右,清原 英司,種村 篤,金田 眞理,室田 浩之,片山 一朗,菊池 康,金田 安史, 皮膚の科学, 日本皮膚科学会-大阪地方会・京滋地方会, Vol. 17, No. 4, p. 235-235, 2018/08
  • HVJ-Eベクターを用いた遺伝子機能スクリーニング法による血管内皮由来の新規酸化ストレス調節因子の探索, 永澤 元規,鷹見 洋一,中神 啓徳,山本 浩一,金田 安史,楽木 宏実, 日本内分泌学会雑誌, (一社)日本内分泌学会, Vol. 93, No. 4, p. 1388-1388, 2017/12
  • Characterization of circulating stem/progenitor cells during fatal skin injury regeneration, SHIMBO Takashi,SASAKI Eiji,KITAYAMA Tomomi,KITAYAMA Tomomi,NISHIDA Mami,NISHIDA Mami,YAMAZAKI Sho,YAMAZAKI Sho,OUCHI Yuya,OUCHI Yuya,YAMAOKA Sachiko,KIKUCHI Yasushi,KANEDA Yasufumi,TAMAI Katsuto, 日本研究皮膚科学会年次学術大会・総会プログラム, Vol. 42nd, 2017/11/02
  • Comprehensive analysis on HMGB1-induced circulating cells during cutaneous tissue regeneration, T. Shimbo,M. Nishida,T. Kitayama,R. Yamamoto,E. Takaki,Y. Kikuchi,Y. Kaneda,K. Tamai, JOURNAL OF INVESTIGATIVE DERMATOLOGY, ELSEVIER SCIENCE INC, Vol. 137, No. 10, p. S308-S308, 2017/10
  • Systemic administration of HMGB1 peptide drastically improves survival of the RDEB model mice by mobilizing multipotent stem/progenitor cells from bone marrow, K. Tamai,S. Yamazaki,X. Wang,M. Nishida,T. Shimbo,Y. Kikuchi,L. Bruckner-Tuderman,J. Uitto,I. Katayama,Y. Kaneda, JOURNAL OF INVESTIGATIVE DERMATOLOGY, ELSEVIER SCIENCE INC, Vol. 137, No. 10, p. S223-S223, 2017/10
  • HVJ-Eベクターを用いた遺伝子機能スクリーニング法による血管内皮由来の新規酸化ストレス調節因子の探索, 永澤 元規,鷹見 洋一,中神 啓徳,山本 浩一,金田 安史,楽木 宏実, 日本高血圧学会総会プログラム・抄録集, (NPO)日本高血圧学会, Vol. 40回, p. 428-428, 2017/10
  • Subcutaneous transplantation of allogenic mesenchymal stromal cells ameliorates intractable ulcers in recessive dystrophic epidermolysis bullosa patients, K. Tamai,Y. Kikuchi,L. Zhang,Y. Komurasaki,T. Yamaoka,Y. Kaneda, JOURNAL OF INVESTIGATIVE DERMATOLOGY, ELSEVIER SCIENCE INC, Vol. 137, No. 5, p. S56-S56, 2017/05
  • Systemic HMGB1 administration ameliorates cutaneous and non-cutaneous manifestations in a dystrophic epidermolysis bullosa model mouse, T. Shimbo,S. Yamazaki,X. Wang,Y. Kikuchi,L. Bruckner-Tuderman,Y. Kaneda,K. Tamai, JOURNAL OF INVESTIGATIVE DERMATOLOGY, ELSEVIER SCIENCE INC, Vol. 137, No. 5, p. S156-S156, 2017/05
  • α-synuclein(SNCA)の老化に伴う血管内皮機能障害における新規病態生理機能, 鷹見洋一,中神啓徳,竹屋泰,武田朱公,山本浩一,森下竜一,金田安史,樂木宏実, Dementia Japan, Vol. 31, No. 4, 2017
  • Evaluation of a novel photosensitizing drug having antitumor effect for advanced prostate cancer, Sachiko Saito,Mizuho Inai,Norihiro Honda,Hisanao Hazama,Yasufumi Kaneda,Kunio Awazu, Progress in Biomedical Optics and Imaging - Proceedings of SPIE, Vol. 10417, 2017/01/01
  • パーキンソン病原因分子αシヌクレインの加齢性血管内皮機能障害における新規病態生理機能, 鷹見 洋一,中神 啓徳,山本 浩一,森下 竜一,金田 安史,楽木 宏実, 日本内分泌学会雑誌, (一社)日本内分泌学会, Vol. 92, No. 3, p. 893-893, 2017/01
  • 前立腺癌におけるAR-V7の発現制御機構, 川村 憲彦,佐賀 公太郎,河嶋 厚成,氏家 剛,永原 啓,藤田 和利,植村 元秀,野々村 祝夫,金田 安史, 日本癌学会総会記事, 日本癌学会, Vol. 75回, p. P-2241, 2016/10
  • Imaging Mass Spectrometry for Multiple Drugs Administered in Cancer Cells with Laser Desorption/Ionization using Zeolite Matrix, Vol. 2016, No. 66, p. 21-26, 2016/09/26
  • Encapsulation of talaporfin sodium into replication deficient virus particles for photodynamic therapy, Vol. 16, No. 18, p. 1-6, 2016/08/05
  • Gene knockout of NANOG and NANOGP8 mediated by CRISPR/Cas9 system decreases the malignant potential of prostate cancer cells, Norihiko Kawamura,Keisuke Nimura,Atsunari Kawashima,Takeshi Ujike,Akira Nagahara,Kazutoshi Fujita,Motohide Uemura,Yasufumi Kaneda,Norio Nonomura, CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, Vol. 76, 2016/07
  • In Vitro-Synthesized Sendai Virus RNA Fragments Induced Antitumor Immunity and Cancer Cell-Selective Apoptosis, Tomoyuki Nishikawa,Li-Wen Liu,Yasufumi Kaneda, MOLECULAR THERAPY, NATURE PUBLISHING GROUP, Vol. 24, p. S59-S60, 2016/05
  • PHASE I/II CLINICAL TRIAL TO ASSESS SAFETY AND EFFICACY OF INTRATUMORAL AND SUBCUTANEOUS INJECTION OF HVJ-E TO CASTRATION RESISTANT PROSTATE CANCER PATIENTS, Kazutoshi Fujita,Yasutomo Nakai,Koji Hatano,Norihiko Kawamura,Atsunari Kawashima,Takeshi Ujike,Akira Nagahara,Motohide Uemura,Yasufumi Kaneda,Norio Nonomura, JOURNAL OF UROLOGY, ELSEVIER SCIENCE INC, Vol. 195, No. 4, p. E762-E762, 2016/04
  • GENE KNOCKOUT OF NANOG AND NANOGP8 MEDIATED BY CRISPR/CAS9 DECREASES THE MALIGNANT POTENTIAL OF PROSTATE CANCER CELLS, Norihiko Kawamura,Keisuke Nimura,Hiromichi Nagano,Takahiro Yoshida,Atsunari Kawashima,Takeshi Ujike,Akira Nagahara,Kazutoshi Fujita,Motohide Uemura,Yasufumi Kaneda,Norio Nonomura, JOURNAL OF UROLOGY, ELSEVIER SCIENCE INC, Vol. 195, No. 4, p. E872-E872, 2016/04
  • NANOG・NANOGP8各遺伝子のノックアウトにより、前立腺癌細胞のmalignant potentialは低下する, 川村 憲彦,二村 圭介,長野 広通,吉田 栄宏,河嶋 厚成,氏家 剛,永原 啓,藤田 和利,植村 元秀,金田 安史,野々村 祝夫, 日本泌尿器科学会総会, (一社)日本泌尿器科学会総会事務局, Vol. 104回, p. PP2-096, 2016/04
  • 去勢抵抗性再燃前立腺癌患者を対象としたHVJ-E腫瘍内投与および皮下投与の安全性及び有効性の評価のための臨床試験(第I/II相臨床試験), 藤田 和利,川村 憲彦,波多野 浩士,吉田 栄宏,河嶋 厚成,氏家 剛,永原 啓,中井 康友,植村 元秀,金田 安史,野々村 祝夫, 日本泌尿器科学会総会, (一社)日本泌尿器科学会総会事務局, Vol. 104回, p. PP2-286, 2016/04
  • パーキンソン病原因遺伝子αシヌクレインの血管老化及び血管内皮機能障害における新規病態生理機能の検討, 鷹見洋一,中神啓徳,山本浩一,森下竜一,金田安史,樂木宏実, 日本高血圧学会総会プログラム・抄録集, Vol. 39th, 2016
  • Mesenchymal cell therapy for recessive dystrophic epidermolysis bullosa, TAMAI Katsuto,KIKUCHI Yasushi,KANEDA Yasufumi,KATAYAMA Ichiro, 日本研究皮膚科学会年次学術大会・総会プログラム, Vol. 40th, 2015/11/16
  • Systemic High Mobility Group Box 1 Administration Suppresses Skin Inflammation By Inducing Accumulation of PDGFR alpha(+) Mesenchymal Cells from Bone Marrow, Eriko Aikawa,Ryo Fujita,Yasufumi Kaneda,Katsuto Tamai, MOLECULAR THERAPY, NATURE PUBLISHING GROUP, Vol. 23, p. S260-S260, 2015/05
  • ドセタキセル抵抗性の前立腺癌細胞では、CXCR4・p-ERK1/2・c-Mycのsignaling loopが形成され、腫瘍造成能が亢進している, 川村 憲彦,波多野 浩士,中田 渡,吉田 栄宏,河嶋 厚成,氏家 剛,永原 啓,藤田 和利,植村 元秀,金田 安史,野々村 祝夫, 日本泌尿器科学会総会, (一社)日本泌尿器科学会総会事務局, Vol. 103回, p. 709-709, 2015/04
  • Photodynamic therapy using hemagglutinating virus of Japan envelope (HVJ-E): A novel therapeutic approach for the treatment of hormone antagonistic prostate cancer, Mizuho Inai,Masaya Yamauchi,Norihiro Honda,Hisanao Hazama,Shoji Tachikawa,Hiroyuki Nakamura,Tomoki Nishida,Hidehiro Yasuda,Yasufumi Kaneda,Kunio Awazu, Progress in Biomedical Optics and Imaging - Proceedings of SPIE, Vol. 9308, 2015/01/01
  • Hemagglutinating virus of Japan envelope (HVJ-E) allows targeted and efficient delivery of photosensitizer for photodynamic therapy against advanced prostate cancer, Mizuho Inai,Masaya Yamauchi,Norihiro Honda,Hisanao Hazama,Shoji Tachikawa,Hiroyuki Nakamura,Tomoki Nishida,Hidehiro Yasuda,Yasufumi Kaneda,Kunio Awazu, Optical Molecular Probes, Imaging and Drug Delivery, OMP 2015, 2015/01/01
  • HMGB1 accelerates skin regeneration by inducing bone marrow mesenchymal stromal cells, AIKAWA Eriko,KOMURASAKI Yuki,FUJITA Ryo,KANEDA Yasufumi,KATAYAMA Ichiro,TAMAI Katsuto, 日本研究皮膚科学会年次学術大会・総会プログラム, Vol. 39th, 2014/11/10
  • 薬剤耐性前立腺がん細胞へのPDTの検討 : 非ウイルスベクターとPplX脂質を用いた新規光感受性薬剤の開発 (特集 がんを抑え込む光線治療), 粟津 邦男,金田 安史,山内 将哉, 光アライアンス, 日本工業出版, Vol. 25, No. 9, p. 17-22, 2014/09
  • HMGB1 stimulates bone marrow mesenchymal stem/stromal cells to accelerate skin regeneration, E. Aikawa,R. Fujita,Y. Kikuchi,Y. Kaneda,K. Tamai, JOURNAL OF INVESTIGATIVE DERMATOLOGY, NATURE PUBLISHING GROUP, Vol. 134, p. S98-S98, 2014/09
  • ドセタキセル療法後の前立腺癌細胞では、CXCR4・ERK1/2・c-Mycが恒常的に活性化し、腫瘍形成能が増加している(Chemoresistant prostate cancer cells increase the tumorigenicity via constitutive signaling of CXCR4, ERK1/2 and c-Myc), 川村 憲彦,波多野 浩士,木内 利郎,林 拓自,松崎 恭介,中田 渡,吉田 栄宏,氏家 剛,永原 啓,藤田 和利,植村 元秀,金田 安史,野々村 祝夫, 日本癌学会総会記事, 日本癌学会, Vol. 73回, p. P-1286, 2014/09
  • HMGB1 MOBILIZES PDGFR alpha-POSITIVE CELLS FROM BONE MARROW TO REGENERATE INJURED EPITHELIA, Katsuto Tamai,Takenao Chino,Shin Iinuma,Nao Manjyo,Ryo Fujita,Takehiko Yamazaki,Yasushi Kikuchi,Yasufumi Kaneda, JOURNAL OF GENE MEDICINE, WILEY-BLACKWELL, Vol. 16, No. 7-8, p. 257-257, 2014/07
  • EFFICIENT ERADICATION OF CASTRATION-RESISTANT HUMAN PROSTATE CANCERS BY NONREPLICATING ONCOLYTIC VIRUS, INACTIVATED SENDAI VIRUS PARTICLE, Koji Hatano,Yoshifumi Kawaguchi,Yasuhide Miyamoto,Norio Nonomura,Yasufumi Kaneda, JOURNAL OF GENE MEDICINE, WILEY-BLACKWELL, Vol. 16, No. 7-8, p. 258-258, 2014/07
  • Inactive Sendai virus (HVJ-E) induces selective cell death in prostate cancer cells through TRAIL induction, Taeko Miyagi,Shimbo Takashi,Yuki Inoue,Yasufumi Kaneda, JOURNAL OF GENE MEDICINE, WILEY-BLACKWELL, Vol. 16, No. 7-8, p. 219-219, 2014/07
  • DEVELOPMENT OF DNA VACCINE FOR HIGH BLOOD PRESSURE - IMMUNOTHERPY FOR ANGIOTENSIN II., Hironori Nakagami,Ryuichi Morishita,Yasufumi Kaneda, JOURNAL OF GENE MEDICINE, WILEY-BLACKWELL, Vol. 16, No. 7-8, p. 255-255, 2014/07
  • Development of laser ionization techniques for evaluation of the effect of cancer drugs using imaging mass spectrometry, Hiroki Kannen,Hisanao Hazama,Yasufumi Kaneda,Tatsuya Fujino,Kunio Awazu, International Journal of Molecular Sciences, Vol. 15, p. 11234-11244, 2014/06/25
  • Allogeneic Mesenchymal Stem Cell Transplantation for Dystrophic Epidermolysis Bullosa, Katsuto Tamai,Yasushi Kikuchi,Ranhnan Cho,Sachiko Ezoe,Yasufumi Kaneda, MOLECULAR THERAPY, NATURE PUBLISHING GROUP, Vol. 22, p. S186-S186, 2014/05
  • Cancer Immunotherapy Using a Cancer-Targeting Platelet Vector Incorporating Viral Particles, Tomoyuki Nishikawa,Yasufumi Kaneda, MOLECULAR THERAPY, NATURE PUBLISHING GROUP, Vol. 22, p. S244-S244, 2014/05
  • PS-101-1 神経芽腫におけるCaM kinase II活性化を介した新たな細胞死誘導機構の解明(PS-101 基礎 その他-1,ポスターセッション,第114回日本外科学会定期学術集会), 野村 元成,福澤 正洋,金田 安史, 日本外科学会雑誌, 一般社団法人日本外科学会, Vol. 115, No. 2, p. 776-776, 2014/03/05
  • Observation of drug delivering process using a novel drug for photodynamic therapy named porphyrus envelope, No. 43, p. 67-71, 2014
  • Development of virosome-mediated cancer therapy, Yasufumi Kaneda, JOURNAL OF PHARMACOLOGICAL SCIENCES, JAPANESE PHARMACOLOGICAL SOC, Vol. 124, p. 60P-60P, 2014
  • In vivo mobilization of bone marrow mesenchymal stem cells accelerates cutaneous regeneration in epidermolysis bullosa, K. Tamai,Y. Kaneda, HUMAN GENE THERAPY, MARY ANN LIEBERT, INC, Vol. 24, No. 12, p. A29-A29, 2013/12
  • Recent advances and developments in the antitumor effect of the HVJ envelope vector on malignant melanoma: From the bench to clinical application, A. Tanemura,E. Kiyohara,I. Katayama,Y. Kaneda, Cancer Gene Therapy, Vol. 20, No. 11, p. 599-605, 2013/11
  • PDGER alpha-positive mesenchymal stem/progenitor cells in bone marrow migrate in RDEB mouse skin by CXCR4/SDF-1 alpha axis to provide type VII collagen after bone marrow cell transplantation, S. Iinuma,E. Aikawa,Y. Kikuchi,T. Chino,R. Fujita,J. A. McGrath,J. Uitto,I. Katayama,Y. Kaneda,K. Tamai, JOURNAL OF INVESTIGATIVE DERMATOLOGY, NATURE PUBLISHING GROUP, Vol. 133, p. S140-S140, 2013/05
  • TRAIL and Noxa are selectively up-regulated in prostate cancer cells downstream of the RIG-I/MAVS signaling pathway by non-replicating Sendai virus particles., Koji Hatano,Yasutomo Nakai,Taeko Matsushima-Miyagi,Motonari Nomura,Wataru Nakata,Takahiro Yoshida,Mototaka Sato,Atsunari Kawashima,Akira Nagahara,Kazutoshi Fujita,Motohide Uemura,Hitoshi Takayama,Yasufumi Kaneda,Norio Nonomura, CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, Vol. 73, No. 8, 2013/04
  • Development of laser ionization imaging mass spectrometry for pharmacokinetic analysis of cancer drugs, KANNEN Hiroki,MORIGUCHI Naoki,HAZAMA Hisanao,HATANO Hiroshi,KANEDA Yasufmi,FUJINO Tatsuya,AWAZU Kunio, Vol. 2013, No. 11, p. 27-32, 2013/03/04
  • パーキンソン病関連分子αシヌクレインの新規機能-加齢性疾患としてのメタボリック症候群及びその心血管合併症の病態での役割-, 鷹見洋一,中神啓徳,神出計,山本浩一,森下竜一,金田安史,樂木宏実, 日本血管生物医学会学術集会プログラム・抄録集, Vol. 21st, 2013
  • パーキンソン病原因分子αシヌクレインの加齢によるメタボリック症候群における病態生理的役割, 鷹見洋一,中神啓徳,神出計,山本浩一,森下竜一,金田安史,楽木宏実, 日本高血圧学会総会プログラム・抄録集, Vol. 36th, 2013
  • Cross-talk between Bone Marrow and Tissue Injury : Novel Regenerative Therapy for Severely Damaged Tissues by Mobilizing Bone Marrow Mesenchymal Stem Cells in Vivo [Innovation in Transplant and Regenerative Medicine. The 13th Meeting of Hirosaki International Forum of Medical Science. Communication Center of Hirosaki University School of Medicine. September 9, 2011, Hirosaki, Japan], Tamai Katsuto,Kaneda Yasufumi, The Hirosaki medical journal, Hirosaki University, Vol. 64, p. S1-S5, 2013
  • A non-replicating oncolytic viral particle as a novel therapeutic tool against cancers, Yasufumi Kaneda, HUMAN GENE THERAPY, MARY ANN LIEBERT INC, Vol. 23, No. 10, p. A18-A19, 2012/10
  • 前立腺癌におけるガングリオシド合成に関与するシアル酸転移酵素の発現制御機構(Transcriptional control of sialyltransferases required for the production of gangliosides in prostate cancer cells), 波多野 浩士,宮本 泰豪,中井 康友,野々村 祝夫,金田 安史, 日本癌学会総会記事, 日本癌学会, Vol. 71回, p. 468-468, 2012/08
  • Systemic Administration of Platelet Vector Containing Inactivated Sendai Virus Particle Eradicates Melanoma in Mice, Tomoyuki Nishikawa,Yasufumi Kaneda, MOLECULAR THERAPY, NATURE PUBLISHING GROUP, Vol. 20, p. S264-S264, 2012/05
  • Crosstalk mechanism between injured epithelia and bone marrow, Katsuto Tamai,Yasushi Kikuchi,Shin Iinuma,Ryo Fujita,Nao Manjyo,Yasufumi Kaneda, FASEB JOURNAL, FEDERATION AMER SOC EXP BIOL, Vol. 26, 2012/04
  • EXPRESSION OF GANGLIOSIDES, GD1A AND SIALYL PARAGLOBOSIDE, IS REGULATED BY NF-kappa B-DEPENDENT TRANSCRIPTIONAL CONTROL OF alpha 2,3-SIALYLTRANSFERASE I, II AND VI IN HUMAN CASTRATION-RESISTANT PROSTATE CANCER CELLS, Koji Hatano,Yasutomo Nakai,Yasuhide Miyamoto,Yasufumi Kaneda,Norio Nonomura, JOURNAL OF UROLOGY, ELSEVIER SCIENCE INC, Vol. 187, No. 4, p. E196-E197, 2012/04
  • 癌の遺伝子治療 HVJ-Eを用いた去勢抵抗性前立腺癌に対する新たながん治療の開発, 中井 康友,波多野 浩士,宮本 泰豪,金田 安史,野々村 祝夫, 日本泌尿器科学会雑誌, (一社)日本泌尿器科学会, Vol. 103, No. 2, p. 90-90, 2012/03
  • 去勢抵抗性前立腺癌細胞においてガングリオシドGD1aおよびSPGの発現は、NF-κBによるα2,3-sialyltransferase I、IIおよびVIの転写制御を介して調節される, 波多野 浩士,中井 康友,宮本 泰豪,金田 安史,野々村 祝夫, 日本泌尿器科学会雑誌, (一社)日本泌尿器科学会, Vol. 103, No. 2, p. 461-461, 2012/03
  • 転写因子Tbx18とWt1はSlugの発現調節を介して心外膜間葉転換を制御する, 武市真希子,二村圭祐,森雅樹,中神啓徳,金田安史, 日本分子生物学会年会プログラム・要旨集(Web), Vol. 35th, 2012
  • High mobility group box 1(HMGB1)は間葉系幹細胞を骨髄から動員し、損傷上皮を再生すっる(High mobility group box 1 (HMGB1) mobilizes mesenchymal stem cells from bone marrow to regenerate injured epithelia), Tamai Katsuto,Chino Takenao,Kikuchi Yasushi,Yamazaki Takehiko,Katayama Ichiro,McGrat John A,Uitto Jouni,Kaneda Yasufumi, 日本研究皮膚科学会年次学術大会・総会プログラム, (一社)日本研究皮膚科学会, Vol. 36回, p. 202-202, 2011/12
  • Therapeutic Lymphangiogenesis for Lymphedema by Gene Therapy of Hepatocyte Growth Factor Plasmid DNA, SAITO Yukihiro,NAKAGAMI Hironori,AZUMA Nobuyoshi,MORISHITA Ryuichi,KANEDA Yasufumi,SASAJIMA Tadahiro, Vol. 51, No. 4, p. 447-452, 2011/11/25
  • アンドロゲン非依存性前立腺癌のHVJ-E感受性機構の研究(Mechanism of efficient eradication of castration-resistant prostate cancer cells by inactivated Sendai virus particle), 波多野 浩士,宮本 泰豪,中井 康友,野々村 祝夫,金田 安史, 日本癌学会総会記事, 日本癌学会, Vol. 70回, p. 51-52, 2011/09
  • Mechanism of efficient eradication of castration-resistant human prostate cancer cells by inactivated Sendai virus particle, Koji Hatano,Yasutomo Nakai,Yasuhide Miyamoto,Yasufumi Kaneda,Norio Nonomura, CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, Vol. 71, 2011/04
  • 新たながん治療に向けたアンドロゲン非依存性前立腺癌のHVJ-E感受性機構の研究, 波多野 浩士,中井 康友,宮本 泰豪,金田 安史,野々村 祝夫, 日本泌尿器科学会雑誌, (一社)日本泌尿器科学会, Vol. 102, No. 2, p. 445-445, 2011/03
  • 転写因子とヒストンメチル化酵素による協調的な転写制御機構, 二村圭祐,浦聖恵,金田安史, 日本内分泌学会雑誌, Vol. 87, No. 1, 2011
  • ヒストンの多種多様性を介した転写制御は健康のもと, 浦(青田)聖恵,浦(青田)聖恵,二村圭祐,平尾晶子,柏木克信,金田安史, 日本農芸化学会大会講演要旨集, Vol. 2011, 2011
  • DEFECT IN A HISTONE H3 LYSINE 36 TRIMETHYL-TRANSFERASE WHSC1 CAUSES DISORDERED TRANSCRIPTION IN ES CELLS., Kiyoe Ura,Keiske Nimura,Yasufumi Kaneda, JOURNAL OF GENE MEDICINE, JOHN WILEY & SONS LTD, Vol. 12, No. 12, p. 1051-1051, 2010/12
  • A HISTONE H3 LYSINE 36 TRIMETHYL-TRANSFERASE WHSC1 LINKS TRANSCRIPTION FACTORS TO WOLF-HIRSCHHORN SYNDROME., Keisuke Nimura,Kiyoe Ura,Hidetaka Shiratori,Yasufumi Kaneda, JOURNAL OF GENE MEDICINE, JOHN WILEY & SONS LTD, Vol. 12, No. 12, p. 1051-1051, 2010/12
  • ENDOTHELIAL FHL-2 SUPPRESSES VEGF-INDUCED PI3K/AKT PATHWAY THROUGH INTERACTION WITH SPHINGOSINE KINASE-1, Hiroki Hayashi,Hironori Nakagami,Yoichi Takami,Hiroshi Koriyama,Masaki Mori,Katsuto Tamai,Ryuichi Morishita,Yasufumi Kaneda, JOURNAL OF GENE MEDICINE, JOHN WILEY & SONS LTD, Vol. 12, No. 12, p. 1026-1026, 2010/12
  • THE COMBINATION OF CHEMOTHERAPY WITH IMMUNE-COMPETENT HVJ-E CONTAINING RAD51 siRNA ELICITED VARIEGATED ANTI-TUMOR EFFECTS AND SYNERGISTICALLY SUPPRESSED MELANOMA., Eiji Kiyohara,Ichiro Katayama,Katsuto Tamai,Yasufumi Kaneda, JOURNAL OF GENE MEDICINE, JOHN WILEY & SONS LTD, Vol. 12, No. 12, p. 1037-1038, 2010/12
  • ZYXIN MEDIATES ACTIN FIBER REORGANIZATION IN EPITHELIAL-MESENCHYMAL TRANSITION AND CONTRIBUTES TO ENDOCARDIAL MORPHOGENESIS, Masaki Mori,Hironori Nakagami,Nobutaka Koibuchi,Koichi Miura,Yoichi Takami,Hiroshi Koriyama,Hiroki Hayashi,Hisataka Sabe,Naoki Mochizuki,Ryuichi Morishita,Yasufumi Kaneda, JOURNAL OF GENE MEDICINE, JOHN WILEY & SONS LTD, Vol. 12, No. 12, p. 1050-1050, 2010/12
  • MODIFICATION OF NOVEL ANGIOGENIC PEPTIDE, AG-30, TOWARD CLINICAL APPLICATION, Hironori Nakagami,Tomoyuki Nishikawa,Katsuto Tamai,Yasufumi Kaneda, JOURNAL OF GENE MEDICINE, JOHN WILEY & SONS LTD, Vol. 12, No. 12, p. 1022-1022, 2010/12
  • ANALYSIS ON SIGNAL PATHWAY OF AN ANTIMICROBIAL AND ANIGOGENIC PEPTIDE, AG-30, STIMULATED ENDOTHELIAL CELLS, Tomoyuki Nishikawa,Hironori Nakagami,Ryuichi Morishita,Akito Maeda,Katsuto Tamai,Yasu-fumi Kaneda, JOURNAL OF GENE MEDICINE, JOHN WILEY & SONS LTD, Vol. 12, No. 12, p. 1027-1027, 2010/12
  • DEVELOPMENT OF ANTI-CANCER STRATEGIES USING HVJ ENVELOPE, Yasufumi Kaneda, JOURNAL OF GENE MEDICINE, JOHN WILEY & SONS LTD, Vol. 12, No. 12, p. 1015-1015, 2010/12
  • NOVEL THERAPEUTIC AND PROPHYLACTIC VACCINE (HVJ-ENVELOPE/HSP65 DNA+IL-12 DNA) AGAINST TUBERCULOSIS USING CYNOMOLGUS MONKEY, Masaji Okada,Yoko Kita,Toshihiro Nakajima,Noriko Kanamaru,Satomi Hashimoto,Tetsuji Nagasawa,Yasufumi Kaneda,Shigeto Yoshida,Yasuko Nishida,Hitoshi Nakatani,Kyoko Takao,Chie Kishigami,Shiho Nishimatsu,Makoto Matsumoto,E. V. Tan,Paul Saunderson,Mitsunori Sakatani, JOURNAL OF GENE MEDICINE, JOHN WILEY & SONS LTD, Vol. 12, No. 12, p. 1067-1067, 2010/12
  • GENOME-WIDE ASSOCIATION STUDY IN JAPANESE POPULATION IDENTIFIES SUSCEPTIBLE LOCI FOR PERIPHERAL ARTERIAL DISEASE., Hiroshi Koriyama,Hironori Nakagami,Tomohiro Katsuya,Ken Sugimoto,Hiroshi Akasaka,Shigeyuki Saitoh,Shiro Maeda,Yusuke Nakamura,Yasufumi Kaneda,Hiromi Rakugi,Ryuichi Morishita,Kazuaki Shimamoto,Toshio Ogihara, JOURNAL OF GENE MEDICINE, JOHN WILEY & SONS LTD, Vol. 12, No. 12, p. 1046-1046, 2010/12
  • A NOVEL STRATEGY OF THE GENE THERAPY FOR PAD USING SMALL RNA INTERFERENCE OF COLD SHOCK DOMAIN PROTEIN A, Yukihiro Saito,Hironori Nakagami,Ryuichi Morishita,Nobuyoshi Azuma,Tadahiro Sasajima,Yasufumi Kaneda, JOURNAL OF GENE MEDICINE, JOHN WILEY & SONS LTD, Vol. 12, No. 12, p. 1036-1036, 2010/12
  • Investigation of pathogenic roles of karyopherin alpha2 in keratinocyte proliferative disorders, Noriko Umegaki,Katsuto Tamai,Keisuke Nimura,Satoshi Serada,Tetsuji Naka,Takehiko Yamazaki,Hajime Nakano,Yasufumi Kaneda,Ichiro Katayama, JOURNAL OF INVESTIGATIVE DERMATOLOGY, NATURE PUBLISHING GROUP, Vol. 130, p. S86-S86, 2010/09
  • Skin grafts recruit bone marrow-derived mesenchymal stem cells through SDF-1 alpha/CXCR4 interaction to enhance tissue regeneration, Shin Iinuma,Katsuto Tamai,Takenao Chino,John A. McGrath,Jouni Uitto,Noriko Umegaki,Ichiro Katayama,Hajime Iizuka,Yasufumi Kaneda, JOURNAL OF INVESTIGATIVE DERMATOLOGY, NATURE PUBLISHING GROUP, Vol. 130, p. S75-S75, 2010/09
  • 心臓発生におけるヒストン修飾の役割, 二村圭祐,浦聖恵,金田安史, 生化学, 2010
  • 膀胱癌,前立腺癌治療薬 (新薬展望2010) -- (治療における最近の新薬の位置付け〈薬効別〉--新薬の広場), 波多野 浩士,金田 安史, 医薬ジャ-ナル, 医薬ジャ-ナル社, Vol. 46, No. 1, p. 185-191, 2010
  • 【新薬展望2010】治療における最近の新薬の位置付け<薬効別> 新薬の広場 膀胱癌、前立腺癌治療薬, 波多野 浩士,金田 安史, 医薬ジャーナル, (株)医薬ジャーナル社, Vol. 46, No. 増刊, p. 395-401, 2010/01
  • MICRORNA TRANSFERRED TO HUMAN ADIPOSE TISSUE-DERIVED STEM CELLS BY LENTIVIRUS VECTOR ENHANCED ADIPOGENESIS THROUGH DOWNREGULATION OF HOMEOBOX C8, Masaki Mori,Hironori Nakagami,Hiroki Hayashi,Hiroshi Koriyama,Yoichi Takami,Katsuto Tamai,Yasufumi Kaneda, JOURNAL OF GENE MEDICINE, JOHN WILEY & SONS LTD, Vol. 11, No. 12, p. 1167-1167, 2009/12
  • FHL-2 Suppresses VEGF-Induced Phosphatidylinositol 3-Kinase/Akt Activation via Interaction With Sphingosine Kinase-1 (vol 29, pg 909, 2009), Yasufumi Kaneda, ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, LIPPINCOTT WILLIAMS & WILKINS, Vol. 29, No. 12, p. E132-E132, 2009/12
  • IDENTIFICATION OF ENDOGENOUS ANGIOGENIC REPRESSOR, FHL-2, VIA DIRECT INTERACTION WITH SPHINGOSINE KINASE-1 IN ENDOTHELIAL CELLS, Hiroki Hayashi,Hironori Nakagami,Yoichi Takami,Hiroshi Koriyama,Masaki Mori,Katsuto Tamai,Ryuichi Morishita,Yasufumi Kaneda, JOURNAL OF GENE MEDICINE, JOHN WILEY & SONS LTD, Vol. 11, No. 12, p. 1152-1153, 2009/12
  • COLD SHOCK DOMAIN PROTEIN A, NOVEL REPRESSOR OF TUMOR-ANGIOGENESIS AND - LYMPHANGIOGENESIS FOR CANCER GENE THERAPY, Yukihiro Saito,Hironori Nakagami,Ryuichi Morishita,Nobuyoshi Azuma,Tadahiro Sasajima,Yasufumi Kaneda, JOURNAL OF GENE MEDICINE, JOHN WILEY & SONS LTD, Vol. 11, No. 12, p. 1152-1152, 2009/12
  • ANALYSIS OF DE NOVO ENGINEERED VARIANTS OF AG-30 FOR THE TREATMENT OF ISCHEMIC DISEASES AND INFECTIOUS DISEASES, Tomoyuki Nishikawa,Hironori Nakagami,Ryuichi Morishita,Akito Maeda,Katsuto Tamai,Kazunori Tomono,Yasufumi Kaneda, JOURNAL OF GENE MEDICINE, JOHN WILEY & SONS LTD, Vol. 11, No. 12, p. 1166-1167, 2009/12
  • NOVEL STRATEGY TO COLLECT BONE MARROW-DERIVED MULTI-LINEAGE PROGENITOR CELLS AS A POTENTIAL TARGET OF GENE AND CELL THERAPY FOR NON-HEMATOPOIETIC GENETIC DISEASES, Katsuto Tamai,Takehiko Yamazaki,Takenao Chino,Yasushi Kikuchi,Yasufumi Kaneda, JOURNAL OF GENE MEDICINE, JOHN WILEY & SONS LTD, Vol. 11, No. 12, p. 1159-1160, 2009/12
  • Basic investigation of boron neutron capture therapy (BNCT) using novel boron agents and accelerator based neutron source, M. Sakai,N. Fujimoto,K. Ishii,I. Murata,C. M. Lee,Y. Kaneda,H. Nakamura,K. Awazu, IFMBE Proceedings, Springer Berlin Heidelberg, Vol. 25, p. 638-641, 2009/12/01
  • 着床期子宮局所におけるSTAT-3活性の役割, 中村 仁美,香山 晋輔,谷口 武,荻田 和秀,熊澤 恵一,張 慶,筒井 建紀,古山 将康,杉野 法広,田村 博史,金田 安史,木村 正, 日本生殖内分泌学会雑誌, 日本生殖内分泌学会, Vol. 14, p. 35-40, 2009/09
  • A novel potential therapy for melanoma by HVJ envelope, E. Kiyohara,K. Tamai,Katayama, I,Y. Kaneda, JOURNAL OF INVESTIGATIVE DERMATOLOGY, NATURE PUBLISHING GROUP, Vol. 129, p. S38-S38, 2009/09
  • The Combination of Chemotherapy with Immune-Competent HVJ-E Containing Rad51 siRNA Elicited Variegated Anti-Tumor Effects and Synergistically Suppressed Melanoma, Eiji Kiyohara,Ichiro Katayama,Katsuto Tamai,Yasufumi Kaneda, MOLECULAR THERAPY, NATURE PUBLISHING GROUP, Vol. 17, p. S111-S111, 2009/05
  • Contribution of PDGFRa-Positive Bone Marrow Cells for Epithelial Regeneration in Genetic Blistering Skin Disease, RDEB, Katsuto Tamai,Takehiko Yamazaki,Takenao Chino,Yasufumi Kaneda, MOLECULAR THERAPY, NATURE PUBLISHING GROUP, Vol. 17, p. S21-S21, 2009/05
  • PE-062 Zyxin Progresses Epithelial-Mesenchymal Transition under the Control of Twist1 and Contributes to Endocardial Morphogenesis(PE011,Congenital Heart Disease (M),Poster Session (English),The 73rd Annual Scientific Meeting of The Japanese Circulation Society), Mori Masaki,Nakagami Hironori,Koibuchi Nobutaka,Miura Koichi,Takami Yoichi,Koriyama Hiroshi,Hayashi Hiroki,Sabe Hisataka,Mochizuki Naoki,Morishita Ryuichi,Kaneda Yasufumi, Circulation journal : official journal of the Japanese Circulation Society, Japanese Circulation Society, Vol. 73, p. 414-414, 2009/03/01
  • PE-275 A Novel Strategy of the Gene Therapy for PAD Using Small RNA Interference of Cold Shock Domain Protein A(PE046,Atherosclerosis (Basic, Clinical/Diagnosis) (IHD),Poster Session (English),The 73rd Annual Scientific Meeting of The Japanese Circulation Society), Saito Yukihiro,Nakagami Hironori,Azuma Nobuyoshi,Morishita Ryuichi,Kaneda Yasufumi,Sasajima Tadahiro, Circulation journal : official journal of the Japanese Circulation Society, Japanese Circulation Society, Vol. 73, p. 468-468, 2009/03/01
  • HP-039-1 血管新生遺伝子治療の新たな治療戦略 : 閉塞性動脈疾患における内因性血管新生制御機構へのアプローチ(血管:末梢血管3,ハイブリッドポスター,第109回日本外科学会定期学術集会), 齊藤 幸裕,中神 啓徳,東 伸良,金田 安史,笹嶋 唯博, 日本外科学会雑誌, 一般社団法人日本外科学会, Vol. 110, No. 2, p. 460-460, 2009/02/25
  • ヒストンH3K36トリメチル化酵素WHSC1の異常は転写因子機能障害によって4p-症候群を引き起こす, 二村圭祐,浦聖恵,金田安史, 細胞工学, Vol. 28, No. 9, 2009
  • 病態と細胞核 8.ヒストンH3K36メチル化による転写調整と疾患, 浦聖恵,二村圭祐,金田安史, 実験医学, Vol. 27, No. 17, 2009
  • ヒストンH3K36tri-メチル化酵素Whsc1の欠損は転写異常によって先天性心疾患を伴うWolf-Hirschhorm syndromeを引き起こす, 二村圭祐,浦聖恵,白鳥秀卓,金田安史, 日本分子生物学会年会講演要旨集, Vol. 32nd, No. Vol.1, 2009
  • 血管新生因子,AG-30,によるシグナル伝達経路の解析, 西川智之,中神啓徳,金田安史, 日本分子生物学会年会講演要旨集, Vol. 32nd, No. Late-Breaking Abstracts, 2009
  • Identification of Novel Therapeutic Targets for Metabolic Syndrome by Functional Gene Screening, H. Nakagami,T. Katsuya,Y. Takami,H. Rakugi,R. Morishita,Y. Kaneda, CLINICAL AND EXPERIMENTAL HYPERTENSION, TAYLOR & FRANCIS INC, Vol. 31, No. 6, p. 486-486, 2009
  • 難治性着床不全ならびに不育症に対する治療の試み 一過性遺伝子導入方法を用いた着床現象の検討, 中村 仁美,香山 晋輔,谷口 武,荻田 和秀,熊澤 恵一,張 慶,筒井 建紀,古山 将康,杉野 法広,田村 博史,金田 安史,木村 正, Reproductive Immunology and Biology, 日本生殖免疫学会, Vol. 23, No. 2, p. S33-S33, 2008/11
  • OSBPL10 is Identified as a Novel Susceptible Gene for Peripheral Arterial Disease by Genome-Wide Association Study in Japan, Hiroshi Koriyama,Hironori Nakagami,Tomohiro Katsuya,Ken Sugimoto,Hidetoshi Yamashita,Yoichi Takami,Hiroshi Akasaka,Shigeyuki Saitoh,Shiro Maeda,Yusuke Nakamura,Yasufumi Kaneda,Hiromi Rakugi,Kazuaki Shimamoto,Ryuichi Morishita,Toshio Ogihara, CIRCULATION, LIPPINCOTT WILLIAMS & WILKINS, Vol. 118, No. 18, p. S1144-S1144, 2008/10
  • Homeobox C8 Suppresses Adipogenesis of Human Adipose Tissue-Derived Stem, Masaki Mori,Hironori Nakagaml,Yasufumi Kaneda, CIRCULATION, LIPPINCOTT WILLIAMS & WILKINS, Vol. 118, No. 18, p. S279-S279, 2008/10
  • O-1-163 転移性肝腫瘍に対するホウ素中性子補足療法(BNCT)の可能性(転移性肝癌1,一般演題(口演),第63回日本消化器外科学会総会), 藤井 仁,李 千萬,菰田 弘,北川 透,西田 俊朗,金田 安史,澤 芳樹, 日本消化器外科学会雑誌, 一般社団法人日本消化器外科学会, Vol. 41, No. 7, p. 1173-1173, 2008/07/01
  • Genom-wide association study identifies susceptible loci for atherosclesosis obliterance, H. Koriyama,H. Nakagami,T. Katsuya,K. Sugimoto,H. Yamashita,Y. Takami,M. Mori,H. Hayashi,H. Rakugi,R. Morishita,S. Maeda,Y. Nakamura,Y. Kaneda,T. Ogihara, JOURNAL OF HYPERTENSION, LIPPINCOTT WILLIAMS & WILKINS, Vol. 26, p. S139-S139, 2008/06
  • Pivotal roles of CYLD (cylindromatosis) as a deubiquitinating enzyme in vascular remodeling, Y. Takami,H. Nakagami,R. Morishita,T. Katsuya,H. Rakugi,Y. Kaneda,T. Ogihara, JOURNAL OF HYPERTENSION, LIPPINCOTT WILLIAMS & WILKINS, Vol. 26, p. S310-S310, 2008/06
  • SF-059-4 心筋虚血時のCold shock domain protein Aによる血管新生調節機構(第108回日本外科学会定期学術集会), 齊藤 幸裕,中神 啓徳,東 信良,金田 安史,笹嶋 唯博, 日本外科学会雑誌, 一般社団法人日本外科学会, Vol. 109, No. 2, p. 260-260, 2008/04/25
  • WS-4-9 悪性胸膜中皮腫に対するCD44を標的とした分子標的治療に関する基礎的検討(第108回日本外科学会定期学術集会), 李 千萬,藤井 仁,菰田 弘,井上 匡美,塩野 裕之,北川 透,西田 俊朗,奥村 明之進,金田 安史,澤 芳樹, 日本外科学会雑誌, 一般社団法人日本外科学会, Vol. 109, No. 2, p. 148-148, 2008/04/25
  • Development of molecular therapy against intractable human disease using HVJ-E, Yasufumi Kaneda, JOURNAL OF GENE MEDICINE, JOHN WILEY & SONS LTD, Vol. 10, No. 4, p. 437-437, 2008/04
  • Bone marrow replenishes de novo keratinocytes in the regenerating hair follicles via circulating blood, K. Tamai,T. Yamazaki,T. Chino,I. Katayama,I. Uitto,Y. Kaneda, JOURNAL OF INVESTIGATIVE DERMATOLOGY, NATURE PUBLISHING GROUP, Vol. 128, p. S93-S93, 2008/04
  • A novel strategy for construction of tissue-targeting Sendai virus, Masako Kawachi,Katsuto Tamai,Kotaro Saga,Takehiko Yamazaki,Hiroshi Fujita,Takashi Shimbo,Koji Nishifuji,Masayuki Amagai,Yasufumi Kaneda, JOURNAL OF GENE MEDICINE, JOHN WILEY & SONS LTD, Vol. 10, No. 4, p. 469-469, 2008/04
  • Intranasal administration of HVJ-E containing allergen attenuates experimental allergic rhinitis, Eri Yasuoka,Katsuto Tamai,Yasufumi Kaneda, JOURNAL OF GENE MEDICINE, JOHN WILEY & SONS LTD, Vol. 10, No. 4, p. 444-444, 2008/04
  • Eradication of renal cell carcinoma in mice, mediated by NK cell infiltration and activation using inactivated Sendai virus particle, Atsuko Fujihara,Tsuneharu Miki,Yasufumi Kaneda, JOURNAL OF UROLOGY, ELSEVIER SCIENCE INC, Vol. 179, No. 4, p. 38-38, 2008/04
  • Bone marrow-derived keratinocytes can ameliorate abnormality of genetic skin disease, Katsuto Tamai,Takehiko Yamazaki,Satoru Otsuru,Takenao Chino,Yasushi Kikuchi,Keisuke Nimura,Takashi Shimbo,Yasufumi Kaneda, JOURNAL OF GENE MEDICINE, JOHN WILEY & SONS LTD, Vol. 10, No. 4, p. 443-443, 2008/04
  • Bone marrow cell transfer in utero can ameliorate genetic skin abnormalities by raising bone marrow-derived fibroblasts and keratinocytes, T. Chino,K. Tamai,T. Yamazaki,Y. Kitajima,J. Uitto,Y. Kaneda, JOURNAL OF INVESTIGATIVE DERMATOLOGY, NATURE PUBLISHING GROUP, Vol. 128, p. S145-S145, 2008/04
  • OE-040 FHL-2 Expresses in Endothelial Cell and Suppresses VEGF-induced Angiogenesis Via Sphingosine Kinase-1(Arrhythmia, diagnosis/Pathophysiology/EPS(01)(A),Oral Presentation(English),The 72nd Annual Scientific Meeting of the Japanese Circulation Society), Hayashi Hiroki,Nakagami Hironori,Takami Yoichi,Koriyama Hiroshi,Mori Masaki,Morishita Ryuichi,Kaneda Yasufumi, Circulation journal : official journal of the Japanese Circulation Society, Japanese Circulation Society, Vol. 72, p. 190-190, 2008/03/01
  • OE-071 A Genom-Wide Association Study of SNPs in the risk of Atherosclerosis Obliterans(Heart failure, clinical(01)(M),Oral Presentation(English),The 72nd Annual Scientific Meeting of the Japanese Circulation Society), Koriyama Hiroshi,Nakagami Hironori,Katsuya Tomohiro,Sugimoto Ken,Yamashita Hidetoshi,Takami Yoichi,Mori Masaki,Hayashi Hiroki,Rakugi Hiromi,Morishita Ryuichi,Maeda Shiro,Nakamura Yusuke,Kaneda Yasufumi,Ogihara Toshio, Circulation journal : official journal of the Japanese Circulation Society, Japanese Circulation Society, Vol. 72, p. 198-198, 2008/03/01
  • PJ-250 Cold shock domain protein A, novel regulator of angiogenesis in heart.(Coronary circulation, basic/clinical(03)(IHD),Poster Session(Japanese),The 72nd Annual Scientific Meeting of the Japanese Circulation Society), Saitou Yukihiro,Nakagami Hironori,Azuma Nobuyoshi,Morishita Ryuichi,Kaneda Yasufumi,Sasajima Tadahiro, Circulation journal : official journal of the Japanese Circulation Society, Japanese Circulation Society, Vol. 72, p. 574-574, 2008/03/01
  • PJ-042 Pivotal Roles of CYLD (cylindromatosis) as a Deubiquitinating Enzyme in Vasculature(Atherosclerosis, basic(05)(IHD),Poster Session(Japanese),The 72nd Annual Scientific Meeting of the Japanese Circulation Society), Takami Yoichi,Nakagami Hironori,Morishita Ryuichi,Katsuya Tomohiro,Rakugi Hiromi,Kaneda Yasufumi,Ogihara Toshio, Circulation journal : official journal of the Japanese Circulation Society, Japanese Circulation Society, Vol. 72, p. 520-520, 2008/03/01
  • OE-185 Topical application of novel angiogenic peptide, AG-30, in wound healing model(Growth factor/Cytokine(01)(H),Oral Presentation(English),The 72nd Annual Scientific Meeting of the Japanese Circulation Society), Nakagami Hironori,Nishikawa Tomoyuki,Kaneda Yasufumi,Morishita Ryuichi, Circulation journal : official journal of the Japanese Circulation Society, Japanese Circulation Society, Vol. 72, p. 226-227, 2008/03/01
  • NFκBデコイ軟膏によるアトピー性皮膚炎の治療 (特集 アレルギー疾患開発中治療薬の現状) -- (皮膚科), 玉井 克人,金田 安史,片山 一朗, アレルギ-・免疫, 医薬ジャ-ナル社, Vol. 15, No. 3, p. 332-337, 2008/03
  • ゲノムワイド関連解析による閉塞性動脈硬化症感受性遺伝子座の同定, 郡山弘,中神啓徳,勝谷友宏,杉本研,山下英俊,鷹見洋一,赤坂憲,斎藤重幸,前田士朗,中村裕輔,金田安史,樂木宏実,森下竜一,島本和明,荻原俊男,荻原俊男, 日本高血圧学会総会プログラム・抄録集, Vol. 31st, 2008
  • ヒストンH3K36tri-メチル化酵素Whsc1の欠損は転写異常によって先天性心疾患を伴うWolf-Hirschhorn syndromeを引き起こす。, 二村圭祐,浦聖恵,白鳥秀卓,金田安史, 生化学, 2008
  • Small muscle protein,X-linked(SMPX)の心臓における機能の解析, 鷹見洋一,中神啓徳,森下竜一,勝谷友宏,樂木宏実,金田安史,荻原俊男, 日本高血圧学会総会プログラム・抄録集, Vol. 31st, 2008
  • Rapid transport of plasmid DNA into the nucleolus via actin depolymerization using the HVJ envelope vector (vol 9, pg 55, 2007), Saroj Suvanasuthi,Katsuto Tamai,Yasufumi Kaneda, JOURNAL OF GENE MEDICINE, JOHN WILEY & SONS LTD, Vol. 9, No. 12, p. 1105-1105, 2007/12
  • Suppresses VEGF-induced angiogenesis via sphingosine kinase-1, Hiroki Hayashi,Hironori Nakagarm,Yoichi Takami,Hiroshi Koriyama,Masaki Mori,Yasufumi Kaneda, CIRCULATION, LIPPINCOTT WILLIAMS & WILKINS, Vol. 116, No. 16, p. 176-176, 2007/10
  • Anti-inflammatory and anti-proliferative action of cylindromatosis (CYLD) in atherosclerosis as a deubiquitinating enzyme, Yoichi Takami,Hironori Nakagami,Ryuichi Morishita,Tomohiro Katsuya,Hiromi Rakugi,Yasufumi Kaneda,Toshio Ogihara, CIRCULATION, LIPPINCOTT WILLIAMS & WILKINS, Vol. 116, No. 16, p. 108-108, 2007/10
  • Ubiquitin carboxyl-terminal hydrolase L1, a novel deubiquitinating enzyme in the vasculature, attenuates NF-kappa B activation and plays pivotal roles in vascular remodeling, Yojchi Takami,Hnonon Nalkagami,Ryuichi Morishita,Tomohiro Katsuya,Hiromi Rakugi,Yasufumi Kaneda,Toshio Ogihara, CIRCULATION, LIPPINCOTT WILLIAMS & WILKINS, Vol. 116, No. 16, p. 3-3, 2007/10
  • 肝腫瘍ならびに悪性胸膜中皮腫に対するPolymer結合型HVJ-envelope製剤を用いたBNCTの基礎的検討(Basic Investigation of BNCT with HVJ-envelope for Liver metastasis and Malignant Pleural Mesothelioma), 李 千萬,金田 安史,藤井 仁,北川 透,西田 俊朗,中井 啓,松村 明,鈴木 実,小野 公二,田畑 泰彦,澤 芳樹, 日本癌学会総会記事, 日本癌学会, Vol. 66回, p. 278-278, 2007/08
  • 次世代ホウ素中性子捕捉療法のためのDDSの開発, 中村 浩之,金田 安史,松村 明, Drug delivery system, Vol. 22, No. 3, p. 304-304, 2007/05/10
  • Novel vaccination (HVJ-liposome/HSP65 DNA+ IL-12 DNA against Tuberculosis), Masaji Okada,Yoko Kita,Toshihiro Nakajima,Noriko Kanamaru,Satomi Hashimoto,Tetsuji Nagasawa,Yasufumi Kaneda,Yasuko Nishida,Reiko Fukamizu,Yoshie Tsunai,Ruriko Inoue,Hitoshi Nakatani,Yumi Namie,Junko Yamada,Kyoko Takao,Ritsuko Asai,Ryoko Asaki,Esterlina Babie Tan,Mitsunori Sakatani, JOURNAL OF IMMUNOLOGY, AMER ASSOC IMMUNOLOGISTS, Vol. 178, 2007/04
  • 新規血管・リンパ管新生抑制分子 Cold shock domain protein A : 新規分子を用いた癌増殖, 転移抑制への次世代の治療戦略, 齊藤 幸裕,中神 啓徳,黒岡 正之,東 信良,金田 安史,笹嶋 唯博, 日本外科学会雑誌, 一般社団法人日本外科学会, Vol. 108, p. 76-76, 2007/03/10
  • OJ-195 Pivotal Roles of Deubiquitinating Enzymes UCHL1, HAUSP, and CYLD in Vasculature as an Anti-proliferative and Anti-inflammatory Effect(Atherosclerosis, basic-3, The 71st Annual Scientific Meeting of the Japanese Circulation Society), Takami Yoichi,Nakagami Hironori,Katsuya Tomohiro,Rakugi Hiromi,Morishita Ryuichi,Kaneda Yasufumi,Ogihara Toshio, Circulation journal : official journal of the Japanese Circulation Society, Japanese Circulation Society, Vol. 71, p. 302-302, 2007/03/01
  • 3 Functional Analysis of Novel Antimicrobial Peptide, AG (Angiogenic Peptide)-30, with Angiongenic Property, toward Clinical Application(The 71st Annual Scientific Meeting of the Japanese Circulation Society), Nakagami Hironori,Nishikawa Tomoyuki,Morishita Ryuichi,Tabata Yasuhiko,Tatsu Yoshihiro,Tomono Kazunori,Ogihara Toshio,Kaneda Yasufumi, Circulation journal : official journal of the Japanese Circulation Society, Japanese Circulation Society, Vol. 71, p. 52-52, 2007/03/01
  • Favorable effects of statins beyond lipid lowering, Hironori Nakagami,Yasufumi Kaneda,Tosbio Ogihara,Ryuichi Morishita, FUTURE LIPIDOLOGY, FUTURE MEDICINE LTD, Vol. 1, No. 1, p. 75-80, 2007/02
  • 脱ユビキチン化酵素CYLD(cylindromatosis)の血管における機能, 鷹見洋一,中神啓徳,森下竜一,勝谷友宏,楽木宏実,金田安史,荻原俊男, 日本高血圧学会総会プログラム・抄録集, Vol. 30th, 2007
  • マウスDnmt3bのクロマチン高次構造特異的な結合, 柏木克信,金田安史,浦聖惠, 生化学, 2007
  • 新規ヒストンH3K36tri-メチル化酵素WHSC1の機能解析とマウス発生における役割。, 二村圭祐,二村圭祐,浦聖恵,丹羽仁史,金田安史, 生化学, 2007
  • Pivotal role of deubiquitinating enzymes, UCHL1 (Ubiquitin Carboxyl-terminal Hydrolase L1) and CYLD (Cylindromatosis) in vascular remodeling, 鷹見洋一,中神啓徳,森下竜一,勝谷友宏,楽木宏実,金田安史,荻原俊男, 日本内分泌学会雑誌, Vol. 83, No. 2, 2007
  • 悪性胸膜中皮腫に対するDDS 製剤を用いたホウ素中性子療法（BNCT）の 開発に関する基礎的検討, 李千萬,北川透,藤井仁,中井啓,塩野裕之,奥村明之進,西田俊朗,鈴木実,田畑泰彦,小野公二,松村明,金田安史,澤芳樹, 第107 回日本外科学会定期学術集会パネルディスカッション（2007.4.13．大 阪）, 2007
  • A large deletion of the PROS1 gene in a deep vein thrombosis patient with protein S deficiency., Miyake, T,Aoki, M,Masaki, H,Kawasaki, T,Oishi, M,Kataoka, K,Ogihara, T,Kaneda, Y,Morishita, R, Thromb Haemost, Vol. 98, No. 4, p. 783-9, 2007
  • 骨形成因子の徐放によって再生誘導 された骨組織における骨髄由来細胞の役割, 木村祐,林直樹,宮崎伸彦,大鶴聰,玉井克人,金田安史,田畑泰彦, 第28 回日本炎症・再生医学会（2007.8.2－3．東京）, 2007
  • 骨形成因子の徐放による骨組織再生 誘導における骨髄由来細胞の役割, 木村祐,林直樹,宮崎伸彦,大鶴聰,玉井克人,金田安史,田畑泰彦, 第56 回高分子学会年次大会（2007.5.29－31．京都）, 2007
  • Development of high throughput functional screening of cardiovascular therapeutic genes using the HVJ-E vector: Analysis of a novel angiogenic peptide, AG-30, Tomoyuki Nishikawa,Hironori Nakagami,Katsuto Tamai,Yasufumi Kaneda, JOURNAL OF GENE MEDICINE, JOHN WILEY & SONS LTD, Vol. 8, No. 12, p. 1443-1444, 2006/12
  • Novel high through-put functinal screening by HVJ-E - targetting of antivascular remodeling factors in hypertension, Yoichi Takami,Hironori Nakagami,Tomohiro Katsuya,Ryuichi Morishita,Hiromi Rakugi,Yasufumi Kaneda,Toshio Ogihara, JOURNAL OF HYPERTENSION, LIPPINCOTT WILLIAMS & WILKINS, Vol. 24, p. 237-237, 2006/12
  • Association of a gene polymorphism of novel Z-disc protein, myospryn, and left ventricular diastolic dysfunction, Hironori Nakagami,Tomohiro Katsuya,Ryuichi Morishita,Yoichi Takami,Hiroshi Akasaka,Hiromi Rakugi,Yasufumi Kaneda,Toshio Ogihara, JOURNAL OF HYPERTENSION, LIPPINCOTT WILLIAMS & WILKINS, Vol. 24, p. 381-381, 2006/12
  • Suppression of experimental abdominal aortic aneurysm in rats by treatment with angiotensin II receptor blocker, Suguru Shiraya,Motokuni Aoki,Takashi Miyake,Shigetsugu Ohgi,Yasufumi Kaneda,Toshio Ogilhara,Ryuichi Morishita, JOURNAL OF HYPERTENSION, LIPPINCOTT WILLIAMS & WILKINS, Vol. 24, p. 110-110, 2006/12
  • Hypertension accelerated experimental abdominal aortic aneurysm through upregulation of transcription factors, NFKB and ETS, Suguru Shiraya,Motokuni Aoki,Takashi Miyake,Shigetsugu Ohgi,Yasufumi Kaneda,Toshio Ogihara,Ryuichi Morishita, JOURNAL OF HYPERTENSION, LIPPINCOTT WILLIAMS & WILKINS, Vol. 24, p. 55-55, 2006/12
  • Ubiquitincarboxyl-terminalesterase L1, causative gene of Parkinson's disease, has anti-inflammatory action in vascular cells, Yoichi Takami,Hironori Nakagami,Tomohiro Katsuya,Ryuichi Morishita,Hiromi Rakugi,Yasufumi Kaneda,Toshio Ogihara, JOURNAL OF HYPERTENSION, LIPPINCOTT WILLIAMS & WILKINS, Vol. 24, p. 54-55, 2006/12
  • Development of functional gene screening for therapeutic angiogenesis in next generation, NAKAGAMI Hironori,KANEDA Yasufumi,MORISHITA Ryuichi, Vol. 29, No. 3, p. 81-84, 2006/10/13
  • gamma-secretase is new therapeutic target for anti-angiogenic therapy, Hiroki Hayashi,Hironori Nakagami,Yukihiro Saito,Yoichi Talkami,Tomoyuki Nishikawa,Naoyuki Sato,Ryuichi Morishita,Yasufumi Kaneda, HYPERTENSION, LIPPINCOTT WILLIAMS & WILKINS, Vol. 48, No. 4, p. E94-E94, 2006/10
  • Ubiquitin carboxyl-terminal esterase L1, causative gene of Parkinson's disease, modulates anti-inflammatory-mediated vascular remodeling, Yoichi Takami,Hironori Nakagami,Ryuichi Morishita,Tomohiro Katsuya,Hiromi Rakugi,Yasufumi Kaneda,Toshio Ogihara, CIRCULATION, LIPPINCOTT WILLIAMS & WILKINS, Vol. 114, No. 18, p. 257-257, 2006/10
  • Gene polymorphism of novel Z-disc protein, myospryn, is associated with left ventricular hypertrophy and diastolic dysfunction, Hironori Nakagami,Tomohiro Katsuya,Ryuichi Morishita,Yasushi Kikuchi,Hiroshi Akasaka,Hiromi Rakugi,Yasufumi Kaneda,Toshio Ogihara, HYPERTENSION, LIPPINCOTT WILLIAMS & WILKINS, Vol. 48, No. 4, p. E78-E78, 2006/10
  • Differential regulation of karyopherin alpha 2 expression by TGF-beta 1 and IFN-gamma in normal human epidermal keratinocytes: Evident contribution of KPNA2 for nuclear translocation of IRF-1, N. Umegaki,K. Tamai,H. Nakano,R. Moritsugu,T. Yamazaki,Y. Kaneda,K. Hanada,Katayama, I, JOURNAL OF INVESTIGATIVE DERMATOLOGY, NATURE PUBLISHING GROUP, Vol. 126, p. 95-95, 2006/08
  • Acceleration of wound healing by combined gene transfer of hepatocyte growth factor and prostacyclin synthase with Shima Jet, Y. Kunugiza,N. Tomita,Y. Taniyama,T. Tomita,M. K. Osako,K. Tamai,T. Tanabe,Y. Kaneda,H. Yoshikawa,R. Morishita, GENE THERAPY, NATURE PUBLISHING GROUP, Vol. 13, No. 15, p. 1143-1152, 2006/08
  • Inactivated Sendai Virus Particle (HVJ-E) Solely Induces Specific Anti-Tumor Immune Response and Eradicates Murine Carcinoma, Masayuki Kurooka,Yasufumi Kaneda, MOLECULAR THERAPY, NATURE PUBLISHING GROUP, Vol. 13, p. S241-S241, 2006/05
  • Bone Marrow Stem Cells Are Potent Targets for Gene Therapy of Epidermolysis Bullosa, a Genetic Blistering Skin Disease, Katsuto Tamai,TaKehiko Yamazaki,Otsuru Satoru,Takenao Chino,Yasushi Kikuchi,Yasufumi Kaneda, MOLECULAR THERAPY, NATURE PUBLISHING GROUP, Vol. 13, p. S174-S174, 2006/05
  • Eradication of Renal Cell Carcinoma in Mice Mediated by NK Cell Activation Using Inactivated Sendai Virus Particle (HVJ-E), Atsuko Fujihara,Masayuki Kurooka,Tsuneharu Miki,Yasufumi Kaneda, MOLECULAR THERAPY, NATURE PUBLISHING GROUP, Vol. 13, p. S107-S107, 2006/05
  • Development of High Throughput Functional Screening of Cardiovascular Therapeutic Genes Using the HVJ-E Vector, Tomoyuki Nishikawa,Hironori Nakagami,Atsuhi Matsuki,Yukihiro Saito,Ryuichi Morishita,Katsuto Tamai,Yasufumi Kaneda, MOLECULAR THERAPY, NATURE PUBLISHING GROUP, Vol. 13, p. S336-S336, 2006/05
  • De Novo Human Artificial Chromosome Formation Is Predetermined by Initial Chromatin Assembly and Transcriptional Patterns after Transfection, Hiroshi Nakashima,Megumi Nakano,Ryoko Ohnishi,Yasushi Hiraoka,Yasufumi Kaneda,Akio Sugino,Hiroshi Masumoto, MOLECULAR THERAPY, NATURE PUBLISHING GROUP, Vol. 13, p. S149-S149, 2006/05
  • Induction of Immune Tolerance to Transgene Products by Mixed Chimerism with Low Dose Irradiation, Satoru Otsuru,Katsuto Tamai,Takehiko Yamazaki,Takenao Chino,Hideki Yoshikawa,Yasufumi Kaneda, MOLECULAR THERAPY, NATURE PUBLISHING GROUP, Vol. 13, p. S382-S382, 2006/05
  • Transgenic Bone Marrow Cell Transplantation in fetal mouse circulation induces continuous immunotolerance against cutaneous transgene products after birth, T. Chino,K. Tamai,M. Endo,S. Otsuru,T. Yamazaki,Y. Kikuchi,I. Katayama,Y. Kitajima,J. Uitto,Y. Kaneda, JOURNAL OF INVESTIGATIVE DERMATOLOGY, NATURE PUBLISHING GROUP, Vol. 126, p. 77-77, 2006/04
  • The development of novel HVJ-liposome/HSP65 DNA plus IL-12 DNA vaccination against tuberculosis using cynomolgus monkey, Masaji Okada,Yoko Kita,Noriko Kanamaru,Satomi Hashimoto,Takao Tanaka,Hiroko Takai,Yukari Fukunaga,Yayoi Sakaguchi,Izumi Furukawa,Naoko Takatani,Miwa Izumiya,Shigeto Yoshida,Yasufumi Kaneda,Toshihiro Nakajima,Makoto Matsumoto,Robert Gelber,Esterlina v Tan,E. C. Dera Cruz,David N. McMurray,Mitsunori Sakatani, JOURNAL OF IMMUNOLOGY, AMER ASSOC IMMUNOLOGISTS, Vol. 176, p. S109-S109, 2006/04
  • Robust bone marrow stem cells migrate to the engrafted newborn mouse skin and provide the epidermal keratinocytes, K. Tamai,T. Yamazaki,S. Otsuru,Y. Kikuchi,T. Chino,I. Katayama,J. Uitto,Y. Kaneda, JOURNAL OF INVESTIGATIVE DERMATOLOGY, NATURE PUBLISHING GROUP, Vol. 126, p. 69-69, 2006/04
  • Hepatocyte growth factor (HGF)によるリンパ管新生作用およびリンパ浮腫に対する遺伝子治療, 齊藤 幸裕,中神 啓徳,森下 竜一,金田 安史,東 信良,笹嶋 唯博, 日本外科学会雑誌, 一般社団法人日本外科学会, Vol. 107, No. 2, p. 244-244, 2006/03/05
  • PE-383 HGF Gene Therapy Ameliorates Secondary Lymphedema through Lymphangiogenesis(Genetics/Genetically engineered models/Gene therapy-2 (M) PE64,Poster Session (English),The 70th Anniversary Annual Scientific Meeting of the Japanese Circulation Society), Saito Yukihiro,Nakagami Hironori,Takami Yoichi,Morishita Ryuichi,Ogihara Toshio,kaneda Yasufumi, Circulation journal : official journal of the Japanese Circulation Society, Japanese Circulation Society, Vol. 70, p. 429-429, 2006/03/01
  • PJ-652 Over-expression of HGF Improves Learning and Memory and Prevents Progressive Shrinkage of Thalamus in the Chronic Stage of Cerebral Infarction(Cerebrovascular circulation/Stroke-3 (H) PJ110,Poster Session (Japanese),The 70th Anniversary Annual Scientific Meeting of the Japanese Circulation Society), Shimamura Munehisa,Sato Naoyuki,Hayashi Takuya,Iida Hidehiro,Nakamura Toshikazu,Kaneda Yasufumi,Ogihara Toshio,Morishita Ryuichi, Circulation journal : official journal of the Japanese Circulation Society, Japanese Circulation Society, Vol. 70, p. 651-651, 2006/03/01
  • PJ-098 Ubiquitin C-terminal Hydroxylase L1 (UCHL1), the Causative Genes of Inherited Parkinson's Disease, Has an Anti-inflammatory Action in Endothelial Cells(Molecular biology, vascular-3 (H) PJ17,Poster Session (Japanese),The 70th Anniversary Annual Scientific Meeting of the Japanese Circulation Society), Takami Yoichi,Nakagami Hironori,Katsuya Tomohiro,Rakugi Hiromi,Morishita Ryuichi,Kaneda Yasufumi,Ogihara Toshio, Circulation journal : official journal of the Japanese Circulation Society, Japanese Circulation Society, Vol. 70, p. 513-514, 2006/03/01
  • Development of polymer-conjugated HVJ envelope vector to enhance the transfection efficiency in vitro and in vivo, H Mima,Y Kaneda, JOURNAL OF GENE MEDICINE, JOHN WILEY & SONS LTD, Vol. 8, No. 3, p. 391-392, 2006/03
  • NF-κBデコイDNA軟膏 (特集 アレルギーの分子標的薬開発の現況), 玉井 克人,金田 安史,森下 竜一, アレルギ-科, 科学評論社, Vol. 21, No. 3, p. 240-243, 2006/03
  • P1-387 Stat-3活性化不全によるマウス着床不全モデルの作製とヒト検体における解析(Group 53 不妊・不育VII,一般演題,講演要旨,第58回日本産科婦人科学会学術講演会), 木村 正,中村 仁美,荻田 和秀,香山 晋輔,筒井 建紀,下屋 浩一郎,谷口 武,古山 将康,金田 安史,村田 雄二, 日本産科婦人科學會雜誌, 日本産科婦人科学会, Vol. 58, No. 2, p. 499-499, 2006
  • P1-553 妊娠中期マウスのfeto-maternal interfaceへのVEGF遺伝子強制発現は血圧を低下させる(Group 73 妊娠高血圧症候群III,一般演題,講演要旨,第58回日本産科婦人科学会学術講演会), 香山 晋輔,木村 正,中村 仁美,荻田 和秀,吉田 晋,渡辺 宜信,下屋 浩一郎,古山 将康,金田 安史,村田 雄二, 日本産科婦人科學會雜誌, 日本産科婦人科学会, Vol. 58, No. 2, p. 555-555, 2006
  • P1-531 妊娠中期マウスfeto-maternal interfaceでのIL-8強制発現(Group 70 早産VI,一般演題,講演要旨,第58回日本産科婦人科学会学術講演会), 田畑 知沙,香山 晋輔,木村 正,中村 仁美,荻田 和秀,熊澤 恵一,筒井 建紀,古山 将康,金田 安史,村田 雄二, 日本産科婦人科學會雜誌, 日本産科婦人科学会, Vol. 58, No. 2, p. 547-547, 2006
  • Prevention of abdominal aortic aneurysms by simultaneous inhibition of NFκB and ets using chimeric decoy oligonucleotides in a rabbit model, MIYAKE T, Gene Ther., Vol. 13, p. 695-704, 2006
  • 骨形成因子（BMP-2）徐放体を用いた骨組織再生誘導における骨髄由来細胞の役割, 木村祐,宮崎伸彦,林直樹,大鶴聰,玉井克人,金田安史,田畑泰彦, 第28回日本バイオマテリアル学会大会（2006.11.27－28. 東京）, 2006
  • 【遺伝子診療学 遺伝子診断の進歩と遺伝子治療の展望】 遺伝子治療 現状と展望 各論 膠原病・アレルギー疾患に対する遺伝子治療 NFκBデコイDNAによるアトピー性皮膚炎治療, 玉井 克人,金田 安史,中邨 弘重,青木 元邦,森下 竜一,橋本 公二,森田 明理,片山 一朗,花田 勝美, 日本臨床, (株)日本臨床社, Vol. 63, No. 増刊12 遺伝子診療学, p. 659-663, 2005/12
  • Eradication of hepatocellular carcinoma xenografts by radiolabelled, lipiodol-inducible gene therapy, Y Kawashita,A Ohtsuru,F Miki,H Kuroda,M Morishita,Y Kaneda,K Hatsushiba,T Kanematsu,S Yamashita, GENE THERAPY, NATURE PUBLISHING GROUP, Vol. 12, No. 22, p. 1633-1639, 2005/11
  • Gene transfer of HGF gene improves learning and memory in the chronic stage of cerebral infarction, M Shimamura,N Sato,M Aoki,S Waguri,T Hayashi,T Ogihara,Y Kaneda,R Morishita, CIRCULATION, LIPPINCOTT WILLIAMS & WILKINS, Vol. 112, No. 17, p. U336-U337, 2005/10
  • Two years follow-up of clinical trial of human gene therapy for peripheral arterial disease using hepatocyte growth factor gene transfer, H Makino,M Aoki,J Azuma,Y Takeya,H Kurinami,Y Kaneda,T Ogihara,R Morishita, CIRCULATION, LIPPINCOTT WILLIAMS & WILKINS, Vol. 112, No. 17, p. U474-U474, 2005/10
  • Novel autologous cell therapy in ischemic limb disease through growth factor secretion by cultured adipose tissue-derived stromal cells, H Nakagami,K Maeda,Y Kaneda,T Ogihara,R Morishita, HYPERTENSION, LIPPINCOTT WILLIAMS & WILKINS, Vol. 46, No. 4, p. 867-867, 2005/10
  • Identification of novel angiogenic peptide, Ag-30, H Nakagami,T Nishikawa,R Morishita,Y Kaneda, CIRCULATION, LIPPINCOTT WILLIAMS & WILKINS, Vol. 112, No. 17, p. U256-U256, 2005/10
  • 脳梗塞後認知機能障害に対するHGF遺伝子を用いた遺伝子治療についての検討, 島村宗尚,里直行,佐田政隆,川上浩司,林拓也,飯田秀博,金田安史,荻原俊男,森下竜一, 日本内分泌学会雑誌, Vol. 81, No. 2, 2005/09/20
  • 超音波と超音波造影剤を用いた脳への遺伝子導入法についての検討―中枢性循環調節機序の解明をめざして, 島村宗尚,里直行,谷山義明,青木元邦,金田安史,森下竜一, 日本高血圧学会総会プログラム・抄録集, Vol. 28th, 2005/09/01
  • Hypertension accelerated experimental abdominal aortic aneurysm through up-regulation of NF kappa B and Ets, K Miwa,M Aoki,T Miyake,T Kawasaki,M Iwai,M Oishi,K Kataoka,S Ohgi,T Ogihara,Y Kaneda,R Morishita, JOURNAL OF HYPERTENSION, LIPPINCOTT WILLIAMS & WILKINS, Vol. 23, p. S358-S358, 2005/06
  • Development of Novel High Throughput Functional Screening System Based on HVJ-E Vector : Screening of Anti-vascular Remodeling Factor in Hypertension(Hypertension, Basic 2 (H), The 69th Annual Scientific Meeting of the Japanese Circulation Society), Takami Yoichi,Nakagami Hironori,Katsuya Tomohiro,Rakugi Hiromi,Morishita Ryuichi,Kaneda Yasufumi,Ogihara Toshio, Circulation journal : official journal of the Japanese Circulation Society, Japanese Circulation Society, Vol. 69, p. 538-538, 2005/03/01
  • Recovery of Learning and Memory by Gene Therapy Using Hepatocyte Growth Factor Gene After Focal Cerebral Ishcemia in Rats(Gene Therapy/Genetic Engineering (IHD), The 69th Annual Scientific Meeting of the Japanese Circulation Society), Shimamura Munehisa,Sato Naoyuki,Aoki Motokuni,Waguri Satoshi,Uchiyama Yasuo,Matsumoto Kunio,Hayashi Takuya,Iida Hidehiro,Nakamura Toshikazu,Kaneda Yasufumi,Ogihara Toshio,Morishita Ryuichi, Circulation journal : official journal of the Japanese Circulation Society, Japanese Circulation Society, Vol. 69, p. 306-306, 2005/03/01
  • Two Years Follow-up of Clinical Trial of Human Gene Therapy for Peripheral Arterial Disease Using Hepatocyte Growth Factor Gene Transfer(Peripheral Circulation/Vascular Disease (H), The 69th Annual Scientific Meeting of the Japanese Circulation Society), Makino Hirofumi,Aoki Motokuni,Hashiya Naotaka,Azuma Junya,Kurinami Hitomi,Takeya Yasushi,Kaneda Yasufumi,Morishita Ryuichi,Ogihara Toshio, Circulation journal : official journal of the Japanese Circulation Society, Japanese Circulation Society, Vol. 69, p. 104-104, 2005/03/01
  • A Novel Autologous Cell Therapy into Ischemic Limb Diseases by Adipose Tissue-derived Stromal Cells through Growth Factor Secretion(Vasoactive Compound/Growth Factor/Cytokine 1 (H), The 69th Annual Scientific Meeting of the Japanese Circulation Society), Nakagami Hironori,Maeda Kazuhisa,Morishita Ryuichi,Kaneda Yasufumi,Ogihara Toshio, Circulation journal : official journal of the Japanese Circulation Society, Japanese Circulation Society, Vol. 69, p. 171-171, 2005/03/01
  • The development of novel strong HVJ-liposome/HSP65 DNA+IL-12 DNA vaccination against tuberculosis, M Okada,S Yoshida,T Tanaka,S Kuwayama,Y Kita,N Kanamaru,Y Muraki,S Hashimoto,H Takai,C Okada,Y Fukunaga,Y Sakaguchi,Furukawa, I,K Yamada,M Izumiya,Y Inoue,Y Kaneda,M Sakatani, FASEB JOURNAL, FEDERATION AMER SOC EXP BIOL, Vol. 19, No. 4, p. A895-A895, 2005/03
  • Recovery of cognitive function with gene therapy using helpatocyte growth factor gene after ischemic stroke, M Shimamura,N Sato,M Aoki,S Waguri,T Hayashi,H Iida,Y Uchiyama,T Nakamura,T Ogihara,Y Kaneda,R Morishita, STROKE, LIPPINCOTT WILLIAMS & WILKINS, Vol. 36, No. 2, p. 513-513, 2005/02
  • Hepatocyte growth factor(HGF)によるリンパ管新生作用, 斉藤幸裕,斉藤幸裕,中神啓徳,鷹見洋一,森下竜一,金田安史,東信良,笹嶋唯博, 日本高血圧学会総会プログラム・抄録集, Vol. 28th, 2005
  • HVJ-Eベクターを用いたHigh Throughput Screeningによる新規遺伝子機能スクリーニング-血管リモデリング抑制遺伝子の検索-, 鷹見洋一,中神啓徳,勝谷友宏,楽木宏実,森下竜一,金田安史,荻原俊男, 日本高血圧学会総会プログラム・抄録集, Vol. 28th, 2005
  • マウスDnmt3bのクロマチン高次構造特異的な結合, 柏木克信,浦聖恵,金田安史, 日本分子生物学会年会講演要旨集, Vol. 28th, 2005
  • 未分化ES細胞で高いH3K4モノメチル化はSET7に依存しない, 二村圭祐,浦聖恵,金田安史, 日本分子生物学会年会講演要旨集, Vol. 28th, 2005
  • 脂肪由来未分化細胞を用いた血管新生細胞治療, 中神啓徳,前田和久,森下竜一,荻原俊男,金田安史, 再生医療, Vol. 4, 2005
  • 強磁性粒子を用いた新規遺伝子導入法の開発と評価, 寺園文吾,武田真一,泉佳伸,江間喜美子,西嶋茂宏,金田安史,中神啓徳, 日本ME学会大会論文集, Vol. 44th, 2005
  • Hemagglutinating Virus of Japan envelope (HVJ-E) ベクターを用いた一過性遺伝子導入によるマウス着床期におけるNF-kappaB活性化の生理的意義の検討(生殖生理・病理XV, 第57回日本産科婦人科学会), 木村 正,中村 仁美,荻田 和秀,香山 晋輔,辻江 智子,筒井 建紀,下屋 浩一郎,金田 安史,古山 将康,村田 雄二, 日本産科婦人科學會雜誌, 日本産科婦人科学会, Vol. 57, No. 2, p. 674-674, 2005
  • 超音波と超音波造影剤を用いたラット脊髄への遺伝子導入についての検討, 島村宗尚,里直行,栗波仁美,金田安史,森下竜一, 日本神経学会総会プログラム・抄録集, Vol. 46th, 2005
  • 超音波を用いた中枢神経への遺伝子導入の検討, 島村宗尚,里直行,青木元邦,金田安史,森下竜一, 臨床神経学, Vol. 44, No. 12, 2004/12/01
  • HGF遺伝子を用いた脳梗塞後における記憶障害に対する遺伝子治療の検討, 島村 宗尚,里 直行,青木 元邦,和栗 聡,内山 安男,林 拓也,飯田 秀博,金田 安史,荻原 俊男,森下 竜一, 日本高血圧学会総会プログラム・抄録集, (NPO)日本高血圧学会, Vol. 27回, p. 44-44, 2004/10
  • Periostin as a novel factor responsible for ventricular dilation, N Katsuragi,Y Taniyama,N Nakamura,Y Hasegawa,K Kawashima,K Sugimura,Y Kaneda,T Ogihara,R Morishita, CIRCULATION, LIPPINCOTT WILLIAMS & WILKINS, Vol. 110, No. 17, p. 104-104, 2004/10
  • Development of efficient plasmid DNA transfer into adult rat central nervous system using microbubble-enhanced ultrasound, M Shimamura,N Sato,Y Taniyama,S Yamamoto,M Endoh,H Kurinami,M Aoki,T Ogihara,Y Kaneda,R Morishita, GENE THERAPY, NATURE PUBLISHING GROUP, Vol. 11, No. 20, p. 1532-1539, 2004/10
  • Enhanced tumor-specific long-term immunity of hemaggluttinating virus of Japan-mediated dendritic cell-tumor fused cell vaccination-by coadministration with CpG oligodeoxynucleotides, K Hiraoka,S Yamamoto,S Otsuru,S Nakai,K Tamai,R Morishita,T Ogihara,Y Kaneda, JOURNAL OF IMMUNOLOGY, AMER ASSOC IMMUNOLOGISTS, Vol. 173, No. 7, p. 4297-4307, 2004/10
  • 超音波を用いた中枢神経への遺伝子導入の検討, 島村宗尚,里直行,青木元邦,栗波仁美,金田安史,荻原俊男,森下竜一, 日本高血圧学会総会プログラム・抄録集, Vol. 27th, 2004/09/06
  • 核酸医薬外用剤のアトピー性皮膚炎への臨床応用 (特集 アトピー性皮膚炎治療の進歩), 玉井 克人,金田 安史,中邨 弘重, アレルギ-・免疫, 医薬ジャ-ナル社, Vol. 11, No. 8, p. 1084-1088, 2004/08
  • 重症アトピー性皮膚炎に対する核酸医薬治療--転写因子NF-κBを標的としたデコイDNA軟膏の臨床応用 (第1土曜特集 アトピー性皮膚炎) -- (治療--現況と最近の進歩), 玉井 克人,金田 安史,中邨 弘重, 医学のあゆみ, 医歯薬出版, Vol. 210, No. 1, p. 101-104, 2004/07/03
  • A novel therapeutic strategy to treat brain ischemia: Over-expression of hepatocyte growth factor gene reduced ischemic injury without cerebral edema in rat model, M Shimamura,N Sato,T Ogihara,Y Kaneda,R Morishita, MOLECULAR THERAPY, ACADEMIC PRESS INC ELSEVIER SCIENCE, Vol. 9, p. S88-S88, 2004/05
  • Prevention of onset of Parkinson's disease by in vivo gene transfer of human hepatocyte growth factor in primate model: A model of gene therapy for Parkinson's disease, H Koike,A Ishida,M Shimamura,N Sato,N Tomita,Y Kaneda,R Morishita, MOLECULAR THERAPY, ACADEMIC PRESS INC ELSEVIER SCIENCE, Vol. 9, p. S196-S196, 2004/05
  • Improvement of myocardial dysfunction by therapeutic angiogenesis induced by transfection of HGF gene using left ventricular electromechanical mapping in porcine chronic myocardial infarction model, J Azuma,Y Taniyama,M Aoki,Y Kaneda,T Ogihara,R Morisita, MOLECULAR THERAPY, ACADEMIC PRESS INC ELSEVIER SCIENCE, Vol. 9, p. S74-S74, 2004/05
  • Development of HVJ-E high throughput gene function screening system: Screening of endothelial cell growth factors, T Nishikawa,H Nakagami,CY Yo,Y Kaneda, MOLECULAR THERAPY, ACADEMIC PRESS INC ELSEVIER SCIENCE, Vol. 9, p. S113-S114, 2004/05
  • Essential role of HGF (hepatocyte growth factor) in blood formation in Xenopus, N Koibuchi,Y Kaneda,Y Taniyama,K Matsumoto,T Nakamura,T Ogihara,R Morishita, BLOOD, AMER SOC HEMATOLOGY, Vol. 103, No. 9, p. 3320-3325, 2004/05
  • Efficient ultrasound-mediated gene transfer of NFKB decoy into donor kidneys prolonged survival of rat renal allografts, H Azuma,N Tomita,T Sakamoto,S Kiyama,Y Kaneda,R Morishita,Y Katsuoka, JOURNAL OF UROLOGY, LIPPINCOTT WILLIAMS & WILKINS, Vol. 171, No. 4, p. 488-488, 2004/04
  • 超音波を用いた中枢神経への遺伝子導入の検討, 島村宗尚,里直行,青木元邦,金田安史,森下竜一, 日本神経学会総会プログラム・抄録集, Vol. 45th, 2004/04/01
  • SF-043-2 HVJ-Envelope法を用いたNFκB decoy導入による移植静脈グラフト内膜肥厚抑制の検討, 清水 紀之,東 信良,平田 哲,西川 智之,森下 竜一,金田 安史,笹嶋 唯博, 日本外科学会雑誌, 一般社団法人日本外科学会, Vol. 105, p. 236-236, 2004/03/15
  • FRS-013 Long Term Evaluation of Clinical Trial of Human Gene Therapy for Peripheral Arterial Disease Using Hepatocyte Growth Factor Gene Transfer(Angiogenesis and Regeneration Medicine in Cardiovascular Medicine (M) : FRS3)(Featured Research Session (English)), Makino Hirofumi,Morishita Ryuichi,Aoki Motokuni,Hashiya Naotaka,Yamazaki Keita,Azuma Junya,Kaneda Yasufumi,Ogihara Toshio, Circulation journal : official journal of the Japanese Circulation Society, Japanese Circulation Society, Vol. 68, p. 93-93, 2004/03/01
  • OE-328 Increase in DNA Synthesis of Cardiomyocytes by Transfection of Antisense p53 and Rb Oligodeoxynucleotides : Possibility of Regeneration of Cardiomyocytes(Gene Therapy 2 (IHD) : OE41)(Oral Presentation (English)), Tashiro Hironori,Aoki Motokuni,Isobe Mitsuaki,Kaneda Yasufumi,Morishita Ryuichi, Circulation journal : official journal of the Japanese Circulation Society, Japanese Circulation Society, Vol. 68, p. 220-220, 2004/03/01
  • PJ-477 A Therapeutic Strategy to Treat Brain Ischemia : Over-expression of Hepatocyte Growth Factor Gene Reduced Ischemic Injury in Rat Model(Cerebrovascular Circulation/Stroke 1 (H) : PJ80)(Poster Session (Japanese)), Shimamura Munehisa,Sato Naoyuki,Kurinami Hitomi,Aoki Motokuni,Kaneda Yasufumi,Ogihara Toshio,Morishita Ryuichi, Circulation journal : official journal of the Japanese Circulation Society, Japanese Circulation Society, Vol. 68, p. 597-597, 2004/03/01
  • In vivo transient gene transferによるマウス着床期にかかわる転写因子群の検討, 中村 仁美,木村 正,荻田 和秀,香山 晋輔,辻江 智子,筒井 建紀,下屋 浩一郎,古山 将康,金田 安史,村田 雄二, 日本不妊学会雑誌, (一社)日本生殖医学会, Vol. 49, No. 1〜2, p. 35-36, 2004/02
  • Increase in DNA synthesis of cardiac myocytes by transfection of antisense p53 and Rb oligodeoxynucleotides(ODN); Possibility of regeneration of cardiac myocytes, H Tashiro,M Aoki,Y Kaneda,M Isobe,R Morishita, JOURNAL OF HYPERTENSION, LIPPINCOTT WILLIAMS & WILKINS, Vol. 22, p. S77-S77, 2004/02
  • Clinical results of TREAT-HGF (Japan trial to treat peripheral arterial disease by therapeutic angiogenesis using hepatocyte growth factor gene transfer), N Hashiya,R Morishita,M Aoki,K Yamasaki,H Makino,Y Kaneda,T Ogihara, JOURNAL OF HYPERTENSION, LIPPINCOTT WILLIAMS & WILKINS, Vol. 22, p. S145-S145, 2004/02
  • VEGF (164) induces transformation of blood cells precursors into endothelial cells in developing posterior blood island, N Koibuchi,Y Taniyama,T Ogihara,Y Kaneda,R Morishita, JOURNAL OF HYPERTENSION, LIPPINCOTT WILLIAMS & WILKINS, Vol. 22, p. S74-S74, 2004/02
  • Results of safety from human clinical gene therapy using HGF (TREAT-HGF), H Makino,M Aoki,N Hashiya,K Yamasaki,T Ogihara,R Morishita,Y Kaneda, JOURNAL OF HYPERTENSION, LIPPINCOTT WILLIAMS & WILKINS, Vol. 22, p. S196-S196, 2004/02
  • A novel therapeutic strategy to treat brain ischemia: Overexpression of hepatocyte growth factor gene reduced ischemic injury without brain edema in rat model, M Shimamura,N Sato,M Aoki,Y Kaneda,T Ogihara,R Morishita, JOURNAL OF HYPERTENSION, LIPPINCOTT WILLIAMS & WILKINS, Vol. 22, p. S84-S85, 2004/02
  • 磁性高分子を用いた新規遺伝子導入法の開発, 寺園文吾,武田真一,泉佳伸,江間喜美子,西嶋茂宏,金田安史,中神啓徳, 日本ME学会秋季大会論文集, Vol. 18th, 2004
  • 細胞への遺伝子導入効率向上に最適な表面修飾法の検討, 三島史人,武田真一,泉佳伸,西嶋茂宏,中神啓徳,金田安史, 日本ME学会秋季大会論文集, Vol. 18th, 2004
  • 磁性高分子を用いた次世代Drug Delivery System(DDS)の開発, 中神啓徳,金田安史,三島史人,武田真一,西嶋茂弘, 日本ME学会秋季大会論文集, Vol. 18th, 2004
  • 9-21.Hemagglutinating Virus of Japan envelope(HVJ-E) vectorを用いた一過性遺伝子導入によるマウス着床期にかかわる転写因子の検討(第40群 生殖生理・病理5)(一般演題), 中村 仁美,木村 正,荻田 和秀,香山 晋輔,辻江 智子,筒井 建紀,下屋 浩一郎,古山 将康,金田 安史,村田 雄二, 日本産科婦人科學會雜誌, 日本産科婦人科学会, Vol. 56, No. 2, p. 437-437, 2004
  • A novel therapeutic strategy to treat brain ischemia: over-expression of hepatocyte growth factor gene reduced ischemic injury without brain edema in rat model., M Shimamura,N Sato,M Aoki,S Waguri,Y Uchiyama,T Ogihara,Y Kaneda,R Morishita, STROKE, LIPPINCOTT WILLIAMS & WILKINS, Vol. 35, No. 1, p. 282-282, 2004/01
  • Modification of plasmid DNA-based gene transfer into central nerve system, Y Taniyama,M Shimamura,N Sato,N Tomita,M Endho,J Azuma,K Iekushi,Y Kaneda,T Ogihara,R Monshita, STATE OF THE ART: ULTRASONICS IN MEDICINE, ELSEVIER SCIENCE BV, Vol. 1274, p. 159-163, 2004
  • In vivo gene transfection with hepatocyte growth factor via the pulmonary artery induces angiogenesis in the rat lung, Ono Masamichi,Sawa Yoshiki,Matsumoto Kunio,Nakamura Toshikazu,Kaneda Yasufumi,Matsuda Hikaru, Shinzo, Japan Heart Foundation, Vol. 36, No. 2, p. 87-94, 2004
  • Intrathecal injection of HVJ-E containing HGF gene to cerebrospinal fluid can prevent and ameliorate hearing impairment in rats, K Oshima,M Shimamura,S Mizuno,K Tamai,K Doi,R Morishita,T Nakamura,T Kubo,Y Kaneda, FASEB JOURNAL, FEDERATION AMER SOC EXP BIOL, Vol. 18, No. 1, p. 212-214, 2004/01
  • A novel combination of suicide gene therapy and histone deacetylase inhibitor for treatment of malignant melanoma., S Yamamoto,T Aiken,Y Kaneda, CLINICAL CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, Vol. 9, No. 16, p. 6250S-6251S, 2003/12
  • ラット中大脳動脈閉塞モデルにおける肝細胞増殖因子(HGF)遺伝子による遺伝子治療の検討, 島村 宗尚,里 直行,青木 元邦,和栗 聡,内山 安男,金田 安史,荻原 俊男,森下 竜一, 日本高血圧学会総会プログラム・抄録集, (NPO)日本高血圧学会, Vol. 26回, p. 187-187, 2003/10
  • NFkB decoy oligodeoxynucleotides suppressed the progression of osteoarthritis in rat., H Hashimoto,T Tomita,Y Kunugiza,A Nampei,R Morishita,Y Kaneda,H Yoshikawa, ARTHRITIS AND RHEUMATISM, WILEY-LISS, Vol. 48, No. 9, p. S630-S630, 2003/09
  • 安全な移植技術の開発をめざして 厚生労働省ミレニアム・プロジェクト(ヒトゲノム・再生医療等研究事業)報告, 磯部 光章,井上 一知,上出 利光,金田 安史,澤 芳樹,鈴木 盛一,中村 敏一,中山 俊憲,天野 純,伊藤 宏,岸原 健二,砂村 真琴,陳 孟鳳,場集田 寿,林 衆治,梨井 康,野本 亀久雄, 移植, (一社)日本移植学会, Vol. 38, No. 4, p. 263-277, 2003/08
  • TNF combined with IFN-alpha accelerates NF-kappa B-mediated apoptosis through enhancement of Fas expression in colon cancer cells, M Kimura,M Haisa,H Uetsuka,M Takaoka,T Ohkawa,R Kawashima,T Yamatsuji,M Gunduz,Y Kaneda,Y Naomoto, CELL DEATH AND DIFFERENTIATION, NATURE PUBLISHING GROUP, Vol. 10, No. 6, p. 718-728, 2003/06
  • Potential therapeutic application of NF kappa B decoy oligodeoxynucleotides on joint destruction of collagen-induced arthritis in cynomolgus monkeys, T Tomita,H Hashimoto,R Morishita,Y Kunugiza,N Tomita,A Waki,S Kuroda,Y Kaneda,H Yoshikawa, MOLECULAR THERAPY, ACADEMIC PRESS INC ELSEVIER SCIENCE, Vol. 7, No. 5, p. S397-S397, 2003/05
  • Hepatocyte growth factor gene transfer in cerebrospinal fluid can prevent and ameliorate hearing impairment in rats, K Oshima,M Shimamura,K Tamai,R Morishita,Y Kaneda, MOLECULAR THERAPY, ACADEMIC PRESS INC ELSEVIER SCIENCE, Vol. 7, No. 5, p. S251-S251, 2003/05
  • Development and first clinical trial of NFkB decoy DNA ointment for treatment of severe atopic dermatitis patients in Japan, K Tamai,M Ryuichi,H Nakamura,K Hanada,Y Kaneda, MOLECULAR THERAPY, ACADEMIC PRESS INC ELSEVIER SCIENCE, Vol. 7, No. 5, p. S450-S450, 2003/05
  • Novel nonviral vector of dendritic cells to induce anti-melanoma immunity, H Ota,S Yamamoto,K Hiraoka,DSB Hoon,Y Kaneda, MOLECULAR THERAPY, ACADEMIC PRESS INC ELSEVIER SCIENCE, Vol. 7, No. 5, p. S170-S170, 2003/05
  • An effective non-viral delivery system of plasmid DNA into mouse malignant melanoma using of ultrasound, S Yamamoto,Y Taniyama,Y Kaneda, MOLECULAR THERAPY, ACADEMIC PRESS INC ELSEVIER SCIENCE, Vol. 7, No. 5, p. S282-S282, 2003/05
  • Co-transfection of human hepatocyte growth factor and prostacyclin synthase gene enhanced therapeutic angiogenesis in rat and rabbit ischemia model, H Koike,N Tomita,T Tanabe,Y Kaneda,R Morishita, MOLECULAR THERAPY, ACADEMIC PRESS INC ELSEVIER SCIENCE, Vol. 7, No. 5, p. S232-S233, 2003/05
  • NFkBとEtsに対するChimera decoyを用いた大動脈瘤の拡大抑制効果, 三宅 隆,青木 元邦,中嶋 英喜,金田 安史,森下 竜一, 日本外科学会雑誌, 一般社団法人日本外科学会, Vol. 104, p. 237-237, 2003/04/30
  • Transfection of NFKB decoy ODN using ultrasound-mediated gene transfer into donor kidneys prolonged rat renal allograft survival, H Azuma,N Tomita,T Sakamoto,S Kiyama,Y Kaneda,R Morishita,Y Katsuoka, JOURNAL OF UROLOGY, LIPPINCOTT WILLIAMS & WILKINS, Vol. 169, No. 4, p. 485-486, 2003/04
  • The Role of Hepatocyte Growth Factor (HGF) in Vasculogenesis and Angiogenesis in Xenopus Development, Koibuchi Nobutaka,Morishita Ryuichi,Ogihara Toshio,Kaneda Yasufumi, Circulation journal : official journal of the Japanese Circulation Society, Japanese Circulation Society, Vol. 67, p. 503-503, 2003/03/01
  • Heat Shock Protein 70-Induced Cardioprotection Involves Preservation of Manganese Superoxide Disumutase Activity, Associated with Mitochondria! Protection and Apoptosis Reduction, Suzuki Ken,Sawa Yoshiki,Kaneda Yasufumi,Matsuda Hikaru, Circulation journal : official journal of the Japanese Circulation Society, Japanese Circulation Society, Vol. 67, p. 413-413, 2003/03/01
  • Gene Therapy to Treat Diabetic Neuropathy : Improvement of Diabetic Peripheral Neuropathy by HGF Gene and Prostacyclin Synthase Gene Transfer, Koike Hiromi,Tomita Naruya,Iguchi Sota,Kaneda Yasufumi,Ogihara Toshio,Morishita Ryuichi, Circulation journal : official journal of the Japanese Circulation Society, Japanese Circulation Society, Vol. 67, p. 603-603, 2003/03/01
  • Therapeutic Angiogenesis Induced by Transfection of Hepatocyte Growth Factor (HGF) Gene in Porcine Myocardial Infarction Model, Azuma Junya,Aoki Motokuni,Yamazaki Keita,Kaneda Yasufumi,Ogihara Toshio,Morishita Ryuichi, Circulation journal : official journal of the Japanese Circulation Society, Japanese Circulation Society, Vol. 67, p. 603-603, 2003/03/01
  • Therapeutic Angiogenesis Induced by Endotherial Nitric Oxide Synthase Gene through VEGF Expression in Rat Hindlimb Ischemia Model, Namba Tsunetatsu,Morishita Ryuichi,Noma Takahisa,Murakami Kazushi,Tsuji Teppei,Ishizawa Makoto,Ohmori Koji,Mizushige Katsufumi,Ogihara Toshio,Kaneda Yasufumi,Kohno Masakazu, Circulation journal : official journal of the Japanese Circulation Society, Japanese Circulation Society, Vol. 67, p. 595-595, 2003/03/01
  • Results of Safety from Human Clinical Gene Therapy Using HGF (TREAT-HGF), Makino Hirofumi,Morishita Ryuichi,Aoki Motokuni,Yamazaki Keita,Hashiya Naotaka,Azuma Junya,Kurinami Hitomi,Kaneda Yasufumi,Ogihara Toshio, Circulation journal : official journal of the Japanese Circulation Society, Japanese Circulation Society, Vol. 67, p. 594-594, 2003/03/01
  • Co-Transfection of Human Hepatocyte Growth Factor and Prostacyclin Synthase Gene Enhanced Therapeutic Angiogenesis in Rat and Rabbit Ischemia Model, Koike Hiromi,Tomita Naruya,Iguchi Sota,Kaneda Yasufumi,Ogihara Toshio,Morishita Ryuichi, Circulation journal : official journal of the Japanese Circulation Society, Japanese Circulation Society, Vol. 67, p. 603-603, 2003/03/01
  • Overexpression of HGF (Hepatocyte Growth Factor) Reduced Ischemic Injury in Rat Permanent Middle Cerebral Artery Occlusion (MCAO) Model, Shimamura Munehisa,Morishita Ryuichi,Aoki Motokuni,Ogihara Toshio,Kaneda Yasufumi, Circulation journal : official journal of the Japanese Circulation Society, Japanese Circulation Society, Vol. 67, p. 629-629, 2003/03/01
  • Vascular Specific Organogenesis from Embryonic Stem Cells on Three Dimensional Layer of Matrigel, Nakagawa Namika,Hayashi Shinichiro,Kaneda Yasufumi,Ogihara Toshio,Morishita Ryuichi, Circulation journal : official journal of the Japanese Circulation Society, Japanese Circulation Society, Vol. 67, p. 240-240, 2003/03/01
  • Long Term Evaluation of Results from the First Stage in the Clinical Trial of Gene Therapy for Peripheral Arterial Disease, Kurinami Hitomi,Morishita Ryuichi,Aoki Motokuni,Hashiya Naotaka,Makino Hirofumi,Yamazaki Keita,Azuma Junya,Kaneda Yasufumi,Ogihara Toshio, Circulation journal : official journal of the Japanese Circulation Society, Japanese Circulation Society, Vol. 67, p. 373-373, 2003/03/01
  • Inhibitory Effect of Chimera Decoy Oligodeoxynucleotides (ODN) against Ets and NFκ B on the Progression of Rabbit Experimental Aortic Aneurysms (AAA), Miyake Takashi,Aoki Motokuni,Nakashima Hideki,Kaneda Yasufumi,Ogihara Toshio,Morishita Ryuichi, Circulation journal : official journal of the Japanese Circulation Society, Japanese Circulation Society, Vol. 67, p. 373-373, 2003/03/01
  • Acceleration of Neointimal Hyperplasia in Lp (a) Transgenic Mice : Contribution of Lp (a) in the Pathogenesis of Vascular Disease, Iguchi Sola,Morishita Ryuichi,Sakaki Minako,Aoki Motokuni,Ogihara Toshio,Kaneda Yasufumi, Circulation journal : official journal of the Japanese Circulation Society, Japanese Circulation Society, Vol. 67, p. 334-334, 2003/03/01
  • Increase in DNA Synthesis of Cardiac Myocytes by Transfection ofP53 and Rb Antisense : Possibility of Cardiac Myocytes Regeneration, Tashiro Hironori,Aoki Motokuni,Isobe Mitsuaki,Kaneda Yasufumi,Morishita Ryuichi, Circulation journal : official journal of the Japanese Circulation Society, Japanese Circulation Society, Vol. 67, p. 267-268, 2003/03/01
  • Clinical Results of TREAT-HGF (Japan Trial to Treat Peripheral Arterial Disease by Therapeutic Angiogenesis Using Hepatocyte Growth Factor Gene Transfer), Hashiya Naotaka,Morishita Ryuichi,Aoki Motokuni,Makino Hirofumi,Yamazaki Keita,Azuma Junya,Kurinami Hitomi,Kaneda Yasufumi,Ogihara Toshio, Circulation journal : official journal of the Japanese Circulation Society, Japanese Circulation Society, Vol. 67, p. 148-149, 2003/03/01
  • 新しい結核ワクチンの開発とELISPOT assay(自動解析)を用いたT細胞活性化によるワクチン効果の解析, 田中 高生,喜多 洋子,井上 義一,坂谷 光則,岡田 全司,桑山 さち子,村木 裕美子,稲永 由紀子,金丸 典子,橋元 里実,高井 寛子,渡邊 悠子,岡田 知佳,森 珠里,石崎 邦子,松本 久美,岡 美穂,黒川 恵理,吉田 栄人,金田 安史,大原 直也,内藤 真理子,山田 毅,松本 壮吉,Reed Steven,Skeiky Yasir,Gillis Steven, 結核, (一社)日本結核病学会, Vol. 78, No. 3, p. 278-278, 2003/03
  • Transfection of NF kappa B-decoy oligodeoxynucleotides using efficient ultrasound-mediated gene transfer into donor kidneys prolonged survival of rat renal allografts, H Azuma,N Tomita,Y Kaneda,H Koike,T Ogihara,Y Katsuoka,R Morishita, GENE THERAPY, NATURE PUBLISHING GROUP, Vol. 10, No. 5, p. 415-425, 2003/03
  • Inhibition of NF kappa B activation using cis-element 'decoy' of NF kappa B binding site reduces neointimal formation in porcine balloon-injured coronary artery model, K Yamasaki,T Asai,M Shimizu,M Aoki,N Hashiya,H Sakonjo,H Makino,Y Kaneda,T Ogihara,R Morishita, GENE THERAPY, NATURE PUBLISHING GROUP, Vol. 10, No. 4, p. 356-364, 2003/02
  • Enhanced angiogenesis and improvement of neuropathy by cotransfection of human hepatocyte growth factor and prostacyclin synthase gene, H Koike,R Morishita,S Iguchi,M Aoki,K Matsumoto,T Nakamura,C Yokoyama,T Tanabe,T Ogihara,Y Kaneda, FASEB JOURNAL, FEDERATION AMER SOC EXP BIOL, Vol. 17, No. 2, p. 779-+, 2003/02
  • Dnmt3b遺伝子座におけるクロマチン構造と遺伝子発現制御機構, 森田奈亜子,浦聖恵,丹羽仁史,金田安史, 日本分子生物学会年会プログラム・講演要旨集, Vol. 26th, 2003
  • 第1部 クロマチン制御とエピジェネティクス 第1章 ヒストン修飾とクロマチン構造の変化 3.リンカーヒストンによるクロマチンリモデリングの制御, 浦聖恵,柏木克信,金田安史, 実験医学, Vol. 21, No. 11, 2003
  • スタチンはNADPH oxidaseを介した酸化ストレスの抑制により心肥大を抑制する, 中神啓徳,森下竜一,萩原俊男,金田安史,LIAO J K, 日本内分泌学会雑誌, Vol. 79, No. 2, 2003
  • アトピー性皮膚炎に対する転写因子NFκBデコイDNA軟膏の臨床研究(シンポジウム4 アトピー性皮膚炎治療の進歩), 玉井 克人,森下 竜一,中邨 弘重,青木 元邦,花田 勝美,金田 安史, アレルギー, 一般社団法人 日本アレルギー学会, Vol. 52, No. 8, p. 752-752, 2003
  • Current Status of Human Gene Therapy, KANEDA Yasufumi, Vol. 42, No. 5, p. 777-785, 2002/11/07
  • 遺伝子治療臨床研究の現状--慢性疾患 血管疾患に対する遺伝子治療 (第1土曜特集 遺伝子治療--現状とその近未来), 小池 弘美,森下 竜一,金田 安史, 医学のあゆみ, 医歯薬出版, Vol. 203, No. 5, p. 296-301, 2002/11/02
  • Expression of matrix metalloproteinases in cardiac allograft vasculopathy and its attenuation by anti MMP-2 ribozyme gene transfection, K Yamaura,K Tsukioka,J Suzuki,M Fujimori,Y Wada,K Ito,R Morishita,Y Kaneda,M Isobe,J Amano, CIRCULATION, LIPPINCOTT WILLIAMS & WILKINS, Vol. 106, No. 19, p. 116-116, 2002/11
  • Novel therapeutic strategy to treat abdominal aortic aneurysms (AAA) by chimera decoy oligodeoxynucleotides (ODN) against NF kappa B and Ets binding sites, H Nakashima,M Aoki,M Takashi,S Ohgi,Y Kaneda,T Ogihara,R Morishita, CIRCULATION, LIPPINCOTT WILLIAMS & WILKINS, Vol. 106, No. 19, p. 69-70, 2002/11
  • 遺伝子治療による脳保護療法の可能性, 斎藤洋一,秋山智洋,萩原靖,中島義和,加藤天美,恵口豊,金田安史,吉峰俊樹, 日本脳神経外科学会総会抄録集, Vol. 61st, No. CD-ROM Abstracts, 2002/10/02
  • 腎疾患に対する新しい遺伝子導入法による遺伝子治療の可能性 治療用超音波装置と超音波造影剤の応用, 冨田 奈留也,森下 竜一,小池 弘美,谷山 義明,東 治人,勝岡 洋二,金田 安史,荻原 俊男, 日本高血圧学会総会プログラム・抄録集, (NPO)日本高血圧学会, Vol. 25回, p. 231-231, 2002/10
  • Delivery of NF kappa B decoy using ultrasound-mediated transfer method into the donor kidney prolonged survival of rat renal allograft., N Tomita,H Azuma,H Koike,Y Kaneda,Y Katsuoka,T Ogihara,R Morishita, JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, LIPPINCOTT WILLIAMS & WILKINS, Vol. 13, p. 355A-355A, 2002/09
  • Establishment of a novel gene transfer method into the kidney mediated by ultrasound with microbubbles, N Tomita,R Morishita,H Koike,Y Taniyama,Y Kaneda,J Higaki,T Ogihara, HYPERTENSION, LIPPINCOTT WILLIAMS & WILKINS, Vol. 40, No. 3, p. 428-428, 2002/09
  • Prevention and regression of atopic dermatitis by ointment containing NF-kB decoy oligodeoxynucleotides in NC/Nga atopic mouse model, H Nakamura,M Aoki,K Tamai,M Oishi,T Ogihara,Y Kaneda,R Morishita, GENE THERAPY, NATURE PUBLISHING GROUP, Vol. 9, No. 18, p. 1221-1229, 2002/09
  • Hemagglutinating virus of Japan (HVJ) envelope vector as a versatile gene delivery system, Y Kaneda,T Nakajima,T Nishikawa,S Yamamoto,H Ikegami,N Suzuki,H Nakamura,R Morishita,H Kotani, MOLECULAR THERAPY, ACADEMIC PRESS INC ELSEVIER SCIENCE, Vol. 6, No. 2, p. 219-226, 2002/08
  • Hemagglutinating virus of Japan (HVJ) envelope vector as a versatile gene delivery system, Y Kaneda,T Nakajima,T Nishikawa,S Yamamoto,H Ikegami,N Suzuki,H Nakamura,R Morishita,H Kotani, MOLECULAR THERAPY, ACADEMIC PRESS INC ELSEVIER SCIENCE, Vol. 6, No. 2, p. 219-226, 2002/08
  • VEGFおよびHGF遺伝子導入による血管再生 (再生医学・再生医療) -- (第4部 組織再生・臓器再生の展望), 小池 弘美,森下 竜一,金田 安史, 現代化学増刊, 東京化学同人, No. 41, p. 144-147, 2002/07
  • Development of second generation of therapeutic angiogenesis strategy using co-transfection of human prostacyclin synthase (PGIS) gene with vascular endothelial growth factor, H Koike,R Morishita,N Tomita,Y Taniyama,T Tanabe,T Ogihara,Y Kaneda, JOURNAL OF HYPERTENSION, LIPPINCOTT WILLIAMS & WILKINS, Vol. 20, p. S180-S180, 2002/06
  • Preliminary clinical results from treat-HGF (Japan trial to treat peripheral arterial disease by therapeutic angiogenesis using HGF gene transfer), N Hashiya,R Morishita,M Aoki,H Makino,K Yamasaki,M Ohishi,Y Kaneda,T Ogihara, JOURNAL OF HYPERTENSION, LIPPINCOTT WILLIAMS & WILKINS, Vol. 20, p. S253-S253, 2002/06
  • Acceleration of neointimal hyperplasia in Lp(a) transgenic mice: Contribution of Lp(a) in the pathogenesis of vascular disease, S Iguchi,R Morishita,M Aoki,Y Kaneda,T Ogihara, JOURNAL OF HYPERTENSION, LIPPINCOTT WILLIAMS & WILKINS, Vol. 20, p. S138-S138, 2002/06
  • Impairment of collateral formation in Lp(a) transgenic mice: Therapeutic angiogenesis induced by human hepatocyte growth factor gene, S Iguchi,R Morishita,M Sakaki,M Aoki,Y Kaneda,T Ogihara, JOURNAL OF HYPERTENSION, LIPPINCOTT WILLIAMS & WILKINS, Vol. 20, p. S137-S137, 2002/06
  • Suppression of experimental aortic aneurysms by chimera decoy oligodeoxynucleotides (ODN) against ets and NF kappa B binding sites: Novel molecular intervention to treat abdominal aortic aneurysms, H Nakashima,M Aoki,T Kawasaki,S Ohgi,Y Kaneda,R Morishita, JOURNAL OF HYPERTENSION, LIPPINCOTT WILLIAMS & WILKINS, Vol. 20, p. S182-S182, 2002/06
  • Gene therapy for preventing delayed neuronal death using hepatocyte growth factor, M Shimamura,R Morishita,S Yoshimura,K Hayashi,M Aoki,Y Kaneda,T Ogihara, JOURNAL OF HYPERTENSION, LIPPINCOTT WILLIAMS & WILKINS, Vol. 20, p. S179-S179, 2002/06
  • Development of novel therapeutic angiogenesis strategy using co-transfection of human prostacyclin synthase (PGIS) gene with hepatocyte growth factor (HGF) in rabbit ischemic hindlimb model as preclinical study, H Koike,R Morishita,N Tomita,Y Taniyama,T Tanabe,T Ogihara,Y Kaneda, JOURNAL OF HYPERTENSION, LIPPINCOTT WILLIAMS & WILKINS, Vol. 20, p. S180-S180, 2002/06
  • Novel high efficiency gene transfer technique into neonatal cardiac myocyte: Second generation of HVJ vector (HVJ-envelope), H Tashiro,M Aoki,M Isobe,Y Kaneda,R Morishita, JOURNAL OF HYPERTENSION, LIPPINCOTT WILLIAMS & WILKINS, Vol. 20, p. S181-S181, 2002/06
  • Hepatocyte growth factor specifies hematopoietic mesoderm in Xenopus embryos, N Koibuchi,R Morishita,T Ogihara,Y Kaneda, JOURNAL OF HYPERTENSION, LIPPINCOTT WILLIAMS & WILKINS, Vol. 20, p. S172-S173, 2002/06
  • No increase in human hepatocyte growth factor concentration in the patients transfected with human HGF plasmid: Preliminary clinical results from treat-HGF, H Makino,R Morishita,M Aoki,N Hashiya,K Yamasaki,M Ohishi,Y Kaneda,T Ogihara, JOURNAL OF HYPERTENSION, LIPPINCOTT WILLIAMS & WILKINS, Vol. 20, p. S181-S181, 2002/06
  • 血管再生医療とプロスタサイクリン, 小池 弘美,森下 竜一,金田 安史, 血管, Vol. 25, No. 2, p. 41-46, 2002/05/19
  • HVJ-liposome 法を応用した肝細胞癌特異的な自殺遺伝子治療 : I^<131>-Lipiodol による遺伝子制御システムの開発, 川下 雄丈,金田 安史,大津留 晶,山下 俊一,矢永 勝彦,古井 純一郎,河野 茂,兼松 隆之, Drug delivery system, Vol. 17, No. 3, p. 244-244, 2002/05/10
  • 腎移植を標的とした遺伝子導入法の確立, 冨田 奈留也,森下 竜一,東 治人,小池 弘美,勝岡 洋治,檜垣 實男,金田 安史,荻原 俊男, 日本腎臓学会誌, (一社)日本腎臓学会, Vol. 44, No. 3, p. 255-255, 2002/04
  • No increase in human HGF concentration in the patients transfected with human HGF plasmid : preliminary clinical results from TREAT-HGF, Makino Hirofumi,Aoki Motokuni,Yamasaki Keita,Hashiya Naotaka,Ohishi Mitsuru,Ogihara Toshio,Morishita Ryuichi,Kaneda Yasufumi, Circulation journal : official journal of the Japanese Circulation Society, Japanese Circulation Society, Vol. 66, p. 704-704, 2002/03/31
  • Hepatocyte growth factor specifies hemotopoitic mesoderm in Xenopus embryos, Koibuchi Nobutaka,Morishita Ryuichi,Kaneda Yasufumi,Ogihara Toshio, Circulation journal : official journal of the Japanese Circulation Society, Japanese Circulation Society, Vol. 66, p. 706-706, 2002/03/31
  • Effect of E2F decoy on inhibitation of neointima formation in pig coronary arteries after balloon injury and stent implantation, Yamazaki Keita,Aoki Motokuni,Makino Hirofumi,Hashiya Naotaka,Nakashima Hideki,Ogihara Toshio,Morishita Ryuichi,Kaneda Yasufumi, Circulation journal : official journal of the Japanese Circulation Society, Japanese Circulation Society, Vol. 66, p. 702-702, 2002/03/31
  • Gene Therapy for Abdominal Aortic Aneurysm (AAA) using Decoy Strategy against ets binding site, Nakashima Hideki,Kaneda Yasufumi,Morishita Ryuichi,Aoki Motokuni,Kawasaki Tomio,Ohgi Shigetsugu, Circulation journal : official journal of the Japanese Circulation Society, Japanese Circulation Society, Vol. 66, p. 703-703, 2002/03/31
  • Impairment of collateral formation in Lp(a) transgenic mice : Therapeutic angiogenesis induced by human hepatocyte growth factor (HGF) gene, Iguchi Sohta,Morishita Ryuichi,Sakaki Minako,Kaneda Yasufumi,Aoki Motokuni,Ogihara Toshio, Circulation journal : official journal of the Japanese Circulation Society, Japanese Circulation Society, Vol. 66, p. 704-704, 2002/03/31
  • Novel High Efficiency Gene transfer Technique into neonatal cardiac myocyte : Second Generation of HVJ vector (HVJ-envelope), Tashiro Hironori,Kaneda Yasufumi,Morishita Ryuichi,Aoki Motokuni,Isobe Mitsuaki, Circulation journal : official journal of the Japanese Circulation Society, Japanese Circulation Society, Vol. 66, p. 705-705, 2002/03/31
  • Novel molecular intervention to treat abdominal aortic aneurysms (AAA) using chimera decoy oligodeoxynucleotides (ODN) against ets and NFkB binding sites, Nakashima Hideki,Kaneda Yasufumi,Morishita Ryuichi,Aoki Motokuni,Kawasaki Tomio,Ohgi Shigetsugu, Circulation journal : official journal of the Japanese Circulation Society, Japanese Circulation Society, Vol. 66, p. 314-314, 2002/03/31
  • Preliminary clinical results from TREAT-HGF (Japan Trial to Treat Peripheral Arterial Disease by Therapeutic Angiogenesis Using HGF Gene Transfer), Hashiya Naotaka,Aoki Motokuni,Yamasaki Keita,Makino Hirofumi,Ohishi Mitsuru,Ogihara Toshio,Morishita Ryuichi,Kaneda Yasufumi, Circulation journal : official journal of the Japanese Circulation Society, Japanese Circulation Society, Vol. 66, p. 314-314, 2002/03/31
  • Development of Novel Therapeutic Angiogenesis Strategy Using Co-transfection of Human PGIS Gene with HGF as Preclinical Study, Koike Hiromi,Morishita Ryuichi,Kaneda Yasufumi,Tomita Naruya,Taniyama Yoshiaki,Ogihara Toshio,Tanabe Tadashi, Circulation journal : official journal of the Japanese Circulation Society, Japanese Circulation Society, Vol. 66, p. 566-566, 2002/03/31
  • Transcription factor, ets-1, is a novel angiogenic molecule : Implication to ciene therapy to treat peripheral arterial disease, Nakashima Hideki,Jo Nobuo,Kaneda Yasufumi,Morishita Ryuichi,Aoki Motokuni,Ohgi Shigetsugu, Circulation journal : official journal of the Japanese Circulation Society, Japanese Circulation Society, Vol. 66, p. 408-408, 2002/03/31
  • Evaluation of utility of prostagrandin E1 in the patients with ASO : Protective effect on endothelial function through up-regulation of HGF, Makino Hirofumi,Aoki Motokuni,Yamasaki Keita,Hashiya Naotaka,Ogihara Toshio,Morishita Ryuichi,Kaneda Yasufumi, Circulation journal : official journal of the Japanese Circulation Society, Japanese Circulation Society, Vol. 66, p. 734-734, 2002/03/31
  • Preliminary clinical results from TREAT-HGF : Gene therapy for PAD, Aoki Motokuni,Hashiya Naotaka,Makino Hirofumi,Yamasaki Keita,Ogihara Toshio,Morishita Ryuichi,Kaneda Yasufumi, Circulation journal : official journal of the Japanese Circulation Society, Japanese Circulation Society, Vol. 66, p. 34-34, 2002/03/31
  • 腹部大動脈瘤に対する核酸医薬を用いた遺伝子治療, 川崎 富夫,中嶋 英喜,青木 元邦,岩井 雅弘,應儀 成二,金田 安史,荻原 敏男,森下 竜一, 日本外科学会雑誌, 一般社団法人日本外科学会, Vol. 103, p. 329-329, 2002/03/10
  • etsデコイを用いた腹部大動脈瘤に対する遺伝子治療の可能性, 中嶋 英喜,青木 元邦,川崎 富夫,岩井 雅弘,應義 成二,金田 安史,森下 竜一, 日本外科学会雑誌, 一般社団法人日本外科学会, Vol. 103, p. 329-329, 2002/03/10
  • Novel DNA and recombinant BCG vaccinations against tuberculosis by the augmentation of cytotoxic activity, M Okada,S Yoshida,N Ohara,T Yamada,Y Kaneda,T Tanaka,Y Kita,S Kuwayama,Y Muraki,Y Inanaga,N Kanamaru,Y Inoue,M Matsumoto,K Kimura,M Sakatani,T Mori, FASEB JOURNAL, FEDERATION AMER SOC EXP BIOL, Vol. 16, No. 4, p. A308-A309, 2002/03
  • Development of safe and efficient novel nonviral gene transfer using ultrasound: enhancement of transfection efficiency of naked plasmid DNA in skeletal muscle, Y Taniyama,K Tachibana,K Hiraoka,M Aoki,S Yamamoto,K Matsumoto,T Nakamura,T Ogihara,Y Kaneda,R Morishita, GENE THERAPY, NATURE PUBLISHING GROUP, Vol. 9, No. 6, p. 372-380, 2002/03
  • Impairment of collateral formation in lipoprotein(a) transgenic mice - Therapeutic angiogenesis induced by human hepatocyte growth factor gene, R Morishita,M Sakaki,K Yamamoto,S Iguchi,M Aoki,K Yamasaki,K Matsumoto,T Nakamura,R Lawn,T Ogihara,Y Kaneda, CIRCULATION, LIPPINCOTT WILLIAMS & WILKINS, Vol. 105, No. 12, p. 1491-1496, 2002/03
  • 血管新生療法 (特集 微小循環障害) -- (微小循環基礎研究のUp date), 小池 弘美,森下 竜一,金田 安史, 現代医療, 現代医療社, Vol. 34, No. 4, p. 2739-2743, 2002
  • 超音波を利用した遺伝子治療--超音波による遺伝子導入 (特集2 超音波エネルギーを使った治療法), 平岡 和也,森下 竜一,金田 安史, 超音波techno, 日本工業出版, Vol. 14, No. 1, p. 63-66, 2002/01
  • Prevention and regression of atopic dermatitis by ointment containing NFkB decoy oligodeoxynucleotides in NC/Nga atopic mice model, H Nakamura,M Aoki,K Tamai,M Oishi,T Ogihara,Y Kaneda,R Morishita, JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, MOSBY, INC, Vol. 109, No. 1, p. S86-S87, 2002/01
  • Decorin Antisense Gene Therapy Decreases Creep Behavior of Early Ligament Scar, NAKAMURA Norimasa,SHINO Konsei,KANEDA Yasufumi,HART David A.,SHRIVE Nigel G.,FRANK Cyril B., Vol. 21, No. 4, p. 37-44, 2001/12/31
  • New technologies for gene therapy, KANEDA Yasufumi, Bioscience & industry, Vol. 59, No. 11, p. 11-16, 2001/11/01
  • Hepatocyte growth factor (HGF) separates acute graft-versus-host disease (GVHD) from graft-versus-leukemia (GVL) effects and promotes T cell immune reconstitution., T Iwasaki,T Kuroiwa,T Hamano,Y Kataoka,T Imado,T Okamoto,Y Kaneda,K Matsumoto,T Nakamura,J Fujimoto,E Kakishita, BLOOD, AMER SOC HEMATOLOGY, Vol. 98, No. 11, p. 650A-650A, 2001/11
  • Effect of NFkB decoy oligonucleotides (ODN) on neointimal formation in rat and porcine balloon injury model: A new decoy strategy for restenosis after PTCA as pre-clinical study, K Yamasaki,T Asai,M Shimizu,R Makino,K Hiraoka,N Hashiya,T Shimizu,M Aoki,Y Kaneda,R Morishita,T Ogihara, CIRCULATION, LIPPINCOTT WILLIAMS & WILKINS, Vol. 104, No. 17, p. 543-543, 2001/10
  • Gene delivery of prostaglandin synthase maintains patency of the newborn lamb arterial duct, T Humpl,SHE Zaidi,JY Coe,J Russell,Y Kaneda,L Benson,M Rabinovitch, CIRCULATION, LIPPINCOTT WILLIAMS & WILKINS, Vol. 104, No. 17, p. 356-356, 2001/10
  • Nuclear factor-kappa B decoy attenuates neuronal damage after global brain ischemia: A future strategy for brain protection during circulatory arrest, T Ueno,Y Sawa,S Kitagawa-Sakakida,NM Nishimura,R Morishita,Y Kaneda,E Kohmura,T Yoshimine,H Matsuda, JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, MOSBY, INC, Vol. 122, No. 4, p. 720-727, 2001/10
  • 血管病の遺伝子治療 (循環器領域における遺伝子治療・診断へのアプローチ), 平岡 和也,森下 竜一,金田 安史, ハートナーシング, メディカ出版, Vol. 14, No. 9, p. 910-915, 2001/09
  • Saftey delivery of E2F decoy using ultrasound with microbubble agents (Optison) inhibits intial hyperplasia after balloon injury in rat carotid artery., R Morishita,K Hiraoka,N Hashiya,H Makino,M Aoki,Y Kaneda,T Ogihara, HYPERTENSION, LIPPINCOTT WILLIAMS & WILKINS, Vol. 38, No. 3, p. 532-532, 2001/09
  • Gene therapy in vascular medicine: recent advances and future perspectives, R Morishita,M Aoki,Y Kaneda,T Ogihara, PHARMACOLOGY & THERAPEUTICS, PERGAMON-ELSEVIER SCIENCE LTD, Vol. 91, No. 2, p. 105-114, 2001/08
  • HVJ-AVE liposomeを用いたbcl-2遺伝子導入による脳虚血モデルでの中枢神経保護作用の検討, 萩原 靖,齋藤 洋一,甲村 英二,金田 安史,吉峰 俊樹, 脳循環代謝, 日本脳循環代謝学会, Vol. 13, No. 2, p. 73-74, 2001/07
  • 肝細胞増殖因子 (第1土曜特集 循環調節ホルモン研究の新展開), 小池 弘美,森下 竜一,金田 安史, 医学のあゆみ, 医歯薬出版, Vol. 197, No. 9, p. 718-722, 2001/06/02
  • 超音波治療器と造影剤(オプチゾン)によるラット腎臓への遺伝子導入法, 小池 弘美,森下 竜一,冨田 奈留也,谷山 義明,立花 克郎,東 治人,金田 安史, 日本腎臓学会誌, (一社)日本腎臓学会, Vol. 43, No. 3, p. 190-190, 2001/04
  • Application of NFκB decoy oligonucleotides for arthritis as a gene therapy, TOMITA Tetsuya,MORISHITA Ryuichi,TOMITA Naruya,KANEDA Yasufumi,YOSHIKAWA Hideki,OCHI Takahiro, Vol. 21, No. 2, p. 101-108, 2001/03/28
  • SF4f-5 筋肉内Electroporation法(EP法)を用いた癌DNAワクチン法の開発, 山田 正治,関本 貢嗣,門田 守人,森下 竜一,金田 安史, 日本外科学会雑誌, 一般社団法人日本外科学会, Vol. 102, p. 84-84, 2001/03/10
  • SF7a-2 心移植後慢性拒絶反応におけるEgr-1の発現様式, 及びEgr-1抑制による拒絶反応抑制効果の検討, 和田 有子,藤森 実,小出 直彦,麻沼 和彦,月岡 勝晶,北原 博人,中野 博文,黒田 秀雄,鈴木 淳一,澤 芳樹,金田 安史,磯部 光章,天野 純, 日本外科学会雑誌, 一般社団法人日本外科学会, Vol. 102, No. 0, 2001/03/10
  • 血管新生療法と細胞増殖因子--循環器疾患の遺伝子治療 (特集 疾病克服への細胞増殖因子研究--基礎・診断・治療), 小池 弘美,森下 竜一,金田 安史, モレキュラ-メディシン, 中山書店, Vol. 38, No. 3, p. 328-333, 2001/03
  • Inhibition of angiogenesis by NK4, an antagonist of hepatocyte growth factor., M Nakabayashi,R Morishita,Y Kaneda,K Matsumoto,T Nakamura,M Kamei,Y Tano, INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, ASSOC RESEARCH VISION OPHTHALMOLOGY INC, Vol. 42, No. 4, p. S90-S90, 2001/03
  • 核酸医薬E2Fデコイを用いた再狭窄予防, 青木元邦,荻原俊男,森下竜一,金田安史,大須賀慶悟,中村仁信, Japanese Circulation Journal, Vol. 65, No. Supplement 1-B, 2001/03/01
  • Repeat coronary artery bypass via left thoracotomy [8], Taichi Sakaguchi,Yoshiki Sawa,Norihide Fukushima,Motonobu Nishimura,Hajime Ichikawa,Yasufumi Kaneda,Hikaru Matsuda, Annals of Thoracic Surgery, Vol. 71, No. 2, 2001
  • Gene therapy: Current status and promise, Y. Kaneda, Folia Pharmacologica Japonica, Vol. 117, No. 4, p. 299-306, 2001
  • Effcient introduction of macromolecules and oligonucleotides into brain capillary endothelial cells using HVJ-liposomes (vol 8, pg 207, 2000), H Matsuo,T Okamura,J Chen,H Takanaga,H Ohtani,Y Kaneda,M Naito,T Tsuruo,Y Sawada, JOURNAL OF DRUG TARGETING, HARWOOD ACAD PUBL GMBH, Vol. 9, No. 1, p. U2-U2, 2001
  • Usefulness of repeated direct intratumoral gene transfer using hemagglutinating virus of Japan-liposome method for cytosine deaminase suicide gene therapy, Kanyama, H.,Tomita, N.,Yamano, T.,Aihara, T.,Miyoshi, Y.,Ohue, M.,Sekimoto, M.,Sakita, I.,Tamaki, Y.,Kaneda, Y.,Senter, P.D.,Monden, M., Cancer Research, Vol. 61, No. 1, p. 14-18, 2001
  • Detection of peritoneal micrometastases of gastric carcinoma with green fluorescent protein and carcinoembryonic antigen promoter, Kaneko, K.,Yano, M.,Yamano, T.,Tsujinaka, T.,Miki, H.,Akiyama, Y.,Taniguchi, M.,Fujiwara, Y.,Doki, Y.,Inoue, M.,Shiozaki, H.,Kaneda, Y.,Monden, M., Cancer Research, Vol. 61, No. 14, p. 5570-5574, 2001
  • Antitumor activity of tumor necrosis factor-α conjugated with polyvinylpyrrolidone on solid tumors in mice, H. Kamada,Y. Tsutsumi,Y. Yamamoto,T. Kihira,Y. Kaneda,Y. Mu,H. Kodaira,S. I. Tsunoda,S. Nakagawa,T. Mayumi, Cancer Research, Vol. 60, p. 6416-6420, 2000/12/07
  • Safe and efficient gene transfer into porcine hepatocytes using Sendai virus-cationic liposomes for bioartificial liver support, Y Kawashita,A Ohtsuru,H Fujioka,Y Kamohara,Y Kawazoe,N Sugiyama,S Eguchi,H Kuroda,J Furui,S Yamashita,Y Kaneda,T Kanematsu, ARTIFICIAL ORGANS, BLACKWELL SCIENCE INC, Vol. 24, No. 12, p. 932-938, 2000/12
  • Novel therapeutic strategy for restenosis using ribozyme oligonucleotides against transforming growth factor-beta, K Yamamoto,R Morishita,N Tomita,H Nakagami,M Aoki,J Higaki,Y Kaneda,T Ogihara, HYPERTENSION, LIPPINCOTT WILLIAMS & WILKINS, Vol. 36, No. 4, p. 728-729, 2000/10
  • Overexpression of angiotensin II type 2 receptors by HVJ-liposome method modified ventricular remodeling via a p53 associated pathway in rats, K Shinmura,M Tani,R Morishita,M Aoki,T Ogihara,Y Kaneda, CIRCULATION, LIPPINCOTT WILLIAMS & WILKINS, Vol. 102, No. 18, p. 180-180, 2000/10
  • Hgf/NK4 as potential antagonist for diabetic retinopathy: Inhibition of VEGF-induced angiogenesis by HGF/NK4., M Nakabayashi,H Nakagami,K Yamamoto,M Aoki,Y Kaneda,R Morishita, CIRCULATION, LIPPINCOTT WILLIAMS & WILKINS, Vol. 102, No. 18, p. 249-249, 2000/10
  • Mitogenic and anti-apoptotic actions of hepatocyte growth factor through ERK, STAT3 and AKT in human aortic endothelial cells, H Nakagami,R Morishita,K Yamamoto,Y Taniyama,M Aoki,Y Kaneda,M Horiuchi,T Ogihara, HYPERTENSION, LIPPINCOTT WILLIAMS & WILKINS, Vol. 36, No. 4, p. 708-708, 2000/10
  • Pre-clinical studies of therapeutic angiogenesis induced by human hepatocyte growth factor (HGF) gene in rat and rabbit hind limb ischemia models, Y Taniyama,R Morishita,M Aoki,Y Kei,Y Keita,Y Kaneda,T Ogihara, HYPERTENSION, LIPPINCOTT WILLIAMS & WILKINS, Vol. 36, No. 4, p. 706-706, 2000/10
  • HVJ-AVE liposome封入bcl-2遺伝子髄腔内注入による脳保護作用の検討, 萩原 靖,齋藤 洋一,甲村 英二,金田 安史,吉峰 俊樹, 日本脳神経外科学会総会抄録集, (一社)日本脳神経外科学会, Vol. 59回, p. 64-64, 2000/10
  • Virosomes: Evolution of the liposome as a targeted drug delivery system, Yasufumi Kaneda, Advanced Drug Delivery Reviews, Elsevier Science Publishers B.V., Vol. 43, No. 2-3, p. 197-205, 2000/09/30
  • p21 gene transfer into rheumatoid synovitis suppressed the articular cartilage degradation., T Tomita,K Takahi,N Tomita,R Morishita,H Takano,H Tsuboi,K Shi,T Nakase,Y Kaneda,H Yoshikawa,T Ochi, ARTHRITIS AND RHEUMATISM, LIPPINCOTT WILLIAMS & WILKINS, Vol. 43, No. 9, p. S170-S170, 2000/09
  • 中枢神経系への遺伝子導入による脳保護療法の試み, 萩原 靖,齋藤 洋一,金田 安史,甲村 英二,吉峰 俊樹, 脳循環代謝, 日本脳循環代謝学会, Vol. 12, No. 3, p. 189-196, 2000/09
  • Therapeutic Angiogenesis Induced by Hepatocyte Growth Factor : Potential Gene Therapy for Ischemic diseases, AOKI Motokuni,MORISHITA Ryuichi,TANIYAMA Yoshiaki,KANEDA Yasufumi,OGIHARA Toshio, J. Atheroscler. Thromb., Vol. 7, No. 2, p. 71-76, 2000/08/01
  • Transcription factor decoy for NF kappa B inhibits TNF-alpha-induced cytokine and adhesion molecule expression in vivo, N Tomita,R Morishita,S Tomita,GH Gibbons,L Zhang,M Horiuchi,Y Kaneda,J Higaki,T Ogihara,VJ Dzau, GENE THERAPY, NATURE PUBLISHING GROUP, Vol. 7, No. 15, p. 1326-1332, 2000/08
  • In vivo administration of a nuclear transcription factor-kappa B decoy suppresses experimental crescentic glomerulonephritis, N Tomita,R Morishita,HY Lan,K Yamamoto,M Hashizume,M Notake,K Toyosawa,B Fujitani,W Mu,DJ Nikolic-Paterson,RC Atkins,Y Kaneda,J Higaki,T Ogihara, JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, LIPPINCOTT WILLIAMS & WILKINS, Vol. 11, No. 7, p. 1244-1252, 2000/07
  • Prevention of cardiac allograft arteriosclerosis using antisense proliferating-cell nuclear antigen oligonucleotide, JI Suzuki,M Isobe,R Morishita,T Nishikawa,J Amano,Y Kaneda, TRANSPLANTATION, LIPPINCOTT WILLIAMS & WILKINS, Vol. 70, No. 2, p. 398-400, 2000/07
  • DNAのメチル化とクロマチンを介した転写調節 (転写因子の機能--転写制御複合体形成のダイナミクス) -- (ヒストン修飾酵素と転写制御複合体形成), 浦 聖恵,金田 安史, 蛋白質核酸酵素, 共立出版, Vol. 45, No. 9, p. 1465-1472, 2000/06
  • 核酸医薬の最新技術--循環器疾患の遺伝子治療, 小池 弘美,森下 竜一,金田 安史, バイオインダストリ-, シ-エムシ-, Vol. 17, No. 5, p. 13-19, 2000/05
  • Widespread gene transfection into the central nervous system of primates, Y Hagihara,Y Saitoh,Y Kaneda,E Kohmura,T Yoshimine, GENE THERAPY, STOCKTON PRESS, Vol. 7, No. 9, p. 759-763, 2000/05
  • DECORIN ANTISENSE GENE THERAPY DECREASES CREEP BEHAVIOUR OF EARLY LIGAMENT SCAR, NAKAMURA NORIMASA,SHINO KONSEI,KANEDA YASUFUMI,OCHI TAKAHIRO,HART DAVID A.,SHRIVE NIGEL G.,FRANK CYRIL B., Vol. 20, No. 2, p. 140-140, 2000/04/25
  • Gene therapy for attenuating cardiac allograft arteriosclerosis using ex vivo antisense proliferating-cell nuclear antigen oligonucleotide transfection by HVJ-liposome method., J Suzuki,M Isobe,R Morishita,J Amano,Y Kaneda, TRANSPLANTATION, LIPPINCOTT WILLIAMS & WILKINS, Vol. 69, No. 8, p. S353-S353, 2000/04
  • Therapeutic effect of hepatocyte growth factor in TNBS induced colitis., K Oh,T Ueki,J Fujimoto,Y Kaneda,T Nakamura,H Takahashi, GASTROENTEROLOGY, W B SAUNDERS CO, Vol. 118, No. 4, p. A864-A864, 2000/04
  • Efficiency of a polyvalent human melanoma antigen DNA-HVJ-liposome vaccine., M Tanaka,S Fujii,SKS Huang,K Hashimoto,Y Kaneda,DSB Hoon, FASEB JOURNAL, FEDERATION AMER SOC EXP BIOL, Vol. 14, No. 6, p. A1139-A1139, 2000/04
  • Gene Therapy for Rheumatoid Arthritis, TOMITA T., Vol. 74, No. 3, 2000/03/25
  • SF8-2 遺伝子治療によるニホンザル移植心冠状動脈硬化の抑制, 川内 基裕,鈴木 淳一,磯部 光章,森下 竜一,金田 安史,高本 眞一, 日本外科学会雑誌, 一般社団法人日本外科学会, Vol. 101, p. 125-125, 2000/03/10
  • PP-1614 HVJ-liposome法を用いたメラノーマに対する癌ワクチンの検討, 山田 正治,山本 誠司,森下 竜一,冨田 尚裕,門田 守人,金田 安史, 日本外科学会雑誌, 一般社団法人日本外科学会, Vol. 101, p. 611-611, 2000/03/10
  • PDIII-5 血管壁をターゲットとした遺伝子治療の開発 : ヒト臨床研究に望んで, 森下 竜一,金田 安史,荻原 俊男, Japanese circulation journal, 社団法人日本循環器学会, Vol. 64, p. 60-60, 2000/03/01
  • IS026 Hypoxia Induced Endothelial Apoptosis Through the Activation of NFkB : In Vivo Evidence of Importance of NFkb in Endothelial Cell Regulation, Nata Toshie,Morishita Ryuichi,Aoki Motokuni,Matsushita Hidetsugu,Ogihara Toshio,Kaneda Yasufumi, Japanese circulation journal, Japanese Circulation Society, Vol. 64, p. 128-128, 2000/03/01
  • 0699 肝細胞増殖因子(HGF)による血管内皮細胞死抑制作用のメカニズム解明, 中神 啓徳,森下 竜一,山本 圭,谷山 義明,青木 元邦,山崎 慶太,荻原 俊男,金田 安史, Japanese circulation journal, 社団法人日本循環器学会, Vol. 64, p. 361-361, 2000/03/01
  • 0698 転写因子ets-1を介した肝細胞増殖因子(HGF)の抗線維化および血管新生作用, 谷山 義明,青木 元邦,中神 啓徳,山本 圭,山崎 慶太,荻原 俊男,森下 竜一,金田 安史, Japanese circulation journal, 社団法人日本循環器学会, Vol. 64, p. 361-361, 2000/03/01
  • 0432 TGF-βリボザイムを用いた血管再狭窄に対する遺伝子治療の可能性, 山本 圭,冨田 奈留也,守口 篤,檜垣 実男,荻原 俊男,森下 竜一,谷山 義明,中神 啓徳,松下 英嗣,金田 安史, Japanese circulation journal, 社団法人日本循環器学会, Vol. 64, p. 293-293, 2000/03/01
  • 0909 NFkBデコイ遺伝子導入による実験的自己免疫性心筋炎の抑制, 横関 整,鈴木 淳一,北林 浩,渡辺 徳,久保 恵嗣,磯部 光章,森下 竜一,金田 安史, Japanese circulation journal, 社団法人日本循環器学会, Vol. 64, p. 413-413, 2000/03/01
  • P034 高血糖刺激による血管内皮細胞死のメカニズムについて, 中神 啓徳,森下 竜一,山本 圭,青木 元邦,谷山 義明,山崎 慶太,荻原 俊男,金田 安史, Japanese circulation journal, 社団法人日本循環器学会, Vol. 64, p. 467-467, 2000/03/01
  • P235 ラット頚動脈バルーン傷害モデルにおけるNFkBデコイによる再狭窄予防, 林 克彦,吉村 紳一,坂井 昇,森下 竜一,金田 安史,中神 啓徳,松本 圭子,山本 圭,荻原 俊男, Japanese circulation journal, 社団法人日本循環器学会, Vol. 64, p. 517-517, 2000/03/01
  • P872 低酸素状態におけるヒト低酸素状態における尿細管上皮細胞死の分子機構の検討, 山本 圭,谷山 義明,中神 啓徳,冨田 奈留也,萩原 俊男,森下 竜一,金田 安史,吉村 紳一, Japanese circulation journal, 社団法人日本循環器学会, Vol. 64, p. 678-678, 2000/03/01
  • P079 ラット及びウサギ閉塞性動脈硬化症(ASO)モデルへの肝細胞増殖因子(HGF)遺伝子の導入による血管新生作用 : HGF蛋白動脈内投与との比較, 谷山 義明,青木 元邦,中神 啓徳,山本 圭,山崎 慶太,荻原 俊男,森下 竜一,金田 安史, Japanese circulation journal, 社団法人日本循環器学会, Vol. 64, p. 478-478, 2000/03/01
  • 低酸素状態におけるHGF(Hepatocyto Growth Factor)などの細胞増殖因子の血管内皮細胞傷害抑制についての分子機構の検討, 山本 圭,林 真一郎,松下 英嗣,中神 啓徳,谷山 義明,檜垣 実男,荻原 俊男,森下 竜一,金田 安史, Japanese Circulation Journal, (一社)日本循環器学会, Vol. 64, No. Suppl.I, p. 435-435, 2000/03
  • Transfection of cis element "decoy" against transcription factor binding site into choroidal neovascularization by subretinal injection, N Jo,N Ogata,T Otsuji,L Wang,M Matumura,M Aoki,R Morishita,Y Kaneda, INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, ASSOC RESEARCH VISION OPHTHALMOLOGY INC, Vol. 41, No. 4, p. S834-S834, 2000/03
  • Inhibition of human endothelial cell proliferation through attenuation of phosphorylation of mitogen-activated protein kinases by HGF/NK4., M Nakabayashi,R Morishita,Y Kaneda,K Matsumoto,T Nakamura,M Kamei,Y Tano, INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, ASSOC RESEARCH VISION OPHTHALMOLOGY INC, Vol. 41, No. 4, p. S634-S634, 2000/03
  • Angiogenesis induced by hepatocyte growth factor in non-infarcted myocardium and infarcted myocardium: up-regulation of essential transcription factor for angiogenesis, ets, M Aoki,R Morishita,Y Taniyama,Kida, I,A Moriguchi,K Matsumoto,T Nakamura,Y Kaneda,J Higaki,T Ogihara, GENE THERAPY, STOCKTON PRESS, Vol. 7, No. 5, p. 417-427, 2000/03
  • Gene Therapy in Ligament Healing towards Tissue Regeneration, NAKAMURA N.,OZKAN Ilhan,FRANK Cyril B., Vol. 74, No. 2, 2000/02/25
  • 中枢神経系へのbcl-2遺伝子の広範囲な導入による脳保護療法の試み, 萩原 靖,齋藤 洋一,甲村 英二,湯口 博導,谷口 理章,金田 安史,恵口 豊,辻本 賀英,吉峰 俊樹, 脳循環代謝, 日本脳循環代謝学会, Vol. 11, No. 4, p. 426-427, 2000/02
  • In vivo evidence of the importance of cardiac angiotensin-converting enzyme in the pathogenesis of cardiac hypertrophy, J Higaki,M Aoki,R Morishita,Kida, I,Y Taniyama,N Tomita,K Yamamoto,A Moriguchi,Y Kaneda,T Ogihara, ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, LIPPINCOTT WILLIAMS & WILKINS, Vol. 20, No. 2, p. 428-434, 2000/02
  • クロマチン構造変換がヌクレオチド除去修復に果たす役割, 浦聖恵,金田安史,伊藤敬,岩井成憲,花岡文雄, 日本分子生物学会年会プログラム・講演要旨集, Vol. 23rd, 2000
  • ES細胞におけるDnmt3b遺伝子のクロマチンを介した転写調節機構の解析, 石田智咲,浦聖恵,丹羽仁史,佐々木裕之,金田安史, 日本分子生物学会年会プログラム・講演要旨集, Vol. 23rd, 2000
  • Molecular mechanism of cell death pathway induced by high D-glucose in human endothelial cell, H Nakagami,R Morishita,K Yamamoto,M Horiuchi,Y Kaneda,T Ogihara, JOURNAL OF HYPERTENSION, LIPPINCOTT WILLIAMS & WILKINS, Vol. 18, p. S199-S199, 2000
  • The role of oxidative stress in apoptosis of endothelial cells, T Nata,N Aoki,R Morishita,T Ogihara,Y Kaneda, JOURNAL OF HYPERTENSION, LIPPINCOTT WILLIAMS & WILKINS, Vol. 18, p. S210-S210, 2000
  • Pre-clinical studies of therapeutic angiogenesis induced by human hepatocyte growth factor gene in rat and rabbit hind limb ischemia models, Y Taniyama,R Morishita,M Aoki,H Nakagami,K Yamamoto,K Yamasaki,Y Kaneda,T Ogihara, JOURNAL OF HYPERTENSION, LIPPINCOTT WILLIAMS & WILKINS, Vol. 18, p. S182-S182, 2000
  • Inhibition of the p53 tumor suppressor gene results in growth of human aortic vascular smooth muscle cells (VSMC): Potential role of p53 in regulation of VSMC growth, K Yamasaki,M Aoki,R Morishita,K Yasufumi,T Ogihara, JOURNAL OF HYPERTENSION, LIPPINCOTT WILLIAMS & WILKINS, Vol. 18, p. S13-S13, 2000
  • Gene transfer of the serine elastase inbhibitor elafin delays neointimal formation and protects against atherosolerotic degeneration of vein grafts, SB O'Blenes,SHE Zaidi,AYL Cheah,B McIntyre,Y Kaneda,M Rabinovitch, CIRCULATION, LIPPINCOTT WILLIAMS & WILKINS, Vol. 100, No. 18, p. 96-96, 1999/11
  • RNA melanoma vaccine: Induction of antitumor immunity by human glycoprotein 100 mRNA immunization, WZ Zhou,DSB Hoon,SKS Huang,S Fujii,K Hashimoto,R Morishita,Y Kaneda, HUMAN GENE THERAPY, MARY ANN LIEBERT INC PUBL, Vol. 10, No. 16, p. 2719-2724, 1999/11
  • Present and Future in the gene therapy for cardiovascnlar disease, MORISHITA Ryuihi,OGIHARA Toshio,KANEDA Yasufumi, Journal of Atherosclerosis and Thrombosis, Japan Atherosclerosis Society, Vol. 26, No. 9, p. 263-268, 1999/10/15
  • Radioisotope gene therapy for hepatocellular carcinoma in vivo using radioinducible promoter., Y Kawashita,A Ohtsuru,F Miki,H Fujioka,T Kanematsu,Y Kaneda,S Yamashita, HEPATOLOGY, W B SAUNDERS CO, Vol. 30, No. 4, p. 341A-341A, 1999/10
  • Hepatocyte growth factor (HGF) gene therapy of graft-vs-host disease (GVHD) in mice., T Kuroiwa,T Iwasaki,Y Kataoka,Y Seto,N Iwata,T Ueki,Fujimoto, I,E Okamoto,K Matsumoto,T Nakamura,Y Kaneda,E Kakishita, HEPATOLOGY, W B SAUNDERS CO, Vol. 30, No. 4, p. 339A-339A, 1999/10
  • 神経細胞死 中枢神経系への広範囲なbcl-2遺伝子導入による脳保護療法の試み, 萩原 靖,齋藤 洋一,金田 安史,甲村 英二,吉峰 俊樹, 日本脳神経外科学会総会抄録集, (一社)日本脳神経外科学会, Vol. 58回, p. 52-52, 1999/10
  • Oligonucleotide decoy for transcriptional factor E2F inhibits RA synovial cell proliferation in vitro., T Tomita,H Takano,N Tomita,K Shi,R Morishita,M Kaneko,Y Kaneda,TO Suita, ARTHRITIS AND RHEUMATISM, LIPPINCOTT WILLIAMS & WILKINS, Vol. 42, No. 9, p. S107-S107, 1999/09
  • 修復靱帯へのアンチセンス遺伝子治療 : 至的遺伝子導入法の検討, 中村 憲正,史野 根生,金田 安史,越智 隆弘,HART David A.,SHRIVE Nigel G.,FRANK Cyril B., 日本整形外科學會雜誌 = The Journal of the Japanese Orthopaedic Association, Vol. 73, No. 8, 1999/08/25
  • P21遺伝子導入による慢性関節リウマチ滑膜増殖の制御, 冨田 哲也,竹内 英二,金子 元春,冨田 奈留也,森下 竜一,高野 裕史,史 賢林,高樋 康一郎,関 宏,金田 安史,越智 隆弘, 日本整形外科學會雜誌 = The Journal of the Japanese Orthopaedic Association, Vol. 73, No. 8, 1999/08/25
  • 家兎修復靱帯へのデコリンアンチセンス遺伝子治療, 中村 憲正,史野 根生,金田 安史,越智 隆弘,BOORMAN Richard S.,HART David A.,SHRIVE Nigel G.,FRANK Cyril B., 日本整形外科學會雜誌 = The Journal of the Japanese Orthopaedic Association, Vol. 73, No. 8, 1999/08/25
  • Angiotensinogen gene-activating elements regulate blood pressure in the brain, T Nishii,A Moriguchi,R Morishita,K Yamada,S Nakamura,N Tomita,Y Kaneda,A Fukamizu,H Mikami,J Higaki,T Ogihara, CIRCULATION RESEARCH, LIPPINCOTT WILLIAMS & WILKINS, Vol. 85, No. 3, p. 257-263, 1999/08
  • Gene therapy using HVJ-liposomes: the best of both worlds?, Y Kaneda,Y Saeki,R Morishita, MOLECULAR MEDICINE TODAY, ELSEVIER SCI LTD, Vol. 5, No. 7, p. 298-303, 1999/07
  • リモデリングに注目した再狭窄の遺伝子治療法の開発, 森下 竜一,荻原 俊男,金田 安史, 血管, Vol. 22, No. 2, p. 33-41, 1999/06/26
  • 霊長類中枢神経系に対する広範囲な遺伝子導入, 萩原 靖,齋藤 洋一,甲村 英二,谷口 理章,金田 安史,吉峰 俊樹, 神経組織の成長・再生・移植研究会学術集会プログラム・予稿集, 神経組織の成長・再生・移植研究会, Vol. 14回, p. 72-72, 1999/06
  • Regression of hepatocellular carcinoma in vitro and in vivo by radiosensitizing suicide gene therapy under the inducible and spatial control of radiation, Y Kawashita,A Ohtsuru,Y Kaneda,Y Nagayama,Y Kawazoe,S Eguchi,H Kuroda,H Fujioka,M Ito,T Kanematsu,S Yamashita, HUMAN GENE THERAPY, MARY ANN LIEBERT INC PUBL, Vol. 10, No. 9, p. 1509-1519, 1999/06
  • Gene Therapy for Myocardial Infarction by In Vivo Transfer of Human Hepatocyte Growth Factor (HGF), TOMITA N.,MORISHITA R.,AOKI M.,MORIGUCHI A.,KANEDA Y.,HIGAKI J.,OGIHARA T., Vol. 39, No. 5, p. 213-218, 1999/05/25
  • The Mechanism of Vein Graft Disease : Gene Transfer to Vein Graft by HVJ-liposome Method, SAWA Y,BAI H. -Z,YAMAKAWA T,IMAGAWA H,KANEDA Y,MASUDA J,MATSUDA H, 脈管学 : 日本脈管学会機関誌 : the journal of Japanese College of Angiology, Vol. 39, No. 5, p. 219-224, 1999/05/25
  • 動脈硬化症の遺伝子治療, 森下 竜一,荻原 俊男,金田 安史, 遺伝子医学, メディカルドゥ, Vol. 3, No. 2, p. 326-331, 1999/05
  • Molecular design of conjugated tumor necrosis factor-alpha: Synthesis and characteristics of polyvinyl pyrrolidone modified tumor necrosis factor-alpha, H Kamada,Y Tsutsumi,S Tsunoda,T Kihira,Y Kaneda,Y Yamamoto,S Nakagawa,Y Horisawa,T Mayumi, BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, ACADEMIC PRESS INC, Vol. 257, No. 2, p. 448-453, 1999/04
  • In vivo gene transfer to intestine using HVJ-liposome, K Oh,J Fujimoto,T Hirano,E Okamoto,Y Kaneda, GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, Vol. 116, No. 4, p. A914-A914, 1999/04
  • Inhibition of hepatic outgrowth of human hepatoma in nude mice by repetitive transfection of HSV-TK gene under the control of AFP-promoter, J Fujimoto,T Hirano,Y Kaneda,S Kaneko,Saito, I,T Tamaoki, GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, Vol. 116, No. 4, p. A1213-A1213, 1999/04
  • P129 低酸素により誘導された内皮細胞死における転写調節因子NFkBの役割 : 心筋梗塞発症における内皮のバリアーとしての役割, 松下 英嗣,谷山 義明,青木 元邦,中神 啓徳,中村 俊紀,守口 篤,檜垣 實男,荻原 俊男,森下 竜一,金田 安史, Japanese circulation journal, 社団法人日本循環器学会, Vol. 63, No. 1, p. 481-481, 1999/03/01
  • 1058 TGF-βリボザイムを用いた血管再狭窄に対する遺伝子治療の可能性, 山本 圭,冨田 奈留也,松下 英嗣,谷山 義明,中神 啓徳,守口 篤,檜垣 實男,荻原 俊男,森下 竜一,金田 安史, Japanese circulation journal, 社団法人日本循環器学会, Vol. 63, No. 1, p. 415-415, 1999/03/01
  • 1056 肝細胞増殖因子(HGF)遺伝子導入による内皮再生による再狭窄の遺伝子治療 : HGF遺伝子を用いた補充療法の有用性, 森下 竜一,金田 安史,中村 成史,守口 篤,青木 元邦,駒井 則夫,松本 圭子,檜垣 實男,荻原 俊男,中村 敏一, Japanese circulation journal, 社団法人日本循環器学会, Vol. 63, No. 1, p. 415-415, 1999/03/01
  • 1055 肝細胞増殖因子(HGF)による閉塞性動脈硬化症の遺伝子治療 : ラットモデルにおけるHGF過剰発現による血流改善効果の解析The, 谷山 義明,森下 竜一,松下 英嗣,青木 元邦,中村 好男,冨田 奈留也,中村 俊紀,檜垣 實男,荻原 俊男,金田 安史, Japanese circulation journal, 社団法人日本循環器学会, Vol. 63, No. 1, p. 414-414, 1999/03/01
  • 0143 がん抑制遺伝子p53喪失は新生内膜肥厚を誘導する : ラット頚動脈及びヒト血管平滑筋細胞での検討, 松下 英嗣,青木 元邦,谷山 義明,中神 啓徳,守口 篤,檜垣 寅男,萩原 俊男,森下 竜一,金田 安史,下里 貴, Japanese circulation journal, 社団法人日本循環器学会, Vol. 63, No. 1, p. 183-183, 1999/03/01
  • In vivo transfection of cis element "decoy" against NFkB binding site choroidal neovascularization, T Otsuji,N Ogata,M Uyama,Y Kaneda,R Morishita, INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, ASSOC RESEARCH VISION OPHTHALMOLOGY INC, Vol. 40, No. 4, p. S937-S937, 1999/03
  • Reversing liver cirrhosis: impact of gene therapy for liver cirrhosis, J Fujimoto,Y Kaneda, GENE THERAPY, STOCKTON PRESS, Vol. 6, No. 3, p. 305-306, 1999/03
  • P-954 HVJ-Liposome法によるブタ生体肝への遺伝子導入 : その効率と安全性, 川下 雄丈,藤岡 ひかる,川添 康,杉山 望,江口 晋,古井 純一郎,大津留 晶,山下 俊一,金田 安史,兼松 隆之, 日本外科学会雑誌, 一般社団法人日本外科学会, Vol. 100, p. 550-550, 1999/02/10
  • P-955 ラット生体肝への遺伝子導入効率を向上させるための模索 : 門脈内one shot注入法と門脈 : 下大静脈間再灌流法の比較検討, 田村 浩章,川下 雄丈,川添 康,杉山 望,江口 晋,藤岡 ひかる,古井 純一郎,大津留 晶,山下 俊一,金田 安史,兼松 隆之, 日本外科学会雑誌, 一般社団法人日本外科学会, Vol. 100, p. 550-550, 1999/02/10
  • P-688 遺伝子導入による肝虚血再潅流傷害の予防に関する研究, 吉住 朋晴,池田 康博,金田 安史,西崎 隆,居石 克夫,杉町 圭蔵, 日本外科学会雑誌, 一般社団法人日本外科学会, Vol. 100, p. 483-483, 1999/02/10
  • WS7b-4 人工肝臓臨床応用に向けた一、二の工夫.肝細胞障害抑制のための細胞保護と遺伝子操作, 藤岡 ひかる,川下 雄丈,川添 康,江口 晋,東 尚,古井 純一郎,兼松 隆之,金田 安史, 日本外科学会雑誌, 一般社団法人日本外科学会, Vol. 100, p. 69-69, 1999/02/10
  • Hepatocyte growth factor gene therapy of liver cirrhosis in rats, T Ueki,Y Kaneda,H Tsutsui,K Nakanishi,Y Sawa,R Morishita,K Matsumoto,T Nakamura,H Takahashi,E Okamoto,J Fujimoto, NATURE MEDICINE, NATURE AMERICA INC, Vol. 5, No. 2, p. 226-230, 1999/02
  • Hepatocyte growth factor gene therapy of liver cirrhosis in rats, T Ueki,Y Kaneda,H Tsutsui,K Nakanishi,Y Sawa,R Morishita,K Matsumoto,T Nakamura,H Takahashi,E Okamoto,J Fujimoto, NATURE MEDICINE, NATURE AMERICA INC, Vol. 5, No. 2, p. 226-230, 1999/02
  • Gene transfer in utero biologically engineers a patent ductus arteriosus in lambs by arresting fibronectin-dependent neointimal formation, CAE Mason,JL Bigras,SB O'Blenes,B Zhou,B McIntyre,N Nakamura,Y Kaneda,M Rabinovitch, NATURE MEDICINE, NATURE AMERICA INC, Vol. 5, No. 2, p. 176-182, 1999/02
  • Bioconjugation of bioactive peptide : Synthetic peptide YIGSR conjugated with poly (styrene comaleic acid) enhanced its inhibitory effect on lung metastasis of B16BL6 melanoma cells, MU Yu,KAMADA Haruhiko,KANEDA Yoshihisa,YAMAMOTO Yoko,KODAIRA Hiroshi,TSUNODA Shin-ichi,TSUTSUMI Yasuo,MAEDA Mitsuko,KAWASAKI Koichi,NOMIZU Motoyoshi,MAYUMI Tadanori,Mayumi Tadanori, Drug Delivery System, THE JAPAN SOCIETY OF DRUG DELIVERY SYSTEM, Vol. 14, No. 2, p. 129-135, 1999
  • Intratumoral injection of oligonucleotides to the NF kappa B binding site inhibits cachexia in a mouse tumor model, Kawamura, I,R Morishita,N Tomita,E Lacey,M Aketa,S Tsujimoto,T Manda,M Tomoi,Kida, I,J Higaki,Y Kaneda,K Shimomura,T Ogihara, GENE THERAPY, STOCKTON PRESS, Vol. 6, No. 1, p. 91-97, 1999/01
  • Bioconjugation of laminin peptide YIGSR with poly(styrene co-maleic acid) increases its antimetastatic effect on lung metastasis of B16-BL6 melanoma cells, Mu Y,Kamada H,Kaneda Y,Yamamoto Y,Kodaira H,Tsunoda S,Tsutsumi Y,Maeda M,Kawasaki K,Nomizu M,Yamada Y,Mayumi T, Biochem. Biophys. Res. Commun., Vol. 255, No. 1, p. 75-79, 1999
  • Dative Pd(0)-Mo(II) in a linearly aligned tetrametal system: Preparation, characterization and reaction of a tetranuclear Pd(0)-Mo(II)- Mo(II)-Pd(0) supported by four 6-diphenylphosphino-2-pyridonate ligands [14], K. Mashima,A. Fukumoto,H. Nakano,Y. Kaneda,K. Tani,A. Nakamura, Journal of the American Chemical Society, Vol. 120, No. 46, p. 12151-12152, 1998/11/25
  • Transfection of antisense p53 oligonucleotides into rat carotid artery resulted in an abnormal growth of vascular smooth muscle cells (VSMC), but not neovascularization: In vivo evidence of importance of p53 in the regulation of VSMC, H Matsushita,R Morishita,M Aoki,Y Kaneda,T Ogihara, CIRCULATION, LIPPINCOTT WILLIAMS & WILKINS, Vol. 98, No. 17, p. 797-798, 1998/10
  • Differential regulation of the brain angiotensinogen (Aogen) gene between spontaneously hypertensive (SHR) and Wistar Kyoto rat (WKY), T Nishii,A Moriguchi,R Morishita,N Tomita,Y Kaneda,J Higaki,T Ogihara, HYPERTENSION, LIPPINCOTT WILLIAMS & WILKINS, Vol. 32, No. 3, p. 615-615, 1998/09
  • Inhibition of proliferation of synovial cells from patients with rheumatoid arthritis by overexpression of p21 gene through induction of apoptosis., T Tomita,E Takeuchi,N Tomita,R Morishita,M Kaneko,H Matsushita,H Takano,N Tsumaki,Y Kaneda,T Ochi, ARTHRITIS AND RHEUMATISM, LIPPINCOTT WILLIAMS & WILKINS, Vol. 41, No. 9, p. S239-S239, 1998/09
  • Suppression of Joint Destruction by NFκB Decoy with Intraarticular Injection Mediated by HVJ-liposome, TOMITA T., Vol. 72, No. 8, 1998/08/25
  • The Early Effect of hepatocyte Growth Factor Gene Introduction on Rat Healing Patellar Tendon, NATSUUME T., Vol. 72, No. 8, 1998/08/25
  • Brain protection by human bcl-2 gene transfection into rat CNS, HAGIHARA Y.,SAITOH Y.,KANEDA Y.,EGUCHI Y.,TSUJIMOTO Y.,ARITA N., Vol. 10, No. 1, p. 3-4, 1998/06/06
  • Importance of transcriptional cis-element and binding protein of angiotensinogen gene in the central regulation of blood pressure, T Nishii,A Moriguchi,R Morishita,N Tomita,Y Kaneda,J Higaki,T Ogihara, JOURNAL OF HYPERTENSION, LIPPINCOTT WILLIAMS & WILKINS, Vol. 16, p. S114-S114, 1998/06
  • Importance of transcriptional factor NF kappa B in hypoxia-induced death and apoptosis of human aortic endothelial cells, H Matsushita,R Morishita,S Hayashi,Y Taniyama,N Tomita,H Nakagami,K Yamamoto,A Moriguchi,Y Kaneda,J Higaki,T Ogihara, JOURNAL OF HYPERTENSION, LIPPINCOTT WILLIAMS & WILKINS, Vol. 16, p. S64-S64, 1998/06
  • Inhibition of intimal hyperplasia after vein grafting by in vivo transfer of human senescent cell-derived inhibitor-1 gene, H Bai,R Morishita,Kida, I,T Yamakawa,W Zhang,M Aoki,H Matsushita,A Noda,R Nagai,Y Kaneda,J Higaki,T Ogihara,Y Sawa,H Matsuda, GENE THERAPY, STOCKTON PRESS, Vol. 5, No. 6, p. 761-769, 1998/06
  • Antisense oligonucleotide-induced suppression of calpain mu expression prevents oxidative stress-induced hepatocyte injury., K Umeshita,H Miyoshi,M Sakon,H Ariyoshi,K Taniguchi,S Kishimoto,M Wang,H Nagano,T Kawasaki,M Gotoh,Y Kaneda,M Monden, GASTROENTEROLOGY, W B SAUNDERS CO, Vol. 114, No. 4, p. A1357-A1357, 1998/04
  • In Vivo Gene Transfection With Heat Shock Protein 70 Enhances Myocardial Tolerance to Ischemia-Reperfusion Injury in Rat, SUZUKI Ken,SAWA Yoshiki,KANEDA Yasufumi,ICHIHARA Hajime,SHIRAKURA Ryota,MATSUDA Hikaru, Journal of cardiology, Vol. 31, No. 3, p. 187-188, 1998/03/15
  • 肝虚血再灌流傷害に対する遺伝子治療, 吉住 朋晴,米満 吉和,金田 安史,矢永 勝彦,居石 克夫,杉町 圭蔵, 日本外科学会雑誌, 一般社団法人日本外科学会, Vol. 99, p. 333-333, 1998/03/10
  • 肝細胞増殖因子(HGF)を用いた肝切除後肝不全への遺伝子治療, 植木 孝浩,藤元 治朗,平野 公通,鄭 一秀,金田 安史,松本 邦夫,中村 敏一,岡本 英三, 日本外科学会雑誌, 一般社団法人日本外科学会, Vol. 99, p. 327-327, 1998/03/10
  • AFP プロモーターを用いた肝細胞癌での特異的遺伝子発現による遺伝子治療の研究, 平野 公通,藤元 治朗,斉藤 泉,金田 安史,岡本 英三, 日本外科学会雑誌, 一般社団法人日本外科学会, Vol. 99, p. 452-452, 1998/03/10
  • HVJ-liponsomeを用いたブタ肝細胞への遺伝子導入法の確立 : beads上培養肝細胞への遺伝子導入, 川下 雄丈,藤岡 ひかる,川添 康,江口 晋,古井 純一郎,大津留 晶,山下 俊一,金田 安史,兼松 隆之, 日本外科学会雑誌, 一般社団法人日本外科学会, Vol. 99, p. 421-421, 1998/03/10
  • 遺伝子導入を用いた肝虚血再潅流傷害の制御 : Ca^<++>依存性蛋白分解酵素calpainに対するアンチセンスの効果, 梅下 浩司,三好 秀幸,谷口 一則,左近 賢人,木村 文彦,岸本 慎一,永野 浩昭,金田 安史,後藤 満一,門田 守人, 日本外科学会雑誌, 一般社団法人日本外科学会, Vol. 99, p. 422-422, 1998/03/10
  • P521 In vivo遺伝子導入法による心筋梗塞後左室リモデリングにおけるアンジオテンシン2型受容体(AT2)の役割の解明, 新村 健,玉城 香代子,谷 正人,森下 竜一,青木 元邦,荻原 俊男,金田 安史, Japanese circulation journal, 社団法人日本循環器学会, Vol. 62, p. 515-515, 1998/02/28
  • 1060 高血圧型血管肥厚に対するキマーゼ遺伝子の病態生理学的意義, 中村 成史,守口 篤,森下 竜一,西居 忠彦,松本 圭子,林 真一郎,富田 奈留也,松下 英嗣,檜垣 實男,荻原 俊男,金田 安史,浦田 秀則,下里 貴, Japanese circulation journal, 社団法人日本循環器学会, Vol. 62, p. 370-370, 1998/02/28
  • 1046 培養成熟ラット心筋細胞へのHVJ-リポソーム法を用いた遺伝子導入, 新村 健,山村 憲,菅沼 由佳子,高山 美智代,長谷川 浩,海老原 良典,玉城 香代子,谷 正人,森下 竜一,荻原 俊男,金田 安史, Japanese circulation journal, 社団法人日本循環器学会, Vol. 62, p. 367-367, 1998/02/28
  • IS033 UP-REGULATION OF KEY TRANSCRIPTIONAL FACTOR FOR ANGIOGENESIS, ETS, AND INDUCTION OF ANGIOGENESIS BY IN VIVO GENE TRANSFER OF HUMAN HEPATOCYTE GROWTH FACTOR (HGF) INTO MYOCARDIUM, Morishita Ryuichi,Aoki Motokuni,Matsushita Hidetsugu,Hayashi Shin-ichiro,Tomita Naruya,Moriguchi Atsushi,Matsumoto Kunio,Nakamura Toshikazu,Kaneda Yasufumi,Higaki Jitsuo,Ogihara Toshio, Japanese circulation journal, Japanese Circulation Society, Vol. 62, p. 23-23, 1998/02/28
  • 0115 中枢性血圧調節における転写因子結合配列及び結合蛋白の重要性, 西居 忠彦,守口 篤,森下 竜一,冨田 奈留也,中村 成史,桧垣 實夫,荻原 俊男,金田 安史, Japanese circulation journal, 社団法人日本循環器学会, Vol. 62, p. 133-133, 1998/02/28
  • 0988 心肥大への局所アンジオテンシン変換酵素(ACE)の関与の直接証明 : ラット心臓へのヒトACE遺伝子の導入による心肥大モデル作成, 青木 元邦,森下 竜一,松下 英嗣,谷山 義明,中神 啓徳,林 真一郎,冨田 奈留也,守口 篤,檜垣 實男,荻原 俊男,金田 安史, Japanese circulation journal, 社団法人日本循環器学会, Vol. 62, p. 352-352, 1998/02/28
  • 1011 NFKBデコイ遺伝子導入による心筋梗塞治療の可能性 : 低酸素状態における内皮細胞死に対する抑制作用およびその機序の検討, 松下 英嗣,森下 竜一,林 真一郎,谷山 義明,冨田 奈留也,中村 成史,中神 啓徳,山本 圭,守口 篤,檜垣 實男,萩原 俊男,金田 安史, Japanese circulation journal, 社団法人日本循環器学会, Vol. 62, p. 358-358, 1998/02/28
  • Gene therapy of restenosis by in vivo gene transfer of human hepatocyte growth factor (HGF) through the accelation of re-endothelialization., NAKAMURA S.,Morishita Ryuichi,Moriguchi Atsushi,Tomita Naruya,Matsushita Hidetsugu,Hayashi Shin-ichiro,Kaneda Yasufumi,Higaki Jitsuo,Ogihara Toshio,Matsumoto Kunio,Nakamura Toshikazu, Jpn Circ J, Japanese Circulation Society, Vol. 62, p. 21-21, 1998
  • Gene transfer and kidney disease, Enyu Imai,Yoshitaka Isaka,Yoshitaka Akagi,Yasufumi Kaneda,Masatsugu Hori, Journal of Nephrology, Vol. 11, No. 1, p. 16-19, 1998/01
  • HVJ-liposome mediated gene transfer into hepatocyte in vivo. (共), HIRANO T,FUJIMOTO J,UEKI T,YAMAMOTO H,OKAMOTO E,TAKAHASHI H,MORISITA R,SAWA Y,KANEDA Y, J Hepatolo, Vol. 29, No. 6, p. 910-914, 1998
  • Amino-Acids and Peptides. XXXI. Preparation of Analogs of the Laminin-Related Peptide YIGSR and Their Inhibitory Effect on Experimental Metastasis, MAEDA Mitsuko,IZUNO Yasuhiro,KAWASAKI Koichi,KANEDA Yoshihisa,MU Yu,TSUTSUMI Yasuo,NAKAGAWA Shinsaku,MAYUMI Tadanori, Chemical and Pharmaceutical Bulletin, The Pharmaceutical Society of Japan, Vol. 46, No. 2, p. 347-350, 1998
  • Bioconjugation of tumor necrosis factor-alpha with the copolymer of divinyl ether and maleic anhydride increasing its antitumor potency, Y Kaneda,Y Yamamoto,S Tsunoda,H Kamada,Y Tsutsumi,T Hirano,T Mayumi, BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, ACADEMIC PRESS INC ELSEVIER SCIENCE, Vol. 239, No. 1, p. 160-165, 1997/10
  • In vivo HGF gene delivery to liver promoted liver regeneration and inhibited lethal liver failure induced by hepatic resection for liver fibrosis/cirrhosis, J Fujimoto,T Ueki,T Hirano,Y Kaneda,K Matsumoto,T Nakamura,E Okamoto, HEPATOLOGY, W B SAUNDERS CO, Vol. 26, No. 4, p. 921-921, 1997/10
  • Gene therapy for rat liver cirrhosis by skeletal muscle secretion of hepatocyte growth factor, T Ueki,T Hirano,E Okamoto,Y Kaneda,K Matsumoto,T Nakamura,J Fujimoto, HEPATOLOGY, W B SAUNDERS CO, Vol. 26, No. 4, p. 254-254, 1997/10
  • Novel gene therapy strategy for atherosclerosis using ribozyme against apolipoprotein (a) gene, R Morishita,J Higaki,N Tomita,Y Kaneda,T Ogihara, ATHEROSCLEROSIS, ELSEVIER SCI IRELAND LTD, Vol. 134, No. 1-2, p. 41-41, 1997/10
  • Re-endothelialization therapeutics for restenosis: In vivo gene transfer of human hepatocyte growth factor (HGF) gene resulted in an inhibition of neointimal formation after balloon injury, accompanied by restore of nitric oxide (NO), S Nakamura,A Moriguchi,R Morishita,J Higaki,Y Kaneda,T Nakamura,T Ogihara, CIRCULATION, AMER HEART ASSOC, Vol. 96, No. 8, p. 3745-3745, 1997/10
  • Cre/loxP switching system using HVJ-liposome enhanced specific gene expression under the control of AFP promoter in hepatocellular carcinoma, T Hirano,T Ueki,E Okamoto,Y Kaneda,Saito, I,T Tamaoki,J Fujimoto, HEPATOLOGY, W B SAUNDERS CO, Vol. 26, No. 4, p. 1582-1582, 1997/10
  • In vivo evidence of importance of cardiac angiotensin converting enzyme (ACE) in the pathogenesis of cardiac hypertrophy, M Aoki,H Matsushita,Y Kaneda, CIRCULATION, AMER HEART ASSOC, Vol. 96, No. 8, p. 4282-4282, 1997/10
  • Efficient transfer of synthetic ribozymes into cells using hemagglutinating virus of Japan (HVJ)-cationic liposomes - Application for ribozymes that target human T-cell leukemia virus type I tax/rex mRNA, Kitajima, I,N Hanyu,Y Soejima,R Hirano,S Arahira,S Yamaoka,R Yamada,Maruyama, I,Y Kaneda, JOURNAL OF BIOLOGICAL CHEMISTRY, AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC, Vol. 272, No. 43, p. 27099-27106, 1997/10
  • In vivo evidence of importance of cardiac angiotensin converting enzyme (ACE) in the pathogenesis of cardiac hypertrophy, M Aoki,R Morishita,H Matsushita,N Tomita,A Moriguchi,Y Kaneda,J Higaki,T Ogihara, HYPERTENSION, AMER HEART ASSOC, Vol. 30, No. 3, p. P9-P9, 1997/09
  • Modulation of phenotype and induction of apoptosis in vascular smooth muscle cells (VSMC) by transfer of human senescent cell-derived inhibitor-1 gene, H Matsushita,R Morishita,M Aoki,Kida, I,HZ Bai,Y Kaneda,J Higaki,T Ogihara, HYPERTENSION, AMER HEART ASSOC, Vol. 30, No. 3, p. P190-P190, 1997/09
  • In vivo transaction of NF-kappa B decoy reduced severity of rat collagen-induced arthritis as a gene therapy, T Tomita,E Takeuchi,N Tomita,R Morishita,H Hashimoto,M Kaneko,K Yamamoto,Y Kaneda,T Ochi, ARTHRITIS AND RHEUMATISM, LIPPINCOTT-RAVEN PUBL, Vol. 40, No. 9, p. 1136-1136, 1997/09
  • Functional analysis of cis-element and binding protein as regulators of angiotensinogen generation in the central nerve system, T Nishii,A Moriguchi,R Morishita,N Tomita,Y Kaneda,J Higaki,T Ogihara, HYPERTENSION, AMER HEART ASSOC, Vol. 30, No. 3, p. P108-P108, 1997/09
  • Feasibility of decoy strategy by targeting the transcription factor NF kappa B in anti-GBM nephritis., N Tomita,R Morishita,M Hashizume,M Yasuba,M Notake,B Fujitani,K Yamamoto,H Lan,Y Kaneda,J Higaki,T Ogihara, JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, AMER SOC NEPHROLOGY, Vol. 8, p. A2172-A2172, 1997/09
  • Gene Therapy of Cardiovascular diseases by protein-modified liposomes, KANEDA Yasufumi,MORISHITA Ryuichi, Vol. 20, No. 3, p. 141-146, 1997/08/31
  • Direct in vivo Gene Transfer to Healing Rat Patellar Ligament by Intra-arterial Delivery of HVJ-liposomes, NATSUUME T,OZKAN Ilhan, 日本整形外科學會雜誌 = The Journal of the Japanese Orthopaedic Association, Vol. 71, No. 8, 1997/08/25
  • Antimetastatic effect of synthetic Glu-Ile-Leu-Asp-Val peptide derivatives containing D-amine acids, Y Kaneda,Y Yamamoto,N Okada,Y Tsutsumi,S Nakagawa,M Kakiuch,M Maeda,K Kawasaki,T Mayumi, ANTI-CANCER DRUGS, RAPID SCIENCE PUBLISHERS, Vol. 8, No. 7, p. 702-707, 1997/08
  • 161 肝虚血再潅流傷害にたいする遺伝子治療(<特集>第50回日本消化器外科学会総会), 吉住 朋晴,米満 吉和,金田 安史,矢永 勝彦,杉町 圭蔵,居石 克夫, 日本消化器外科学会雑誌, 一般社団法人日本消化器外科学会, Vol. 30, No. 6, p. 1391-1391, 1997/06/01
  • Transient Introduction of a Foreign Gene into Healing Rat Patellar Ligament, NAKAMURA N., Vol. 71, No. 3, 1997/03/25
  • P633 心臓における局所肝細胞増殖因子HGF系の意義 : 心筋梗塞モデルラットにおける心HGFの変化, 青木 元邦,森下 竜一,松下 英嗣,冨田 奈留也,守口 篤,檜垣 実男,荻原 俊男,金田 安史, Japanese circulation journal, 社団法人日本循環器学会, Vol. 61, p. 544-544, 1997/03/05
  • P618 心血管組織への臓器特異的かつ均一なin vivo遺伝子導入法の確立, 新村 健,森下 竜一,青木 元邦,檜垣 実男,荻原 俊男,金田 安史, Japanese circulation journal, 社団法人日本循環器学会, Vol. 61, p. 541-541, 1997/03/05
  • 0108 アンジオテンシノージェン遺伝子の組織での発現調整に関わる転写因子結合配列の機能解析, 西居 忠彦,守口 篤,森下 竜一,冨田 奈留也,中村 成史,檜垣 實男,荻原 俊男,金田 安史, Japanese circulation journal, 社団法人日本循環器学会, Vol. 61, p. 138-138, 1997/03/05
  • 0096 培養成熟ラット心筋線維芽細胞における2型アンジオテンシン受容体機構の役割, 新村 健,森下 竜一,青木 元邦,檜垣 実男,荻原 俊男,金田 安史, Japanese circulation journal, 社団法人日本循環器学会, Vol. 61, p. 135-135, 1997/03/05
  • 0709 肝細胞増殖因子(HGF)遺伝子導入による血管新生誘導 : 心筋梗塞に対する遺伝子による血管新生療法の可能性, 青木 元邦,森下 竜一,松下 英嗣,冨田 奈留也,守口 篤,檜垣 実男,荻原 俊男,金田 安史, Japanese circulation journal, 社団法人日本循環器学会, Vol. 61, p. 289-289, 1997/03/05
  • 1041 血管内皮特異的増殖因子である肝細胞増殖因子(HGF)遺伝子導入による冠血管拡張術後再狭窄の内皮再生促進型遺伝子治療, 中村 成史,森下 竜一,守口 篤,木田 岩男,青木 元邦,冨田 奈留也,松下 英嗣,檜垣 實男,荻原 俊男,松本 邦夫,中村 敏一,金田 安史,左近上 博司, Japanese circulation journal, 社団法人日本循環器学会, Vol. 61, p. 373-373, 1997/03/05
  • 1035 血管平滑筋細胞の分化制御機構 : Senescent Cell-Derived Inhibitor (sdi-1)遺伝子による細胞分化制御及びアポトーシス誘導機構の解明, 松下 英嗣,森下 竜一,青木 元邦,木田 岩男,冨田 奈留也,林 真一郎,守口 篤,檜垣 実男,荻原 俊男,金田 安史, Japanese circulation journal, 社団法人日本循環器学会, Vol. 61, p. 371-371, 1997/03/05
  • 0966 遺伝子導入法を用いた心局所アンジオテンシン変換酵素(ACE)の過剰発現と心肥大の誘導, 青木 元邦,森下 竜一,松下 英嗣,冨田 奈留也,守口 篤,檜垣 実男,荻原 俊男,金田 安史, Japanese circulation journal, 社団法人日本循環器学会, Vol. 61, p. 354-354, 1997/03/05
  • IS049 APOPTOSIS MEDIATED BY P53 THROUGH BAX PATHWAY IN HUMAN AORTIC VASCULAR SMOOTH MUSCLE CELLS, Aoki M.,Morishita R.,Higaki J.,Tomita N.,Kaneda Y.,Ogihara T., Japanese circulation journal, Japanese Circulation Society, Vol. 61, p. 31-31, 1997/03/05
  • Gene transfer into the glomerulus by the hemagglutinating virus of Japan-liposome method, Enyu Imai,Yoshitaka Isaka,Yoshitaka Akagi,Yasufumi Kaneda, Experimental Nephrology, Vol. 5, No. 2, p. 112-117, 1997/03
  • DEVELOPMENT OF IN VIVO GENE TRANSFER METHODS TOWARDS FUTURE GENE THERAPY, KANEDA Yasufumi,MORISHITA Ryuichi, Vol. 45, No. 2, p. 99-105, 1997/02/25
  • I-230 HVJ-Cationic Liposome の安全性の検討(<特集>第49回日本消化器外科学会総会), 吉住 朋晴,米満 吉和,金田 安史,矢永 勝彦,杉町 圭蔵,居石 克夫, 日本消化器外科学会雑誌, 一般社団法人日本消化器外科学会, Vol. 30, No. 2, p. 536-536, 1997/02/01
  • II-193 HVJ-liposome による生体肝への反復遺伝子導入の検討(<特集>第49回日本消化器外科学会総会), 平野 公通,藤元 治朗,山本 秀尚,植木 孝治,王 孔志,金田 安史,岡本 英三, 日本消化器外科学会雑誌, 一般社団法人日本消化器外科学会, Vol. 30, No. 2, p. 631-631, 1997/02/01
  • In vivo transfer of a foreign gene to keratinocytes using the hemagglutinating virus of Japan liposome method, D Sawamura,XM Meng,S Ina,H Ishikawa,K Tamai,K Nomura,K Hanada,Hashimoto, I,Y Kaneda, JOURNAL OF INVESTIGATIVE DERMATOLOGY, BLACKWELL SCIENCE INC, Vol. 108, No. 2, p. 195-199, 1997/02
  • Prevention of graft arteriopathy by antisense cdk2 kinase oligonucleotide, Suzuki J,Isobe M,Morishita R,Aoki M,Horie S,Okubo Y,Kaneda Y,Sawa Y,Matsuda H,Ogihara T,Sekiguchi M, Nature Medicine, Vol. 3, No. 8, p. 900-903, 1997
  • In vivo transfection of cis elementdecoyagainst nuclear factor-KB binding site prevents myo cardial infarction., MORISHITA R,AOKI M,KIDA I,TOMITA N,MAEDA K,SAWA Y,KANEDA Y,HIGAKI J,OGIHARA T, 3/,894-899, Vol. 3, No. 8, p. 894-899, 1997
  • Amino acids and peptides. XXXII. A bifunctional poly(ethylene glycol) hybrid of fibronectin related peptides, Maeda M,Izuno Y,Kawasaki K,Kaneda Y,Mu Y,Tsutsumi Y,Lem K. W,Mayumi T, Biochem. Biophys. Res. Commun., Vol. 241, No. 2, p. 595-598, 1997
  • Amino acids and peptides .29. Synthesis and antimetastatic effects of peptides and peptide-poly(ethylene glycol) hybrids related to the core sequence of the type III connecting segment domain of fibronectin, K Kawasaki,M Maeda,S Inoue,Y Yamashiro,Y Kaneda,Y Mu,Y Tsutsumi,S Nakagawa,T Mayumi, BIOLOGICAL & PHARMACEUTICAL BULLETIN, PHARMACEUTICAL SOC JAPAN, Vol. 19, No. 12, p. 1574-1579, 1996/12
  • In vivo anti-tumor efficacy of polyethylene glycol-modified tumor necrosis factor-alpha against tumor necrosis factor-resistant tumors, Y Tsutsumi,S Tsunoda,Y Kaneda,H Kamada,T Kihira,S Nakagawa,Y Yamamoto,Y Horisawa,T Mayumi, JAPANESE JOURNAL OF CANCER RESEARCH, JAPANESE CANCER ASSOCIATION, Vol. 87, No. 10, p. 1078-1085, 1996/10
  • Molecular design of hybrid tumour necrosis factor-alpha .2. The molecular size of polyethylene glycol-modified tumour necrosis factor-alpha affects its antitumour potency, Y Tsutsumi,S Tsunoda,H Kamada,T Kihira,S Nakagawa,Y Kaneda,T Kanamori,T Mayumi, BRITISH JOURNAL OF CANCER, STOCKTON PRESS, Vol. 74, No. 7, p. 1090-1095, 1996/10
  • In vivo transfection of cis element ''decoy'' against NF kappa B binding site prevented myocardial infarction as a gene therapy, R Morishita,T Sugimoto,M Aoki,N Tomita,A Moriguchi,Kida, I,K Maeda,Y Sawa,Y Kaneda,J Higaki,T Ogihara, CIRCULATION, AMER HEART ASSOC, Vol. 94, No. 8, p. 1313-1313, 1996/10
  • Repeated in vivo gene transfer into adult rat liver using HVJ-liposome., J Fujimoto,T Hirano,T Ueki,H Yamamoto,E Okamoto,Y Sawa,R Morishita,Y Kaneda, HEPATOLOGY, W B SAUNDERS CO, Vol. 24, No. 4, p. 42-42, 1996/10
  • Ribozyme oligonucleotides against apolipoprotein(a) gene cleavages selectively apolipoprotein(a), but not plasminogen, gene: Novel gene therapy strategy for atherosclerosis, R Morishita,J Higaki,Kida, I,M Aoki,A Moriguchi,R Lawn,Y Kaneda,T Ogihara, CIRCULATION, AMER HEART ASSOC, Vol. 94, No. 8, p. 217-217, 1996/10
  • In vivo transfection of antisense oligodeoxynucleotides directed against p53 and RB (retinoblastoma susceptibility gene product) resulted in re-entry of cell cycle in terminally differentiated adult cardiac myocytes, M Aoki,R Morishita,Kida, I,A Moriguchi,Y Kaneda,T Ogihara, CIRCULATION, AMER HEART ASSOC, Vol. 94, No. 8, p. 2764-2764, 1996/10
  • Hypoxia down regulated a novel angiogenic growth factor, hepatocyte growth factor (HGF) in human vascular cells, and transfection of HGF gene rescued endothelial cell death induced by hypoxia, S Hayashi,R Morishita,M Aoki,Kida, I,A Moriguchi,Y Kaneda,K Matsumoto,T Nakamura,J Higaki, CIRCULATION, AMER HEART ASSOC, Vol. 94, No. 8, p. 2706-2706, 1996/10
  • Introduction and expression of the human HGF gene in adult rat liver., T Ueki,T Hirano,H Yamamoto,E Okamoto,Y Kaneda,Y Sawa,T Nakamura,J Fujimoto, HEPATOLOGY, W B SAUNDERS CO, Vol. 24, No. 4, p. 43-43, 1996/10
  • Effect of gene transfer of human angiotensin II processing enzymes into the rat brain on blood pressure and neuroendocrine responses, K Yamada,A Moriguchi,R Morishita,Y Kaneda,H Mikami,H Urata,J Higaki,T Ogihara, HYPERTENSION, AMER HEART ASSOC, Vol. 28, No. 3, p. P9-P9, 1996/09
  • Potential gene therapy for glomerulonephritis: Transfection of NF kappa B decoy inhibited TNF-alpha induced cytokines and adhesion molecules expression in vivo., R Morishita,N Tomita,GH Gibbons,S Tomita,L Zhang,Y Kaneda,T Ogihara,VJ Dzau, JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, AMER SOC NEPHROLOGY, Vol. 7, No. 9, p. A2323-A2323, 1996/09
  • Apoptosis mediated by p53 in human aortic vascular smooth muscle cells; Studies from transfection of antisense against p53 and retinoblastoma gene product (Rb), M Aoki,R Morishita,J Higaki,Kida, I,A Moriguchi,Y Kaneda,T Ogihara, HYPERTENSION, AMER HEART ASSOC, Vol. 28, No. 3, p. P29-P29, 1996/09
  • Potential gene therapy for rheumatoid arthritis: Transfection of NF kappa B decoy inhibited production of interleukin-1 from synovial tissue of patients with rheumatoid arthritis., T Tomita,H Hashimoto,N Tomita,R Morishita,E Takeuchi,SB Lee,K Hayashida,J Hashimoto,Y Kaneda,T Ochi, ARTHRITIS AND RHEUMATISM, LIPPINCOTT-RAVEN PUBL, Vol. 39, No. 9, p. 577-577, 1996/09
  • Transcription factor decoy for NF kappa B inhibits TNF-alpha induced expressions of cytokine and adhesion molecule in mesangial cells., N Tomita,R Morishita,GH Gibbons,S Tomita,Y Kaneda,T Ogihara,VJ Dzau, JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, AMER SOC NEPHROLOGY, Vol. 7, No. 9, p. A2382-A2382, 1996/09
  • Importance of transcriptional cis-element of angiotensinogen in the central regulation of blood pressure., K Yamada,A Moriguchi,R Morishita,Y Kaneda,H Mikami,J Higaki,T Ohihara, HYPERTENSION, AMER HEART ASSOC, Vol. 28, No. 3, p. 74-74, 1996/09
  • Molecular design of hybrid tumor necrosis factor-alpha III: Polyethylene glycol-modified tumor necrosis factor-alpha has markedly enhanced antitumor potency due to longer plasma half-life and higher tumor accumulation, Y Tsutsumi,T Kihira,S Tsunoda,H Kamada,S Nakagawa,Y Kaneda,T Kanamori,T Mayumi, JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, WILLIAMS & WILKINS, Vol. 278, No. 3, p. 1006-1011, 1996/09
  • Early Effect of in vivo Introduction of Platelet-derived Growth Factor (PDGF) Gene into Healing Patellar Tendon, NAKAMURA N., Vol. 70, No. 8, 1996/08/25
  • Selective enhancement by tumor necrosis factor-alpha of vascular permeability of new blood vessels induced with agarose hydrogel-entrapped Meth-A fibrosarcoma cells, N Okada,Y Kaneda,H Miyamoto,Y Yamamoto,H Mizuguchi,Y Tsutsumi,S Nakagawa,T Mayumi, JAPANESE JOURNAL OF CANCER RESEARCH, JAPANESE CANCER ASSOCIATION, Vol. 87, No. 8, p. 831-836, 1996/08
  • In vivo gene transfer of insulin gene into neonatal rats by the HVJ-liposome method resulted in sustained transgene expression, N Tomita,R Morishita,J Higaki,S Tomita,M Aoki,T Ogihara,Y Kaneda, GENE THERAPY, STOCKTON PRESS, Vol. 3, No. 6, p. 477-482, 1996/06
  • Hemagglutinating virus of Japan(HVI)-liposome method for introducing exogenous genes into keratinocytes in vivo., D Sawamura,S Meng,K Tamai,H Ishikawa,K Nomura,Hashimoto, I,Y Kaneda, JOURNAL OF INVESTIGATIVE DERMATOLOGY, BLACKWELL SCIENCE INC, Vol. 106, No. 4, p. 573-573, 1996/04
  • In vivo HVJ-liposome mediated gene transfer into adult rat liver., T Hirano,E Okamoto,H Yamamoto,T Ueki,K Nakanishi,M Takeuchi,Y Kaneda,J Fujimoto, GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, Vol. 110, No. 4, p. A1213-A1213, 1996/04
  • Potential gene therapy using E2F decoy approach with HVJ-liposome method to glomerulonephritis in rats., N Tomita,GH Gibbons,J Kim,S Tomita,L Zhang,Y Kaneda,D Baran,VJ Dzau, JOURNAL OF INVESTIGATIVE MEDICINE, SLACK INC, Vol. 44, No. 3, p. A319-A319, 1996/03
  • Potential gene therapy for glomerulonephritis: Transfection of NF kappa B decoy inhibited TNF-alpha induced cytokine and adhesion molecules expression in vivo, N Tomita,R Morishita,GH Gibbons,S Tomita,M Horiuchi,L Zhang,Y Kaneda,T Ogihara,VJ Dzau, JOURNAL OF INVESTIGATIVE MEDICINE, SLACK INC, Vol. 44, No. 3, p. A281-A281, 1996/03
  • SII-3-追加発言 心筋不全発生における細胞情報伝達機構及びapoptosisの関与, 澤 芳樹,谷口 和博,竹谷 哲,鍵崎 康治,河口 直正,大西 俊造,金田 安史,松田 暉, Japanese circulation journal, 社団法人日本循環器学会, Vol. 60, p. 12-12, 1996/02/20
  • 1069 中枢性血圧調節における脳内アンジオテンシノーゲン遺伝子の転写因子結合配列AGEの機能解析, 山田 和生,守口 篤,森下 竜一,中野 信明,中村 成史,青木 元邦,三上 洋,檜垣 実男,荻原 俊男,金田 安史,深水 昭吉,村上 和雄, Japanese circulation journal, 社団法人日本循環器学会, Vol. 60, p. 315-315, 1996/02/20
  • 0976 サイトカイン及び接着因子誘導に対する転写因子NFkBの機能検討 : おとり型核酸医薬を用いて, 森下 竜一,檜垣 実男,青木 元邦,木田 岩男,林 真一郎,守口 篤,荻原 俊男,金田 安史,杉本 聡子,前田 和宏, Japanese circulation journal, 社団法人日本循環器学会, Vol. 60, p. 292-292, 1996/02/20
  • 1136 アポリポプロティン(a)に対するリボザイムを用いた動脈硬化症の遺伝子治療, 森下 竜一,檜垣 実男,木田 岩男,青木 元邦,林 真一郎,守口 篤,荻原 俊男,金田 安史,山田 晋吾,櫻林 郁之介, Japanese circulation journal, 社団法人日本循環器学会, Vol. 60, p. 332-332, 1996/02/20
  • 1133 癌抑制遺伝子Rb, p53アンチセンス導入による心筋細胞の細胞周期の進展 : 心筋細胞増殖の可能性, 青木 元邦,森下 竜一,木田 岩男,林 真一郎,姚 香景,守口 篤,檜垣 実男,荻原 俊男,金田 安史, Japanese circulation journal, 社団法人日本循環器学会, Vol. 60, p. 331-331, 1996/02/20
  • 1168 脳への遺伝子導入法を用いた血圧調節におけるヒト・キマーゼ遺伝子の機能解明, 山田 和生,守口 篤,森下 竜一,中村 成史,檜垣 實男,三上 洋,荻原 俊男,金田 安史,浦田 秀則, Japanese circulation journal, 社団法人日本循環器学会, Vol. 60, p. 340-340, 1996/02/20
  • 1135 心臓への高効率な遺伝子導入法の確立及び心筋細胞への肝細胞増殖因子(HGF)遺伝子導入による血管新生の誘導 : 心筋梗塞に対する遺伝子治療, 青木 元邦,森下 竜一,木田 岩男,林 真一郎,姚 香景,守口 篤,檜垣 実男,荻原 俊男,金田 安史,松本 邦夫,中村 敏一, Japanese circulation journal, 社団法人日本循環器学会, Vol. 60, p. 332-332, 1996/02/20
  • 0045 肝細胞増殖因子(HGF)遺伝子導入による血管内皮細胞増殖促進 : 再狭窄の遺伝子治療としての内皮細胞再生療法, 林 真一郎,森下 竜一,檜垣 実男,青木 元邦,木田 岩男,守口 篤,荻原 俊男,松本 邦夫,中村 敏一,金田 安史, Japanese circulation journal, 社団法人日本循環器学会, Vol. 60, p. 58-58, 1996/02/20
  • 0093 遺伝子導入による心筋虚血耐性の向上に関する研究 : heat shock protein 70高度発現による心筋保護効果, 鈴木 憲,澤 芳樹,市川 肇,門場 啓司,松田 暉,白倉 良太,金田 安史, Japanese circulation journal, 社団法人日本循環器学会, Vol. 60, p. 70-70, 1996/02/20
  • 0159 癌抑制遺伝子Rb, p53による血管平滑筋細胞増殖機構及びアポトーシス誘導の解明, 青木 元邦,森下 竜一,木田 岩男,林 真一郎,姚 香景,守口 篤,檜垣 実男,荻原 俊男,金田 安史, Japanese circulation journal, 社団法人日本循環器学会, Vol. 60, p. 86-86, 1996/02/20
  • P335 おとり型核酸医薬(デコイ)法を用いたレニン遺伝子発現の組織特異性の解明, 冨田 佐和子,冨田 奈留也,森下 竜一,檜垣 實男,荻原 俊男,金田 安史,堀内 正嗣,山田 武彦, Japanese circulation journal, 社団法人日本循環器学会, Vol. 60, p. 433-433, 1996/02/20
  • P359 アンチセンス-オリゴヌクレオチド(ODN)の中枢への導入と血圧調節機構解明への利用, 山田 和生,守口 篤,森下 竜一,檜垣 實男,青木 元邦,三上 洋,荻原 俊男,金田 安史, Japanese circulation journal, 社団法人日本循環器学会, Vol. 60, p. 439-439, 1996/02/20
  • 0094 心筋虚血再灌流障害におけるbcl-2遺伝子の役割 : 遺伝子導入によるbcl-2蛋白高度発現の心筋保護効果, 澤 芳樹,門場 啓司,白 鴻志,鈴木 憲,松田 暉,辻本 英賀,金田 安史, Japanese circulation journal, 社団法人日本循環器学会, Vol. 60, No. 0, 1996/02/20
  • 1134 転写調節因子NFkBに対するおとり型核酸医薬(デコイ)による心筋梗塞の遺伝子治療, 森下 竜一,檜垣 実男,青木 元邦,木田 岩男,林 真一郎,守口 篤,荻原 俊男,澤 芳樹,松田 暉,金田 安史,杉本 聡子,前田 和宏, Japanese circulation journal, 社団法人日本循環器学会, Vol. 60, No. 0, 1996/02/20
  • P273 遺伝子を導入した培養心筋細胞の生体内心臓への生着 : 心筋梗塞の遺伝子治療への応用, 青木 元邦,森下 竜一,木田 岩男,林 真一郎,姚 香景,森口 篤,檜垣 実男,荻原 俊男,沢 芳樹,松田 暉,白倉 良太,金田 安史, Japanese circulation journal, 社団法人日本循環器学会, Vol. 60, No. 0, 1996/02/20
  • Application of antisense oligodeoxynucleotides (ODNs) for the intervention of kidney disease: Antisense ODNs for transforming growth factor-β- suppressed glomerulosclerosis in experimental glomerulonephritis, Enyu Imai,Yoshitaka Isaka,Yoshitaka Akagi,Makoto Arai,Toshiki Moriyama,Masaru Takenaka,Tetsuya Kaneko,Masaru Horio,Akio Ando,Yoshimasa Orita,Yasufumi Kaneda,Naohiko Ueda,Takenobu Kamada, Contributions to Nephrology, Vol. 118, p. 86-93, 1996
  • Preparation of RGD-polyoxyalkyleneamine hybrid and its inhibitory effect on experimental metastasis, Izuno Y,Kurosaka T,Maeda M,Kawasaki K,Kaneda Y,Mu Y,Tsutsumi Y,Nakagawa S,Mayumi T, Peptide Chem., No. 1996, p. 265-268, 1996
  • Prevention of Restenosis After Angioplasty : Efficacy of Antisense Strategy Against Cell Cycle Regulatory Genes, MORISHITA Ryuich,HIGAKI Jitsuo,AOKI Motokuni,NAKAMURA Yoshio,OGIHARA Toshio,KANEDA Yasufumi, Journal of Atherosclerosis and Thrombosis, Japan Atherosclerosis Society, Vol. 23, No. 1, p. 51-56, 1995/10/20
  • INTENTIONAL INDUCTION OF CELL-CYCLE ARREST ON VASCULAR SMOOTH-MUSCLE CELLS MEDIATED BY THE WILD-TYPE P53 GENE-TRANSFER, Y YONEMITSU,Y KANEDA,Y HATA,Y NAKASHIMA,K SUEISHI, CIRCULATION, AMER HEART ASSOC, Vol. 92, No. 8, p. 2387-2387, 1995/10
  • IN-VIVO GENE-THERAPY OF ANTI-THY-1 NEPHRITIS USING E2F DECOY OLIGONUCLEOTIDE, N TOMITA,J KIM,GH GIBBONS,D BARAN,M OGBORN,RAK STAHL,S TOMITA,L ZHANG,Y KANEDA,VJ DZAU, JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, WILLIAMS & WILKINS, Vol. 6, No. 3, p. 887-887, 1995/09
  • IN-VIVO DIRECT GENE-TRANSFER INTO ARTICULAR-CARTILAGE USING HVJ-LIPOSOMES, T TOMITA,H HASHIMOTO,N TOMITA,SB LEE,R MORISHITA,Y KANEDA,T OCHI, ARTHRITIS AND RHEUMATISM, LIPPINCOTT-RAVEN PUBL, Vol. 38, No. 9, p. 1467-1467, 1995/09
  • ROLE OF TRANSCRIPTIONAL FACTOR AGE 2 OF ANGIOTENSINOGEN GENE IN THE PATHOGENESIS OF HIGH BLOOD-PRESSURE IN SPONTANEOUSLY HYPERTENSIVE RATS (SHR), T MORISHITA,J HIGAKI,N TOMITA,M AOKI,Y NAKAMURA,A MORIGUCHI,K YAMADA,S HAYASHI,KIDA, I,H MIKAMI,Y KANEDA,T OGIHARA, HYPERTENSION, AMER HEART ASSOC, Vol. 26, No. 3, p. 547-547, 1995/09
  • GENE-TRANSFER OF HUMAN ANGIOTENSIN-CONVERTING ENZYME (ACE) INTO THF RAT-BRAIN CAUSES SUSTAINED BLOOD-PRESSURE ELEVATION, K YAMADA,A MORIGUCHI,R MORISHITA,J HIGAKI,M AOKI,H MIKAMI,Y KANEDA,T OGIHARA, HYPERTENSION, AMER HEART ASSOC, Vol. 26, No. 3, p. 557-557, 1995/09
  • IN-VIVO ELUCIDATION OF NEGATIVE REGULATION OF TISSUE-SPECIFIC RENIN GENE-EXPRESSION BY TRANSCRIPTIONAL FACTOR DECOY APPROACH, S TOMITA,N TOMITA,T YAMADA,LN ZHANG,T OGIHARA,Y KANEDA,M HORIUCHI,VJ DZAU, HYPERTENSION, AMER HEART ASSOC, Vol. 26, No. 3, p. 555-555, 1995/09
  • Direct in vivo Gene Transfer into Healing Rat Patellar Ligament, NAKAMURA N., Vol. 69, No. 8, 1995/08/25
  • In vivo Direct Gene Transfer into Articular Cartilage Using HVJ-liposomes, TOMITA T., Vol. 69, No. 8, 1995/08/25
  • In vivo Gene Transfer for the Therapy of Vascular Diseases, KANEDA Yasufumi,MORISHITA Ryuichi, Journal of Atherosclerosis and Thrombosis, Japan Atherosclerosis Society, Vol. 22, No. 11, p. 819-823, 1995/07/31
  • TRANSIENT DECREASE IN HIGH BLOOD-PRESSURE BY IN-VIVO TRANSFER OF ANTISENSE OLIGODEOXYNUCLEOTIDES AGAINST RAT ANGIOTENSINOGEN, N TOMITA,R MORISHITA,J HIGAKI,M AOKI,Y NAKAMURA,H MIKAMI,A FUKAMIZU,K MURAKAMI,Y KANEDA,T OGIHARA, HYPERTENSION, AMER HEART ASSOC, Vol. 26, No. 1, p. 131-136, 1995/07
  • INCREASED EXPRESSION OF DNA COINTRODUCED WITH NUCLEAR-PROTEIN IN ADULT-RAT LIVER, Y KANEDA,R MORISHITA,N TOMITA, JOURNAL OF MOLECULAR MEDICINE-JMM, SPRINGER VERLAG, Vol. 73, No. 6, p. 289-297, 1995/06
  • GENETIC-ENGINEERING OF VEIN GRAFTS RESISTANT TO ATHEROSCLEROSIS, MJ MANN,GH GIBBONS,RS KERNOFF,FP DIET,PS TSAO,JP COOKE,Y KANEDA,VJ DZAU, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, NATL ACAD SCIENCES, Vol. 92, No. 10, p. 4502-4506, 1995/05
  • P184 アンチセンスオリゴの血管内薬理動態の研究 : HVJ-リポソーム法のオリゴ導入のメカニズム, 森下 竜一,檜垣 実男,青木 元邦,冨田 奈留也,守口 篤,山田 和生,中村 好男,三上 洋,荻原 俊男,金田 安史, Japanese circulation journal, 社団法人日本循環器学会, Vol. 59, p. 447-447, 1995/03/01
  • 0042 転写因子E2Fに対する二重鎖核酸化合物(デコイ)による血管拡張術後再狭窄に対する遺伝子治療, 森下 竜一,檜垣 実男,青木 元邦,冨田 奈留也,守口 篤,山田 和生,中村 好男,三上 洋,荻原 俊男,金田 安史,Dzau V.J., Japanese circulation journal, 社団法人日本循環器学会, Vol. 59, p. 53-53, 1995/03/01
  • IN-VIVO DIRECT GENE-TRANSFER INTO JOINTS USING HVJ-LIPOSOMES, T TOMITA,H HASHIMOTO,N TOMITA,N NAKAMURA,R MORISHITA,Y KANEDA,T OCHI, JOURNAL OF CELLULAR BIOCHEMISTRY, WILEY-LISS, p. 385-385, 1995/03
  • GENE-TRANSFER INTO NEONATAL RATS RESULTED IN SUSTAINED EXPRESSION BY HVJ-LIPOSOMES, N TOMITA,R MORISHITA,J HIGAKI,S TOMITA,M AOKI,H MIKAMI,Y KANEDA,T OGIHARA, JOURNAL OF CELLULAR BIOCHEMISTRY, WILEY-LISS, p. 401-401, 1995/03
  • DIRECT IN-VIVO GENE-TRANSFER INTO HEALING PATELLAR LIGAMENT, N NAKAMURA,S HORIBE,N MATSUMOTO,T TOMITA,Y TORITSUKA,Y KANEDA,K SHINO, JOURNAL OF CELLULAR BIOCHEMISTRY, WILEY-LISS, p. 381-381, 1995/03
  • 0664 ラット生体内心臓への直接投与及び心外膜下投与による遺伝子導入法の確立, 青木 元邦,森下 竜一,檜垣 実男,冨田 奈留也,守口 篤,山田 和生,中村 好男,三上 洋,荻原 俊男,金田 安史,福田 宏嗣,沢 芳樹,白倉 良太,松田 暉, Japanese circulation journal, 社団法人日本循環器学会, Vol. 59, No. 0, 1995/03/01
  • 0666 遺伝子導入による心筋虚血耐性獲得に関する研究 : TGF-βの心筋保護効果, 澤 芳樹,福田 宏嗣,白 鴻志,鈴木 憲,松田 暉,森下 竜一,青木 元邦,金田 安史, Japanese circulation journal, 社団法人日本循環器学会, Vol. 59, No. 0, 1995/03/01
  • P185 HVJ-liposomeを用いた心筋へのin vivo遺伝子導入法の開発に関する研究, 澤 芳樹,福田 宏嗣,白 鴻志,鈴木 憲,松田 暉,森下 竜一,青木 元邦,金田 安史, Japanese circulation journal, 社団法人日本循環器学会, Vol. 59, No. 0, 1995/03/01
  • P392 大伏在静脈グラフトへの遺伝子導入によるvein graft diseaseの制御, 今川 弘,島崎 靖久,澤 芳樹,高橋 俊樹,白 鴻志,金田 安史,森下 竜一,中埜 粛,松田 暉, Japanese circulation journal, 社団法人日本循環器学会, Vol. 59, No. 0, 1995/03/01
  • P501 ラット心筋梗塞モデルへのアンチセンスオリゴヌクレオチド導入法の確立 : 心疾患の遺伝子治療へのHVJ-liposome法の応用, 青木 元邦,森下 竜一,檜垣 実男,冨田 奈留也,守口 篤,山田 和生,中村 好男,三上 洋,荻原 俊男,金田 安史,福田 宏嗣,沢 芳樹,白倉 良太,松田 暉, Japanese circulation journal, 社団法人日本循環器学会, Vol. 59, No. 0, 1995/03/01
  • GENE-THERAPY INHIBITING NEOINTIMAL VASCULAR LESION - IN-VIVO TRANSFER OF ENDOTHELIAL-CELL NITRIC-OXIDE SYNTHASE GENE, HE VONDERLEYEN,GH GIBBONS,R MORISHITA,NP LEWIS,L ZHANG,M NAKAJIMA,Y KANEDA,JP COOKE,VJ DZAU, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, NATL ACAD SCIENCES, Vol. 92, No. 4, p. 1137-1141, 1995/02
  • A gene therapy strategy using a transcription factor decoy of the E2F binding site inhibits smooth muscle proliferation in vivo, MORISHITA R., Proc Natl Acad Sci USA, Vol. 92, No. 13, p. 5855-5859, 1995
  • Yoshida M, Sakuma J, Hayashi S, Abe K, Saito I, Harada S, Sakatani M, Yamamoto S, Matsumoto N, Kaneda Y, et al. A histologically distinctive interstitial pneumonia induced by overexpression of the interleukin 6, transforming growth factor beta 1, or pl・・・, YOSHIDA M,SAKUMA J,HAYASHI S,ABE K,SAITO I,SAKATANI M,MATSUMOTO N,KANEDA Y,KISHIMOTO T, Proc Natl Acad Sci USA., Vol. 92, No. 21, p. 9570-9574, 1995
  • In vivo transfection of genes for rennin and angiotensinogen into the glomerular cells induced phenotypic change of the mesangial cells and glomerular sclerosis, ARAI M., Biochim Biophys Res Commun, Vol. 206, No. 2, p. 525-532, 1995
  • Liposome mediated gene transfer.Yanagihara,I.Kaneda,Y.Inui,K & Okada,S, Molecular and Cell Biology of Human Gene Therapeutics (Chapman & Hall,London), p. 64-80, 1995
  • PHARMACOKINETICS OF ANTISENSE OLIGODEOXYRIBONUCLEOTIDES (CYCLIN-B-1 AND CDC-2 KINASE) IN THE VESSEL WALL IN-VIVO - ENHANCED THERAPEUTIC UTILITY FOR RESTENOSIS BY HVJ-LIPOSOME DELIVERY, R MORISHITA,GH GIBBONS,Y KANEDA,T OGIHARA,VJ DZAU, GENE, ELSEVIER SCIENCE BV, Vol. 149, No. 1, p. 13-19, 1994/11
  • PTCA後再狭窄の実験動物における遺伝子治療 : 細胞周期調節遺伝子群に対するアンチセンスオリゴおよびNO遺伝子導入による血管平滑筋細胞の増殖抑制, 森下 竜一,桧垣 実男,荻原 俊男,金田 安史, 動脈硬化 = The journal of Japan Atherosclerosis Society, Vol. 22, No. 5, p. 384-384, 1994/10/20
  • APOLIPOPROTEIN-E DEFICIENT MICE CREATED BY SYSTEMIC ANTISENSE OLIGONUCLEOTIDES ADMINISTRATION - A NEW MODEL FOR LIPOPROTEIN METABOLISM STUDIES, RI MORISHITA,GH GIBBONS,N TOMITA,L ZHANG,Y KANEDA,T OGIHARA,VJ DZAU, CIRCULATION, AMER HEART ASSOC, Vol. 90, No. 4, p. 134-134, 1994/10
  • DECOY OLIGONUCLEOTIDE TO STUDY THE ROLE OF THE AP-1 COMPLEX ON ANGIOTENSIN-II MEDIATED TRANSFORMING GROWTH-FACTOR-BETA-1 EXPRESSION, R MORISHITA,M HORIUCHI,N TOMITA,Y KANEDA,GH GIBBONS, CIRCULATION, AMER HEART ASSOC, Vol. 90, No. 4, p. 636-636, 1994/10
  • ANTISENSE OLIGONUCLEOTIDE INHIBITION OF LOCAL ANGIOTENSIN-CONVERTING ENZYME RESULTED IN THE INHIBITION OF NEOINTIMAL FORMATION AFTER VASCULAR INJURY, R MORISHITA,Y KANEDA,N TOMITA,W LEE,LN ZHANG,GH GIBBONS, CIRCULATION, AMER HEART ASSOC, Vol. 90, No. 4, p. 142-142, 1994/10
  • IN-VIVO TRANSFECTION OF TRANSFORMING GROWTH-FACTOR-BETA IMPROVES THE MYOCARDIAL TOLERANCE TO ISCHEMIA-REPERFUSION INJURY, Y SAWA,H MATSUDA,H BAI,K SUZUKI,Y KANEDA, CIRCULATION, AMER HEART ASSOC, Vol. 90, No. 4, p. 91-91, 1994/10
  • A NOVEL MOLECULAR STRATEGY USING CIS-ELEMENT DECOY OF E2F BINDING-SITE INHIBITS SMOOTH-MUSCLE PROLIFERATION IN-VIVO, R MORISHITA,GH GIBBONS,M HORIUCHI,KE ELLISON,M NAKAJIMA,N TOMITA,L ZHANG,Y KANEDA,T OGIHARA,VJ DZAU, CIRCULATION, AMER HEART ASSOC, Vol. 90, No. 4, p. 191-191, 1994/10
  • IN-VIVO TRANSFER OF ANTISENSE OLIGONUCLEOTIDE AGAINST RAT ANGIOTENSINOGEN WITH HVJ-LIPOSOME DELIVERY RESULTED THE REDUCTION OF BLOOD-PRESSURE IN SHR, N TOMITA,R MORISHITA,J HIGAKI,Y KANEDA,H MIKAMI,T OGIHARA, HYPERTENSION, AMER HEART ASSOC, Vol. 24, No. 3, p. 397-397, 1994/09
  • ANTIMETASTATIC EFFECTS OF SYNTHETIC PEPTIDES CONTAINING THE CORE SEQUENCE OF THE TYPE-III CONNECTING SEGMENT DOMAIN (IIICS) OF FIBRONECTIN, S YAMAMOTO,Y KANEDA,N OKADA,S NAKAGAWA,K KUBO,S INOUE,M MAEDA,Y YAMASHIRO,K KAWASAKI,T MAYUMI, ANTI-CANCER DRUGS, RAPID SCIENCE PUBLISHERS, Vol. 5, No. 4, p. 424-428, 1994/08
  • SYSTEMIC ADMINISTRATION OF HVJ VIRAL COAT LIPOSOME COMPLEX CONTAINING INSULIN VECTOR DECREASES GLUCOSE-LEVELS IN DIABETIC MICE - A MODEL OF GENE-THERAPY, R MORISHITA,GH GIBBONS,Y KANEDA,T YAMADA,L ZHANG,T OGIHARA,VJ DZAU, CLINICAL RESEARCH, SLACK INC, Vol. 42, No. 2, p. A211-A211, 1994/04
  • APOLIPOPROTEIN-E-DEFICIENT MICE CREATED BY SYSTEMIC ADMINISTRATION OF ANTISENSE OLIGONUCLEOTIDES - A NEW MODEL FOR LIPOPROTEIN METABOLISM STUDIES, R MORISHITA,GH GIBBONS,M NAKAJIMA,L ZHANG,Y KANEDA,T OGIHARA,VJ DZAU, CLINICAL RESEARCH, SLACK INC, Vol. 42, No. 2, p. A176-A176, 1994/04
  • OVEREXPRESSION OF CONSTITUTIVE, ENDOTHELIAL-TYPE NITRIC-OXIDE SYNTHASE AS AN IN-VIVO GENE-TRANSFER APPROACH TO PREVENT NEOINTIMA FORMATION AFTER VASCULAR INJURY, H VONDERLEYEN,GH GIBBONS,R MORISHITA,NP LEWIS,F DIET,JP COOKE,L ZHANG,Y KANEDA,VJ DZAU, CLINICAL RESEARCH, SLACK INC, Vol. 42, No. 2, p. A180-A180, 1994/04
  • INTIMAL HYPERPLASIA AFTER VASCULAR INJURY IS INHIBITED BY ANTISENSE CDK-2 KINASE OLIGONUCLEOTIDES, R MORISHITA,GH GIBBONS,KE ELLISON,M NAKAJIMA,H VONDERLEYEN,LN ZHANG,Y KANEDA,T OGIHARA,VJ DZAU, JOURNAL OF CLINICAL INVESTIGATION, ROCKEFELLER UNIV PRESS, Vol. 93, No. 4, p. 1458-1464, 1994/04
  • HVJ-リポゾーム法によるアンジオテンシノールゲンアンチセンスオリゴマーの導入 : 第58回日本循環器学会学術集会, 冨田 奈留也,檜垣 實男,楽木 宏実,三上 洋,荻原 俊男,金田 安史, Japanese circulation journal, 社団法人日本循環器学会, Vol. 58, p. 293-293, 1994/03/01
  • IN-VIVO GENE-TRANSFER TO PREVENT NEOINTIMA HYPERPLASIA AFTER VASCULAR INJURY - EFFECT OF OVEREXPRESSION OF CONSTITUTIVE NITRIC-OXIDE SYNTHASE, H VONDERLEYEN,GH GIBBONS,R MORISHITA,NP LEWIS,L ZHANG,Y KANEDA,JP COOKE,VJ DZAU, FASEB JOURNAL, FEDERATION AMER SOC EXP BIOL, Vol. 8, No. 5, p. A802-A802, 1994/03
  • ANTISENSE (AS) OLIGONUCLEOTIDES (ODN) DIRECTED AT CELL-CYCLE REGULATORY GENES AS THERAPEUTIC STRATEGY TO PREVENT RESTENOSIS, R MORISHITA,GH GIBBONS,KE ELLISON,M NAKAJIMA,H VONDERLEYEN,L ZHANG,Y KANEDA,T OGIHARA,VJ DZAU, CLINICAL RESEARCH, SLACK INC, Vol. 42, No. 1, p. A14-A14, 1994/02
  • DIRECT IN-VIVO INTRODUCTION OF VARIOUS GENES INTO RAT-KIDNEY BY HVJ-LIPOSOMES, E IMAI,Y ISAKA,N TOMITA,Y FUJIWARA,R MORISHITA,J HIGAKI,N UEDA,T OGIHARA,T KAMADA,Y KANEDA, JOURNAL OF CELLULAR BIOCHEMISTRY, WILEY-LISS, p. 226-226, 1994/01
  • NOVEL STRATEGIES TO ENHANCE THE EFFICACY OF ANTISENSE OLIGONUCLEOTIDES FOR IN-VIVO GENE-THERAPY, R MORISHITA,GH GIBBONS,Y KANEDA,W LEE,LN ZHANG,T OGIHARA,VJ DZAU, JOURNAL OF CELLULAR BIOCHEMISTRY, WILEY-LISS, p. 239-239, 1994/01
  • AUTOCRINE/PARACRINE RENIN-ANGIOTENSIN AS A DETERMINANT OF VASCULAR STRUCTURE - A GENE-TRANSFER EXPERIMENTAL APPROACH, R MORISHITA,GH GIBBONS,KE ELLISON,L ZHANG,Y KANEDA,T OGIHARA,VJ DZAU, JOURNAL OF CELLULAR BIOCHEMISTRY, WILEY-LISS, p. 302-302, 1994/01
  • IN-VIVO REDUCTION OF RAT ANGIOTENSINOGEN BY HVJ-LIPOSOMES CONTAINING ANTISENSE OLIGONUCLEOTIDE, N TOMITA,Y KANEDA,J HIGAKI,T OGIHARA, JOURNAL OF CELLULAR BIOCHEMISTRY, WILEY-LISS, p. 230-230, 1994/01
  • Virus (Sendai virus envelopes) mediated gene transfer.Kaneda,Y, Cell Biology : A laboratory Handbook (Academic Press Inc., Orlando, Florida), Vol. 3, p. 50-57, 1994
  • INTRODUCTION OF A FOREIGN GENE INTO THE KIDNEY IN-VIVO - DEVELOPMENT OF GLOMERULOSCLEROSIS BY THE TRANSFECTION OF GENES FOR PDGF AND TGF-BETA, E IMAI,Y ISAKA,Y FUJIWARA,Y KANEDA,T KAMADA,N UEDA, EXTRACELLULAR MATRIX IN THE KIDNEY, KARGER, Vol. 107, p. 205-215, 1994
  • THE ANALYSIS OF 40-KDA NUCLEAR-PROTEIN, P40, IN INTERPHASE CELLS AND MITOTIC CELLS, Y KANEDA,K KINOSHITA,M SATO,K TANAKA,Y KANEDA, JOURNAL OF CELL SCIENCE, COMPANY OF BIOLOGISTS LTD, Vol. 106, p. 741-748, 1993/11
  • ATRIAL-NATRIURETIC-PEPTIDE (ANP) GENE-TRANSFER ON CULTURED VASCULAR SMOOTH-MUSCLE CELLS (VSMC) AND ENDOTHELIAL-CELL GROWTH, R MORISHITA,GH GIBBONS,RE PRATT,N TOMITA,Y KANEDA,VJ DZAU, CIRCULATION, AMER HEART ASSOC, Vol. 88, No. 4, p. 181-181, 1993/10
  • ENHANCED EFFECTIVENESS OF HVJ MEDIATED GENE-TRANSFER INTO CULTURED RAT NEONATAL CARDIAC MYOCYTES, K ELLISON,N BISHOPRIC,K WEBSTER,R MORISHITA,GH GIBBONS,Y KANEDA,B SATO,VJ DZAU, CIRCULATION, AMER HEART ASSOC, Vol. 88, No. 4, p. 139-139, 1993/10
  • LONG-TERM INHIBITION OF NEOINTIMAL HYPERPLASIA BY A SINGLE INTRALUMINAL ADMINISTRATION OF COMBINATION ANTISENSE OLIGONUCLEOTIDES, R MORISHITA,GH GIBBONS,KE ELLISON,M NAKAJIMA,LN ZHANG,Y KANEDA,T OGIHARA,VJ DZAU, CIRCULATION, AMER HEART ASSOC, Vol. 88, No. 4, p. 81-81, 1993/10
  • A VIRAL-MEDIATED ANTISENSE OLIGONUCLEOTIDE DELIVERY SYSTEM TO PREVENT RESTENOSIS, R MORISHITA,GH GIBBONS,KE ELLISON,H VONDERLEYEN,L ZHANG,Y KANEDA,VJ DZAU, CIRCULATION, AMER HEART ASSOC, Vol. 88, No. 4, p. 371-371, 1993/10
  • AUTOCRINE PARACRINE RENIN-ANGIOTENSIN AS A DETERMINANT OF VASCULAR STRUCTURE - A GENE-TRANSFER APPROACH EXPERIMENT, R MORISHITA,GH GIBBONS,KE ELLISON,LN ZHANG,Y KANEDA,T OGIHARA,VJ DZAU, HYPERTENSION, AMER HEART ASSOC, Vol. 22, No. 3, p. 423-423, 1993/09
  • NOVEL INTRALUMINAL MOLECULAR DELIVERY OF ANTISENSE CDC-2 KINASE AND CYCLIN-A OLIGONUCLEOTIDES INHIBITS NEOINTIMAL HYPERPLASIA, R MORISHITA,GH GIBBONS,KE ELLISON,M NAKAJIMA,L ZHANG,Y KANEDA,T OGIHARA,VJ DZAU, CLINICAL RESEARCH, SLACK INC, Vol. 41, No. 2, p. A211-A211, 1993/04
  • ROLE OF VASCULAR ANGIOTENSIN-CONVERTING ENZYME (ACE) AS A DETERMINANT OF VASCULAR CELL-GROWTH INVIVO - A GENE-TRANSFER EXPERIMENTAL APPROACH, R MORISHITA,GH GIBBONS,KE ELLISON,L ZHANG,Y KANEDA,T OGIHARA,VJ DZAU, CLINICAL RESEARCH, SLACK INC, Vol. 41, No. 2, p. A215-A215, 1993/04
  • DIRECT INVIVO GENE-TRANSFER BY HVJ-LIPOSOMES, Y KANEDA,N TOMITA,J HIGAKI,R MORISHITA,T OGIHARA, JOURNAL OF CELLULAR BIOCHEMISTRY, WILEY-LISS, p. 237-237, 1993/03
  • ENHANCED EFFECTIVENESS OF ANTISENSE OLIGO-NUCLEOTIDES IN VASCULAR SMOOTH-MUSCLE CELLS (VSMC) BY HVJ MEDIATED GENE-TRANSFER, R MORISHITA,GH GIBBONS,KE ELLISON,W LEE,Y KANEDA,T OGIHARA,VJ DZAU, JOURNAL OF CELLULAR BIOCHEMISTRY, WILEY-LISS, p. 239-239, 1993/03
  • INTRODUCTION OF PLASMID DNA AND NUCLEAR-PROTEIN INTO CELLS BY USING ERYTHROCYTE-GHOSTS, LIPOSOMES, AND SENDAI VIRUS, Y KANEDA,K KATO,M NAKANISHI,T UCHIDA, METHODS IN ENZYMOLOGY, ACADEMIC PRESS INC JNL-COMP SUBSCRIPTIONS, Vol. 221, p. 317-327, 1993
  • INVIVO GENE-TRANSFER INTO INTACT BLOOD-VESSELS - A NOVEL AND EFFICIENT METHOD, R MORISHITA,GH GIBBONS,LN ZHANG,Y KANEDA,T OGIHARA,VJ DZAU, CIRCULATION, AMER HEART ASSOC, Vol. 86, No. 4, p. 227-227, 1992/10
  • NOVEL GENE-TRANSFER METHOD FOR STUDY OF VASCULAR RENIN-ANGIOTENSIN SYSTEM (RAS), R MORISHITA,G GIBBONS,Y KANEDA,T OGIHARA,DZAU, V, HYPERTENSION, AMER HEART ASSOC, Vol. 20, No. 3, p. 441-441, 1992/09
  • 新しい遺伝子導入法を用いたラット肝臓におけるヒトレニン遺伝子の発現, 冨田 奈留也,桧垣 実男,三上 洋,荻原 俊男,金田 安史,深水 昭吉,村上 和雄, Japanese circulation journal, 社団法人日本循環器学会, Vol. 56, p. 139-139, 1992/03/01
  • EFFICIENT AND SELECTIVE GENE INTRODUCTION METHOD INTO GLOMERULAR CELLS OF RAT-KIDNEY, N TOMITA,Y KANEDA,R MORISHITA,J HIGAKI,K KATAHIRA,H MIKAMI,K KATO,T OGIHARA, HYPERTENSION, AMER HEART ASSOC, Vol. 18, No. 3, p. 402-402, 1991/09
  • EXPRESSION OF HEPATITIS-B VIRUS SURFACE-ANTIGEN IN ADULT-RAT LIVER - CO-INTRODUCTION OF DNA AND NUCLEAR-PROTEIN BY A SIMPLIFIED LIPOSOME METHOD, K KATO,M NAKANISHI,Y KANEDA,T UCHIDA,Y OKADA, JOURNAL OF BIOLOGICAL CHEMISTRY, AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC, Vol. 266, No. 6, p. 3361-3364, 1991/02
  • INTRODUCTION AND EXPRESSION OF THE HUMAN INSULIN GENE IN ADULT-RAT LIVER, Y KANEDA,K IWAI,T UCHIDA, JOURNAL OF BIOLOGICAL CHEMISTRY, AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC, Vol. 264, No. 21, p. 12126-12129, 1989/07
  • Increased expression of DNA cointroduced with nuclear protein in adult rat liver., Science, Vol. vol. 243, pp375-378, 1989
  • Increased expression of DNA cointroduced with nuclear protein in adult rat liver, Yasufumi Kaneda,Kunimitsu Iwai,Tsuyoshi Uchida, Science, Vol. 243, No. 4889, p. 375-378, 1989
  • THE IMPROVED EFFICIENT METHOD FOR INTRODUCING MACROMOLECULES INTO CELLS USING HVJ (SENDAI VIRUS) LIPOSOMES WITH GANGLIOSIDES, Y KANEDA,T UCHIDA,J KIM,M ISHIURA,Y OKADA, EXPERIMENTAL CELL RESEARCH, ACADEMIC PRESS INC JNL-COMP SUBSCRIPTIONS, Vol. 173, No. 1, p. 56-69, 1987/11
  • REGIONAL ASSIGNMENT OF 5 GENES ON HUMAN CHROMOSOME-19, Y KANEDA,H HAYES,T UCHIDA,MC YOSHIDA,Y OKADA, CHROMOSOMA, SPRINGER VERLAG, Vol. 95, No. 1, p. 8-12, 1987
  • MONOCLONAL-ANTIBODY AGAINST THE NUCLEUS REVEALS A PROTEIN FOUND IN CYTOPLASMIC GRANULES, THE NUCLEAR-ENVELOPE AND THE PERICHROMOSOMAL REGION, M WATAYAKANEDA,T SAKURAI,Y KANEDA,H SUGAWA,Y OKADA,T UCHIDA, CELL STRUCTURE AND FUNCTION, JAPAN SOC CELL BIOLOGY, Vol. 10, No. 4, p. 507-507, 1985/12
  • ENTRY OF DIPHTHERIA-TOXIN INTO CELLS - POSSIBLE EXISTENCE OF CELLULAR FACTOR(S) FOR ENTRY OF DIPHTHERIA-TOXIN INTO CELLS WAS STUDIED IN SOMATIC-CELL HYBRIDS AND HYBRID TOXINS, Y KANEDA,T UCHIDA,E MEKADA,M NAKANISHI,Y OKADA, JOURNAL OF CELL BIOLOGY, ROCKEFELLER UNIV PRESS, Vol. 98, No. 2, p. 466-472, 1984
  • CHROMOSOMAL ASSIGNMENT OF THE GENE FOR HUMAN ELONGATION FACTOR-II, Y KANEDA,MC YOSHIDA,K KOHNO,T UCHIDA,Y OKADA, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, NATL ACAD SCIENCES, Vol. 81, No. 10, p. 3158-3162, 1984

Industrial Property Rights

  • 骨髄間葉系および/または多能性幹細胞の血中動員による組織再生促進剤, 玉井 克人,金田 安史,山▲崎▼ 尊彦,知野 剛直,佐賀 公太郎,遠藤 真弓, 特願2017-091506, 出願日:2017/05/02
  • HVJ−EおよびCXCL2を含む抗がん剤, 金田 安史,中島 俊洋, JP2016074464, 出願日:2016/08/23
  • 損傷組織の機能的再生促進医薬, 玉井 克人,山崎 尊彦,知野 剛直,金田 安史, 特願2016-006778, 出願日:2016/01/18
  • 油性菓子生地のコンチング方法及び装置, 金田 安史,坂本 真,倉盛 宏一,大江田 浩光,河原 友春, 特願2014-195233, 出願日:2014/09/25
  • 骨髄間葉系および/または多能性幹細胞の血中動員による組織再生促進剤, 玉井 克人,金田 安史,山▲崎▼ 尊彦,知野 剛直,佐賀 公太郎,遠藤 真弓, 特願2015-197705, 出願日:2015/10/05
  • 骨髄間葉系および/または多能性幹細胞の血中動員による組織再生促進剤, 玉井 克人,金田 安史,山▲崎▼ 尊彦,知野 剛直,佐賀 公太郎,遠藤 真弓, 特許第6199936号, 特願2015-197705, 出願日:2015/10/05
  • 間葉系幹細胞の誘引剤, 北村 圭子,稲見 雄太,仲尾次 浩一,濱田 和彦,前田 明人,古元 義,金田 安史,玉井 克人, 特許第6010671号, 特願2015-179926, 出願日:2015/09/11
  • 間葉系幹細胞の誘引剤, 北村 圭子,稲見 雄太,仲尾次 浩一,濱田 和彦,前田 明人,古元 義,金田 安史,玉井 克人, 特願2015-179926, 出願日:2015/09/11
  • 末梢循環への骨髄由来多能性幹細胞動員薬, 玉井 克人,山崎 尊彦,知野 剛直,金田 安史, 特願2014-188899, 出願日:2014/09/17
  • 末梢循環への骨髄由来多能性幹細胞動員薬, 玉井 克人,山崎 尊彦,知野 剛直,金田 安史, 特許第6002727号, 特願2014-188899, 出願日:2014/09/17
  • Cancer therapy using HVJ-E combined with immune check-point inhibitor, KANEDA Yasufumi,etc, 特願2016-214198, 出願日:2016/11/01
  • 新規プリオノイド病用治療薬, 金田 安史,福島雅典,中島俊洋, 出願日:2016
  • Gene therapy using HVJ-E containing CXCL2 gene, KANEDA Yasufumi, 特願2015-164600, 出願日:2015/08/24
  • Anti-cancer reagent, KANEDA Yasufumi,etc, 特許US 7871765B2(米)4855250号(日本), 特願PCT/JP2005/006820, 出願日:2005
  • VIRUS ENVELOPE VECTOR FOR GENE TRANSFER, KANEDA Yasufumi, 特許US6913923B2, 出願日:2002/02/02
  • VIRUS ENVELOPE VECTOR FOR GENE TRANSFER, KANEDA Yasufumi, 特許第3942362号, 特願2001-26185, 出願日:2001/02/01
  • 細胞ワクチン
  • 所望の機能的性質を有する核酸の単離方法およびそのためのキット
  • 化学療法剤を封入した医薬製剤
  • HVJの融合タンパク質を有する遺伝子移入ビヒクル
  • 遺伝子導入のためのウイルスエンベロープベクター１

Works

  • 知的クラスター ”未来医療のための分子医薬創成技術”「, 2002 - 2006
  • 地域新生コンソーレアム「バイオ医薬デザイン用高精度生体高分子機能予測システムの開発」, 2003 - 2004

Awards

  • 文部科学大臣賞「産官学連携推進功労者」, 2003
  • 第3回バイオビジネスコンペ優秀賞, 2003
  • London Life Award, 1997
  • 心脈管作動物質学会賞, 1996

Social Activities

  • 遺伝子治療の新たな課題, 日本再生医療学会, リスクコミュニケーションシンポジウム, 2018/12/16 - 2018/12/16
  • 遺伝子治療の新たな課題, 日本再生医療学会, リスクコミュニケーションシンポジウム, 2018/08/05 - 2018/08/05
  • 遺伝子治療の現状と課題, 日本再生医療学会, リスクコミュニケーションシンポジウム, 2017/12/03 - 2017/12/03
  • 1. 加速する遺伝子治療製品の実用化とゲノム編集への対応, 日本再生医療学会, リスクコミュニケーションシンポジウム, 2016/07/23 - 2017/07/23
  • 遺伝子治療のリスクとベネフィット, 日本再生医療学会, リスクコミュニケーションシンポジウム, 2017/07/15 - 2017/07/15

Committee Memberships

  • -: 日本癌学会 評議員, 2009 - Present
  • Journal of Gene Medicine, Associate Editor, 2000 - Present
  • Molecular Therapy, Editorial Board, 1999 - Present
  • 日本遺伝子細胞治療学会, 理事長, 2009/07 - 2018/07
  • アメリカ遺伝子細胞治療学会, 国際委員会委員, 2012 - 2018
  • -: 日本遺伝子診療学会 理事, 2000 -